Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
.	O

Although	B
a	O
few	B
other	O-
studies	I
have	O
correlated	B
array	O
-	O
based	O
methylation	O
levels	O
with	O
repetitive	O
element	O
methylation	O
markers	O
(	O
Fryer	O
et	O
al	O
.	O

These	O
features	O
were	O
also	O
linked	B
to	O
an	O
impairment	O
of	O
the	O
browning	O
process	O
of	O
the	O
white	O
adipose	O
tissue	O
(	O
Geurts	O
et	O
al	O
.,	O
2015	O
).	O

The	O
only	B
significant	O
predictor	B
found	B
was	O
group	O
affiliation	O
(	O
p	O
<	O
0	O
.	O
001	O
;	O
Otable	O
2	O
).	O

Influenza	O
vaccination	O
was	O
self	B
-	I
reported	I
;	O
however	O
,	O
interviewers	O
validated	O
this	O
information	O
using	O
vaccination	O
cards	O
and	O
/	O
or	O
antenatal	O
medical	O
records	O
if	B
available	I
.	O

Recurrent	O
PTB	O
rates	O
for	O
this	O
subgroup	O
were	O
42	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
mL	O
(	O
N	O
=	O
57	O
),	O
24	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
20	O
to	O
<	O
30	O
ng	O
/	O
mL	O
(	O
N	O
=	O
34	O
),	O
24	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
30	O
to	O
<	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
25	O
)	O
and	O
13	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
≥	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
24	O
).	O

Also	O
,	O
intervention	O
exposure	O
,	O
as	B
measured	O
by	O
estimated	B
number	O
of	O
antepartum	O
messages	O
delivered	O
and	O
number	O
of	O
antepartum	O
days	O
enrolled	O
in	O
the	O
messaging	O
campaign	O
,	O
were	O
assessed	O
for	O
all	O
study	O
participants	O
in	O
the	O
intervention	O
group	O
.	O

Introduction	O
In	O
2013	O
,	O
an	O
estimated	B
2	O
.	O
8	O
million	O
deaths	O
occurred	O
in	O
the	O
neonatal	O
period	O
globally	B
[	O
1	O
].	O

Our	O
aim	B
was	O
to	B
assess	I
whether	B
oral	O
supplementation	O
of	O
vitamin	O
D3	O
(	O
cholecalciferol	O
)	O
will	B
reduce	O
the	O
incidence	O
and	O
severity	O
of	O
pneumonia	O
in	O
a	O
high	O
-	O
risk	O
infant	O
population	O
.	O

Bos	O
taurus	O
cattle	O
generally	O
have	O
higher	O
marbling	O
and	O
better	O
tenderness	O
than	O
do	O
Bos	O
indicus	O
animals	O
[	O
1	O
,	O
37	O
].	O

While	O
ensuring	O
a	O
95	O
%	O
coverage	O
rate	O
is	O
ideal	B
and	O
would	B
result	O
in	O
a	O
major	B
mortality	O
reduction	O
,	O
this	O
process	O
will	B
take	O
time	O
.	O

Consequences	O
in	O
newborns	O
are	O
low	O
birth	O
weight	O
,	O
neonatal	O
rickets	O
,	O
a	O
risk	O
of	O
neonatal	O
hypocalcaemia	O
,	O
asthma	O
and	O
/	O
or	O
type	O
1	O
diabetes	O
.	O

†	O
t	O
-	O
test	O
,	O
*	O
chi	O
-	O
square	O
.	O

Neonatal	O
oxygen	O
deprivation	O
can	B
be	O
quantified	O
by	O
several	O
measurements	O
,	O
including	O
low	O
Apgar	O
score	O
,	O
fetal	O
distress	O
,	O
caesarian	O
delivery	O
,	O
threatened	O
abortion	O
,	O
and	O
hemorrhage	O
during	O
pregnancy	O
[	O
68	O
].	O

The	O
investigators	O
found	B
signs	O
of	O
kidney	O
damage	O
that	O
increased	O
with	O
higher	O
daily	O
intake	O
of	O
uranium	O
in	O
the	O
drinking	O
water	O
.	O
27	O
Uranium	O
appears	B
to	O
exert	O
its	O
chemical	O
effects	B
on	O
the	O
kidney	O
’	O
s	O
proximal	O
tubules	O
.	O
28Arsenic	O
and	O
cadmium	O
—	O
which	O
,	O
along	O
with	O
other	B
potentially	B
hazardous	O
metals	O
,	O
are	O
sometimes	B
found	B
in	O
uranium	O
tailings29	O
—	O
create	O
similar	B
signatures	O
of	O
metal	O
damage	O
in	O
the	O
kidneys	O
.	O
30	O
Lewis	O
’	O
s	O
early	O
data	O
from	O
the	O
DiNEH	O
Project	O
suggest	B
that	O
self	O
-	O
reported	O
kidney	O
disease	O
,	O
hypertension	O
,	O
and	O
autoimmune	O
diseases	O
were	O
more	O
prevalent	O
among	O
people	O
who	O
lived	O
closer	O
to	O
mine	O
waste	O
sites	O
.	O
31Her	O
colleague	O
at	O
the	O
University	O
of	O
New	O
Mexico	O
,	O
immunologist	O
Ester	O
Erdei	O
,	O
believes	B
the	O
increase	O
in	O
hypertension	O
and	O
autoimmune	O
diseases	O
might	B
be	O
connected	B
to	O
consumption	O
of	O
contaminated	O
water	O
.	O

In	O
unadjusted	O
analysis	O
,	O
T1	O
25OHD	O
was	O
associated	B
with	O
IUFD	O
and	O
women	O
with	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
at	O
T1	O
had	O
more	O
than	O
fourfold	O
higher	O
odds	O
of	O
IUFD	O
(	O
OR	O
=	O
4	O
.	O
52	O
,	O
p	O
=	O
0	O
.	O
034	O
).	O

Herb	O
users	O
were	O
more	O
likely	O
to	O
make	O
a	O
dietary	O
change	O
during	O
pregnancy	O
.	O

Therefore	O
,	O
the	O
up	O
-	O
regulation	O
of	O
'	O
AMPK	O
signaling	O
'	O
in	O
developmental	O
periods	O
I	O
,	O
II	O
and	O
III	O
in	O
AP	O
offspring	O
accounts	O
for	O
metabolic	O
health	O
in	O
AP	O
offspring	O
,	O
but	O
not	O
in	O
LP	O
offspring	O
.	O

Further	B
study	I
is	B
warranted	I
to	O
clarify	O
how	B
stress	O
intensity	O
affects	B
animal	O
performance	O
and	O
fat	O
deposition	O
.	O

Also	O
,	O
few	O
maternal	O
psychosocial	O
predictors	O
of	O
offspring	O
weight	O
status	O
were	O
observed	O
within	O
both	O
overweight	O
/	O
obese	O
and	O
normal	O
weight	O
mothers	O
.	O

75	O
%	O
of	O
black	O
and	O
19	O
%	O
of	O
white	O
women	O
were	O
vitamin	O
D	O
deficient	O
in	O
the	O
first	O
trimester	O
.	O

However	B
,	O
we	O
confirmed	B
our	O
second	O
hypothesis	B
that	O
there	O
was	O
a	O
dose	O
-	O
response	O
effect	B
of	O
text4baby	O
,	O
with	O
higher	O
levels	O
of	O
text	O
message	O
exposure	O
predicting	B
lower	O
self	B
-	I
reported	I
alcohol	O
consumption	O
.	O

We	O
identified	B
additive	O
and	O
modifiable	O
maternal	O
risk	B
factors	I
that	O
would	B
benefit	B
most	B
from	O
risk	O
reduction	O
and	O
targeted	O
vitamin	O
D	O
supplementation	O
.	O

Objectives	B
:	O
We	O
examined	B
associations	B
between	O
in	O
utero	O
exposures	O
,	O
infant	O
growth	O
,	O
and	O
methylation	O
of	O
repetitive	O
elements	O
and	O
gene	O
-	O
associated	O
DNA	O
in	O
human	O
term	O
placenta	O
tissue	O
samples	O
.	O

Another	O
factor	O
possibly	B
associated	B
with	O
pet	O
ownership	O
is	O
increased	O
Vitamin	O
D	O
among	O
family	O
members	O
as	O
pet	O
keeping	O
may	B
be	I
correlated	B
with	O
lifestyles	O
involving	O
increased	O
outdoor	O
exposure	O
,	O
such	O
as	O
dog	O
walking	O
.	O

However	B
,	O
a	O
clinical	O
study	O
that	O
included	O
280	O
pregnant	O
women	O
did	B
not	I
demonstrate	B
correlations	B
between	O
concentrations	O
of	O
VD	O
and	O
PE	O
[	O
59	O
],	O
probably	B
due	B
to	I
its	O
multi	O
-	O
causal	O
etiology	O
.	O

After	O
adjusting	O
for	O
the	O
total	O
number	O
of	O
prenatal	O
visits	O
,	O
we	O
noted	B
independent	O
effects	B
of	O
area	O
of	O
residence	O
and	O
level	O
of	O
education	O
on	O
the	O
use	O
of	O
supplements	O
:	O
women	O
from	O
urban	O
areas	O
and	O
those	O
with	O
more	O
than	O
9	O
years	O
of	O
formal	O
education	O
were	O
more	O
likely	B
to	O
have	O
used	O
folic	O
acid	O
(	O
urban	O
area	O
:	O
aOR	O
,	O
1	O
.	O
5	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
2	O
-	O
1	O
.	O
5	O
;	O
9	O
–	O
12	O
years	O
of	O
education	O
:	O
aOR	O
,	O
4	O
.	O
8	O
;	O
95	O
%	O
CI	O
,	O
2	O
.	O
3	O
-	O
10	O
.	O
0	O
;	O
>	O
12	O
years	O
of	O
school	O
:	O
aOR	O
,	O
8	O
.	O
1	O
;	O
95	O
%	O
CI	O
,	O
3	O
.	O
7	O
-	O
18	O
.	O
0	O
)	O
and	O
multivitamin	O
supplements	O
(	O
urban	O
area	O
:	O
aOR	O
,	O
1	O
.	O
7	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
0	O
-	O
2	O
.	O
7	O
;	O
>	O
12	O
years	O
of	O
school	O
:	O
aOR	O
,	O
3	O
.	O
5	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
7	O
-	O
7	O
.	O
4	O
)	O
(	O
Table	O
5	O
).	O

We	O
examined	B
several	O
additional	O
models	O
with	O
various	O
cutpoints	O
for	O
25	O
(	O
OH	O
)	O
D	O
based	B
on	I
clinical	O
guidelines	B
and	O
previous	B
literature	O
,	O
while	O
adjusting	O
for	O
maternal	O
PIH	O
and	O
maternal	O
BMI	O
at	O
delivery	O
.	O

Possible	O
responses	O
included	O
Yes	O
,	O
Sometimes	O
,	O
or	O
No	O
,	O
with	O
a	O
score	O
in	O
any	O
one	O
domain	O
>	O
2SD	O
below	O
the	O
mean	O
considered	O
indicative	O
of	O
the	O
need	O
for	O
further	O
assessment	O
and	O
when	O
identified	O
,	O
the	O
primary	O
caregiver	O
was	O
advised	O
to	O
seek	O
additional	O
medical	O
advice	O
.	O

Increases	O
in	O
stress	O
were	O
related	B
to	O
lower	O
offspring	O
weight	O
status	O
in	O
normal	O
weight	O
mothers	O
(	O
adjusted	O
analyses	O
)	O
and	O
overweight	O
/	O
obese	O
mothers	O
(	O
unadjusted	O
analyses	O
),	O
which	O
is	O
consistent	B
with	O
earlier	O
research	O
on	O
stress	O
in	O
relation	B
to	O
inadequate	O
GWG	O
[	O
45	O
]	O
and	O
long	O
-	O
term	O
offspring	O
health	O
[	O
46	O
].	O

(	O
2015	O
).	O

Between	O
-	O
group	O
comparisons	O
were	O
made	O
using	O
t	O
or	O
Wilcoxon	O
tests	O
,	O
and	O
within	O
-	O
group	O
comparisons	O
were	O
made	O
using	O
paired	O
t	O
-	O
test	O
or	O
Mann	O
-	O
Whitney	O
U	O
-	O
tests	O
.	O

Results	O
Descriptive	O
analysis	O
From	O
July	O
21st	O
through	O
December	O
4th	O
2014	O
,	O
we	O
interviewed	O
and	O
collected	O
surveys	O
on	O
4808	O
post	O
-	O
partum	O
women	O
.	O

Results	O
are	O
shown	O
as	O
means	O
or	O
adjusted	O
means	O
with	O
SD	O
or	O
SEM	O
.	O

Specifically	O
,	O
Bonferroni	O
analysis	O
indicated	B
that	O
RC	O
males	O
also	O
displayed	O
higher	O
body	O
weight	O
than	O
CC	O
males	O
in	O
several	O
weeks	O
of	O
the	O
post	O
-	O
weaning	O
period	O
that	O
comprise	O
the	O
adulthood	O
(	O
postnatal	O
weeks	O
15	O
–	O
18	O
and	O
postnatal	O
week	O
19	O
).	O

trials	O
[	O
12	O
]	O
and	O
the	O
Bodnar	O
et	O
al	O
.	O

Therefore	B
,	O
there	O
is	O
an	O
urgent	B
need	B
of	O
randomised	O
controlled	O
trials	O
of	O
vitamin	O
D	O
supplementation	O
to	O
investigate	O
the	O
maternal	O
and	O
neonatal	O
health	O
benefits	O
of	O
correcting	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
[	O
24	O
].	O

Even	B
so	I
,	O
this	B
study	I
will	B
provide	O
a	O
comprehensive	O
and	O
unique	B
database	O
from	O
an	O
urban	O
South	O
African	O
setting	O
which	O
will	B
allow	O
for	O
cross	O
-	O
sectional	O
,	O
prospective	O
and	O
retrospective	O
analyses	O
to	O
describe	O
the	O
nutritional	O
status	O
and	O
dietary	O
intake	O
of	O
pregnant	O
women	O
,	O
and	O
to	B
determine	I
associations	B
with	O
health	O
outcome	O
measures	O
.	O

As	O
part	O
of	O
the	O
FFQ	O
,	O
the	O
participants	O
reported	O
how	O
often	O
,	O
on	O
average	O
,	O
they	O
ate	O
salmon	O
-	O
type	O
fish	O
(	O
Baltic	O
herring	O
,	O
herring	O
,	O
or	O
mackerel	O
),	O
white	O
fish	O
(	O
cod	O
,	O
saithe	O
,	O
or	O
pike	O
),	O
caviar	O
,	O
or	O
shellfish	O
(	O
e	O
.	O
g	O
.,	O
shrimp	O
):	O
never	O
-	O
seldom	O
,	O
1	O
-	O
3	O
times	O
/	O
month	O
,	O
1	O
time	O
/	O
week	O
,	O
2	O
times	O
/	O
week	O
,	O
3	O
-	O
4	O
times	O
/	O
week	O
,	O
5	O
-	O
6	O
times	O
/	O
week	O
,	O
1	O
time	O
/	O
day	O
,	O
2	O
times	O
/	O
day	O
or	O
3	O
times	O
/	O
day	O
.	O

Data	O
from	O
the	O
feeding	O
response	O
to	O
AM251	O
were	O
analyzed	O
by	O
two	O
-	O
way	O
ANOVA	O
with	O
treatment	O
and	O
diet	O
as	O
factors	O
.	O

The	O
authors	O
suggested	B
that	O
a	O
combination	O
of	O
seasonal	O
changes	O
to	O
an	O
individuals	O
’	O
physical	O
activity	O
,	O
diet	O
,	O
sunlight	O
exposure	O
,	O
weather	O
pattern	O
,	O
psychological	O
variables	O
,	O
and	O
weight	O
changes	O
may	B
be	I
contributing	O
factors	B
[	O
23	O
].	O

The	O
odds	O
ratios	O
of	O
MS	O
among	O
individuals	O
who	O
reported	O
spending	O
at	O
least	O
2	O
hours	O
per	O
day	O
in	O
the	O
sun	O
during	O
holidays	O
and	O
at	O
weekends	O
at	O
ages	O
6	O
-	O
10	O
years	O
were	O
0	O
.	O
47	O
(	O
95	O
%	O
CI	O
0	O
.	O
26	O
-	O
0	O
.	O
84	O
)	O
for	O
winter	O
and	O
0	O
.	O
50	O
(	O
0	O
.	O
24	O
-	O
1	O
.	O
02	O
)	O
for	O
exposure	O
;	O
inverse	O
but	B
weaker	O
associations	B
were	O
observed	B
with	O
sun	O
exposure	O
at	O
older	O
ages	O
.	O

3	O
.	O
6	O
.	O

Conclusion	O
The	O
obesogenic	O
phenotype	O
in	O
offspring	O
from	O
HV	O
fed	O
dams	O
is	O
prevented	O
by	O
feeding	O
HV	O
or	O
HFol	O
pup	O
diets	O
,	O
possibly	B
due	B
to	I
post	O
-	O
weaning	O
modulation	O
of	O
food	O
intake	O
regulatory	O
mechanisms	O
.	O

Some	B
members	O
of	O
the	O
BMP	O
family	O
were	O
shown	O
to	O
play	O
a	O
role	B
in	O
energy	O
homeostasis	O
and	O
the	O
early	O
steps	O
of	O
adipogenesis	O
,	O
in	O
particular	O
.	O

2011	O
).	O

Vaginal	O
smears	O
were	O
initially	O
evaluated	O
under	O
wet	O
conditions	O
where	O
the	O
sample	O
was	O
placed	O
on	O
a	O
glass	O
microscope	O
slide	O
and	O
examined	O
under	O
a	O
light	O
microscope	O
at	O
20	O
–	O
40	O
×	O
magnification	O
.	O

The	O
validity	O
and	O
reliability	O
of	O
FFQ	O
had	O
been	O
previously	O
evaluated	O
[	O
20	O
].	O

In	O
our	B
study	I
,	O
an	O
approximate	B
4	O
-	O
fold	O
change	O
in	O
the	O
GR	O
α	O
/	O
GR	O
-	O
P	O
in	O
preterm	O
labor	O
was	O
detected	B
.	O

Concerning	O
the	O
potential	B
explanations	B
of	O
the	O
differential	B
phenotypic	O
features	O
between	O
males	O
and	O
females	O
,	O
the	O
leptin	O
sensibility	O
can	B
play	O
an	O
important	B
role	B
.	O

Acute	O
aortic	O
dissection	O
during	O
the	O
third	O
trimester	O
of	O
pregnancy	O
has	B
been	I
attributed	B
to	O
hemodynamic	O
alterations	O
that	O
occur	O
in	O
late	O
pregnancy	O
.	O

Voxiva	O
collected	O
data	O
on	O
all	O
text4baby	O
participants	O
through	O
enrollment	O
and	O
follow	O
-	O
up	O
service	O
contacts	O
[	O
36	O
].	O

A	O
recent	B
study	I
published	O
in	O
The	O
Lancet	O
examined	B
preterm	O
birth	O
prevention	O
potential	O
in	O
39	O
high	O
-	O
income	O
countries	O
and	O
estimated	B
that	O
if	B
five	O
interventions	B
reached	O
high	O
coverage	O
there	O
would	B
only	B
be	O
a	O
5	O
%	O
relative	O
reduction	O
of	O
preterm	O
birth	O
rate	O
from	O
9	O
·	O
59	O
%	O
to	O
9	O
·	O
07	O
%	O
of	O
livebirths	O
by	O
2015	O
,	O
averting	O
an	O
estimated	B
58	O
,	O
000	O
preterm	O
births	O
and	O
saving	O
US	O
$	O
3	O
billion	O
annually	O
[	O
11	O
].	O

Yet	B
,	O
our	O
main	O
results	O
were	O
repeated	B
in	O
a	O
subgroup	O
analysis	O
of	O
only	B
those	O
women	O
to	O
whom	O
an	O
OGTT	O
was	O
performed	O
.	O

Adapted	O
from	O
Lawn	O
et	O
al	O
.,	O
2008	O
;	O
Rubens	O
et	O
al	O
.,	O
2010	O
.	O

Finally	O
,	O
PFAS	O
affect	B
adipose	O
tissue	O
development	O
and	O
the	O
regulatory	O
systems	O
involved	B
in	O
body	O
weight	O
homeostasis	O
,	O
which	O
may	B
impact	B
fetal	O
growth	O
outcomes	O
[	O
20	O
],	O
including	O
those	O
that	O
occur	O
after	O
birth	O
such	O
as	O
infant	O
mortality	O
or	O
cardiovascular	O
disease	O
which	O
are	O
beyond	O
the	O
scope	O
of	O
this	O
study	O
[	O
16	O
,	O
17	O
].	O

*	O
Note	O
that	O
Control	O
offspring	O
inFigure	O
3andFigure	O
4are	O
the	O
same	O
animals	O
.	O

The	O
results	O
from	O
infant	O
gut	O
microbiome	O
cluster	O
analyses	O
are	O
consistent	B
with	O
this	O
observation	O
.	O

In	O
humans	O
,	O
low	O
protein	O
intake	O
by	O
women	O
in	O
late	O
pregnancy	O
has	O
been	O
associated	B
with	O
low	O
birth	O
weight	O
,	O
a	O
marker	B
of	O
risk	B
for	O
obesity	O
and	O
other	O
metabolic	O
disorders	O
later	O
in	O
life	O
(	O
14	O
).	O

Ethics	O
statement	O
The	O
Institutional	O
Review	O
Board	O
at	O
the	O
Nicaraguan	O
Ministry	O
of	O
Health	O
reviewed	O
and	O
approved	O
the	O
protocol	O
.	O

One	O
participant	O
assigned	O
to	O
the	O
intervention	O
arm	O
and	O
two	O
in	O
the	O
control	O
arm	O
were	O
later	O
found	O
to	O
be	O
ineligible	O
because	O
another	O
woman	O
residing	O
in	O
the	O
same	O
household	O
compound	O
had	O
previously	O
been	O
enrolled	O
in	O
the	O
study	O
;	O
data	O
collection	O
was	O
discontinued	O
upon	O
identification	O
of	O
the	O
ineligibility	O
criteria	O
.	O

Conclusions	O
Studies	B
of	O
text4baby	O
have	O
helped	O
to	O
build	O
the	O
mHealth	O
evidence	B
base	I
.	O

The	O
median	O
was	O
used	O
as	O
the	O
measure	O
of	O
central	O
tendency	O
.	O

Anthropometry	O
and	O
blood	O
samples	O
were	O
collected	O
from	O
participants	O
during	O
village	O
visits	O
Sample	O
size	O
Mean	O
recruitment	O
haemoglobin	O
for	O
the	O
PMMST	O
study	O
was	O
11	O
.	O
7	O
g	O
/	O
dL	O
,	O
(	O
SD	O
1	O
.	O
5	O
g	O
/	O
dL	O
)	O
for	O
a	O
population	O
of	O
1156	O
.	O

These	O
approaches	O
,	O
however	B
,	O
assign	O
equal	O
weight	O
and	O
importance	O
to	O
all	O
chemicals	O
,	O
irrespective	O
of	O
their	O
predictive	O
value	O
.	O

Activation	O
of	O
the	O
RAS	O
may	B
play	O
a	O
significant	O
role	B
in	O
the	O
development	O
of	O
mechanisms	O
that	O
lead	B
to	I
kidney	O
damage	O
[	O
33	O
].	O

To	O
ensure	O
a	O
high	O
standard	O
of	O
analysis	O
for	O
serum	O
25OHD	O
concentrations	O
,	O
the	O
laboratory	O
participates	O
in	O
an	O
external	O
quality	O
assurance	O
scheme	O
;	O
Vitamin	O
D	O
External	O
Quality	O
Assessment	O
Scheme	O
(	O
DEQAS	O
).	O

This	O
increase	O
in	O
C	O
-	O
reactive	O
protein	O
has	B
been	I
found	I
to	O
have	O
a	O
correlation	B
with	O
a	O
risk	O
for	O
autism	O
spectrum	O
disorders	O
[	O
29	O
].	O

Measures	O
of	O
cardiorespiratory	O
fitness	O
however	B
,	O
improved	O
.	O

However	B
,	O
according	B
to	I
literature	B
data	I
and	O
our	B
own	I
experience	I
pregnancy	O
after	O
thyroid	O
cancer	O
has	B
been	I
shown	I
to	O
have	O
no	O
significant	O
effect	O
on	O
morbidity	O
,	O
disease	O
-	O
free	O
period	O
or	O
survival	O
time	O
.	O

UVB	O
intensity	O
is	O
a	O
positive	O
predictor	B
of	O
live	O
birth	O
following	O
fresh	O
ET	O
,	O
whereas	B
altitude	O
and	O
annualized	O
average	O
regional	O
temperature	O
have	O
an	O
inverse	O
relationship	B
with	O
live	O
birth	O
ratio	O
following	O
fresh	O
ET	O
[	O
63	O
].	O

Women	O
exposed	O
in	O
utero	O
to	O
the	O
estrogen	O
-	O
like	O
compound	O
DES	O
show	O
a	O
higher	O
prevalence	O
for	O
left	O
handedness	O
[	O
195	O
,	O
196	O
].	O

As	O
well	O
as	O
being	O
a	O
source	O
of	O
essential	B
nutrients	O
,	O
fish	O
are	O
also	O
a	O
potential	B
source	O
of	O
contaminants	O
including	O
mercury	O
,	O
polychlorinated	O
biphenyls	O
and	O
dioxins	O
[	O
9	O
].	O

While	B
SGAs	O
readily	O
cross	O
the	O
placenta	O
,	O
14the	O
existing	O
studies	B
that	O
have	O
investigated	O
the	O
reproductive	O
safety	B
of	O
these	O
agents	O
did	O
not	B
reach	O-
conclusive	I
results	O
due	B
to	I
the	O
methodological	O
limitations	B
,	O
small	B
sample	O
sizes	O
and	O
failure	B
to	O
assess	O
SGAs	O
in	O
monotherapy	O
.	O

This	O
is	O
carried	O
out	O
at	O
each	O
age	O
point	O
of	O
the	O
index	O
child	O
—	O
at	O
birth	O
and	O
at	O
ages	O
5	O
and	O
9	O
.	O

Weak	O
Infrastructure	O
and	O
Political	O
Commitment	O
The	O
efforts	O
of	O
World	O
Food	O
Programme	O
(	O
WFP	O
)	O
in	O
overcoming	O
micronutrient	O
deficiencies	O
in	O
nutritionally	O
-	O
vulnerable	O
groups	O
and	O
low	O
-	O
income	O
food	O
-	O
deficit	O
countries	O
continue	O
to	O
be	O
thwarted	B
by	O
challenges	B
such	O
as	O
technical	O
and	O
managerial	O
capacity	O
constraints	O
,	O
the	B
need	I
for	O
systematic	O
compliance	O
with	O
procurement	O
specifications	O
and	O
quality	O
control	O
,	O
clearer	O
policies	O
on	O
micronutrient	O
content	O
labeling	O
,	O
and	O
the	B
need	I
for	O
cash	O
resources	O
to	O
support	O
many	O
aspects	O
associated	O
with	O
local	O
processing	O
and	O
fortification	O
activities	O
[	O
57	O
].	O

Untraced	O
women	O
were	O
more	O
likely	B
to	O
be	O
nulliparous	O
,	O
to	O
have	O
lower	O
mean	O
anthropometric	O
indices	O
and	O
were	O
more	O
likely	B
to	O
have	O
received	O
formal	O
schooling	O
.	O

Results	O
.	O

Discussion	O
The	O
etiology	O
of	O
autism	O
is	O
unknown	B
,	O
although	B
perinatal	O
and	O
neonatal	O
exposures	O
have	B
been	I
the	O
focus	B
of	O
recent	B
epidemiologic	O-
research	I
[	O
57	O
].	O

Reactive	O
oxygen	O
species	O
are	O
also	O
proposed	B
to	O
stimulate	O
the	O
production	O
of	O
alpha	O
-	O
ketoglutarate	O
,	O
a	O
co	O
-	O
substrate	O
for	O
TETs	O
and	O
one	O
of	O
the	O
two	O
main	O
classes	O
of	O
histone	O
demethylases	O
(	O
Chervona	O
&	O
Costa2012	O
;	O
Ruiz	O
-	O
Hernandez	O
et	O
al	O
.	O
2015	O
).	O

Chailurkit	O
et	O
al	O
.	O

Vitamin	O
D	O
should	B
be	I
considered	B
in	O
studies	O
of	O
pets	O
and	O
atopic	O
conditions	O
.	O

Those	O
who	O
were	O
never	O
breastfed	O
and	O
only	O
received	O
formula	O
were	O
considered	O
exclusively	O
formula	O
-	O
fed	O
.	O

Adaptive	O
versus	O
adverse	O
epigenetic	O
change	O
Epigenetic	O
change	O
offers	O
a	O
much	O
more	O
versatile	O
,	O
reversible	O
and	O
rapid	O
way	O
for	O
adapting	O
to	O
changes	O
in	O
our	O
environment	O
compared	O
with	O
genetic	O
mutation	O
.	O

Several	O
risk	O
factors	B
during	O
the	O
pregnancy	O
and	O
labor	O
periods	O
have	B
been	I
associated	B
with	O
autism	O
;	O
yet	B
further	B
studies	B
with	O
large	O
populations	O
are	I
needed	I
to	O
establish	O
definitive	O
associations	B
.	O

On	B
the	I
other	I
hand	I
,	O
multiple	O
regression	O
analysis	O
revealed	B
a	O
significant	O
interaction	B
of	O
the	O
three	O
independent	O
variables	O
birth	O
weight	O
,	O
age	O
and	O
BMI	O
in	O
predicting	B
PNN50	O
(	O
Table	O
2	O
).	O

Boys	O
were	O
correlated	B
with	O
mothers	O
but	O
not	O
fathers	O
(	O
table	O
4	O
).	O

The	O
outcome	O
in	O
each	O
model	O
was	O
the	O
infant	O
gut	O
microbiome	O
cluster	O
membership	O
;	O
cluster	O
1	O
was	O
used	O
as	O
the	O
reference	O
in	O
all	O
models	O
.	O

The	O
latter	O
is	O
possibly	B
due	B
to	I
the	O
fact	O
that	O
women	O
using	O
sunscreen	O
lotion	O
are	O
more	O
often	O
exposed	O
to	O
the	O
sun	O
.	O

Therefore	O
,	O
pregnancy	O
in	O
thyroid	O
cancer	O
patients	O
is	O
not	O
unusual	O
,	O
and	O
about	O
10	O
%	O
of	O
thyroid	O
cancers	O
occurring	O
during	O
reproductive	O
years	O
are	O
diagnosed	O
during	O
pregnancy	O
or	O
in	O
the	O
early	O
post	O
-	O
partum	O
period	O
.	O

Surgeon	O
General	O
has	O
also	O
participated	O
in	O
media	O
outreach	O
to	O
publicise	O
the	O
Report	O
Cards	O
and	O
their	O
recommended	O
actions	O
.	O

Bailey	O
et	O
al	O
had	O
discovered	B
that	O
,	O
after	O
transplacental	O
circulation	O
,	O
the	O
concentration	O
of	O
C3	O
-	O
epi	O
-	O
25	O
(	O
OH	O
)	O
D	O
was	O
significant	O
higher	O
in	O
infants	O
than	O
mother	O
[	O
44	O
].	O

MHF	O
–	O
dams	O
fed	O
a	O
high	O
fat	O
diet	O
pre	O
-	O
conceptionally	O
and	O
throughout	O
pregnancy	O
and	O
lactation	O
;	O
PLHF	O
–	O
dams	O
fed	O
a	O
chow	O
diet	O
pre	O
-	O
conceptionally	O
and	O
a	O
high	O
fat	O
diet	O
through	O
pregnancy	O
and	O
lactation	O
only	O
.	O

Approximately	B
25	O
-	O
30	O
g	O
of	O
calcium	O
are	O
transferred	O
to	O
the	O
fetal	O
skeleton	O
by	O
the	O
end	O
of	O
pregnancy	O
,	O
most	O
of	O
which	O
is	O
transferred	O
during	O
the	O
last	O
trimester	O
.	O

Thus	B
,	O
identifying	O
optimal	B
mHealth	O
dosages	O
could	B
have	O
potential	B
major	B
benefits	B
for	O
future	B
programs	O
in	O
terms	O
of	O
cost	O
effectiveness	B
and	O
outcomes	O
.	O

In	O
juvenile	O
piglets	O
(	O
stage	O
28	O
dpn	O
)	O
483	O
probe	O
-	O
sets	O
differed	O
between	O
LP	O
and	O
AP	O
offspring	O
.	O

Thus	B
,	O
it	O
is	O
unclear	B
whether	B
exposure	O-
to	O-
SGAs	O-
may	B
cause	O-
fetal	O-
-	O-
weight	O-
gain	O-
directly	O-
or	I
indirectly	O
by	O
inducing	O
maternal	O
weight	O
gain	O
prior	O
to	O
conception	O
.	O

The	O
Animal	O
Use	O
Protocol	O
was	O
approved	O
by	O
the	O
McGill	O
University	O
Animal	O
Care	O
Committee	O
.	O

According	O
to	O
the	O
Lambda	O
test	O
,	O
this	O
correlation	B
was	O
significantly	O
greater	O
in	O
group	O
A	O
than	O
in	O
group	O
B	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

The	O
Korean	O
Feeding	O
Standard	O
for	O
Hanwoo	O
[	O
160	O
]	O
describes	O
how	O
to	O
feed	O
Korean	O
cattle	O
at	O
each	O
stage	O
(	O
growth	O
,	O
early	O
fattening	O
,	O
and	O
late	O
fattening	O
stages	O
).	O

It	O
was	O
translated	O
to	O
Persian	O
and	O
was	O
used	O
in	O
the	O
study	O
by	O
Mazhari	O
and	O
Nakhaee	O
,	O
with	O
a	O
validity	O
and	O
reliability	O
of	O
0	O
.	O
76	O
and	O
0	O
.	O
83	O
,	O
respectively	O
[	O
42	O
].	O

Authors	O
state	B
that	O
the	O
proliferation	O
of	O
spermatogenic	O
cells	O
was	O
decreased	O
with	O
calcium	O
-	O
dependent	O
down	O
regulation	B
of	O
cyclin	O
E	O
and	O
CDK2	O
,	O
and	O
up	O
regulation	B
of	O
p53	O
and	O
p21	O
expression	O
,	O
which	O
is	O
not	O
a	O
direct	O
effect	B
of	O
active	O
vitamin	O
D	O
deficiency	O
.	O

[	O
32	O
],	O
the	O
proportion	O
of	O
women	O
taking	O
folic	O
acid	O
varies	B
between	O
0	O
.	O
9	O
%	O
and	O
49	O
%	O
before	O
conception	O
and	O
between	O
0	O
.	O
5	O
%	O
and	O
52	O
%	O
in	O
the	O
peri	O
-	O
conception	O
period	O
.	O

After	O
adjusting	O
for	O
socio	O
-	O
demographic	O
factors	B
,	O
more	O
than	O
four	O
prenatal	O
visits	O
and	O
level	O
of	O
nutritional	O
knowledge	O
remained	B
associated	B
with	O
iron	O
supplementation	O
.	O

In	O
addition	O
,	O
studies	O
within	O
categories	O
1	O
and	O
2	O
may	B
also	O
enable	O
the	O
identification	O
of	O
markers	O
and	O
/	O
or	O
mechanisms	O
of	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
through	O
a	O
weight	O
of	O
evidence	B
approach	O
(	O
e	O
.	O
g	O
.	O

Japanese	O
Black	O
cattle	O
breed	O
has	O
the	O
highest	O
IMF	O
content	O
in	O
the	O
world	O
,	O
and	O
Korean	O
cattle	O
(	O
also	O
called	O
Hanwoo	O
)	O
the	O
second	O
highest	O
.	O

The	O
MS	O
generally	B
increases	O
with	O
slaughter	O
age	O
in	O
Korean	O
cattle	O
.	O

In	O
a	O
sensitivity	O
analysis	O
,	O
the	O
effect	B
of	O
maternal	O
fruit	O
consumption	O
on	O
the	O
infant	O
gut	O
microbiome	O
in	O
babies	O
born	O
vaginally	O
persisted	O
when	O
restricted	O
to	O
infants	O
who	O
were	O
exclusively	O
breastfed	O
(	O
generalized	O
UniFrac	O
distance	O
PERMANOVA	O
,	O
p	O
=	O
0	O
.	O
022	O
;	O
Table	O
2	O
)	O
.	O

The	O
physiological	O
response	O
to	O
sunlight	O
exposure	O
,	O
beyond	O
that	O
of	O
vitamin	O
D	O
production	O
,	O
includes	O
regulation	O
of	O
biological	O
circadian	O
and	O
circannual	O
rhythms	O
,	O
control	O
of	O
circulating	O
melatonin	O
,	O
as	O
well	O
as	O
production	O
of	O
nitric	O
oxide	O
,	O
a	O
vasodilator	O
,	O
and	O
beta	O
-	O
endorphins	O
which	O
promote	O
a	O
feeling	O
of	O
well	O
-	O
being	O
[	O
11	O
–	O
13	O
].	O

Stratified	O
random	O
sampling	O
was	O
performed	O
in	O
this	O
study	O
.	O

Results	O
Approximately	O
5	O
.	O
3	O
%	O
of	O
the	O
study	O
cohort	O
developed	O
gestational	O
diabetes	O
mellitus	O
(	O
68	O
of	O
1	O
,	O
290	O
).	O

Exposure	O
to	O
Tobacco	O
Smoke	O
One	O
of	O
the	O
most	O
frequently	B
discussed	I
risk	O
factors	O
for	O
induction	O
of	O
sensitization	O
in	O
all	O
populations	O
and	O
age	O
groups	O
is	O
tobacco	O
smoke	O
(	O
active	O
smoking	O
or	O
the	O
passive	O
environmental	O
exposure	O
).	O

Environmental	O
Risk	O
Factors	O
for	O
Atopy	O
The	O
causes	O
of	O
allergy	O
in	O
general	O
and	O
of	O
specific	O
sensitization	O
in	O
newborns	O
in	O
particular	O
have	O
not	B
yet	I
been	O-
completely	I
determined	I
.	O

There	O
was	O
no	O
relationship	O
between	O
compliance	O
and	O
outcome	O
so	O
this	O
was	B
not	I
further	O
considered	O
in	O
the	O
analysis	O
.	O

Promising	B
evidence	O
came	O
from	O
a	O
trial	O
in	O
China	O
investigating	O
the	O
effects	B
of	O
IFA	O
supplements	O
in	O
pregnancy	O
on	O
neonatal	O
deaths	O
[	O
19	O
].	O

Fasting	O
blood	O
samples	O
were	O
also	O
obtained	O
on	O
follow	O
ups	O
and	O
were	O
used	O
to	O
prepare	O
serums	O
,	O
which	O
were	O
kept	O
similarly	O
.	O

Bonferrroni	O
post	O
-	O
hoc	O
test	O
:*/***	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
males	O
;#	O
P	O
<	O
0	O
.	O
05	O
vs	O
.	O
CC	O
females	O
;$$	O
P	O
<	O
0	O
.	O
01	O
vs	O
.	O
RC	O
males	O
.	O

We	O
will	O
maintain	O
a	O
backup	O
copy	O
of	O
the	O
database	O
on	O
a	O
different	O
server	O
.	O

Maternal	O
intake	O
of	O
sugar	O
during	O
pregnancy	O
and	O
childhood	O
respiratory	O
and	O
atopic	O
outcomes	O
Abstract	O
The	O
possible	B
role	B
of	O
maternal	O
consumption	O
of	O
free	O
sugar	O
during	O
pregnancy	O
in	O
the	O
inception	O
of	O
respiratory	O
and	O
atopic	O
diseases	O
has	O
not	B
been	I
studied	I
.	O

†	O
Mann	O
-	O
Whitney	O
U	O
test	O
.	O

We	O
found	O
that	O
birth	O
weight	O
percentile	O
levels	O
increased	O
by	O
about	O
10	O
and	O
15	O
points	O
,	O
respectively	O
,	O
with	O
a	O
10	O
%	O
increase	O
in	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
levels	O
,	O
suggesting	B
a	O
strong	O
association	B
of	O
repetitive	O
element	O
methylation	O
markers	O
with	O
fetal	O
growth	O
.	O

Recruitment	O
of	O
study	O
participants	O
takes	O
place	O
in	O
two	O
of	O
the	O
seven	O
municipal	O
regions	O
of	O
the	O
city	O
from	O
which	O
four	O
primary	O
health	O
care	O
clinics	O
were	O
identified	O
.	O

Mean	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
levels	O
were	O
also	O
found	O
to	O
be	O
weakly	O
to	O
moderately	O
correlated	B
,	O
with	O
a	O
Pearson	O
correlation	O
of	O
0	O
.	O
29	O
[	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
):	O
0	O
.	O
20	O
,	O
0	O
.	O
38	O
].	O

Specifications	O
table	O
TableSubject	O
areaBiologyMore	O
specific	O
subject	O
areaAnimal	O
nutrition	O
and	O
metabolismType	O
of	O
dataFigure	O
of	O
miRNAs	O
predicted	O
to	O
target	O
GR	O
,	O
Table	O
of	O
miRNAs	O
expressionHow	O
data	O
was	O
acquiredQuantitative	O
PCR	O
analysis	O
was	O
performed	O
using	O
SYBR	O
Premix	O
Ex	O
Taq	O
™	O
PCR	O
Master	O
Mix	O
in	O
Mastercycler	O
®	O
ep	O
realplex	O
PCR	O
detection	O
system	O
.	O
Data	O
formatFiltered	O
and	O
analyzedExperimental	O
factorsMaternal	O
gestational	O
betaine	O
supplementationExperimental	O
featuresRNA	O
isolation	O
and	O
polyadenylation	O
;	O
real	O
-	O
time	O
PCR	O
.	O
Data	O
source	O
locationDafeng	O
,	O
Jiangsu	O
,	O
ChinaData	O
accessibilityData	O
are	O
provided	O
in	O
the	O
paper	O
Value	O
of	O
the	O
data	O
miRNAs	O
participation	O
in	O
post	O
-	O
transcription	O
of	O
genes	O
could	B
be	I
included	I
in	I
other	I
studies	I
of	O
fetal	O
programming	O
.	O

The	O
liver	O
of	O
RC	O
females	O
also	O
showed	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
the	O
de	O
novo	O
lipogenic	O
enzyme	O
Acaca	O
and	O
Fasn	O
,	O
which	O
constitute	O
rate	O
-	O
limit	O
steps	O
in	O
the	O
fatty	O
-	O
acid	O
synthesis	O
,	O
and	O
the	O
liver	O
-	O
specific	O
cholesterol	O
biosynthesis	O
regulators	O
Insig1	O
and	O
Hmgcr	O
.	O

Indeed	O
,	O
discrepancies	B
were	O
also	O
found	B
in	O
the	O
literature	O
.	O

In	O
early	O
childhood	O
,	O
feeding	O
practices	O
,	O
taste	O
acquisition	O
,	O
and	O
eating	O
in	O
the	O
absence	O
of	O
hunger	O
must	B
be	I
considered	B
.	O

Only	B
6	O
%	O
of	O
women	O
started	O
visits	O
in	O
the	O
first	O
trimester	O
while	B
14	O
.	O
5	O
%	O
began	O
in	O
the	O
third	O
trimester	O
.	O

This	O
prevents	B
the	O
conclusion	B
of	O
a	O
definitive	O
relationship	B
without	O
further	B
research	I
,	O
preferably	B
clinical	O
randomised	O
controlled	O
trials	O
,	O
and	O
a	O
proper	O
meta	O
-	O
analysis	O
.	O

In	O
the	O
ventromedial	O
hypothalamic	O
nucleus	O
,	O
dopamine	O
release	O
is	O
required	B
to	O
initiate	O
a	O
meal	O
,	O
and	O
is	O
positively	O
associated	B
with	O
meal	O
number	O
and	O
duration	O
.	O
27	O
,	O
28By	O
possibly	B
reducing	O
dopamine	O
signaling	O
,	O
the	O
HV	O
pup	O
diet	O
may	B
have	O
provided	O
some	B
protection	O
against	O
excess	O
food	O
intake	O
caused	O
by	O
the	O
HV	O
gestational	O
diet	O
.	O

This	O
is	O
also	O
consistent	B
with	O
another	O
study	O
that	O
observed	O
an	O
increased	O
risk	O
of	O
GDM	O
with	O
vitamin	O
D	O
deficiency	O
in	O
early	O
pregnancy	O
(	O
aOR	O
:	O
3	O
.	O
40	O
;	O
95	O
%	O
CI	O
:	O
2	O
.	O
03	O
–	O
4	O
.	O
98	O
[	O
17	O
])	O
and	O
offers	O
potential	B
physiological	O
connections	B
between	O
vitamin	O
D	O
status	O
and	O
the	O
progression	O
of	O
insulin	O
resistance	O
in	O
pregnant	O
women	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Selected	O
characteristics	O
of	O
participant	O
pregnant	O
women	O
(	O
n	O
=	O
3268	O
),	O
post	O
-	O
partum	O
interview	O
,	O
July	O
–	O
December	O
2014	O
,	O
Managua	O
Province	O
,	O
Nicaragua	O
.	O
AllVaccinatedUnvaccinatedp	O
-	O
value	O
†	O
n	O
=	O
3268n	O
=	O
1789n	O
=	O
1479n	O
(%)	O
n	O
(%)	O
n	O
(%)	O
Age	O
<	O
18	O
years415	O
(	O
13	O
)	O
232	O
(	O
13	O
)	O
183	O
(	O
12	O
)	O
0	O
.	O
80	O
18	O
–	O
34	O
years2620	O
(	O
80	O
)	O
1433	O
(	O
80	O
)	O
1187	O
(	O
80	O
)	O
≥	O
35	O
years233	O
(	O
7	O
)	O
124	O
(	O
7	O
)	O
109	O
(	O
7	O
)	O
Number	O
of	O
persons	O
in	O
household	O
2	O
–	O
4898	O
(	O
27	O
)	O
528	O
(	O
30	O
)	O
370	O
(	O
25	O
)	O
0	O
.	O
02	O
5	O
–	O
61070	O
(	O
33	O
)	O
580	O
(	O
32	O
)	O
490	O
(	O
33	O
)	O
7	O
–	O
8707	O
(	O
22	O
)	O
381	O
(	O
21	O
)	O
326	O
(	O
22	O
)	O
>	O
8593	O
(	O
18	O
)	O
300	O
(	O
17	O
)	O
293	O
(	O
20	O
)	O
Delivered	O
at	O
reference	O
*	O
obstetric	O
hospital1722	O
(	O
53	O
)	O
1083	O
(	O
61	O
)	O
639	O
(	O
43	O
)<	O
0	O
.	O
01Education	O
level	O
No	O
education	O
/	O
primary	O
school	O
incomplete421	O
(	O
13	O
)	O
231	O
(	O
13	O
)	O
190	O
(	O
13	O
)	O
0	O
.	O
01	O
Primary	O
school	O
complete337	O
(	O
10	O
)	O
195	O
(	O
11	O
)	O
142	O
(	O
10	O
)	O
Secondary	O
school	O
incomplete1372	O
(	O
42	O
)	O
771	O
(	O
43	O
)	O
601	O
(	O
41	O
)	O
Secondary	O
school	O
complete637	O
(	O
19	O
)	O
353	O
(	O
20	O
)	O
284	O
(	O
19	O
)	O
Technical	O
/	O
university	O
studies501	O
(	O
15	O
)	O
239	O
(	O
13	O
)	O
262	O
(	O
18	O
)	O
Received	O
at	O
least	O
one	O
dose	O
of	O
tetanus	O
vaccine2984	O
(	O
91	O
)	O
1759	O
(	O
98	O
)	O
1225	O
(	O
83	O
)<	O
0	O
.	O
01At	O
least	O
one	O
antenatal	O
visits3172	O
(	O
97	O
)	O
1786	O
(	O
100	O
)	O
1386	O
(	O
94	O
)<	O
0	O
.	O
01Four	O
or	O
more	O
antenatal	O
visits2549	O
(	O
78	O
)	O
1542	O
(	O
86	O
)	O
1007	O
(	O
68	O
)<	O
0	O
.	O
01Gestational	O
age	O
at	O
first	O
antenatal	O
visit	O
(	O
median	O
,	O
quantiles	O
in	O
weeks	O
)	O
12	O
(	O
9	O
,	O
19	O
)	O
12	O
(	O
9	O
,	O
17	O
)	O
13	O
(	O
9	O
,	O
22	O
)<	O
0	O
.	O
01	O
‡	O
Consumption	O
of	O
iron	O
and	O
folic	O
acid1485	O
(	O
45	O
)	O
805	O
(	O
45	O
)	O
680	O
(	O
46	O
)	O
0	O
.	O
59Consumption	O
of	O
albendazol703	O
(	O
22	O
)	O
482	O
(	O
27	O
)	O
221	O
(	O
15	O
)<	O
0	O
.	O
01Consumption	O
of	O
calcium1243	O
(	O
38	O
)	O
722	O
(	O
40	O
)	O
521	O
(	O
35	O
)<	O
0	O
.	O
01Consumption	O
of	O
aspirin938	O
(	O
29	O
)	O
600	O
(	O
34	O
)	O
338	O
(	O
23	O
)<	O
0	O
.	O
01	O
BMI	O
(	O
height	O
and	O
weight	O
measured	O
at	O
1st	O
antenatal	O
visit	O
)	O
Underweight	O
(<	O
18	O
.	O
5	O
)	O
315	O
(	O
10	O
)	O
116	O
(	O
6	O
)	O
199	O
(	O
13	O
)<	O
0	O
.	O
01	O
Normal	O
weight	O
(	O
18	O
.	O
5	O
–	O
24	O
.	O
9	O
)	O
1338	O
(	O
41	O
)	O
808	O
(	O
45	O
)	O
530	O
(	O
36	O
)	O
Overweight	O
(	O
25	O
–	O
29	O
.	O
9	O
)	O
928	O
(	O
28	O
)	O
510	O
(	O
29	O
)	O
418	O
(	O
28	O
)	O
Obesity	O
I	O
(	O
30	O
–	O
34	O
.	O
9	O
)	O
408	O
(	O
12	O
)	O
224	O
(	O
13	O
)	O
184	O
(	O
12	O
)	O
Obesity	O
II	O
(	O
35	O
–	O
39	O
.	O
9	O
)	O
163	O
(	O
5	O
)	O
87	O
(	O
5	O
)	O
76	O
(	O
5	O
)	O
Extreme	O
obesity	O
(>	O
40	O
)	O
88	O
(	O
3	O
)	O
41	O
(	O
2	O
)	O
47	O
(	O
3	O
)	O
Alcohol	O
consumption	O
before	O
pregnancy441	O
(	O
13	O
)	O
220	O
(	O
12	O
)	O
221	O
(	O
15	O
)	O
0	O
.	O
05Renal	O
Disease1266	O
(	O
39	O
)	O
734	O
(	O
41	O
)	O
532	O
(	O
36	O
)<	O
0	O
.	O
01Blood	O
Disease743	O
(	O
23	O
)	O
445	O
(	O
25	O
)	O
298	O
(	O
20	O
)<	O
0	O
.	O
01At	O
least	O
one	O
chronic	O
condition	O
**	O
1855	O
(	O
57	O
)	O
1069	O
(	O
60	O
)	O
786	O
(	O
53	O
)<	O
0	O
.	O
01	O
Number	O
of	O
parturitions	O
11519	O
(	O
46	O
)	O
879	O
(	O
49	O
)	O
640	O
(	O
43	O
)<	O
0	O
.	O
01	O
2	O
–	O
31447	O
(	O
44	O
)	O
768	O
(	O
43	O
)	O
679	O
(	O
46	O
)	O
>	O
3302	O
(	O
9	O
)	O
142	O
(	O
8	O
)	O
160	O
(	O
11	O
)	O
Female1585	O
(	O
49	O
)	O
804	O
(	O
45	O
)	O
781	O
(	O
53	O
)<	O
0	O
.	O
01Preterm	O
birth175	O
(	O
5	O
)	O
95	O
(	O
5	O
)	O
80	O
(	O
5	O
)	O
0	O
.	O
96Small	O
for	O
gestational	O
age343	O
(	O
10	O
)	O
198	O
(	O
11	O
)	O
145	O
(	O
10	O
)	O
0	O
.	O
26Low	O
birth	O
weight195	O
(	O
6	O
)	O
99	O
(	O
6	O
)	O
96	O
(	O
6	O
)	O
0	O
.	O
28	O
X2test	O
.	O

Thus	B
,	O
Korean	O
and	O
Japanese	O
beef	O
production	O
systems	O
have	O
focused	O
on	O
production	O
of	O
highly	O
marbled	O
beef	O
to	O
satisfy	O
their	O
customers	O
and	O
to	O
protect	O
their	O
beef	O
industry	O
against	O
imported	O
beef	O
that	O
has	O
relatively	O
low	O
MS	O
.	O
As	O
described	O
above	O
,	O
several	O
nutritional	O
factors	O
affect	B
IMF	O
deposition	O
,	O
and	O
these	O
factors	O
must	B
be	I
considered	B
to	O
prepare	O
a	O
proper	O
diet	O
to	O
improve	O
marbling	O
at	O
the	O
proper	O
time	O
in	O
the	O
life	O
cycle	O
.	O

The	O
median	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
in	O
pregnant	O
women	O
was	O
21	O
.	O
2	O
ng	O
/	O
mL	O
.	O

Many	B
of	O
them	O
contradict	B
each	I
other	I
,	O
or	O
are	O
at	O
least	O
incoherent	B
.	O

A	O
subgroup	O
of	O
infants	O
from	O
the	O
MIG	O
Study	O
are	O
currently	O
being	O
followed	O
up	O
.	O
72It	O
may	B
be	I
circumspect	B
to	O
await	O
the	O
findings	O
from	O
this	O
follow	O
-	O
up	O
study	O
before	O
metformin	O
can	B
be	O
considered	B
safe	O
for	O
the	O
routine	O
treatment	O
of	O
GDM	O
.	O

Castrating	O
bulls	O
gener	B
ally	I
increases	O
IMF	O
content	O
in	O
several	O
breeds	O
,	O
including	O
Korean	O
cattle	O
and	O
Holstein	O
[	O
9	O
,	O
38	O
–	O
40	O
].	O

These	O
four	O
miRNAs	O
are	O
miR	O
-	O
124a	O
,	O
miR	O
-	O
142	O
-	O
3p	O
,	O
miR	O
-	O
30	O
and	O
miR	O
-	O
204	O
,	O
the	O
miRNAs	O
binding	O
sites	O
on	O
the	O
3	O
′	O
UTR	O
of	O
GR	O
were	O
shown	O
inFig	O
.	O

Additionally	O
,	O
lifestyle	O
behaviours	O
that	O
may	B
be	I
influenced	B
by	O
seasonal	O
changes	O
(	O
dietary	O
intakes	O
,	O
physical	O
activity	O
,	O
and	O
well	O
-	O
being	O
)	O
did	B
not	I
explain	I
the	O
associations	B
between	O
exposure	O
to	O
winter	O
at	O
the	O
first	O
antenatal	O
visit	O
and	O
markers	B
of	O
glucose	O
metabolism	O
.	O

In	O
second	O
trimester	O
,	O
development	O
of	O
muscles	O
,	O
organs	O
occurs	O
,	O
so	O
the	O
diet	O
rich	O
in	O
proteins	O
is	O
advised	O
.	O

In	O
subjects	O
with	O
type	O
2	O
diabetes	O
,	O
the	O
ADOPT	O
Study	O
has	O
demonstrated	B
that	O
metformin	O
is	O
superior	B
to	O
glyburide	O
in	O
this	O
regard	O
.	O
76As	B
there	O
is	O
transplacental	O
passage	O
of	O
metformin	O
,	O
77	O
,	O
78its	O
effect	B
on	O
fetal	O
insulin	O
resistance	O
might	B
even	B
provide	O
further	O
benefit	O
in	B
light	I
of	I
data	O
of	O
insulin	O
resistance	O
and	O
insulin	O
secretory	O
defects	O
in	O
offspring	O
of	O
diabetic	O
pregnancies	O
.	O
19However	B
,	O
any	O
pharmacological	O
agent	O
which	O
crosses	O
the	O
placenta	O
must	B
be	I
viewed	O
with	O
caution	B
as	B
there	O
always	O
remains	B
the	O
possibility	B
of	O
unexpected	B
long	O
-	O
term	O
effects	B
.	O

The	O
study	O
had	O
significant	O
selection	O
and	O
recall	O
biases	B
.	O

The	O
P8	O
rump	O
fat	O
depth	O
was	O
generally	O
greater	O
in	O
Hereford	O
than	O
Angus	O
,	O
and	O
Meat	O
Standard	O
Australia	O
(	O
MSA	O
)	O
MS	O
was	O
generally	O
lower	O
in	O
Hereford	O
than	O
in	O
Angus	O
and	O
Wagyu	O
×	O
Angus	O
.	O

APGAR	O
scores	O
were	O
0	O
,	O
4	O
,	O
and	O
7	O
at	O
one	O
,	O
five	O
,	O
and	O
ten	O
minutes	O
,	O
respectively	O
.	O

(	O
E	O
)	O
Radiograph	O
of	O
the	O
tail	O
of	O
Skm1	O
.	O

This	O
belief	B
among	O
public	O
health	O
and	O
medical	O
professional	O
is	O
justifiable	B
,	O
says	O
Nommsen	O
-	O
Rivers	O
,	O
because	B
formula	O
companies	O
have	O
a	O
long	O
history	O
of	O
dubious	B
marketing	O
practices	O
that	O
can	B
undermine	B
a	O
woman	O
’	O
s	O
confidence	O
in	O
her	O
ability	O
to	O
nourish	O
her	O
baby	O
without	O
the	O
use	O
of	O
their	O
products	O
.	O
4	O
,	O
5Breastfeeding	O
rates	O
began	O
to	O
dwindle	O
worldwide	O
with	O
the	O
advent	O
of	O
infant	O
formula	O
in	O
the	O
1860s	O
.	O
4They	O
reached	O
an	O
all	O
-	O
time	O
low	O
in	O
the	O
United	O
States	O
in	O
1971	O
,	O
when	O
fewer	B
than	O
25	O
%	O
of	O
new	O
mothers	O
initiated	O
breastfeeding	O
at	O
all	O
,	O
and	O
only	B
5	O
%	O
of	O
mothers	O
were	O
still	B
breastfeeding	O
at	O
6	O
months	O
.	O
6Today	O
,	O
largely	B
due	B
to	I
parent	O
education	O
efforts	O
and	O
improved	O
support	O
for	O
lactating	O
mothers	O
,	O
more	O
than	O
75	O
%	O
of	O
U	O
.	O
S	O
.	O
mothers	O
initiate	O
breastfeeding	O
,	O
and	O
about	B
20	O
%	O
of	O
U	O
.	O
S	O
.	O
babies	O
are	O
breastfed	O
exclusively	O
through	O
6	O
months	O
.	O
7	O
Robust	O
milk	O
production	O
depends	O
on	O
frequent	O
and	O
thorough	O
draining	O
of	O
the	O
breast	O
through	O
suckling	O
or	O
pumping	O
.	O

[	O
14	O
]	O
assessed	O
vitamin	O
D	O
status	O
in	O
healthy	O
Thai	O
elderly	O
women	O
and	O
found	O
that	O
two	O
-	O
thirds	O
had	O
vitamin	O
D	O
insufficiency	O
and	O
one	O
-	O
third	O
had	O
vitamin	O
D	O
deficiency	O
.	O

Also	O
,	O
58	O
(	O
2	O
.	O
8	O
%)	O
infants	O
had	O
LBW	O
,	O
while	O
78	O
(	O
3	O
.	O
8	O
%)	O
infants	O
were	O
delivered	O
preterm	O
(	O
Table1	O
).	O

The	O
third	O
section	O
has	O
14	O
chapters	O
and	O
covers	O
various	O
diseases	O
from	O
cardiovascular	O
diseases	O
to	O
HIV	O
/	O
AIDS	O
,	O
osteoporosis	O
,	O
liver	O
diseases	O
and	O
neurological	O
disorders	O
.	O

Many	B
of	O
the	O
findings	B
regarding	O
the	O
relationship	B
between	O
vitamin	O
D	O
deficiency	O
and	O
GDM	O
are	O
based	B
on	I
case	O
-	O
control	O
studies	B
,	O
which	O
may	B
include	O
a	O
potential	B
selection	O
bias	B
.	O

Further	O
adjustment	O
for	O
maternal	O
age	O
,	O
education	O
,	O
smoking	O
status	O
,	O
BMI	O
and	O
race	O
/	O
ethnicity	O
race	O
/	O
ethnicity	O
attenuated	O
these	O
estimates	O
but	B
women	O
reporting	O
no	O
PNV	O
use	O
still	B
had	O
significantly	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
(	O
OR	O
2	O
.	O
1	O
,	O
95	O
%	O
CI	O
1	O
.	O
5	O
,	O
3	O
.	O
0	O
).	O

The	O
Edinburgh	O
Postnatal	O
Depression	O
scale	O
was	O
used	O
to	O
evaluate	O
depression	O
scores	O
.	O

Prenatal	O
vitamins	O
,	O
which	O
contain	O
zinc	O
,	O
are	O
generally	B
obtained	O
via	O
a	O
prescription	O
through	O
the	O
Indian	O
Health	O
Service	O
.	O

PubMed	O
Central	O
:	O

Previous	B
studies	I
have	O
focused	O
on	O
cathelicidin	O
and	O
vitamin	O
D	O
concentrations	O
in	O
patient	O
populations	O
affected	O
by	O
various	O
illnesses	O
or	O
diseases	O
[	O
6	O
],	O
such	O
as	O
tuberculosis	O
[	O
7	O
],	O
pneumonia	O
[	O
8	O
],	O
sepsis	O
[	O
9	O
],	O
HIV	O
[	O
10	O
–	O
12	O
],	O
and	O
end	O
-	O
stage	O
renal	O
disease	O
hemodialysis	O
[	O
13	O
],	O
as	O
well	O
as	O
healthy	O
adult	O
populations	O
[	O
14	O
–	O
19	O
].	O

Compared	O
with	O
whites	O
,	O
blacks	O
had	O
a	O
lower	O
mean	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
level	O
and	O
higher	O
incidence	O
of	O
SGA	O
(	O
P	O
⩽	O
0	O
.	O
01	O
).	O

A	O
study	O
examined	O
the	O
incidence	O
of	O
autism	O
in	O
the	O
neonatal	O
intensive	O
care	O
unit	O
and	O
risk	O
factors	O
connected	B
with	O
autistic	O
development	O
.	O

The	O
ASQ	O
has	O
been	O
validated	O
against	O
the	O
Bayley	O
Scales	O
[	O
32	O
],	O
and	O
in	O
a	O
paediatric	O
population	O
[	O
33	O
].	O

Since	B
socioeconomic	O
status	O
plays	O
a	O
significant	O
role	B
in	O
PTB	O
risk	B
,	O
multivariate	O
logistic	O
regression	O
was	O
used	O
to	O
adjust	O
for	O
socioeconomic	O
status	O
(	O
SES	O
)	O
proxy	B
variables	B
(	O
insurance	O
status	O
and	O
education	O
).	O

(	O
2008	O
)*	O
NicotineRatInjection	O
(	O
sc	O
)	O
(	O
1	O
mg	O
/	O
kg	O
twice	O
/	O
d	O
)	O
Implant	O
(	O
sc	O
)	O
(	O
4	O
µg	O
/	O
kg	O
/	O
min	O
)	O
Combinations	O
of	O
:	O
In	O
utero	O
Neonatal	O
In	O
utero	O
Neonatal	O
F0	O
-	O
F1generationsGrowth	O
retardation	O
Neurological	O
and	O
adrenal	O
abnormalitiesHistone	O
modification	O
DNA	O
methylation	O
Epigenetic	O
machineryLi	O
et	O
al	O
.	O

Thus	O
,	O
correlation	O
estimates	O
obtained	O
are	O
comparable	O
across	O
cohorts	O
and	O
age	O
groups	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
the	O
two	O
study	O
groups	O
in	O
relation	O
to	O
the	O
baseline	O
depression	O
score	O
.	O

Studies	O
have	B
shown	I
that	O
low	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
is	O
associated	B
with	O
psychological	O
symptoms	O
like	O
anxiety	O
,	O
depression	O
and	O
reduced	O
cognitive	O
function	O
[	O
26	O
,	O
27	O
].	O

At	O
least	O
two	O
physicians	O
will	O
independently	O
review	O
the	O
data	O
,	O
and	O
they	O
will	O
base	O
their	O
decision	O
on	O
an	O
agreement	O
.	O

In	O
a	O
study	O
by	O
Hovsepian	O
et	O
al	O
.,	O
in	O
men	O
and	O
women	O
with	O
average	O
age	O
of	O
41	O
.	O
4	O
years	O
in	O
Isfahan	O
,	O
45	O
%	O
of	O
men	O
and	O
52	O
.	O
4	O
%	O
of	O
women	O
had	O
vitamin	O
D	O
concentrations	O
lower	O
than	O
20	O
ng	O
/	O
mL	O
([	O
52	O
]).	O

Furthermore	O
,	O
it	O
must	B
be	I
noted	B
that	O
the	O
effect	B
of	O
depression	O
itself	O
as	O
a	O
factor	O
in	O
autism	O
separate	O
from	O
the	O
administration	O
of	O
SSRIs	O
is	O
a	O
possibility	B
.	O

For	O
1	O
hospital	O
(	O
n	O
=	O
23	O
women	O
)	O
certain	O
questions	O
(	O
mainly	O
nationality	O
,	O
ethnicity	O
,	O
education	O
level	O
)	O
needed	O
to	O
be	O
omitted	O
from	O
the	O
questionnaire	O
upon	O
decision	O
of	O
the	O
ethical	O
committee	O
of	O
this	O
particular	O
hospital	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Geographical	O
distribution	O
of	O
the	O
55	O
hospitals	O
visited	O
in	O
Belgium	O
and	O
the	O
number	O
of	O
pregnant	O
women	O
(	O
n	O
=	O
1311	O
)	O
investigated	O
by	O
site	O
(	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
Belgium	O
2010	O
–	O
2011	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Number	O
of	O
pregnant	O
women	O
by	O
region	O
,	O
trimester	O
and	O
age	O
(	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
among	O
pregnant	O
women	O
Belgium	O
,	O
2010	O
–	O
2011	O
).	O
RegionsBrussels	O
**	O
Flanders	O
**	O
WalloniaAge	O
(	O
years	O
)	O
1sttrimester3rdtrimester1sttrimester3rdtrimester1sttrimester3rdtrimester15	O
–	O
20721110211721	O
–	O
2534277751567326	O
–	O
304139108149765831	O
–	O
3534536975494536	O
–	O
4014142319132441	O
–	O
45231332Total132138289307218219	O
6	O
missing	O
data	O
for	O
age	O
.	O

Although	B
self	B
-	I
reported	I
alcohol	O
consumption	O
would	B
be	I
expected	I
to	B
be	I
lower	O
after	O
pregnancy	O
given	B
social	O
cues	O
and	O
available	O
information	B
about	O
health	O
risks	B
for	O
all	O
participants	O
,	O
the	O
dose	O
-	O
response	O
effect	B
among	O
text4baby	O
participants	O
was	O
pronounced	B
,	O
as	B
high	O
-	O
dose	O
participants	O
were	O
more	O
than	O
twice	O
as	O
likely	B
to	O
abstain	O
from	O
drinking	O
compared	O
to	O
low	O
-	O
dose	O
participants	O
.	O

The	O
emulsifier	O
PROSOL	O
(	O
sodium	O
stearoyl	O
-	O
2	O
-	O
lactylate	O
)	O
increases	O
IMF	O
deposition	O
and	O
QG	O
in	O
Korean	O
cattle	O
[	O
108	O
].	O

Among	O
pregnant	O
women	O
,	O
IDA	O
has	B
been	I
associated	B
with	O
increased	O
risks	O
of	O
low	O
birth	O
weight	O
,	O
prematurity	O
,	O
and	O
maternal	O
morbidity	O
[	O
11	O
].	O

Additionally	O
,	O
since	B
women	O
with	O
a	O
history	O
of	O
PTB	O
have	O
a	O
known	B
2	O
to	O
3	O
-	O
fold	O
increased	B
risk	I
of	O
a	O
recurrent	O
premature	O
delivery	O
compared	B
to	I
women	O
without	O
a	O
history	O
of	O
PTB	O
[	O
18	O
],	O
logistic	O
regression	O
was	O
conducted	O
for	O
this	O
subgroup	O
as	O
well	O
.	O

Even	B
in	O
the	O
last	O
published	O
guidelines	O
the	O
treatment	O
of	O
vitamin	O
D	O
deficient	O
women	O
is	O
not	B
specifically	I
discussed	O
[	O
24	O
].	O

The	O
cRNA	O
was	O
fragmented	O
(≈	O
100	O
bp	O
)	O
and	O
hybridised	O
on	O
Affymetrix	O
GeneChip	O
®	O
porcine	O
Genome	O
Array	O
.	O

Dietary	O
Reference	O
Intakes	O
for	O
macronutrients	O
Institute	O
of	O
Medicine	O
,	O
National	O
Academic	O
Press	O
,	O
Washington	O
:	O
2005	O
).	O

The	O
text4baby	O
program	O
also	O
offers	O
an	O
example	O
of	O
using	O
behavioral	O
theory	B
to	O
the	O
design	O
mHealth	O
interventions	B
[	O
1	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Evaluation	O
of	O
the	O
association	O
of	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
among	O
pregnant	O
women	O
by	O
trimester	O
of	O
vaccination	O
(	O
n	O
=	O
3268	O
),	O
post	O
-	O
partum	O
interview	O
,	O
July	O
–	O
December	O
2014	O
,	O
Managua	O
Province	O
,	O
Nicaragua	O
.	O
Birth	O
outcomesInfluenza	O
vaccine	O
2014	O
seasonInfluenza	O
vaccine	O
2014	O
seasonMultiple	O
Logistic	O
Regression	O
(	O
MLR	O
)	O
Propensity	O
score	O
Model	O
(	O
PSM	O
)†	O
+	O
MLRǂn	O
=	O
1600	O
×	O
1000	O
simulations	O
¥	O
aOR	O
(	O
95	O
%	O
CI	O
)	O
aOR	O
(	O
95	O
%	O
CI	O
)	O
Small	O
for	O
gestational	O
age	O
(	O
SGAi	O
)	O
1	O
.	O
03	O
*(	O
0	O
.	O
82	O
;	O
1	O
.	O
31	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
83	O
;	O
1	O
.	O
24	O
)	O
Preterm	O
birth	O
(	O
PTB	O
)	O
0	O
.	O
95	O
**(	O
0	O
.	O
75	O
;	O
1	O
.	O
20	O
)	O
0	O
.	O
88	O
(	O
0	O
.	O
73	O
;	O
1	O
.	O
06	O
)	O
Low	O
birth	O
weight	O
(	O
LBW	O
)	O
0	O
.	O
89	O
***(	O
0	O
.	O
66	O
;	O
1	O
.	O
22	O
)	O
0	O
.	O
83	O
(	O
0	O
.	O
62	O
;	O
1	O
.	O
06	O
)	O
aOR	O
=	O
Adjusted	O
Odds	O
Ratio	O
.	O

Power	O
analysis	O
estimated	B
the	O
required	O
sample	O
to	O
be	O
996	O
participants	O
in	O
total	O
assuming	B
a	O
10	O
%	O
attrition	B
rate	O
at	O
postpartum	O
follow	O
-	O
up	O
.	O

The	O
nail	O
plate	O
was	O
subsequently	O
reflected	O
back	O
into	O
place	O
.	O

The	O
numbers	O
at	O
the	O
horizontal	O
arrows	O
indicate	O
the	O
quantity	O
of	O
probe	O
-	O
sets	O
significantly	O
regulated	O
between	O
the	O
adjacent	O
ontogenetic	O
stages	O
in	O
either	O
AP	O
or	O
LP	O
offspring	O
,	O
whereas	O
the	O
numbers	O
in	O
the	O
intersections	O
indicate	O
the	O
quantity	O
of	O
probe	O
-	O
sets	O
commonly	O
regulated	O
between	O
stages	O
in	O
AP	O
and	O
LP	O
offspring	O
.	O

Test	O
of	O
feeding	O
response	O
to	O
AM251	O
To	O
evaluate	O
the	O
implication	O
of	O
the	O
cannabinoid	O
CB1	O
receptors	O
in	O
the	O
differential	O
response	O
on	O
caloric	O
intake	O
and	O
chocolate	O
preference	O
,	O
adult	O
rats	O
(	O
postnatal	O
weeks	O
13	O
–	O
14	O
)	O
were	O
firstly	O
treated	O
with	O
a	O
dose	O
of	O
the	O
CB1	O
receptor	O
inverse	O
agonist	O
AM251	O
(	O
3	O
mg	O
/	O
kg	O
)	O
and	O
then	O
exposed	O
to	O
a	O
free	O
choice	O
between	O
a	O
mixture	O
of	O
chocolates	O
and	O
a	O
standard	O
chow	O
.	O

Methods	O
/	O
design	O
The	O
effect	B
of	O
the	O
early	O
use	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
on	O
neonatal	O
mortality	O
will	O
be	B
examined	I
using	O
a	O
community	O
based	O
,	O
cluster	O
randomised	O
controlled	O
trial	O
in	O
five	O
districts	O
with	O
30	O
,	O
000	O
live	O
births	O
.	O

In	O
the	O
study	O
on	O
25	O
(	O
OH	O
)	O
D3	O
,	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3and	O
Ca2	O
+	O
levels	O
,	O
significantly	O
higher	O
concentrations	O
of	O
VD3were	O
confirmed	O
in	O
87	O
patients	O
with	O
endometriosis	O
(	O
62	O
.	O
15	O
±	O
36	O
.	O
9	O
nmol	O
/	O
L	O
vs	O
.	O

The	O
difference	O
in	O
25	O
(	O
OH	O
)	O
D	O
between	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
was	O
investigated	O
with	O
ANCOVA	O
adjusted	O
for	O
season	O
,	O
maternal	O
age	O
,	O
education	O
and	O
prepregnancy	O
BMI	O
.	O

*	O
denotes	O
p	O
<	O
0	O
.	O
05	O
.	O

Twelve	O
weeks	O
after	O
the	O
administration	O
of	O
a	O
single	O
dose	O
of	O
300	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
,	O
this	O
figure	O
was	O
4	O
.	O
2	O
%	O
and	O
71	O
.	O
4	O
%	O
for	O
the	O
IG	O
and	O
CG	O
,	O
respectively	O
.	O

Follow	O
-	O
up	O
data	O
collection	O
was	O
conducted	O
remotely	O
primarily	O
through	O
a	O
secure	O
survey	O
website	O
[	O
23	O
].	O

Studies	O
examining	O
the	O
impact	B
of	O
environmental	O
exposures	O
on	O
DNA	O
methylation	O
have	O
often	O
focused	O
on	O
the	O
global	O
extent	O
of	O
5	O
-	O
methylcytosine	O
,	O
using	O
various	O
approaches	O
(	O
Einstein	O
et	O
al	O
.	O

Samples	O
were	O
GC	O
-	O
RMA	O
normalised	O
(	O
Log2	O
).	O

Upon	O
further	O
exploration	O
through	O
GSEA	O
,	O
we	O
observed	O
an	O
overrepresentation	O
of	O
several	O
TFBSs	O
for	O
transcription	O
factors	O
critical	B
in	O
development	O
,	O
cellular	O
processes	O
,	O
immune	O
modulation	O
,	O
lipid	O
or	O
sterol	O
homeostasis	O
,	O
and	O
gene	O
expression	O
near	O
loci	O
associated	B
with	O
AluYb8	O
,	O
as	O
well	O
as	O
a	O
few	O
developmental	O
and	O
cellular	O
proliferation	O
pathways	O
for	O
LINE	O
-	O
1	O
.	O

At	O
weaning	O
,	O
only	B
eight	O
Skm2	O
mutants	O
out	O
of	O
84	O
progeny	O
were	O
identified	B
(	O
9	O
.	O
5	O
%	O
ratio	O
),	O
suggesting	B
embryonic	O
or	B
perinatal	O
mortality	O
.	O

Study	O
has	B
shown	I
that	O
exposing	O
edible	O
mushroom	O
to	O
ultraviolet	O
B	O
light	O
could	B
increase	O
its	O
Vitamin	O
D2	O
content	O
and	O
raise	O
serum	O
25	O
-	O
OH	O
VitD2	O
in	O
healthy	O
adults	O
[	O
2	O
,	O
3	O
].	O

Hughes	O
et	O
al	O
.	O

She	O
recently	B
presented	O
findings	B
showing	B
an	O
association	B
between	O
increased	O
levels	O
of	O
activated	O
T	O
cells	O
in	O
DiNEH	O
Project	O
participants	O
and	O
greater	O
residential	O
proximity	O
to	O
mine	O
waste	O
sites	O
.	O
36	O
“	O
If	B
we	O
see	O
any	O
of	O
these	O
activated	O
T	O
cells	O
,	O
we	O
know	B
that	O
the	O
immune	O
system	O
is	O
highly	O
reacting	O
to	O
something	B
,”	O
Erdei	O
says	O
.	O

Female	O
rats	O
were	O
maintained	O
on	O
the	O
same	O
diet	O
paradigm	O
as	O
in	O
the	O
pregestational	O
period	O
up	O
to	O
the	O
gestational	O
day	O
20	O
(	O
GD	O
20	O
).	O

The	O
ECS	O
keeps	O
a	O
homeostatic	O
role	O
in	O
regulating	O
energy	O
balance	O
and	O
food	O
intake	O
(	O
Cristino	O
et	O
al	O
.,	O
2014	O
),	O
and	O
its	O
overactivation	O
,	O
mainly	O
via	O
CB1	O
receptors	O
,	O
favors	O
the	O
energy	O
accumulation	O
,	O
increases	O
the	O
appetite	O
for	O
highly	O
palatable	O
foods	O
,	O
decreases	O
the	O
satiety	O
and	O
reduces	O
the	O
energy	O
expenditure	O
.	O

The	O
use	O
of	O
GTT	O
(	O
75	O
g	O
glucose	O
load	O
),	O
rather	B
than	B
glucose	O
challenge	O
test	O
,	O
would	B
have	O
allowed	O
for	O
better	B
comparison	O
with	O
the	O
seasonal	O
gestational	O
diabetes	O
papers	O
discussed	O
,	O
however	B
universal	O
screening	O
for	O
gestational	O
diabetes	O
using	O
GTT	O
is	O
not	O
currently	O
standard	O
practice	O
in	O
Ireland	O
.	O

Data	O
from	O
a	O
review	B
of	I
the	I
literature	I
and	O
the	O
authors	O
'	O
own	B
experience	I
show	B
that	O
in	O
patients	O
undergoing	O
either	O
suppressive	O
or	O
substitutive	O
thyroxine	O
therapy	O
foetal	O
thyroid	O
growth	O
is	O
normal	O
at	O
ultrasound	O
study	O
,	O
newborn	O
thyroid	O
status	O
is	O
normal	O
,	O
and	O
the	O
incidence	O
of	O
maternal	O
morbidity	O
is	O
not	O
influenced	O
by	O
the	O
pregnancy	O
.	O

Conversely	B
,	O
several	B
studies	I
in	O
both	O
rodents	O
and	O
humans	O
have	B
shown	I
that	O
BAT	O
activation	O
(	O
by	O
cold	O
exposure	O
,	O
β3	O
-	O
agonist	O
treatment	O
,	O
transplantation	O
and	O
others	O
)	O
improves	O
glucose	O
tolerance	O
and	O
insulin	O
sensitivity	O
.	O

Conclusion	O
.	O

The	O
means	O
at	O
each	O
time	O
point	O
and	O
for	O
hypothalamic	O
gene	O
expression	O
,	O
folate	O
status	O
and	O
glucose	O
response	O
were	O
compared	O
by	O
one	O
-	O
way	O
analysis	O
of	O
variance	O
using	O
the	O
PROC	O
GLM	O
followed	O
by	O
a	O
Tukey	O
’	O
s	O
post	O
-	O
hoc	O
test	O
.	O

The	O
prevalence	O
of	O
vitamin	O
D	O
insufficiency	O
is	O
high	O
even	B
in	O
sunny	O
climates	O
,	O
such	O
as	O
Brazil	O
'	O
s	O
,	O
principally	O
in	O
adolescents	O
[	O
4	O
].	O

To	B
investigate	I
the	O
role	B
of	O
visfatin	O
in	O
the	O
growth	O
of	O
the	O
fetus	O
and	O
up	O
to	O
a	O
year	O
after	O
birth	O
,	O
we	O
measured	O
serum	O
visfatin	O
levels	O
during	O
6	O
-	O
12	O
and	O
15	O
-	O
20	O
weeks	O
of	O
gestation	O
in	O
an	O
Iranian	O
population	O
.	O

Early	O
weaning	O
(	O
141	O
d	O
of	O
age	O
)	O
followed	O
by	O
a	O
high	O
-	O
starch	O
diet	O
improved	O
MS	O
compared	O
with	O
normal	O
weaning	O
(	O
222	O
d	O
of	O
age	O
)	O
followed	O
by	O
a	O
starch	O
creep	O
-	O
feed	O
diet	O
.	O

Additionally	O
,	O
our	B
findings	I
are	O
observational	B
in	O
nature	O
thus	O
we	O
cannot	B
determine	O
causality	O
.	O

2	O
.	O
9	O
.	O

PubMed	O
Central	O
:	O

Spots	O
were	O
dried	O
in	O
a	O
Vacuum	O
Concentrator	O
(	O
Eppendorf	O
,	O
Hamburg	O
Germany	O
)	O
for	O
25	O
min	O
and	O
rehydrated	O
at	O
4	O
°	O
C	O
in	O
tryptic	O
digest	O
solution	O
(	O
10	O
ng	O
/	O
µl	O
porcine	O
sequencing	O
grade	O
trypsin	O
(	O
Promega	O
)	O
in	O
50	O
mM	O
NH4HCO3	O
)	O
for	O
1	O
h	O
.	O
Remaining	O
tryptic	O
digest	O
solution	O
was	O
removed	O
and	O
gel	O
pieces	O
suspended	O
overnight	O
at	O
37	O
°	O
C	O
in	O
50	O
mM	O
NH4HCO3	O
.	O

In	O
addition	O
,	O
it	B
is	I
possible	I
to	O
have	O
adverse	O
outcomes	O
that	O
are	O
reversible	O
.	O

3	O
.	O

The	O
correlation	B
between	O
testosterone	O
and	O
VD	O
has	O
not	B
been	O-
observed	I
yet	B
in	O
another	B
study	I
conducted	O
in	O
Denmark	O
on	O
307	O
fertile	O
men	O
.	O

Last	O
,	O
the	O
sample	O
size	O
was	O
rather	O
small	B
,	O
and	O
the	O
vitamin	O
D	O
levels	O
of	O
the	O
participants	O
were	O
generally	B
suboptimal	B
in	O
our	B
study	I
.	O

Further	O
,	O
other	B
studies	I
using	O
animal	O
models	B
show	B
that	O
preclinical	O
findings	O
in	O
rodents	O
exposed	O
to	O
SSRIs	O
during	O
development	O
point	B
to	O
an	O
increase	O
in	O
depression	O
and	O
anxiety	O
,	O
exhibiting	O
alteration	O
in	O
social	O
behaviors	O
in	O
the	O
offspring	O
.	O

The	O
effect	B
of	O
each	O
gene	O
is	O
further	O
diluted	O
by	O
variable	B
penetrance	O
[	O
61	O
].	O

First	O
,	O
prenatal	O
and	O
early	O
life	O
experiences	O
influence	B
the	O
trajectory	O
of	O
weight	O
into	O
adulthood	O
(	O
1	O
).	O

Unadjusted	O
odds	O
ratios	O
(	O
OR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
CI	O
)	O
were	O
also	O
calculated	O
.	O

PubMed	O
Central	O
:	O

Both	O
the	O
Diabetes	O
Prevention	O
Program86and	O
the	O
Finnish	O
Diabetes	O
Prevention	O
Study87demonstrated	B
this	O
,	O
with	O
an	O
intensive	O
intervention	O
including	O
lifestyle	O
coaches	O
,	O
strict	O
supervised	O
exercise	O
regimes	O
and	O
caloric	O
restriction	O
.	O

When	O
Grandjean	O
and	O
his	O
team	O
dug	O
a	O
little	O
deeper	O
,	O
they	O
saw	B
that	O
women	O
with	O
the	O
highest	O
PFAS	O
levels	O
in	O
their	O
blood	O
tended	B
to	O
spend	O
less	O
time	O
breastfeeding	O
their	O
babies	O
.	O
22	O
In	O
the	B
study	I
,	O
led	O
by	O
Timmermann	O
—	O
who	O
at	O
the	O
time	O
was	O
pursuing	O
her	O
PhD	O
under	O
Grandjean	O
’	O
s	O
supervision	O
—	O
the	O
researchers	O
estimated	B
the	O
average	O
duration	O
of	O
total	O
breastfeeding	O
(	O
i	O
.	O
e	O
.,	O
with	O
or	O
without	O
any	O
other	O
sources	O
of	O
nutrition	O
)	O
in	O
association	B
with	O
serum	O
levels	O
of	O
two	O
PFASs	O
,	O
perfluorooctane	O
sulfonic	O
acid	O
(	O
PFOS	O
)	O
and	O
perfluorooctanoic	O
acid	O
(	O
PFOA	O
).	O

Despite	B
these	O
limitations	B
,	O
this	O
is	O
the	O
first	B
study	I
to	O
demonstrate	B
a	O
gene	O
-	O
maternal	O
environment	O
synergism	O
in	O
relation	B
to	O
infant	O
birth	O
weight	O
,	O
using	O
a	O
very	O
brief	O
assessment	O
of	O
maternal	O
attitudes	O
to	O
pregnancy	O
.	O

In	O
our	O
study	O
setting	O
,	O
according	O
to	O
the	O
recommendations	O
from	O
the	O
American	O
Diabetes	O
Association	O
(	O
ADA	O
)	O
[	O
25	O
],	O
all	O
pregnant	O
women	O
were	O
screened	O
at	O
24	O
-	O
28	O
weeks	O
gestation	O
using	O
a	O
50	O
gram	O
1	O
-	O
hour	O
oral	O
glucose	O
challenge	O
test	O
.	O

In	O
Bangladesh	O
,	O
Parveen	O
and	O
colleagues	O
found	B
that	O
mothers	O
perceived	O
handwashing	O
is	O
an	O
important	O
approach	O
to	O
nurturing	O
their	O
newborns	O
and	O
young	O
children	O
and	O
that	O
they	O
were	O
more	O
likely	O
to	O
practice	O
the	O
behavior	O
when	O
supported	O
to	O
do	O
so	O
by	O
their	O
families	O
.	O

We	O
used	O
targeted	O
sequencing	O
of	O
the	O
16S	O
rRNA	O
V4	O
-	O
V5	O
hypervariable	O
region	O
to	O
characterize	O
infant	O
gut	O
microbiota	O
.	O

Saki	O
et	O
al	O
.,	O
showed	B
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
southern	O
Iranian	O
children	O
,	O
more	O
than	O
80	O
%	O
were	O
deficient	O
[	O
53	O
].	O

A	O
robust	B
,	O
dose	O
-	O
dependent	B
,	O
causal	O
relationship	B
among	O
a	O
specific	O
environmental	O
exposure	O
,	O
an	O
epigenetic	O
change	O
and	O
an	O
adverse	O
public	B
health	I
outcome	O
is	O
required	B
to	O
classify	O
a	O
chemical	O
as	B
an	O
epigenetic	O
toxicant	O
.	O

EAH	O
in	O
children	O
is	O
associated	B
with	O
higher	O
fasting	O
insulin	O
and	O
leptin	O
levels	O
(	O
64	O
),	O
2	O
hormones	O
that	O
regulate	O
appetite	O
and	O
body	O
weight	O
(	O
68	O
).	O

In	O
the	O
present	O
study	O
,	O
vitamin	O
D	O
restriction	O
during	O
nephrogenesis	O
reduced	O
podocin	O
expression	O
in	O
the	O
F1	O
generation	O
from	O
weaning	O
until	O
six	O
months	O
of	O
age	O
but	B
not	I
in	O
the	O
F2	O
generation	O
.	O

Maternal	O
obesity	O
significantly	O
predicts	O
child	O
and	O
adult	O
obesity	O
in	O
her	O
offspring	O
[	O
4	O
,	O
5	O
],	O
and	O
associated	B
cardio	O
-	O
metabolic	O
risk	O
factors	O
,	O
including	O
hypertension	O
,	O
hyperlipidaemia	O
,	O
diabetes	O
,	O
and	O
cardiovascular	O
disease	O
[	O
6	O
–	O
8	O
].	O

2	O
.	O

Likely	B
,	O
the	O
analysis	O
with	O
PSM	O
corrected	O
for	O
biases	B
related	B
to	O
the	O
probability	O
of	O
influenza	O
vaccination	O
by	O
controlling	O
for	O
differences	O
between	O
vaccinated	O
and	O
unvaccinated	O
women	O
that	O
we	O
were	O
not	O
able	O
to	O
control	O
for	O
in	O
MLR	O
[	O
43	O
].	O

The	O
current	O
body	O
of	O
evidence	B
for	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
is	O
predominantly	B
a	O
collection	O
of	O
human	O
epidemiological	O
data	O
and	O
exploratory	O
in	O
vivo	O
high	O
(	O
often	B
single	O
)	O
dose	O
range	O
studies	O
,	O
performed	O
,	O
not	B
for	O-
regulatory	O-
purposes	O-
,	O-
but	I
to	O
investigate	O
the	O
theoretical	B
potential	B
and	O
putative	B
mechanisms	O
of	O
epigenetic	O
toxicity	O
in	O
biological	O
systems	O
.	O

Role	B
of	O
vitamin	O
D	O
in	O
pregnant	O
women	O
Adequate	O
vitamin	O
D	O
intake	O
is	O
essential	B
for	O
maternal	O
and	O
fetal	O
health	O
during	O
pregnancy	O
,	O
and	O
prevention	B
of	O
adverse	O
outcomes	O
.	O

The	O
results	O
showed	B
that	O
in	O
both	O
subgroups	O
,	O
the	O
vitamin	O
D	O
group	O
had	O
statistically	O
significant	O
higher	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
at	O
childbirth	O
and	O
lower	O
depression	O
score	O
at	O
4	O
and	O
8	O
weeks	O
postpartum	O
than	O
the	O
control	O
group	O
(	O
Table	O
4	O
).	O

Furthermore	O
,	O
sex	O
specific	O
differences	O
in	O
pregnancy	O
outcome	O
have	B
also	O-
been	I
reported	O
whereby	O
the	O
risk	O
of	O
sPTB	O
,	O
PE	O
and	O
GDM	O
are	O
all	O
higher	O
in	O
pregnancies	O
with	O
a	O
male	O
fetus	O
[	O
48	O
–	O
50	O
].	O

All	O
pregnant	O
women	O
in	O
the	O
waiting	O
areas	O
of	O
the	O
ANC	O
clinics	O
are	O
informed	O
about	O
the	O
study	O
.	O

The	O
sample	O
was	O
diverse	O
but	O
self	O
-	O
selected	O
and	O
free	O
of	O
diseases	O
that	O
might	O
contraindicate	O
participation	O
in	O
a	O
lifestyle	O
intervention	O
study	O
;	O
thus	O
,	O
findings	O
may	B
not	O
generalize	O
to	O
the	O
population	O
at	O
large	O
.	O

In	O
adipose	O
tissue	O
,	O
it	O
appears	B
that	O
PPARγ	O
transcriptionally	O
controls	O
FGF21	O
,	O
which	O
then	O
acts	O
as	O
an	O
autocrine	O
or	O
paracrine	O
way	O
to	O
increase	O
PPARγ	O
transcriptional	O
activity	O
in	O
a	O
feed	O
-	O
forward	O
loop	O
system	O
(	O
Wang	O
et	O
al	O
.,	O
2008	O
;	O
Dutchak	O
et	O
al	O
.,	O
2012	O
).	O

Smith	O
and	O
Johnson	O
[	O
57	O
]	O
suggested	B
that	O
the	O
glucose	O
contribution	B
to	O
fat	O
synthesis	O
decreases	O
as	O
cattle	O
become	O
fatter	O
,	O
whereas	B
acetate	O
use	O
increases	O
,	O
especially	O
in	O
the	O
IMF	O
area	O
.	O

Mean	O
haemoglobin	O
concentration	O
change	O
(	O
baseline	O
to	O
follow	O
-	O
up	O
)	O
was	O
compared	O
between	O
treatment	O
groups	O
with	O
analysis	O
of	O
covariance	O
.	O

Children	O
born	O
to	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
are	O
more	O
likely	B
to	O
be	O
identified	O
with	O
moderate	O
to	O
severe	O
cognitive	O
,	O
motor	O
and	O
global	O
developmental	O
delay	O
at	O
3	O
years	O
of	O
age	O
[	O
46	O
],	O
as	O
well	O
as	O
poorer	O
academic	O
achievement	O
extending	O
to	O
14	O
years	O
of	O
age	O
[	O
44	O
,	O
45	O
].	O

In	O
addition	O
,	O
multiplex	O
PCR	O
was	O
performed	O
for	O
detecting	O
Streptococcus	O
pneumoniae	O
,	O
Haemophilus	O
influenzae	O
,	O
Moraxella	O
catarrhalis	O
,	O
Streptococcus	O
pyogens	O
,	O
and	O
Staphylococcus	O
aureus	O
[	O
20	O
].	O

These	O
experiences	O
,	O
combined	O
with	O
repeated	O
exposure	O
to	O
nutritious	O
foods	O
and	O
flavor	O
variety	O
(	O
31	O
-	O
34	O
),	O
should	B
make	O
children	O
more	O
likely	B
to	O
choose	O
a	O
healthy	O
diet	O
.	O

Declaration	O
This	O
article	O
is	O
part	O
of	O
a	O
supplement	O
jointly	O
funded	O
by	O
Save	O
the	O
Children	O
'	O
s	O
Saving	O
Newborn	O
Lives	O
programme	O
through	O
a	O
grant	O
from	O
The	O
Bill	O
&	O
Melinda	O
Gates	O
Foundation	O
and	O
March	O
of	O
Dimes	O
Foundation	O
and	O
published	O
in	O
collaboration	O
with	O
the	O
Partnership	O
for	O
Maternal	O
,	O
Newborn	O
and	O
Child	O
Health	O
and	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
).	O

Maternal	O
characteristics	O
,	O
as	O
well	O
as	O
pregnancy	O
,	O
delivery	O
and	O
neonatal	O
outcomes	O
,	O
were	O
compared	O
between	O
groups	O
.	O

We	O
and	O
others	O
have	O
previously	O
demonstrated	O
that	O
methylation	O
of	O
CpG	O
loci	O
detected	O
through	O
BeadArray	O
platforms	O
can	O
be	O
reliably	O
replicated	O
using	O
alternative	O
detection	O
techniques	O
including	O
pyrosequencing	O
,	O
MassARRAY	O
analysis	O
,	O
and	O
quantitative	O
methylation	O
-	O
specific	O
polymerase	O
chain	O
reaction	O
(	O
Ang	O
et	O
al	O
.	O

We	O
have	O
previously	B
shown	I
that	O
higher	O
vitamin	O
D	O
status	O
in	O
late	O
pregnancy	O
and	O
larger	O
increase	O
in	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
is	O
associated	B
with	O
lower	O
risk	O
of	O
preeclampsia	O
[	O
3	O
].	O

A	O
P	O
-	O
value	O
≤	O
0	O
.	O
05	O
was	O
considered	O
statistically	O
significant	O
.	O

This	O
is	O
similar	O
to	O
that	O
which	O
has	O
previously	B
been	O
shown	O
in	O
the	O
relationship	B
between	O
vitamin	O
D	O
status	O
at	O
≤	O
26	O
weeks	O
’	O
gestation	O
and	O
placental	O
pathology	O
in	O
pregnancy	O
[	O
51	O
]	O
suggesting	B
that	O
male	O
and	O
female	O
fetuses	O
respond	O
differently	O
to	O
maternal	O
vitamin	O
D	O
status	O
.	O

GSEA	O
analysis	O
.	O

Birth	O
outcome	O
data	O
were	O
defined	B
and	O
calculated	O
as	O
follows	O
:	O
(	O
1	O
)	O
gestational	O
age	O
at	O
delivery	O
was	O
calculated	O
using	O
LMP	O
,	O
if	B
available	I
,	O
or	O
gestational	O
age	O
at	O
any	O
ultrasound	O
obtained	O
from	O
antenatal	O
medical	O
records	O
(	O
seeSupplementary	O
material	O
A1for	O
gestational	O
age	O
calculation	O
algorithm	O
);	O
(	O
2	O
)	O
small	O
for	O
gestational	O
age	O
(	O
SGA	O
)	O
was	O
calculated	O
from	O
weight	O
and	O
gestational	O
age	O
at	O
delivery	O
according	B
to	I
the	O
International	O
Fetal	O
and	O
Newborn	O
Growth	O
Consortium	O
for	O
the	O
21st	O
Century	O
,	O
or	O
intergrowth	O
-	O
21st	O
standards	O
[	O
36	O
];	O
(	O
3	O
)	O
preterm	O
birth	O
(	O
PTB	O
)	O
was	O
defined	B
as	O
born	O
with	O
<	O
37	O
weeks	O
of	O
gestational	O
age	O
;	O
and	O
(	O
4	O
)	O
low	O
birth	O
weight	O
(	O
LBW	O
)	O
was	O
defined	B
as	O
born	O
weighing	O
<	O
2500	O
g	O
.	O
Statistical	O
analysis	O
We	O
compared	O
all	O
variables	O
by	O
vaccination	O
status	O
using	O
chi	O
-	O
square	O
test	O
to	O
compare	O
differences	O
between	O
vaccinated	O
and	O
unvaccinated	O
women	O
regardless	O
of	O
trimester	O
of	O
receipt	O
of	O
influenza	O
vaccination	O
.	O

All	O
identified	O
observational	O
cohort	O
studies	O
in	O
the	O
current	O
review	O
used	O
food	O
frequency	O
questionnaires	O
(	O
FFQs	O
)	O
to	O
assess	O
fish	O
intake	O
.	O

Details	O
of	O
study	O
participation	O
are	O
shown	O
inFigure	O
1	O
.	O

Development	O
research	O
Equipment	O
and	O
commodities	O
are	O
considered	B
essential	B
for	O
neonatal	O
care	O
units	O
in	O
high	O
-	O
income	O
countries	O
,	O
yet	B
for	O
many	O
such	O
units	O
in	O
low	O
-	O
income	O
settings	O
,	O
basic	O
equipment	O
and	O
essential	O
medicines	O
are	O
not	O
available	O
or	O
functional	O
.	O

Predictors	O
included	O
both	O
baseline	O
and	O
pregnancy	O
changes	O
over	O
time	O
(	O
between	O
entry	O
and	O
30	O
-	O
weeks	O
gestation	O
).	O

The	O
degree	O
of	O
risk	O
seems	B
to	O
be	O
directly	O
related	B
to	O
the	O
family	O
history	O
of	O
allergy	O
and	O
especially	O
to	O
maternal	O
atopy	O
,[	O
53	O
]	O
particularly	O
when	O
the	O
mother	O
has	O
diagnosed	O
atopic	O
eczema	O
and	O
has	O
elevated	O
IgE	O
levels	O
.	O

No	O
differences	O
in	O
large	O
for	O
gestational	O
age	O
,	O
macrosomia	O
,	O
neonatal	O
hypoglycemia	O
,	O
admission	O
to	O
neonatal	O
intensive	O
care	O
,	O
or	O
fetal	O
anomalies	O
were	O
observed	O
.	O

Our	O
analysis	O
of	O
the	O
relationship	B
between	O
the	O
extent	O
of	O
methylation	O
at	O
these	O
elements	O
and	O
genomewide	O
gene	O
-	O
associated	O
methylation	O
was	O
aimed	B
to	O
better	O
characterize	O
the	O
similarities	O
and	O
differences	O
in	O
the	O
potential	B
functional	O
importance	B
of	O
these	O
markers	O
.	O

The	O
key	B
factor	I
which	O
results	O
in	O
the	O
development	O
of	O
gestational	O
diabetes	O
appears	B
to	I
be	I
a	O
failure	O
to	O
compensate	O
with	O
increased	O
insulin	O
secretion	O
.	O
3As	O
the	O
increase	O
in	O
insulin	O
resistance	O
is	O
greatest	O
in	O
the	O
third	O
trimester	O
,	O
GDM	O
usually	B
develops	O
going	O
into	O
this	O
period	O
.	O

In	O
a	O
four	O
-	O
arm	O
cluster	O
-	O
randomized	O
controlled	O
trial	O
in	O
Pakistan	O
investigating	O
the	O
neonatal	O
mortality	O
effects	B
of	O
umbilical	O
cord	O
cleansing	O
with	O
chlorhexidine	O
and	O
handwashing	O
with	O
soap	O
promotion	O
separately	O
and	O
together	O
,	O
Soofi	O
and	O
colleagues	O
found	B
no	O
benefit	O
from	O
promoting	O
handwashing	O
with	O
soap	O
[	O
9	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Comparison	O
of	O
high	O
and	O
low	O
exposure	O
to	O
text4baby	O
messages	O
:	O
adjusted	O
and	O
unadjusted	O
GEE	O
models	O
.	O
Questionnaire	O
itemsHigh	O
vs	O
low	O
exposureUnadjustedAdjustedaOR	O
(	O
95	O
%	O
CI	O
)	O
P	O
OR	O
(	O
95	O
%	O
CI	O
)	O
P	O
Eating	O
5	O
or	O
more	O
fruits	O
and	O
vegetables	O
per	O
day	O
is	O
important	O
to	O
the	O
health	O
of	O
my	O
developing	O
baby0	O
.	O
744	O
(	O
0	O
.	O
138	O
,	O
4	O
.	O
003	O
).	O
732	O
.	O
511	O
(	O
0	O
.	O
158	O
,	O
39	O
.	O
867	O
).	O
51Taking	O
a	O
prenatal	O
vitamin	O
is	O
important	O
to	O
the	O
health	O
of	O
my	O
developing	O
baby0	O
.	O
760	O
(	O
0	O
.	O
115	O
,	O
5	O
.	O
000	O
).	O
774	O
.	O
216	O
(	O
0	O
.	O
201	O
,	O
88	O
.	O
417	O
).	O
35I	O
am	O
prepared	O
to	O
be	O
a	O
new	O
mother1	O
.	O
471	O
(	O
0	O
.	O
788	O
,	O
2	O
.	O
746	O
).	O
221	O
.	O
609	O
(	O
0	O
.	O
607	O
,	O
4	O
.	O
268	O
).	O
34If	O
I	O
visit	O
my	O
health	O
care	O
provider	O
on	O
a	O
regular	O
basis	O
,	O
I	O
will	O
be	O
a	O
healthy	O
new	O
mother1	O
.	O
033	O
(	O
0	O
.	O
607	O
,	O
1	O
.	O
759	O
).	O
901	O
.	O
288	O
(	O
0	O
.	O
585	O
,	O
2	O
.	O
834	O
).	O
53If	O
I	O
visit	O
my	O
health	O
care	O
provider	O
on	O
a	O
regular	O
basis	O
,	O
my	O
baby	O
will	O
be	O
healthy0	O
.	O
783	O
(	O
0	O
.	O
468	O
,	O
1	O
.	O
313	O
).	O
351	O
.	O
328	O
(	O
0	O
.	O
737	O
,	O
2	O
.	O
393	O
).	O
34Smoking	O
will	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby1	O
.	O
139	O
(	O
0	O
.	O
717	O
,	O
1	O
.	O
810	O
).	O
581	O
.	O
236	O
(	O
0	O
.	O
651	O
,	O
2	O
.	O
350	O
).	O
52Secondhand	O
smoke	O
will	O
not	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby	O
(	O
reverse	O
coded	O
*)	O
0	O
.	O
892	O
(	O
0	O
.	O
668	O
,	O
1	O
.	O
193	O
).	O
440	O
.	O
947	O
(	O
0	O
.	O
631	O
,	O
1	O
.	O
423	O
).	O
79Drinking	O
alcohol	O
will	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby1	O
.	O
088	O
(	O
0	O
.	O
655	O
,	O
1	O
.	O
808	O
).	O
740	O
.	O
803	O
(	O
0	O
.	O
451	O
,	O
1	O
.	O
431	O
).	O
45Taking	O
prenatal	O
vitamins	O
will	O
improve	O
the	O
health	O
of	O
my	O
developing	O
baby1	O
.	O
090	O
(	O
0	O
.	O
782	O
,	O
1	O
.	O
520	O
).	O
611	O
.	O
378	O
(	O
0	O
.	O
861	O
,	O
2	O
.	O
204	O
).	O
18BehaviorsSince	O
you	O
found	O
out	O
about	O
your	O
pregnancy	O
,	O
have	O
you	O
consumed	O
alcoholic	O
beverages	O
?	O
1	O
.	O
344	O
(	O
0	O
.	O
473	O
,	O
3	O
.	O
820	O
).	O
580	O
.	O
212	O
(	O
0	O
.	O
046	O
,	O
0	O
.	O
973	O
).	O
046In	O
the	O
last	O
30	O
days	O
,	O
did	O
you	O
smoke	O
?	O
0	O
.	O
938	O
(	O
0	O
.	O
490	O
,	O
1	O
.	O
794	O
).	O
851	O
.	O
271	O
(	O
0	O
.	O
406	O
,	O
3	O
.	O
980	O
).	O
68Ate	O
3	O
or	O
more	O
servings	O
of	O
fruit	O
a	O
day0	O
.	O
852	O
(	O
0	O
.	O
647	O
,	O
1	O
.	O
122	O
).	O
250	O
.	O
908	O
(	O
0	O
.	O
649	O
,	O
1	O
.	O
271	O
).	O
57Ate	O
3	O
or	O
more	O
servings	O
of	O
vegetables	O
a	O
day0	O
.	O
889	O
(	O
0	O
.	O
679	O
,	O
1	O
.	O
164	O
).	O
390	O
.	O
969	O
(	O
0	O
.	O
673	O
,	O
1	O
.	O
394	O
).	O
86Have	O
you	O
ever	O
gone	O
online	O
to	O
search	O
for	O
prenatal	O
care	O
information	O
?	O
0	O
.	O
992	O
(	O
0	O
.	O
661	O
,	O
1	O
.	O
488	O
).	O
970	O
.	O
893	O
(	O
0	O
.	O
519	O
,	O
1	O
.	O
536	O
).	O
68	O
aAdjusted	O
for	O
age	O
(	O
quintile	O
),	O
parity	O
,	O
imputed	O
marital	O
status	O
,	O
and	O
race	O
.	O

Conclusion	O
:	O
Maternal	O
serum	O
visfatin	O
level	O
shows	B
a	O
relationship	B
with	O
fetal	O
and	O
infant	O
anthropometric	O
indicators	O
,	O
with	O
different	B
effects	B
in	O
the	O
two	O
groups	O
,	O
suggesting	B
visfatin	O
dysfunction	O
in	O
the	O
overweight	O
group	O
before	O
pregnancy	O
.	O

According	B
to	I
our	O
results	O
,	O
a	O
maternal	O
caloric	O
restriction	O
prior	O
to	O
mating	O
could	B
be	I
critical	B
for	O
the	O
less	O
compulsive	O
feeding	O
observed	O
in	O
female	O
offspring	O
.	O

A	O
recent	B
cohort	O-
study	I
of	O
live	O
births	O
in	O
Denmark	O
from	O
1996	O
to	O
2005	O
involving	O
3	O
,	O
892	O
cases	O
of	O
ASD	O
found	B
no	O
significant	O
association	O
,	O
as	B
only	B
52	O
cases	O
of	O
SSRI	O
use	O
were	O
found	B
[	O
39	O
].	O

The	O
secondary	O
hypotheses	B
are	O
that	O
the	O
early	O
availability	O
and	O
promotion	O
of	O
IFA	O
supplements	O
in	O
intervention	O
clusters	O
will	B
reduce	O
preterm	O
delivery	O
by	O
30	O
%	O
(	O
15	O
%	O
in	O
control	O
to	O
10	O
.	O
5	O
%	O
in	O
intervention	O
),	O
and	O
low	O
birth	O
weight	O
by	O
30	O
%	O
(	O
15	O
%	O
in	O
control	O
to	O
10	O
.	O
5	O
%	O
in	O
intervention	O
).	O

On	O
an	O
isoenergetic	O
basis	O
,	O
pregnant	O
sows	O
were	O
fed	O
either	O
a	O
gestational	O
low	O
protein	O
diet	O
(	O
LP	O
,	O
6	O
%	O
CP	O
)	O
or	O
an	O
adequate	O
protein	O
diet	O
(	O
AP	O
,	O
12	O
%	O
CP	O
)	O
to	B
investigate	I
the	O
effects	B
on	O
hepatic	O
gene	O
expression	O
in	O
their	O
fetuses	O
and	O
offspring	O
.	O

Briefly	O
,	O
we	O
conducted	O
a	O
multicentre	O
randomised	O
trial	O
involving	O
women	O
with	O
a	O
singleton	O
pregnancy	O
,	O
between	O
10	O
+	O
0and	O
20	O
+	O
0weeks	O
’	O
gestation	O
,	O
and	O
body	O
mass	O
index	O
≥	O
25	O
.	O
0	O
kg	O
/	O
m2	O
,	O
who	O
were	O
randomised	O
to	O
either	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
(	O
Lifestyle	O
Advice	O
Group	O
)	O
or	O
standard	O
antenatal	O
care	O
(	O
Standard	O
Care	O
Group	O
)	O
[	O
22	O
].	O

Transcriptional	O
excursions	O
regarding	O
stress	O
and	O
immune	O
response	O
The	O
biological	O
effect	O
of	O
glucocorticoids	O
is	O
modulated	O
by	O
glucocorticoid	O
receptors	O
.	O

Conflict	O
of	O
interest	O
statement	O
The	O
authors	O
declare	O
that	O
the	O
research	O
was	O
conducted	O
in	O
the	O
absence	O
of	O
any	O
commercial	O
or	O
financial	O
relationships	O
that	O
could	O
be	O
construed	O
as	O
a	O
potential	O
conflict	O
of	O
interest	O
.	O

The	O
pellet	O
was	O
air	O
dried	O
for	O
5	O
min	O
and	O
resuspended	O
in	O
Buffer	O
2	O
(	O
7M	O
urea	O
,	O
2M	O
thiourea	O
,	O
1	O
%	O
C7bZO	O
).	O

LASSO	O
and	O
Elastic	O
Net	O
regression	O
coefficients	O
were	O
larger	O
in	O
size	O
but	B
with	O
less	B
precise	I
95	O
%	O
intervals	O
compared	B
to	I
BHLM	O
.	O

RMMCH	O
is	O
a	O
provincial	O
hospital	O
focusing	O
on	O
maternal	O
and	O
paediatric	O
healthcare	O
,	O
delivering	O
more	O
than	O
10	O
,	O
000	O
babies	O
annually	O
.	O

Epigenetics	O
encompasses	O
the	O
mechanisms	O
that	O
regulate	O
gene	O
expression	O
without	O
altering	O
the	O
underlying	O
DNA	O
sequence	O
,	O
and	O
the	O
complete	O
epigenetic	O
status	O
of	O
a	O
cell	O
at	O
any	O
given	O
time	O
is	O
termed	O
the	O
epigenome	O
.	O

Characteristics	O
of	O
the	O
women	O
in	O
the	O
two	O
treatment	O
arms	O
were	O
compared	O
using	O
the	O
t	O
test	O
,	O
Mann	O
-	O
Whitney	O
U	O
test	O
,	O
and	O
χ2test	O
for	O
normally	O
distributed	O
,	O
nonnormally	O
distributed	O
,	O
and	O
categorical	O
variables	O
,	O
respectively	O
.	O

One	O
likely	B
reason	B
for	O
the	O
difference	B
is	O
convenience	O
.	O

Thyroid	O
nodules	O
in	O
pregnancy	O
are	O
often	B
misdiagnosed	B
because	B
of	O
physiological	O
thyroid	O
increases	O
during	O
pregnancy	O
,	O
but	B
clinical	O
and	O
ultrasound	O
findings	O
are	O
sufficient	O
to	O
suspect	B
malignancy	O
.	O

In	O
the	O
first	O
dimension	O
,	O
rehydrated	O
strips	O
were	O
focused	O
using	O
an	O
ElectrophoretIQ3	O
isoelectric	O
focusing	O
system	O
(	O
Proteome	O
Systems	O
)	O
for	O
a	O
total	O
of	O
120	O
kVh	O
.	O

Means	O
are	O
adjusted	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
.	O

This	O
may	B
be	I
attributable	O
to	O
the	O
synergistic	O
effects	B
of	O
food	O
[	O
34	O
]	O
and	O
associated	B
with	O
fish	O
being	O
a	O
source	O
of	O
other	B
nutrients	O
which	O
are	O
important	B
for	O
infant	O
development	O
such	O
as	O
iodine	O
and	O
vitamin	O
D	O
.	O
Presently	O
,	O
there	O
have	B
been	I
no	B
randomised	O-
control	O-
trials	I
examining	O
neurocognitive	O
outcomes	O
associated	B
with	O
prenatal	O
multivitamin	O
use	O
and	O
infant	O
neurodevelopment	O
,	O
and	O
these	O
are	O
unlikely	B
to	O
occur	O
given	O
ethical	O
implications	B
of	O
such	O
[	O
35	O
].	O

The	O
notion	B
that	O
human	O
BAT	O
is	O
solely	O
apparent	O
during	O
the	O
neonatal	O
stage	O
prevailed	O
for	O
decades	O
(	O
Heaton	O
,	O
1972	O
;	O
Nedergaard	O
et	O
al	O
.,	O
2007	O
).	O

The	O
physiologically	O
elevated	O
position	O
of	O
the	O
diaphragm	O
and	O
hyperventilation	O
in	O
pregnancy	O
further	O
increase	O
the	O
risk	O
of	O
hypoxia	O
.	O

Still	B
,	O
we	O
cannot	B
rule	I
out	I
that	O
there	O
are	O
unknown	B
confounders	B
that	O
we	O
have	O
not	O
been	O
adjusted	O
for	O
,	O
for	O
example	O
drugs	O
influencing	B
levels	O
of	O
serum	O
lipids	O
or	O
family	O
history	O
of	O
psychiatric	O
illness	O
.	O

However	B
,	O
a	O
functional	O
role	B
for	O
ncDNA	O
was	O
inferred	B
from	O
the	O
strong	O
correlation	B
between	O
increasing	O
ncDNA	O
abundance	O
and	O
increasing	O
organism	O
complexity	O
(	O
Mattick2007	O
).	O

Fasting	O
and	O
post	O
-	O
prandial	O
glucose	O
testing	O
is	O
necessary	B
for	O
monitoring	O
and	O
guidance	O
of	O
therapy	O
.	O

All	O
participants	O
provided	O
written	O
informed	O
consent	O
to	O
participate	O
.	O

The	O
strength	O
of	O
this	B
study	I
is	O
its	O
focus	B
on	O
minority	O
women	O
who	O
are	O
underrepresented	O
in	O
published	O
GWG	O
interventions	O
yet	B
carry	O
increased	O
burden	B
of	O
gaining	O
excessively	O
during	O
pregnancy	O
.	O

Of	O
all	O
pregnancies	O
,	O
1	O
–	O
14	O
%	O
are	O
affected	B
by	O
GDM	O
[	O
9	O
],	O
and	O
globally	B
GDM	O
prevalence	B
has	B
been	I
increasing	O
in	B
line	I
with	I
increasing	O
obesity	O
[	O
10	O
].	O

According	O
to	O
this	O
,	O
AM251	O
was	O
specifically	O
able	O
to	O
reduce	O
chocolate	O
intake	O
in	O
CC	O
male	O
offspring	O
,	O
but	O
not	O
in	O
CC	O
females	O
or	O
RC	O
males	O
.	O

However	B
and	O
despite	B
these	O
limitations	B
,	O
there	O
is	O
a	O
wealth	B
of	I
literature	I
using	O
those	O
two	O
cell	O
lines	O
as	O
experimental	O
models	B
to	O
study	O
placental	O
function	O
.	O

[	O
6	O
]	O
Low	O
dietary	O
calcium	O
intake	O
and	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
associated	B
with	O
deleterious	O
effects	B
on	O
bone	O
mineral	O
homeostasis	O
.	O

Thus	B
,	O
while	B
it	O
is	O
important	B
to	O
fully	O
characterize	O
the	O
hazard	O
,	O
further	B
studies	I
at	O
doses	O
and	O
routes	O
of	O
administration	O
similar	B
to	I
those	O
found	B
in	O
humans	O
are	O
necessary	B
for	O
determining	O
relevance	O
to	O
public	B
health	I
.	O

Due	O
to	O
the	O
guidelines	O
for	O
providing	O
vitamin	O
D	O
supplements	O
to	O
all	O
breast	O
-	O
fed	O
infants	O
,	O
it	O
is	O
not	O
ethically	O
possible	O
to	O
conduct	O
a	O
placebo	O
-	O
controlled	O
study	O
of	O
vitamin	O
D	O
supplementation	O
in	O
the	O
United	O
States	O
.	O

The	O
future	B
of	O
mHealth	O
will	B
include	O
going	O
beyond	O
small	B
-	I
scale	I
pilots	O
and	O
trials	O
and	O
reaching	O
population	O
-	O
level	O
effects	B
through	O
large	O
-	O
scale	O
implementation	O
.	O

Iron	O
fortification	O
of	O
foods	O
might	B
be	O
particularly	B
useful	O
and	O
cost	O
effective	O
in	O
settings	O
where	O
the	O
logistics	O
of	O
oral	O
iron	O
supplementation	O
among	O
pregnant	O
women	O
are	O
highly	O
challenging	B
.	O

Abbreviations	O
25	O
(	O
OH	O
)	O
D	O
:	O
25	O
-	O
hydroxyvitamin	O
D	O
;	O
BMC	O
:	O
Bone	O
Mineral	O
Content	O
;	O
BMD	O
:	O
Bone	O
Mineral	O
Density	O
;	O
DXA	O
:	O
dual	O
-	O
energy	O
x	O
-	O
ray	O
absorptiometry	O
.	O

Both	O
Cell	O
-	O
dyn	O
and	O
Medonic	O
CA530	O
analysers	O
were	O
used	O
for	O
processing	O
of	O
haematological	O
samples	O
due	O
to	O
a	O
technical	O
fault	O
with	O
the	O
Cell	O
-	O
dyn	O
machine	O
.	O

We	O
investigated	O
the	O
offspring	O
'	O
s	O
hepatic	O
gene	O
expression	O
at	O
94	O
dpc	O
,	O
1	O
dpn	O
,	O
28	O
dpn	O
and	O
188	O
dpn	O
by	O
24	O
k	O
-	O
microarray	O
analysis	O
.	O

Maternal	O
vitamin	O
D	O
status	O
associated	B
with	O
birth	O
size	O
:	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
showed	B
a	O
positive	O
association	B
towards	O
birth	O
weight	O
,	O
but	B
UCB	O
25	O
(	O
OH	O
)	O
D	O
an	O
inverse	O
association	B
with	O
head	O
circumference	O
,	O
while	B
only	B
the	O
inverse	O
association	B
with	O
head	O
circumference	O
was	O
verified	B
with	O
linear	O
model	O
.	O

Another	O
study	O
investigating	O
the	O
effect	B
of	O
a	O
paternal	O
folate	O
-	O
deficient	O
diet	O
in	O
mice	O
found	O
a	O
relationship	B
with	O
decreased	O
placental	O
weight	O
,	O
placental	O
folate	O
and	O
an	O
increased	O
expression	O
of	O
the	O
folate	O
transporter	O
folate	O
receptor	O
[	O
7	O
].	O

Statistical	O
analysis	O
was	O
not	O
applied	O
to	O
the	O
relative	O
change	O
in	O
serum	O
25	O
(	O
OH	O
)	O
D	O
values	O
with	O
low	O
baseline	O
versus	O
high	O
baseline	O
data	O
as	O
there	O
is	O
currently	O
no	B
accepted	I
optimal	O
approach	O
for	O
such	O
an	O
evaluation	O
as	O
reviewed	O
recently	B
by	O
Tu	O
and	O
Gilthorpe	O
[	O
8	O
].	O

Estimated	O
BMI	O
correlations	O
,	O
employing	O
the	O
mixed	O
models	O
,	O
and	O
adjusting	O
for	O
age	O
,	O
are	O
shown	O
at	O
each	O
time	O
point	O
for	O
the	O
children	O
and	O
across	O
generations	O
are	O
then	O
displayed	O
intable	O
4	O
.	O

Baseline	O
predictors	B
of	O
anaemia	O
,	O
after	O
adjustment	O
(	O
Table	O
4	O
),	O
included	O
older	O
age	O
OR	O
=	O
2	O
.	O
01	O
(	O
1	O
.	O
16	O
,	O
3	O
.	O
48	O
)	O
and	O
economic	O
deficit	O
OR	O
=	O
1	O
.	O
98	O
(	O
1	O
.	O
21	O
,	O
3	O
.	O
25	O
).	O

Background	O
:	O
Since	O
classical	O
development	O
of	O
medicine	O
in	O
1920	O
,	O
Vitamin	O
D	O
(	O
cholecalciferol	O
,	O
VD	O
)	O
was	O
strongly	B
associated	B
with	O
rickets	O
,	O
after	O
observation	B
that	O
cod	O
liver	O
consumption	O
leads	B
to	O
a	O
regression	O
in	O
rickets	O
symptoms	O
[	O
3	O
].	O

The	O
study	O
was	O
approved	O
by	O
the	O
Institutional	O
Review	O
Boards	O
at	O
the	O
Miriam	O
Hospital	O
,	O
in	O
Providence	O
,	O
RI	O
.,	O
Women	O
and	O
Infants	O
Hospital	O
of	O
Rhode	O
Island	O
Providence	O
,	O
RI	O
and	O
California	O
Polytechnic	O
State	O
University	O
,	O
in	O
San	O
Luis	O
Obispo	O
,	O
Calif	O
.	O
2	O
.	O
2	O
.	O

Studies	O
have	O
consistently	B
found	O
that	O
higher	O
maternal	O
weight	O
entering	O
and	O
during	O
pregnancy	O
increases	O
risk	O
for	O
obesity	O
among	O
offspring	O
in	O
childhood	O
,	O
adolescence	O
,	O
and	O
adulthood	O
[	O
1	O
,	O
2	O
].	O

©	O
Phanie	O
/	O
Alamy	O
Stock	O
Photo	O
Caption	O
(	O
FIG	O
)	O
Education	O
and	O
counseling	O
have	B
been	I
important	B
tools	O
in	O
boosting	O
breastfeeding	O
rates	O
,	O
after	O
decades	O
of	O
marketing	O
messages	O
that	O
insinuated	B
breast	O
milk	O
was	O
insufficient	O
to	O
nourish	O
young	O
babies	O
.	O

Examining	O
large	O
groups	O
of	O
VD	O
-	O
deficient	O
patients	O
should	B
not	I
be	I
a	O
problem	O
—	O
most	B
societies	I
are	O
VD	O
-	O
deficient	O
either	O
way	O
.	O

Care	O
of	O
premature	O
babies	O
is	O
primarily	B
an	O
action	O
gap	B
As	B
evidenced	B
by	O
the	O
large	O
survival	O
gap	B
between	O
babies	O
born	O
in	O
high	O
-	O
income	O
countries	O
and	O
those	O
born	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
,	O
effective	B
interventions	B
exist	O
to	O
reduce	O
death	O
and	O
disability	O
in	O
premature	O
babies	O
,	O
yet	B
this	O
care	O
does	O
not	O
reach	O
the	O
poor	O
and	O
most	O
disadvantaged	O
populations	O
where	O
the	B
burden	I
is	O
highest	O
[	O
6	O
].	O

Conclusions	O
Despite	B
the	O
fact	O
that	O
the	O
seminal	O
work	O
on	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
was	O
published	O
over	O
a	O
decade	O
ago	O
,	O
this	O
area	O
of	O
research	O
largely	O
remains	B
in	O
its	O
infancy	O
,	O
striving	O
to	O
elucidate	B
putative	B
mechanisms	O
of	O
epigenetic	O
toxicity	O
and	O
identify	B
mechanistic	O
associations	B
in	O
human	O
cohorts	O
.	O

It	O
has	B
been	I
suggested	I
but	B
is	O
not	B
proven	I
that	O
early	O
life	O
calcium	O
absorption	O
is	O
primarily	B
non	O
-	O
vitamin	O
D	O
dependent	B
[	O
2	O
].	O

We	O
will	O
have	O
a	O
total	O
number	O
of	O
112	O
BRAC	O
PO	O
for	O
randomisation	O
.	O

Second	O
,	O
the	O
distribution	O
of	O
Bcl	O
I	O
polymorphism	O
seen	B
in	O
this	O
sample	O
may	B
be	I
unique	B
,	O
since	B
there	O
are	O
important	B
geographical	O
/	O
ethnic	O
differences	B
in	O
the	O
prevalence	B
of	O
these	O
polymorphisms	O
.	O

For	O
sustainable	O
effect	B
,	O
interventions	B
to	O
prevent	B
preterm	O
birth	O
in	O
the	O
preconception	O
and	O
antenatal	O
periods	O
and	O
to	O
reduce	O
death	O
and	O
disability	O
in	O
premature	O
babies	O
must	B
be	I
integrated	O
within	O
the	O
existing	O
health	O
system	O
.	O

It	O
has	B
been	I
suggested	I
that	O
these	O
results	O
may	B
reflect	B
a	O
regression	O
to	O
the	O
mean	O
phenomenon	O
or	B
may	B
be	I
related	B
in	B
part	I
to	O
measurement	O
variability	B
(	O
8	O
).	O

Preventive	O
Treatments	O
of	O
Iron	O
Deficiency	O
Anaemia	O
in	O
Pregnancy	O
:	O
A	O
Review	O
of	O
Their	O
Effectiveness	O
and	O
Implications	B
for	O
Health	O
System	O
Strengthening	O
Abstract	O
Objectives	O
.	O

This	B
study	I
aimed	B
to	B
evaluate	I
the	O
relationship	B
between	O
nutritional	O
knowledge	O
and	O
the	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
during	O
pregnancy	O
and	O
to	B
assess	I
the	O
influence	B
of	O
socio	O
-	O
demographic	O
factors	O
and	O
prenatal	O
care	O
.	O

Considering	B
the	O
possible	B
losses	O
,	O
the	O
sample	O
size	O
was	O
set	O
at	O
74	O
people	O
in	O
each	O
group	O
finally	O
.	O

2	O
.	O
10	O
.	O

These	O
surveys	O
were	O
conducted	O
at	O
3	O
and	O
12	O
months	O
post	O
-	O
implementation	O
[	O
15	O
].	O

Another	B
study	I
found	B
increased	O
sympathetic	O
activation	O
and	O
reduced	O
parasympathetic	O
activity	O
,	O
demonstrating	B
autonomic	O
imbalance	O
only	B
in	O
women	O
with	O
low	O
birth	O
weight	O
who	O
submitted	O
to	O
a	O
stress	O
test	O
[	O
20	O
].	O

Twelve	O
mothers	O
of	O
our	O
13	O
infants	O
with	O
IIH	O
received	O
antenatal	O
vitamin	O
D3supplementation	O
.	O

One	O
child	O
in	O
the	O
first	O
sample	O
(	O
1	O
week	O
after	O
the	O
first	O
dose	O
in	O
November	O
,	O
2008	O
)	O
and	O
one	O
in	O
the	O
spring	O
sample	O
(	O
a	O
month	O
after	O
the	O
second	O
dose	O
)	O
of	O
the	O
intervention	O
group	O
had	O
results	O
greater	O
than	O
375	O
nmol	O
/	O
L	O
—	O
a	O
toxic	O
level	O
.	O
6	O
Discussion	O
Our	O
trial	O
in	O
a	O
population	O
known	O
to	O
be	O
vitamin	O
D	O
deficient	O
shows	O
that	O
100	O
000	O
IU	O
(	O
2	O
·	O
5	O
mg	O
)	O
of	O
vitamin	O
D3supplementation	O
once	O
every	O
3	O
months	O
did	O
not	O
affect	O
the	O
incidence	O
or	O
severity	O
of	O
childhood	O
pneumonia	O
,	O
in	O
this	O
population	O
.	O

Although	B
there	O
was	O
no	O
difference	O
in	O
the	O
rate	O
of	O
clinical	O
infection	O
diagnosis	O
between	O
the	O
two	O
arms	O
of	O
the	O
parent	O
trial	O
,	O
longitudinal	O
malaria	O
exposure	O
may	B
have	O
been	O
an	O
effect	B
modifier	I
or	O
confounding	B
variable	O
in	O
this	O
study	O
and	O
ought	O
to	O
be	O
assessed	B
formally	O
in	O
future	B
work	I
.	O

The	O
plasma	O
levels	O
of	O
leptin	O
were	O
measured	O
using	O
a	O
commercial	O
rat	O
leptin	O
ELISA	O
kit	O
(	O
Cat	O
.	O

As	O
in	O
vaginally	O
delivered	O
infants	O
,	O
maternal	O
fish	O
and	O
seafood	O
intake	O
was	O
positively	O
associated	B
with	O
OTUs	O
in	O
the	O
genus	O
Streptococcus	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S5c	O
).	O

Corresponding	O
maternal	O
vitamin	O
D	O
status	O
at	O
different	O
gestations	O
during	O
pregnancy	O
was	O
unknown	B
.	O

However	B
,	O
the	O
exposed	O
group	O
did	O
have	O
a	O
significantly	O
increased	O
rate	O
of	O
LGA	O
neonates	O
.	O

Further	B
study	B
is	I
needed	I
to	O
clarify	O
the	O
effects	B
of	O
dietary	O
vitamin	O
D	O
on	O
MS	O
and	O
QG	O
in	O
beef	O
cattle	O
.	O

We	O
analysed	O
free	O
sugar	O
intake	O
in	O
quintiles	O
:	O
1	O
)	O
as	O
a	O
categorical	O
variable	O
using	O
the	O
lowest	O
quintile	O
as	O
reference	O
to	O
allow	O
for	O
a	O
nonlinear	O
pattern	O
of	O
association	O
and	O
2	O
)	O
as	O
a	O
continuous	O
variable	O
to	O
test	O
for	O
linear	O
trend	O
(	O
i	O
.	O
e	O
.	O

We	O
know	B
a	O
lot	O
about	O
the	O
benefits	B
of	O
breastfeeding	O
for	O
mothers	O
and	O
babies	O
,	O
says	O
Alison	O
Stuebe	O
,	O
an	O
obstetrician	O
/	O
gynecologist	O
at	O
the	O
University	O
of	O
North	O
Carolina	O
School	O
of	O
Medicine	O
,	O
but	B
“	O
we	O
know	B
far	O
less	B
than	O
we	O
should	O
about	O
how	B
the	O
breast	O
functions	O
in	O
lactation	O
and	O
what	B
specific	O
factors	B
might	B
be	O
making	O
it	O
harder	B
than	O
evolution	O
had	O
intended	O
.”	O
“	O
Very	B
few	I
studies	O
have	O
looked	B
at	I
the	O
factors	B
that	O
may	B
interfere	B
with	O
lactation	O
,”	O
agrees	O
Philippe	O
Grandjean	O
,	O
an	O
epidemiologist	O
at	O
the	O
Harvard	O
School	O
of	O
Public	O
Health	O
and	O
the	O
University	O
of	O
Southern	O
Denmark	O
.	O

It	O
is	O
important	B
that	O
the	O
type	O
of	O
fish	O
consumed	O
is	O
low	O
in	O
mercury	O
.	O

Academic	O
and	O
research	O
institutions	O
:	O
Invest	O
•	O
Agree	O
upon	O
and	O
promote	O
an	O
innovative	B
research	B
agenda	I
for	O
prevention	B
of	O
preterm	O
birth	O
and	O
improved	O
pregnancy	O
outcomes	O
and	O
implementation	O
research	O
to	O
reduce	O
deaths	O
from	O
preterm	O
birth	O
.	O

Hence	B
,	O
iron	O
supplementation	O
in	O
pregnancy	O
has	O
become	O
a	O
standard	O
and	O
routine	O
practice	O
as	B
a	O
preventive	O
treatment	O
for	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
in	O
developing	O
countries	O
.	O

If	B
these	O
measures	O
are	O
unsuccessful	B
,	O
then	O
prescription	O
of	O
antiacid	O
drugs	O
should	B
be	I
considered	B
,	O
for	O
example	O
,	O
in	O
the	O
form	O
of	O
a	O
step	O
-	O
up	O
program	O
beginning	O
with	O
antacids	O
,	O
and	O
in	O
case	O
of	O
failure	B
with	O
histamine	O
-	O
2	O
receptor	O
antagonists	O
,	O
whereas	B
proton	O
pump	O
inhibitors	O
should	B
only	B
be	O
used	O
in	O
women	O
with	O
intractable	B
symptoms	O
or	O
complicated	B
reflux	O
disease	O
[	O
111	O
,	O
112	O
].	O

However	B
,	O
allergen	O
avoidance	O
may	B
not	O
be	O
preventive	O
or	O
practical	O
in	O
all	O
cohorts	O
[	O
113	O
].	O

Indeed	O
,	O
resistance	O
to	O
the	O
development	O
of	O
obesity	O
has	O
at	B
least	I
partly	B
been	O
attributed	O
to	O
elevated	O
recruitment	O
of	O
brown	O
adipocytes	O
in	O
skeletal	O
muscle	O
or	O
WAT	O
(	O
Guerra	O
et	O
al	O
.,	O
1998	O
;	O
Almind	O
et	O
al	O
.,	O
2007	O
;	O
Veyrat	O
-	O
Durebex	O
et	O
al	O
.,	O
2009	O
;	O
Harms	O
and	O
Seale	O
,	O
2013	O
).	O

The	O
fetal	O
vitamin	O
D	O
status	O
is	O
dependent	B
on	O
the	O
placental	O
-	O
fetal	O
circulation	O
.	O

Eligible	O
females	O
were	O
invited	O
to	O
attend	O
a	O
recruitment	O
clinic	O
where	O
informed	O
consent	O
was	O
sought	O
in	O
writing	O
from	O
individuals	O
or	O
guardians	O
,	O
in	O
the	O
cases	O
of	O
girls	O
under	O
18	O
-	O
years	O
old	O
.	O

The	O
tailing	O
reactions	O
including	O
2	O
µg	O
RNA	O
samples	O
(	O
500	O
ng	O
/	O
µl	O
),	O
4	O
µl	O
of	O
5	O
×	O
Escherichia	O
coli	O
poly	O
(	O
A	O
)	O
polymerase	O
(	O
E	O
-	O
PAP	O
)	O
buffer	O
,	O
2	O
µl	O
of	O
25	O
mM	O
-	O
MgCl2	O
,	O
2	O
µl	O
of	O
10	O
mM	O
-	O
ATP	O
and	O
0	O
.	O
8	O
µl	O
E	O
-	O
PAP	O
(	O
2	O
U	O
/	O
µl	O
)	O
adjusted	O
to	O
20	O
µl	O
with	O
nuclease	O
-	O
free	O
water	O
.	O

A	O
study	O
of	O
pregnant	O
women	O
in	O
the	O
rural	O
central	O
highlands	O
in	O
2001	O
identified	B
anaemia	O
prevalence	B
in	O
pregnant	O
women	O
,	O
post	O
-	O
partum	O
women	O
and	O
non	O
-	O
pregnant	O
women	O
of	O
53	O
%,	O
62	O
%	O
and	O
54	O
%	O
respectively	O
[	O
11	O
].	O

A	O
significant	O
role	B
for	O
folate	O
in	O
the	O
complete	O
vitamin	O
mixture	O
in	O
determining	O
the	O
effect	B
of	O
the	O
HV	O
diet	O
was	O
supported	B
by	O
the	O
reductions	O
in	O
food	O
intake	O
,	O
body	O
weight	O
and	O
blood	O
glucose	O
.	O

The	O
relationship	O
between	O
visfatin	O
level	O
and	O
neonatal	O
anthropometric	O
indicators	O
at	O
birth	O
In	O
group	O
A	O
,	O
a	O
strong	O
positive	O
relationship	B
was	O
observed	B
between	O
birth	O
head	O
circumference	O
and	O
the	O
first	O
(	O
p1	O
=	O
0	O
.	O
05	O
,	O
r1	O
=	O
0	O
.	O
580	O
)	O
and	O
second	O
trimester	O
visfatin	O
levels	O
(	O
p2	O
=	O
0	O
.	O
051	O
,	O
r2	O
=	O
0	O
.	O
530	O
).	O

)—	O
High	O
Frequency	O
in	O
Normalized	O
Units	O
.	O

For	O
categorical	O
analysis	O
of	O
vitamin	O
D	O
levels	O
,	O
we	O
used	O
cutoff	O
values	O
of	O
:	O
sufficient	O
(⩾	O
50	O
nmol	O
l	O
−	O
1	O
)	O
and	O
deficient	O
(<	O
50	O
nmol	O
l	O
−	O
1	O
).	O
28	O
,	O
29	O
,	O
30	O
,	O
31	O
Statistical	O
analysis	O
Distributions	O
of	O
continuous	O
variables	O
were	O
evaluated	O
for	O
normality	O
graphically	O
using	O
histogram	O
and	O
box	O
plots	O
and	O
are	O
described	O
using	O
means	O
and	O
s	O
.	O
d	O
.	O

For	O
both	O
first	O
and	O
third	O
trimester	O
women	O
there	O
was	O
a	O
clear	O
seasonal	O
trend	B
in	O
the	O
mean	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentrations	O
with	O
lowest	O
concentrations	O
in	O
winter	O
and	O
highest	O
during	O
spring	O
and	O
summer	O
,	O
while	O
decreasing	O
again	O
in	O
autumn	O
.	O

Live	O
-	O
born	O
infants	O
at	O
6	O
-	O
months	O
of	O
age	O
,	O
and	O
whose	O
mother	O
provided	O
consent	O
to	O
ongoing	O
follow	O
-	O
up	O
were	O
eligible	O
.	O

Fasting	O
glucose	O
and	O
HbA1cwere	O
lowest	O
among	O
Greek	O
patients	O
with	O
type	O
2	O
diabetes	O
during	O
August	O
and	O
September	O
[	O
23	O
].	O

It	O
is	O
also	O
important	B
to	O
consider	B
,	O
however	B
,	O
early	O
ex	O
utero	O
exposures	O
.	O

In	O
this	O
context	O
,	O
it	O
is	O
plausible	B
in	O
our	O
experimental	O
model	B
that	O
RC	O
offspring	O
did	O
not	O
showed	O
underweight	O
and	O
,	O
therefore	B
,	O
hyperphagia	O
in	O
any	O
stage	O
.	O

The	O
uncovering	B
of	O
the	O
magnitude	O
of	O
vitamin	O
D	O
deficiency	O
in	O
pregnant	O
women	O
in	O
Belgium	O
(	O
and	O
Western	O
Europe	O
)	O
should	B
be	I
translated	O
into	O
new	B
research	I
in	O
order	O
to	O
fill	O
the	O
huge	O
knowledge	B
gap	I
concerning	B
the	O
adequate	O
amount	O
of	O
vitamin	O
D	O
to	O
prevent	O
and	O
treat	O
vitamin	O
D	O
deficient	O
pregnant	O
women	O
.	O

In	O
brief	O
,	O
800	O
secundigravida	O
women	O
,	O
who	O
had	O
previously	O
delivered	O
a	O
macrosomic	O
infant	O
(>	O
4000	O
g	O
),	O
were	O
randomised	O
to	O
receive	O
either	O
low	O
glycaemic	O
index	O
dietary	O
advice	O
or	O
usual	O
care	O
(	O
no	O
dietary	O
advice	O
)	O
[	O
34	O
].	O

Those	O
who	O
had	O
a	O
longer	O
period	O
of	O
weekly	O
supplementation	O
prior	O
to	O
pregnancy	O
maintained	O
higher	O
Hb	O
concentration	O
during	O
pregnancy	O
[	O
20	O
].	O

We	O
observed	O
a	O
negative	O
association	B
between	O
fruit	O
intake	O
and	O
OTUs	O
of	O
the	O
genus	O
Bifidobacterium	O
and	O
a	O
positive	O
association	B
with	O
OTUs	O
in	O
the	O
Clostridiaceae	O
family	O
in	O
the	O
infant	O
gut	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S2d	O
).	O

Serum	O
VD	O
level	O
correlated	B
well	O
with	O
its	O
follicular	O
concentration	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
and	O
was	O
inversely	O
proportional	O
to	O
BMI	O
of	O
the	O
patients	O
(	O
p	O
=	O
0	O
.	O
04	O
)	O
[	O
54	O
].	O

This	O
was	O
the	O
first	B
use	O
of	O
a	O
newly	B
developed	O
questionnaire	O
,	O
which	O
we	O
administered	O
2	O
–	O
3	O
days	O
after	O
delivery	O
,	O
to	O
include	O
women	O
who	O
may	B
not	O
have	O
engaged	O
with	O
prenatal	O
care	O
.	O

The	O
results	O
from	O
this	B
study	I
may	B
serve	B
as	I
a	I
basis	I
for	O
the	O
development	O
of	O
context	O
-	O
specific	O
nutritional	O
interventions	O
which	O
can	O
improve	O
birth	O
outcomes	O
and	O
long	O
-	O
term	O
quality	O
of	O
life	O
of	O
the	O
mother	O
and	O
her	O
offspring	O
.	O

However	B
,	O
few	O
obesity	O
interventions	O
show	B
clinically	O
or	O
statistically	O
significant	O
weight	O
loss	O
beyond	O
the	O
intervention	O
period	O
(	O
100	O
),	O
which	O
suggests	B
that	O
new	B
and	O
more	B
comprehensive	I
interventions	B
are	I
needed	I
.	O

However	B
,	O
these	O
changes	O
with	O
slaugther	O
age	O
were	O
not	B
observed	I
in	O
double	O
-	O
muscled	O
Belgian	O
Blue	O
bulls	O
[	O
24	O
].	O

Eligible	O
criteria	O
included	O
singleton	O
pregnant	O
women	O
during	O
the	O
first	O
trimester	O
without	O
any	O
medical	O
condition	O
,	O
use	O
of	O
medications	O
,	O
and	O
without	O
following	O
a	O
specific	O
diet	O
.	O

One	O
option	O
would	B
be	I
a	O
national	O
or	O
multinational	O
study	O
based	O
on	O
randomization	O
of	O
school	O
districts	O
or	O
other	O
suitable	O
units	O
in	O
regions	O
of	O
low	O
sunlight	O
intensity	O
,	O
perhaps	B
including	O
multiple	O
outcomes	O
that	O
might	B
be	O
affected	B
by	O
vitamin	O
D	O
,	O
such	O
as	O
diabetes	O
,	O
obesity	O
,	O
respiratory	O
infections	O
,	O
and	O
asthma	O
.	O
4546Alternatively	B
,	O
high	O
-	O
risk	O
first	O
-	O
degree	O
relatives	O
of	O
individu	O
-	O
als	O
with	O
MS	O
could	B
be	I
targeted	O
in	O
a	O
smaller	O
trial	O
,	O
47although	B
randomization	O
and	O
compliance	O
could	B
be	I
more	O
challenging	B
.	O

Furthermore	O
,	O
women	O
with	O
highest	O
quartile	O
of	O
traditional	O
dietary	O
pattern	O
had	O
significantly	O
higher	O
social	O
-	O
economic	O
level	O
,	O
education	O
,	O
and	O
husband	O
'	O
s	O
education	O
compared	O
with	O
those	O
in	O
the	O
lowest	O
quartile	O
.	O

Maternal	O
diet	O
may	B
influence	B
the	O
infant	O
gut	O
microbiome	O
through	O
vertical	O
transfer	O
of	O
maternal	O
microbes	O
to	O
infants	O
during	O
vaginal	O
delivery	O
and	O
breastfeeding	O
.	O

The	O
classical	O
frequency	O
low	O
frequency	O
(	O
LF	O
=	O
0	O
.	O
041	O
–	O
0	O
.	O
15	O
Hz	O
)	O
and	O
high	O
frequency	O
(	O
HF	O
=	O
0	O
.	O
15	O
–	O
0	O
.	O
40	O
Hz	O
)	O
bands	O
were	O
expressed	O
in	O
normalized	O
units	O
(	O
n	O
.	O
u	O
.).	O

Moreover	O
,	O
we	O
demonstrate	B
for	O
the	O
first	B
time	I
the	O
expression	O
of	O
GAS5	O
in	O
human	O
placentas	O
.	O

The	O
nucleus	O
accumbens	O
(	O
NAc	O
)	O
were	O
sampled	O
from	O
all	O
animals	O
according	O
to	O
boundaries	O
determined	O
from	O
a	O
standard	O
rat	O
brain	O
atlas	O
[	O
22	O
].	O

A	O
70	O
%	O
lower	O
risk	B
of	O
PTB	O
was	O
found	B
for	O
women	O
≥	O
20	O
ng	O
/	O
mL	O
vs	O
.	O
<	O
20	O
ng	O
/	O
mL	O
in	O
a	B
study	I
by	O
Perez	O
-	O
Ferre	O
et	O
al	O
.	O

2007	O
).	O

Correlated	O
variables	O
are	O
aggregated	O
by	O
factor	O
analysis	O
.	O

The	O
mean	O
birth	O
weight	O
of	O
our	O
study	O
cohort	O
was	O
3119	O
g	O
and	O
12	O
.	O
8	O
%	O
of	O
our	O
study	O
population	O
was	O
SGA	O
.	O

Vitamin	O
D	O
and	O
calcium	O
deficiency	O
can	B
lead	B
to	I
maternal	O
anorexia	O
with	O
poor	O
weight	O
gain	O
,	O
and	O
impaired	O
bone	O
ossification	O
or	O
osteopenia	O
among	O
newborn	O
infant	O
..	O
Neonatal	O
hypocalcemia	O
with	O
seizures	O
is	O
not	B
uncommon	I
in	O
D	O
-	O
vitamin	O
deficient	O
mothers	O
.	O

VDR	O
and	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
normally	B
increase	O
skeletal	O
muscle	O
function	O
.	O

Any	O
unexpected	O
test	O
result	O
and	O
any	O
symptoms	O
that	O
change	O
over	O
time	O
should	B
be	I
reevaluated	O
after	O
pregnancy	O
.	O

This	O
program	O
has	O
several	O
limitations	B
:	O
the	O
high	O
proportion	O
of	O
concentrate	O
in	O
the	O
diet	O
and	O
long	O
fattening	O
period	O
(>	O
30	O
months	O
,	O
especially	O
in	O
Korean	O
cattle	O
and	O
Japanese	O
Black	O
cattle	O
)	O
may	B
increase	O
feed	O
costs	O
.	O

For	O
searches	O
performed	O
using	O
MASCOT	O
,	O
E	O
-	O
value	O
and	O
Score	O
,	O
as	O
well	O
as	O
matching	O
peptides	O
and	O
sequence	O
coverage	O
,	O
were	O
used	O
to	O
determine	O
matches	O
.	O

Associations	O
between	O
SNPs	O
and	O
change	O
in	O
25	O
(	O
OH	O
)	O
D	O
from	O
14	O
to	O
34	O
weeks	O
of	O
gestation	O
following	O
supplementation	O
with	O
1000	O
IU	O
/	O
d	O
cholecalciferol	O
.	O

In	O
particular	O
the	O
Denver	O
test	O
,	O
utilised	O
in	O
the	O
ALSPAC	O
study	O
[	O
18	O
]	O
has	B
been	I
criticised	B
for	O
its	O
low	O
specificity	O
and	O
potentially	B
outdated	O
‘	O
norm	O
’	O
as	O
it	O
was	O
standardised	O
in	O
1980	O
[	O
30	O
].	O

In	O
attention	O
to	O
exclusion	O
criteria	O
(	O
not	O
to	O
give	O
blood	O
sample	O
or	O
usage	O
of	O
vitamin	O
D	O
supplement	O
during	O
the	O
study	O
period	O
)	O
none	O
of	O
the	O
case	O
and	O
control	O
populations	O
were	O
not	O
excluded	O
from	O
our	O
research	O
.	O

Concurrently	O
,	O
we	O
also	O
examined	B
maternal	O
variables	O
known	B
to	O
potentially	B
affect	B
vitamin	O
D	O
levels	O
and	O
SGA	O
in	O
an	O
effort	O
to	O
better	B
understand	I
the	O
role	B
of	O
these	O
risk	B
factors	I
in	O
vitamin	O
D	O
levels	O
and	O
risk	O
of	O
SGA	O
.	O

Although	B
previously	B
suggested	B
that	O
pregnant	O
women	O
with	O
risks	O
avoid	O
peanuts	O
,	O
a	O
subsequent	B
study	I
found	B
no	B
evidence	I
of	O
prenatal	O
sensitization	O
from	O
maternal	O
consumption	O
of	O
peanuts	O
[	O
100	O
].	O

Maternal	O
short	O
stature	O
is	O
,	O
in	O
turn	O
,	O
a	O
risk	O
factor	O
for	O
birth	O
complications	O
[	O
24	O
]	O
–	O
illustrating	O
the	O
intergenerational	O
effect	B
of	O
poor	O
nutrition	O
.	O

(	O
2016	O
),	O
could	B
impair	O
the	O
sympathetic	O
neurotransmission	O
and	O
hormones	O
involved	B
in	O
energy	O
metabolism	O
(	O
Di	O
Marzo	O
et	O
al	O
.,	O
2001	O
;	O
Keimpema	O
et	O
al	O
.,	O
2013	O
,	O
2014	O
;	O
Cristino	O
et	O
al	O
.,	O
2014	O
).	O

This	O
led	B
to	I
the	O
hypothesis	B
that	O
the	O
age	O
of	O
menarche	O
is	O
directly	O
linked	B
to	O
a	O
critical	O
degree	O
of	O
body	O
fat	O
[	O
8	O
];	O
however	B
although	B
prepubertal	O
nutrition	O
and	O
the	O
age	O
of	O
puberty	O
are	O
certainly	O
associated	B
in	O
some	B
way	O
,	O
this	B
concept	I
did	B
not	I
stand	O
up	O
to	O
critical	O
analysis	O
of	O
the	O
data	O
[	O
9	O
].	O

Nevertheless	B
,	O
fair	O
correlations	B
between	O
mother	O
and	O
cord	O
blood	O
were	O
found	B
in	O
previous	B
and	O
this	B
study	I
as	O
well	O
[	O
9	O
].	O

Assessing	O
self	O
-	O
reported	O
influenza	O
vaccination	O
We	O
assessed	O
the	O
validity	O
of	O
self	O
-	O
reporting	O
influenza	O
vaccination	O
or	O
non	O
-	O
vaccination	O
through	O
random	O
sampling	O
of	O
the	O
self	O
-	O
reported	O
vaccinated	O
and	O
unvaccinated	O
group	O
.	O

Results	O
Dams	O
and	O
pregnancies	O
No	O
differences	O
were	O
observed	O
in	O
weight	O
gain	O
,	O
litter	O
size	O
,	O
or	O
the	O
number	O
of	O
dead	O
pups	O
in	O
either	O
generation	O
between	O
the	O
mothers	O
in	O
the	O
SC	O
and	O
VitD	O
-	O
groups	O
(	O
data	O
not	O
shown	O
).	O

Partial	O
adherence	O
to	O
the	O
model	B
of	O
care	O
may	B
have	O
attenuated	O
changes	O
in	O
medication	O
requirements	O
and	O
dietary	O
patterns	O
.	O

Blood	O
glucose	O
monitoring	O
Women	O
with	O
GDM	O
should	B
perform	O
home	O
blood	O
glucose	O
monitoring	O
.	O

No	O
interaction	O
between	O
diet	O
and	O
sex	O
was	O
detected	O
in	O
hypothalamus	O
,	O
but	B
it	O
was	O
found	B
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Mgll	O
in	O
liver	O
,	O
and	O
Faah	O
,	O
Dagl	O
α	O
,	O
and	O
Dagl	O
β	O
in	O
PAT	O
(	O
TableS2	O
).	O

On	B
the	I
other	I
hand	I
,	O
it	O
might	B
be	O
associated	B
to	O
the	O
transcriptional	O
excursions	O
within	O
the	O
lipid	O
metabolism	O
in	O
LP	O
offspring	O
.	O

The	O
colored	O
dots	O
indicate	O
the	O
degree	O
of	O
average	O
class	O
methylation	O
.	O

Therefore	B
,	O
it	B
is	I
possible	I
that	O
the	O
RAS	O
hyperactivity	O
could	O
,	O
at	B
least	I
in	I
part	I
,	O
mediate	B
the	O
impairment	O
of	O
cardiac	O
vagal	O
tone	O
observed	B
in	O
low	O
birth	O
weight	O
children	O
.	O

Antenatal	O
corticosteroids	O
and	O
Kangaroo	O
Mother	O
Care	O
(	O
KMC	O
)	O
are	O
evidence	B
-	I
based	I
interventions	B
that	O
are	O
feasible	B
to	O
scale	O
up	O
in	O
low	O
-	O
resource	O
settings	O
and	O
may	B
serve	B
as	O
entry	O
points	O
for	O
strengthening	O
health	O
systems	O
[	O
20	O
,	O
21	O
].	O

but	B
sometimes	B
thyroidectomised	O
women	O
need	B
more	O
.	O

Black	O
and	O
Hispanic	O
children	O
also	O
had	O
significantly	O
different	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
at	O
the	O
time	O
of	O
follow	O
-	O
up	O
visit	O
(	O
p	O
=	O
0	O
.	O
023	O
).	O

In	O
addition	O
,	O
a	O
systematic	O
review	O
of	O
several	B
studies	I
found	B
no	B
clear	I
negative	O
association	B
between	O
early	O
solid	O
food	O
introduction	O
and	O
the	O
development	O
of	O
asthma	O
,	O
food	O
allergy	O
,	O
AR	O
,	O
or	O
animal	O
dander	O
allergy	O
[	O
89	O
].	O

Optimising	O
the	O
pre	O
-	O
and	O
inter	O
-	O
pregnancy	O
micronutritional	O
status	O
of	O
women	O
,	O
particularly	B
in	O
low	O
resource	O
settings	O
could	B
be	I
extremely	B
beneficial	O
(	O
Allen	O
2000	O
,	O
Bartley	O
et	O
al	O
2005	O
,	O
Huffman	O
SL	O
et	O
al	O
1998	O
,	O
Owens	O
and	O
Fall	O
2008	O
)	O
and	O
may	B
lead	B
to	I
improved	O
subsequent	O
maternal	O
and	O
pregnancy	O
outcomes	O
.	O

Omnibus	O
tests	O
for	O
the	O
overall	O
association	O
between	O
each	O
repetitive	O
methylation	O
and	O
class	O
methylation	O
were	O
obtained	O
by	O
permutation	O
test	O
,	O
using	O
a	O
test	O
analogous	O
to	O
a	O
Kolmogorov	O
–	O
Smirnov	O
test	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Sample	O
demographics	O
(	O
N	O
=	O
123	O
)	O
N	O
(%)	O
Maternal	O
age	O
(	O
years	O
)<	O
184	O
(	O
2	O
.	O
8	O
)	O
18	O
–	O
2460	O
(	O
41	O
.	O
7	O
)	O
25	O
–	O
3042	O
(	O
29	O
.	O
2	O
)>	O
3038	O
(	O
26	O
.	O
4	O
)	O
Pre	O
-	O
pregnancy	O
BMI	O
Under0	O
(	O
0	O
)	O
Normal48	O
(	O
39	O
.	O
0	O
)	O
Overweight41	O
(	O
33	O
.	O
3	O
)	O
Obese34	O
(	O
27	O
.	O
6	O
)	O
Country	O
of	O
origin	O
United	O
States30	O
(	O
24	O
.	O
4	O
)	O
Mexico59	O
(	O
48	O
.	O
0	O
)	O
Honduras13	O
(	O
10	O
.	O
6	O
)	O
Other	O
Latin	O
Am	O
.	O

2	O
.	O
2	O
.	O

In	O
animal	O
studies	O
,	O
therapeutic	O
immunity	O
to	O
intracranial	O
tumors	O
has	O
been	O
induced	O
by	O
peripheral	O
immunization	O
with	O
interleukin	O
-	O
4	O
(	O
IL	O
-	O
4	O
)	O
transduced	O
glioma	O
cells	O
[	O
100	O
,	O
101	O
].	O

Likewise	O
,	O
non	O
-	O
vaccination	O
status	O
was	O
corroborated	O
if	O
no	O
information	O
on	O
vaccination	O
including	O
specific	O
date	O
for	O
vaccination	O
was	O
identified	O
from	O
these	O
sources	O
.	O

Urine	O
parameters	O
(	O
Table	O
2	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Urine	O
parameters	O
.	O
ParametersF1	O
-	O
SCF1	O
-	O
VitD	O
-	O
F2	O
-	O
SCF2	O
-	O
VitD	O
-	O
WI	O
,	O
g	O
/	O
100	O
g	O
BM	O
/	O
day	O
16	O
.	O
3	O
±	O
1	O
.	O
014	O
.	O
4	O
±	O
1	O
.	O
615	O
.	O
2	O
±	O
1	O
.	O
113	O
.	O
3	O
±	O
1	O
.	O
3	O
Urine	O
output	O
0	O
.	O
05	O
±	O
0	O
.	O
0020	O
.	O
02	O
±	O
0	O
.	O
004	O
†	O
0	O
.	O
04	O
±	O
0	O
.	O
0060	O
.	O
04	O
±	O
0	O
.	O
004	O
Urea	O
,	O
mg	O
/	O
dL	O
36	O
.	O
5	O
±	O
3	O
.	O
8194	O
.	O
7	O
±	O
23	O
.	O
2	O
†	O
45	O
.	O
5	O
±	O
8	O
.	O
158	O
.	O
2	O
±	O
8	O
.	O
5	O
‡	O
Creatinine	O
,	O
mg	O
/	O
dL	O
1	O
.	O
2	O
±	O
0	O
.	O
13	O
.	O
3	O
±	O
0	O
.	O
2	O
†	O
1	O
.	O
0	O
±	O
0	O
.	O
11	O
.	O
4	O
±	O
0	O
.	O
1	O
‡	O
Uric	O
acid	O
,	O
mg	O
/	O
dL	O
0	O
.	O
6	O
±	O
0	O
.	O
21	O
.	O
2	O
±	O
0	O
.	O
60	O
.	O
5	O
±	O
0	O
.	O
10	O
.	O
9	O
±	O
0	O
.	O
3	O
Proteinuria	O
,	O
g	O
/	O
L	O
0	O
.	O
43	O
±	O
0	O
.	O
10	O
.	O
55	O
±	O
0	O
.	O
10	O
.	O
40	O
±	O
0	O
.	O
10	O
.	O
44	O
±	O
0	O
.	O
1	O
Data	O
were	O
kept	O
for	O
six	O
-	O
month	O
-	O
old	O
male	O
offspring	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
.	O

2008	O
).	O

In	O
addition	O
,	O
participants	O
with	O
GDM	O
in	O
this	B
study	I
were	O
mostly	B
urban	O
residents	O
with	O
a	O
higher	O
socioeconomic	O
status	O
.	O

Total	O
GWG	O
was	O
positively	O
predictive	O
of	O
higher	O
child	O
WFA	O
z	O
score	O
at	O
birth	O
(	O
beta	O
=.	O
41	O
;	O
t	O
=	O
4	O
.	O
9	O
;	O
P	O
=	O
.	O
0001	O
)	O
and	O
macrosomia	O
at	O
birth	O
(	O
OR	O
=	O
1	O
.	O
2	O
(	O
1	O
.	O
1	O
,	O
1	O
.	O
3	O
);	O
P	O
=	O
0	O
.	O
001	O
).	O

In	O
obese	O
mothers	O
,	O
lower	O
protein	O
intake	O
early	O
in	O
pregnancy	O
and	O
increased	O
protein	O
intakes	O
over	O
the	O
course	O
of	O
the	O
pregnancy	O
were	O
independently	O
related	B
to	O
higher	O
offspring	O
weight	O
at	O
6	O
months	O
.	O

The	O
recommendations	B
for	O
medical	O
treatment	O
have	B
been	I
summarized	O
by	O
a	O
Working	O
Group	O
of	O
the	O
National	O
Asthma	O
Education	O
and	O
Prevention	O
Program	O
in	O
a	O
report	O
on	O
managing	O
asthma	O
during	O
pregnancy	O
[	O
21	O
].	O

(	O
a	O
)	O
SC	O
offspring	O
and	O
(	O
b	O
)	O
VitD	O
-	O
offspring	O
in	O
the	O
F1	O
generation	O
;	O
(	O
c	O
)	O
SC	O
offspring	O
and	O
(	O
d	O
)	O
VitD	O
-	O
offspring	O
in	O
the	O
F2	O
generation	O
.	O

The	O
homozygous	O
low	O
-	O
frequency	O
allele	O
was	O
used	O
as	O
the	O
reference	O
group	O
,	O
with	O
the	O
β	O
representing	O
the	O
change	O
in	O
25	O
(	O
OH	O
)	O
D	O
(	O
nmol	O
/	O
L	O
)	O
per	O
common	O
allele	O
(	O
additive	O
model	O
).	O

It	O
is	O
also	O
needed	O
for	O
bone	O
growth	O
and	O
bone	O
remodeling	O
by	O
osteoblasts	O
.	O

Laboratory	O
studies	O
of	O
preschool	O
-	O
aged	O
children	O
have	O
also	O
demonstrated	B
that	O
restrictions	O
placed	O
on	O
children	O
'	O
s	O
access	O
to	O
palatable	O
,	O
energy	O
-	O
dense	O
foods	O
can	B
lead	B
to	I
increased	O
food	O
intake	O
when	O
restrictions	O
are	O
lifted	O
and	O
food	O
becomes	O
available	O
(	O
80	O
,	O
81	O
).	O

Reported	O
sleep	O
duration	O
before	O
pregnancy	O
was	O
highly	O
correlated	B
with	O
sleep	O
duration	O
during	O
pregnancy	O
(	O
ρ	O
=	O
0	O
.	O
92	O
,	O
p	O
<	O
0	O
.	O
002	O
).	O

However	B
,	O
contact	O
with	O
and	O
exposure	O
to	O
antigens	O
may	B
be	I
necessary	B
in	O
early	O
life	O
to	O
develop	O
tolerance	O
in	O
the	O
immune	O
system	O
[	O
118	O
].	O

Nowadays	O
,	O
we	O
know	B
that	O
brain	O
cells	O
such	O
as	O
microglia	O
and	O
astrocytes	O
,	O
can	B
secrete	O
cytokines	O
.	O

This	B
review	I
indicates	B
that	O
the	O
benefits	O
of	O
diets	O
providing	O
moderate	O
amounts	O
of	O
fish	O
during	O
pregnancy	O
outweigh	B
potential	B
detrimental	B
effects	B
in	O
regards	O
to	O
offspring	O
neurodevelopment	O
.	O

Disruption	O
of	O
our	O
circadian	O
clock	O
,	O
for	O
example	O
though	O
shift	O
work	O
that	O
interferes	O
with	O
light	O
-	O
dark	O
environmental	O
phases	O
,	O
can	B
negatively	O
affect	B
cardiometabolic	O
function	O
and	O
increase	O
insulin	O
resistance	O
[	O
16	O
].	O

All	O
data	O
are	O
presented	O
as	O
the	O
mean	O
±	O
SD	O
except	O
as	O
noted	O
.	O

In	O
all	O
fitted	O
models	O
,	O
the	O
low	O
level	O
of	O
each	O
dietary	O
pattern	O
(	O
quartile	O
1	O
)	O
was	O
defined	O
as	O
the	O
reference	O
category	O
.	O

Fatty	O
acids	O
of	O
dietary	O
origin	O
are	O
obtained	O
from	O
transporta	O
tion	O
of	O
TG	O
lipoprotein	O
and	O
subsequent	O
uptake	O
after	O
lipoprotein	O
lipase	O
hydrolysis	O
into	O
tissues	O
from	O
the	O
circulation	O
[	O
92	O
,	O
93	O
].	O

BMI	O
tends	B
to	O
decrease	O
during	O
early	O
childhood	O
and	O
then	O
,	O
typically	B
between	O
the	O
ages	O
of	O
6	O
and	O
8	O
,	O
begins	O
to	O
rise	O
again	O
(	O
adiposity	O
rebound	O
).	O

Due	O
to	O
the	O
LP	O
diet	O
a	O
number	O
of	O
molecular	O
routes	O
related	O
to	O
cell	O
cycle	O
and	O
cellular	O
turnover	O
,	O
response	O
to	O
stimuli	O
,	O
as	O
well	O
as	O
energy	O
-,	O
lipid	O
-	O
and	O
amino	O
acid	O
metabolic	O
pathways	O
are	O
shifted	O
on	O
the	O
transcriptional	O
level	O
in	O
the	O
liver	O
at	O
prenatal	O
stages	O
under	O
the	O
direct	O
influence	O
of	O
limited	O
protein	O
and	O
/	O
or	O
amino	O
acid	O
supply	O
,	O
but	O
also	O
postnatal	O
.	O

In	O
order	O
not	O
to	O
deprive	O
the	O
participants	O
from	O
antenatal	O
supplements	O
all	O
participating	O
mothers	O
were	O
allowed	O
to	O
use	O
prescribed	O
supplementation	O
outside	O
this	O
study	O
’	O
s	O
protocol	O
.	O

The	O
risk	O
of	O
vitamin	O
D	O
insufficiency	O
was	O
significantly	O
lower	O
for	O
more	O
educated	O
women	O
and	O
for	O
persons	O
reporting	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
.	O

Such	O
changes	O
could	B
have	O
far	B
-	I
reaching	I
consequences	B
on	O
embryo	O
viability	O
and	O
development	O
(	O
including	O
early	O
germ	O
line	O
formation	O
),	O
and	O
thus	B
subsequent	O
future	B
health	O
and	O
fertility	O
.	O

Indeed	O
,	O
reported	O
handwashing	O
behavior	O
is	O
susceptible	O
to	O
social	O
desirability	O
bias	B
,	O
with	O
wealthier	O
or	O
more	O
educated	O
respondents	O
;	O
that	O
is	O
,	O
those	O
whose	O
children	O
are	O
already	O
at	O
lower	O
risk	O
of	O
neonatal	O
mortality	O
,	O
potentially	B
more	O
likely	B
to	O
overreport	O
handwashing	O
behavior	O
than	O
less	O
wealthy	O
or	O
less	O
educated	O
counterparts	O
[	O
7	O
,	O
8	O
].	O

Further	B
,	O
the	O
conversion	O
of	O
25	O
(	O
OH	O
)	O
D	O
to	O
the	O
active	O
form	O
of	O
the	O
hormone	O
,	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
,	O
was	O
optimized	B
at	O
40	O
ng	O
/	O
mL	O
among	O
pregnant	O
women	O
[	O
13	O
].	O

Finally	O
,	O
136	O
participants	O
completed	O
the	O
EPDS	O
at	O
4	O
and	O
8	O
weeks	O
postpartum	O
.	O

Out	O
of	O
which	O
,	O
184	O
qualified	O
mothers	O
were	O
selected	O
who	O
completed	O
the	O
baseline	O
depression	O
questionnaire	O
.	O

Therefore	O
,	O
these	O
three	O
subjects	O
were	O
included	O
in	O
the	O
analysis	O
.	O

Lu	O
et	O
al	O
.	O

Phthalate	O
metabolites	O
and	O
BPA	O
were	O
creatinine	O
-	O
normalized	O
in	O
μg	O
/	O
g	O
creatinine	O
and	O
measured	O
twice	O
.	O

The	O
placebo	O
control	O
group	O
allowed	O
for	O
an	O
absolute	O
evaluation	O
of	O
the	O
effects	B
of	O
micronutrients	O
on	O
haematological	O
parameters	O
.	O

Evaluation	O
of	O
the	O
reasons	O
why	B
55	O
.	O
2	O
%	O
of	O
respondents	O
changed	O
their	O
ANC	O
site	O
,	O
revealed	B
that	O
the	O
change	O
of	O
residence	O
,	O
closeness	O
to	O
the	O
health	O
facility	O
and	O
the	O
quality	O
of	O
care	O
offered	O
at	O
the	O
previous	O
site	O
were	O
the	O
predominant	O
reasons	O
.	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O

On	O
a	O
subsequent	O
encounter	O
with	O
the	O
allergen	O
,	O
bridging	O
of	O
2	O
or	O
more	O
IgE	O
antibodies	O
leads	O
to	O
degranulation	O
of	O
the	O
mast	O
cell	O
with	O
release	O
of	O
preformed	O
mediators	O
such	O
as	O
histamine	O
,	O
serotonin	O
,	O
tryptase	O
,	O
chymase	O
,	O
kininogenase	O
,	O
and	O
heparin	O
.	O

Therefore	B
,	O
intrauterine	O
growth	O
conditions	O
might	B
be	O
improved	O
through	O
the	O
adoption	O
of	O
certain	O
dietary	O
patterns	O
during	O
pregnancy	O
.	O

A	O
total	O
of	O
25	O
%	O
of	O
the	O
women	O
had	O
25OHD	O
concentrations	O
≥	O
100	O
nmol	O
/	O
L	O
at	O
T3	O
.	O

The	O
mean	O
serum	O
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
in	O
case	O
and	O
control	O
groups	O
were	O
48	O
and	O
62	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
and	O
the	O
difference	O
was	O
significant	O
(	O
P	O
=	O
0	O
.	O
036	O
).	O

The	O
majority	O
of	O
pregnant	O
women	O
are	O
encouraged	O
to	O
healthier	O
dietary	O
changes	O
.	O

This	O
population	O
of	O
women	O
was	O
predominantly	O
Caucasian	O
and	O
thus	O
maternal	O
ethnicity	O
was	O
categorised	O
into	O
2	O
main	O
groups	O
;	O
Caucasian	O
and	O
non	O
-	O
Caucasian	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
and	O
number	O
of	O
positive	O
skin	O
prick	O
tests	O
(	O
SPTs	O
)#	O
Free	O
sugar1	O
positive	O
SPT	O
¶≥	O
2	O
positive	O
SPTs	O
+	O
Adjusted	O
OR	O
§(	O
95	O
%	O
CI	O
)	O
p	O
-	O
trendAdjusted	O
OR	O
§(	O
95	O
%	O
CI	O
)	O
p	O
-	O
trendQuintile	O
1	O
1	O
.	O
001	O
.	O
00	O
Quintile	O
2	O
0	O
.	O
87	O
(	O
0	O
.	O
68	O
–	O
1	O
.	O
12	O
)	O
1	O
.	O
17	O
(	O
0	O
.	O
87	O
–	O
1	O
.	O
57	O
)	O
Quintile	O
3	O
1	O
.	O
07	O
(	O
0	O
.	O
83	O
–	O
1	O
.	O
37	O
)	O
1	O
.	O
14	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
56	O
)	O
Quintile	O
4	O
1	O
.	O
09	O
(	O
0	O
.	O
83	O
–	O
1	O
.	O
43	O
)	O
1	O
.	O
37	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
90	O
)	O
Quintile	O
5	O
1	O
.	O
19	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
63	O
)	O
1	O
.	O
73	O
(	O
1	O
.	O
18	O
–	O
2	O
.	O
52	O
)	O
Per	O
quintile	O
1	O
.	O
06	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
121	O
.	O
13	O
(	O
1	O
.	O
03	O
–	O
1	O
.	O
23	O
)	O
0	O
.	O
006	O
#:	O
no	O
positive	O
SPT	O
was	O
considered	O
as	O
baseline	O
category	O
(	O
n	O
=	O
4797	O
);¶:	O
n	O
=	O
783	O
;+:	O
n	O
=	O
531	O
;§:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

Feed	O
efficiency	O
decreases	O
as	O
animal	O
age	O
and	O
slaughter	O
weight	O
exceed	O
a	O
certain	O
level	O
.	O

These	O
results	O
likely	B
indicate	B
that	O
the	O
up	O
-	O
expression	O
of	O
the	O
cannabinoid	O
receptors	O
in	O
the	O
hypothalamus	O
at	O
adulthood	O
may	B
result	O
from	O
a	O
lower	O
long	O
-	O
term	O
cannabinoid	O
activity	O
that	O
,	O
in	O
turn	O
,	O
could	B
be	I
produced	O
by	O
lower	O
levels	O
of	O
eCBs	O
and	O
N	O
-	O
acylethanolamines	O
(	O
NAEs	O
)	O
in	O
the	O
hypothalamus	O
of	O
male	O
offspring	O
as	B
was	O
previous	B
described	B
at	O
birth	O
(	O
Ramírez	O
-	O
López	O
et	O
al	O
.,	O
2016	O
).	O

It	O
is	O
,	O
therefore	B
,	O
important	B
to	B
assess	I
if	B
the	O
model	B
system	O
being	O
used	O
accurately	B
replicates	O
the	O
in	O
vivo	O
human	O
metabolic	O
environment	O
,	O
and	O
if	B
not	O
to	O
conduct	O
further	B
studies	I
using	O
any	O
additional	O
appropriate	O
metabolites	O
.	O

The	O
impact	B
of	O
UCP1	O
deletion	O
on	O
insulin	O
sensitivity	O
in	O
these	O
mice	O
was	O
not	B
reported	I
.	O

Vitamin	O
D	O
therapy	O
may	B
be	I
of	O
benefit	O
in	O
wheezing	O
children	O
.	O

Excessive	O
rebound	O
and	O
early	O
rebound	O
(	O
before	O
age	O
5	O
)	O
are	O
related	B
to	O
higher	O
BMI	O
in	O
adulthood	O
(	O
83	O
).	O

Prior	O
to	O
randomization	O
,	O
we	O
recorded	O
baseline	O
knowledge	O
of	O
hygiene	O
and	O
beliefs	O
pertaining	O
to	O
childcare	O
and	O
neonatal	O
illness	O
,	O
perceptions	O
of	O
risk	O
and	O
severity	O
of	O
neonatal	O
illness	O
,	O
antenatal	O
care	O
,	O
and	O
demographic	O
information	O
,	O
using	O
questionnaires	O
and	O
observations	O
.	O

For	O
missing	O
data	O
and	O
attrition	O
of	O
participants	O
,	O
a	O
t	O
test	O
was	O
used	O
to	O
compare	O
covariates	O
,	O
including	O
sociodemographic	O
and	O
other	O
variables	O
used	O
in	O
the	O
regressions	O
,	O
between	O
cases	O
with	O
and	O
without	O
missing	O
data	O
to	O
verify	O
whether	O
or	O
not	O
data	O
were	O
missing	O
completely	O
at	O
random	O
.	O

*	O
Studies	O
demonstrating	B
environmentally	O
-	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
that	O
were	O
reversed	O
by	O
an	O
inhibitor	O
/	O
treatment	O
,	O
absent	O
in	O
a	O
knock	O
out	O
/	O
down	O
model	B
,	O
and	O
/	O
or	O
mechanistically	O
linked	B
in	O
a	O
relevant	B
in	O
vitro	O
system	O
.	O

C3	O
-	O
epi	O
-	O
25	O
(	O
OH	O
)	O
D	O
has	O
lower	O
affinity	O
for	O
the	O
vitamin	O
D	O
receptor	O
,	O
thus	O
it	O
own	O
lower	O
bio	O
-	O
function	O
than	O
25	O
(	O
OH	O
)	O
D	O
in	O
vivo	O
.	O

Average	O
maternal	O
intake	O
of	O
vitamin	O
D	O
from	O
foods	O
and	O
prenatal	O
supplements	O
was	O
439	O
±	O
94	O
IU	O
/	O
day	O
.	O

We	O
also	O
considered	B
vitamin	O
D	O
insufficiency	B
as	B
a	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
of	O
21	O
–	O
29	O
ng	O
/	O
ml	O
,	O
and	O
the	O
participants	O
who	O
had	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
of	O
≥	O
30	O
ng	O
/	O
ml	O
as	B
sufficient	O
[	O
19	O
,	O
46	O
].	O

Within	O
our	O
sample	O
,	O
provider	O
advice	O
and	O
accuracy	O
did	O
not	O
vary	O
based	O
on	O
women	O
’	O
s	O
pre	O
-	O
pregnancy	O
BMI	O
.	O

Apart	O
from	O
the	O
long	O
-	O
term	O
health	O
consequences	O
,	O
severe	O
growth	O
-	O
restricted	O
foetuses	O
are	O
at	O
increased	O
risk	O
of	O
stillbirth	O
,	O
and	O
the	O
live	O
births	O
have	O
an	O
increased	O
risk	O
of	O
neonatal	O
death	O
,	O
morbidity	O
and	O
permanent	O
deficits	O
in	O
growth	O
and	O
neurocognitive	O
development	O
[	O
5	O
,	O
6	O
].	O

In	O
Utero	O
Cigarette	O
Smoke	O
Exposure	O
and	O
Age	O
at	O
Menopause	O
It	O
is	O
well	B
documented	I
that	O
women	O
who	O
smoke	O
cigarettes	O
begin	O
menopause	O
earlier	O
than	O
nonsmokers	O
.	O

A	O
prospective	O
randomised	O
controlled	O
trial	O
in	O
adults	O
showed	B
that	O
dietary	O
sugar	O
,	O
and	O
especially	O
fructose	O
,	O
increased	O
levels	O
of	O
C	O
-	O
reactive	O
protein	O
[	O
37	O
].	O

The	O
findings	B
will	B
provide	O
a	O
concrete	O
way	O
for	O
the	O
researchers	O
to	O
give	O
back	O
to	O
the	O
community	O
.	O

Because	O
AAOC	O
might	B
be	O
misdiagnosed	B
as	O
PG	O
or	O
other	O
benign	O
cutaneous	O
neoplasm	O
,	O
it	O
may	B
not	O
be	O
rare	B
but	O
rather	B
underreported	B
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

It	O
is	O
related	B
to	O
excess	O
vasopressinase	O
enzyme	O
activity	O
which	O
is	O
metabolized	O
in	O
the	O
liver	O
.	O

Therefore	O
,	O
the	O
infants	O
were	O
then	O
sedated	O
with	O
oral	O
chloral	O
hydrate	O
(	O
50	O
–	O
75	O
mg	O
/	O
kg	O
)	O
and	O
placed	O
in	O
the	O
supine	O
position	O
,	O
with	O
the	O
neck	O
mildly	O
extended	O
.	O

A	O
Comparative	O
Study	O
of	O
25	O
(	O
OH	O
)	O
Vitamin	O
D	O
Serum	O
Levels	O
in	O
Patients	O
with	O
Multiple	O
Sclerosis	O
and	O
Control	O
Group	O
in	O
Isfahan	O
,	O
Iran	O
Abstract	O
Objectives	O
:	O
There	O
is	O
no	B
study	I
about	O
correlation	B
between	O
vitamin	O
D	O
serum	O
level	O
and	O
multiple	O
sclerosis	O
(	O
MS	O
)	O
in	O
Iran	O
.	O

BMI	O
Table	O
3displays	O
raw	O
BMI	O
correlations	O
for	O
the	O
index	O
child	O
with	O
family	O
members	O
together	O
with	O
the	O
sample	O
size	O
.	O

Models	O
adjusted	O
for	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
delivery	O
hospital	O
,	O
sex	O
of	O
the	O
baby	O
,	O
and	O
ILI	O
for	O
mothers	O
vaccinated	O
in	O
the	O
first	O
trimester	O
;	O
education	O
level	O
,	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
delivery	O
hospital	O
,	O
sex	O
of	O
the	O
baby	O
,	O
number	O
of	O
parturitions	O
,	O
and	O
ILI	O
for	O
mothers	O
vaccinated	O
in	O
the	O
second	O
trimester	O
;	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
and	O
sex	O
of	O
the	O
baby	O
for	O
mothers	O
vaccinated	O
in	O
the	O
third	O
trimester	O
.	O

This	O
index	O
is	O
not	B
recorded	I
in	O
Romania	O
;	O
instead	O
,	O
we	O
evaluated	O
engagement	O
in	O
prenatal	O
care	O
according	O
to	O
Ministry	O
of	O
Health	O
recommendations	B
,	O
which	O
refer	O
to	O
the	O
total	O
number	O
of	O
prenatal	O
consultations	O
and	O
time	O
of	O
initiation	O
of	O
care	O
.	O

Information	O
of	O
the	O
single	O
datasets	O
are	O
stored	O
using	O
anonymous	O
IDs	O
.	O

Carney	O
et	O
al	O
.	O

In	O
the	O
Angus	O
study	O
,	O
early	O
weaning	O
at	O
105	O
d	O
of	O
age	O
and	O
high	O
concentrate	O
feeding	O
for	O
148	O
d	O
followed	O
by	O
grazing	O
and	O
feedlot	O
entry	O
increased	O
both	O
the	O
MS	O
and	O
hot	O
carcass	O
weight	O
(	O
HCW	O
)	O
compared	O
with	O
normal	O
weaning	O
at	O
253	O
d	O
of	O
age	O
(	O
normally	O
weaned	O
calves	O
stayed	O
with	O
their	O
dams	O
to	O
graze	O
on	O
pasture	O
),	O
although	B
feedlot	O
performance	O
remained	O
unchanged	O
[	O
54	O
].	O

With	O
few	O
exceptions	O
(	O
e	O
.	O
g	O
.,	O
PFOA	O
),	O
median	O
concentrations	O
among	O
HOME	O
Study	O
participants	O
tended	B
to	O
be	O
similar	B
to	I
concentrations	O
observed	O
in	O
US	O
women	O
(	O
Table2	O
).	O

However	B
,	O
the	O
relationship	B
between	O
vitamin	O
D	O
levels	O
and	O
lung	O
function	O
in	O
infancy	O
has	O
not	B
been	I
investigated	I
.	O

Since	B
the	O
maternal	O
attitude	O
towards	O
the	O
pregnancy	O
was	O
a	O
significant	B
predictor	B
of	O
fetal	O
birth	O
weight	O
,	O
we	O
reexamined	B
this	O
association	B
as	O
a	O
function	O
of	O
the	O
GR	O
genepolymorphisms	O
,	O
resembling	O
a	O
gene	O
-	O
environment	O
interaction	B
and	O
statistically	O
controlling	O
for	O
mothers	O
'	O
age	O
,	O
BMI	O
,	O
pregnancy	O
planning	O
,	O
and	O
pregnancy	O
nutritional	O
habits	O
,	O
to	O
remove	O
any	O
potential	O
sources	O
of	O
statistical	O
bias	B
that	O
could	O
skew	O
our	O
data	O
.	O

We	O
found	B
a	O
significant	O
correlation	B
(	O
at	O
the	O
0	O
.	O
01	O
level	O
,	O
two	O
-	O
tailed	O
)	O
between	O
maternal	O
pre	O
-	O
pregnancy	O
weight	O
and	O
neonatal	O
birth	O
weight	O
.	O

Infant	O
lung	O
function	O
testing	O
Measurements	O
were	O
taken	O
of	O
healthy	O
infants	O
who	O
had	O
had	O
no	O
respiratory	O
tract	O
infection	O
for	O
at	O
least	O
3	O
weeks	O
.	O

In	O
serum	O
,	O
vitamin	O
D	O
is	O
transported	O
by	O
vitamin	O
D	O
-	O
binding	O
protein	O
(	O
VDBP	O
)	O
to	O
the	O
liver	O
and	O
metabolized	O
to	O
an	O
active	O
form	O
of	O
25	O
-	O
hydroxycalciferol	O
(	O
25	O
[	O
OH	O
]	O
D	O
)	O
[	O
9	O
].	O

The	O
IG	O
was	O
given	O
intramuscular	O
300	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
,	O
while	O
the	O
CG	O
was	O
not	O
.	O

In	O
group	O
A	O
,	O
there	O
was	O
a	O
strong	O
positive	O
relationship	B
between	O
birth	O
head	O
circumference	O
and	O
the	O
first	O
(	O
p1	O
=	O
0	O
.	O
054	O
,	O
r1	O
=	O
0	O
.	O
580	O
)	O
and	O
second	O
trimester	O
visfatin	O
levels	O
(	O
p2	O
=	O
0	O
.	O
051	O
,	O
r2	O
=	O
0	O
.	O
530	O
).	O

Cytokines	O
and	O
hepcidin	O
will	O
be	O
determined	O
using	O
ELISA	O
.	O

If	O
she	O
finds	O
any	O
unused	O
capsules	O
,	O
she	O
will	O
inquire	O
about	O
the	O
missing	O
doses	O
and	O
further	O
counsel	O
the	O
women	O
about	O
the	O
importance	O
of	O
regular	O
consumption	O
of	O
IFA	O
supplements	O
.	O

An	O
OGTT	O
was	O
performed	O
at	O
gestational	O
weeks	O
10	O
to	O
40	O
between	O
October	O
2012	O
and	O
March	O
2014	O
,	O
and	O
the	O
results	O
were	O
collected	O
from	O
prenatal	O
maternity	O
cards	O
or	O
the	O
hospital	O
laboratory	O
database	O
.	O

The	O
importance	B
of	O
an	O
exacerbation	O
of	O
eczema	O
and	O
dermatitis	O
during	O
pregnancy	O
should	B
not	B
be	I
underestimated	I
as	O
readout	O
of	O
the	O
atopic	O
state	O
,	O
being	O
of	O
interest	O
for	O
the	O
genetic	O
predisposition	O
of	O
the	O
newborn	O
[	O
42	O
].	O

Assuming	O
a	O
crude	O
birth	O
rate	O
of	O
23	O
per	O
1000	O
people	O
,	O
10	O
%	O
loss	O
of	O
pregnancies	O
before	O
birth	O
and	O
15	O
%	O
loss	O
to	O
follow	O
up	O
each	O
cluster	O
will	O
yield	O
300	O
births	O
over	O
15	O
months	O
,	O
and	O
this	O
will	B
be	O
sufficient	O
to	O
reach	O
the	O
desired	O
sample	O
size	O
.	O

There	O
was	O
a	O
trend	B
for	O
lower	O
DopaR1	O
expression	O
in	O
the	O
HV	O
offspring	O
weaned	O
to	O
a	O
HV	O
pup	O
diet	O
compared	O
to	O
the	O
RV	O
offspring	O
(	O
P	O
=	O
0	O
.	O
06	O
)	O
(	O
Figure	O
5b	O
).	O

No	B
earlier	O-
studies	I
that	O
we	O
are	B
aware	I
of	I
have	O
evaluated	O
the	O
relationship	B
between	O
adult	O
vitamin	O
D	O
levels	O
and	O
psychotic	O
symptoms	O
.	O

They	O
found	B
that	O
low	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
levels	O
in	O
the	O
second	O
trimester	O
were	O
a	O
risk	O
factor	O
for	O
postnatal	O
depression	O
.	O

Neonatal	O
data	O
collected	O
at	O
birth	O
from	O
the	O
medical	O
file	O
include	O
date	O
and	O
time	O
of	O
birth	O
,	O
gender	O
,	O
Apgar	O
score	O
(	O
at	O
1	O
and	O
5	O
min	O
)	O
[	O
56	O
],	O
vital	O
signs	O
,	O
medical	O
interventions	O
required	O
,	O
foetal	O
distress	O
and	O
presence	O
of	O
meconium	O
stained	O
liquor	O
.	O

Ethical	O
considerations	O
The	O
study	O
was	O
approved	O
by	O
the	O
ethics	O
committee	O
of	O
the	O
“	O
Grigore	O
T	O
.	O
Popa	O
”	O
University	O
of	O
Medicine	O
and	O
Pharmacy	O
in	O
Iaşi	O
and	O
permission	O
to	O
administer	O
the	O
questionnaires	O
was	O
received	O
from	O
the	O
Cuza	O
-	O
Vodă	O
Obstetrics	O
and	O
Gynaecology	O
Clinical	O
Hospital	O
.	O

2008	O
)	O
by	O
rating	O
the	O
quality	O
of	O
individual	O
studies	O
and	O
carrying	O
out	O
a	O
sensitivity	O
analysis	O
by	O
excluding	O
studies	O
for	O
which	O
the	O
quality	O
score	O
was	O
below	O
a	O
chosen	O
value	O
.	O

Similarly	O
,	O
dietary	O
forage	O
level	O
affected	B
MS	O
.	O
Jersey	O
steers	O
fed	O
a	O
low	O
forage	O
diet	O
(	O
6	O
%	O
Sudan	O
grass	O
,	O
6	O
%	O
alfalfa	O
hay	O
and	O
63	O
.	O
15	O
%	O
steam	O
-	O
flaked	O
corn	O
,	O
dry	O
matter	O
[	O
DM	O
]	O
basis	O
)	O
in	O
a	O
feedlot	O
finishing	O
diet	O
had	O
greater	O
MS	O
in	O
the	O
strip	O
loin	O
than	O
did	O
animals	O
fed	O
a	O
high	O
forage	O
level	O
diet	O
(	O
12	O
%	O
Sudan	O
grass	O
,	O
12	O
%	O
alfalfa	O
hay	O
and	O
51	O
.	O
20	O
%	O
steam	O
-	O
flaked	O
corn	O
)	O
[	O
121	O
].	O

For	O
a	O
description	O
of	O
placental	O
tissue	O
use	O
,	O
DNA	O
extraction	O
,	O
and	O
DNA	O
purification	O
procedures	O
,	O
see	O
Supplemental	O
Material	O
,	O
Supplementary	O
Text	O
1	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
).	O

Identifications	O
were	O
based	O
on	O
the	O
observed	O
pI	O
and	O
Mr	O
(	O
kDa	O
)	O
of	O
the	O
matched	O
protein	O
,	O
the	O
number	O
of	O
matching	O
peptide	O
masses	O
and	O
the	O
total	O
percentage	O
of	O
the	O
amino	O
acid	O
sequence	O
that	O
those	O
peptides	O
covered	O
,	O
in	O
comparison	O
to	O
other	O
database	O
entries	O
.	O

2	O
.	O

Lower	O
25OHD	O
in	O
early	O
pregnancy	O
was	O
only	B
associated	B
with	O
pregnancy	O
loss	O
.	O

Although	B
the	O
importance	B
of	O
IFA	O
supplements	O
to	O
prevent	O
maternal	O
anaemia	O
and	O
mortality	O
is	O
widely	O
accepted	O
,	O
most	O
antenatal	O
IFA	O
supplements	O
distribution	O
programs	O
are	O
of	O
low	O
priority	B
.	O

There	O
are	O
,	O
however	B
,	O
no	B
current	O-
established	I
regulatory	O
procedures	O
or	O
guidelines	O
in	O
chemical	O
safety	O
programs	O
for	O
determining	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
.	O

Serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
lower	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
when	O
compared	O
to	O
the	O
women	O
recruited	O
in	O
Auckland	O
and	O
remained	O
lower	O
after	O
adjusting	O
for	O
covariates	O
including	O
maternal	O
body	O
mass	O
index	O
and	O
socioeconomic	O
index	O
(	O
Adelaide	O
:	O
58	O
.	O
4	O
±	O
50	O
.	O
3	O
vs	O
.	O
Auckland	O
:	O
70	O
.	O
2	O
±	O
54	O
.	O
5	O
nmol	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

In	O
multivariable	O
modeling	O
,	O
each	O
EDC	O
exposure	O
was	O
standardized	O
(	O
mean	O
=	O
0	O
,	O
standard	O
deviation	O
=	O
1	O
)	O
and	O
BHLM	O
was	O
fitted	O
using	O
Bayesian	O
software	O
Stan	O
and	O
the	O
'	O
rstan	O
'	O
package	O
in	O
R	O
[	O
40	O
,	O
41	O
].	O

Study	O
Limitations	O
This	B
study	I
provides	O
useful	O
data	O
of	O
the	O
relationship	B
between	O
serum	O
visfatin	O
and	O
the	O
children	O
’	O
s	O
anthropometric	O
markers	O
up	O
to	O
a	O
year	O
after	O
birth	O
.	O

Over	O
the	O
last	O
two	O
decades	O
,	O
there	O
has	O
been	O
a	O
substantial	O
global	O
reduction	O
in	O
under	O
-	O
5	O
child	O
mortality	O
rates	O
.	O

Bell	O
and	O
Greenwood	O
[	O
158	O
]	O
also	O
suggest	B
that	O
effects	B
of	O
fetal	O
programming	O
during	O
early	O
-	O
mid	O
-	O
gestation	O
on	O
postnatal	O
growth	O
or	O
composition	O
are	O
generally	B
minor	O
.	O

There	O
is	O
also	O
evidence	B
that	O
prenatal	O
supplementation	O
with	O
zinc	O
has	O
a	O
positive	O
effect	B
on	O
birth	O
weight	O
[	O
47	O
]	O
and	O
fetal	O
HRV	O
measures	O
[	O
48	O
,	O
49	O
].	O

It	O
locally	O
extends	O
into	O
lymph	O
nodes	O
and	O
into	O
the	O
surrounding	O
muscles	O
and	O
trachea	O
,	O
and	O
may	B
invade	O
lymphatic	O
and	O
blood	O
vessels	O
and	O
metastasize	O
in	O
lungs	O
,	O
bones	O
and	O
liver	O
.	O

Furthermore	O
,	O
evaluating	O
the	O
social	O
characteristics	O
of	O
the	O
assessed	O
cohort	O
would	B
enable	O
us	O
to	O
identify	O
potential	B
confounding	B
variables	O
that	O
may	B
affect	B
pregnancy	O
outcomes	O
,	O
such	O
as	O
socioeconomic	O
status	O
and	O
lifestyle	O
differences	O
.	O

Calbindin	O
is	O
strongly	O
induced	O
by	O
vitamin	O
D	O
[	O
29	O
],	O
and	O
thus	B
it	O
is	O
feasible	B
that	O
the	O
reduction	O
in	O
this	O
protein	O
may	B
be	I
a	O
consequence	O
of	O
the	O
early	O
life	O
reduction	O
in	O
vitamin	O
D	O
.	O
The	O
potential	B
links	B
between	O
vitamin	O
D	O
and	O
neuronal	O
calcium	O
binding	O
proteins	O
has	B
been	I
noted	I
in	O
a	O
recent	O
review	O
article	O
[	O
30	O
]	O
Two	O
members	O
of	O
the	O
dynamin	O
family	O
(	O
dynamin	O
1	O
and	O
dynamin	O
1	O
-	O
like	O
proteins	O
)	O
were	O
also	O
significantly	O
down	O
-	O
regulated	O
.	O

Average	O
daily	O
intake	O
of	O
dairy	O
products	O
,	O
egg	O
,	O
animal	O
organ	O
and	O
seafood	O
was	O
calculated	O
based	O
on	O
participants	O
’	O
dietary	O
record	O
.	O

[	O
59	O
]	O
have	B
reported	I
that	O
prenatal	O
undernutrition	O
,	O
in	O
contrast	O
to	O
postnatal	O
undernutrition	O
,	O
leads	O
to	O
reduced	O
longevity	O
in	O
mice	O
.	O

Polyomaviruses	O
have	B
been	I
shown	I
to	O
induce	O
brain	O
tumors	O
in	O
animals	O
[	O
128	O
–	O
131	O
]	O
and	O
have	B
been	I
detected	O
in	O
human	O
gliomas	O
[	O
132	O
].	O

Oral	O
antidiabetic	O
agents	O
in	O
gestational	O
diabetes	O
There	O
is	O
controversy	B
regarding	O
the	O
use	O
of	O
oral	O
hypoglycemic	O
agents	O
during	O
pregnancy	O
.	O

This	O
is	O
due	B
to	I
follow	O
-	O
up	O
testing	O
being	O
on	O
the	O
recommended	O
test	O
order	O
set	O
but	B
still	O
needing	O
provider	O
selection	O
compared	O
to	O
the	O
initial	O
test	O
which	O
is	O
automated	O
as	O
part	O
of	O
the	O
initial	O
prenatal	O
screening	O
.	O

We	O
also	O
examined	O
GWG	O
as	O
an	O
independent	O
predictor	O
and	O
potential	B
mediator	O
of	O
effects	O
of	O
maternal	O
prenatal	O
behaviors	O
on	O
weight	O
outcomes	O
(	O
Table	O
4	O
).	O

Additionally	O
,	O
the	O
diagnosis	O
of	O
GDM	O
indicates	O
that	O
the	O
mother	O
has	O
a	O
predisposition	O
to	O
diabetes	O
.	O

Our	B
study	I
revealed	B
that	O
a	O
single	O
high	O
dose	O
injection	O
of	O
vitamin	O
D	O
is	O
more	O
economic	O
and	O
effective	O
particularly	B
in	O
lactating	O
mothers	O
who	O
refrain	O
from	O
consuming	O
oral	O
daily	O
doses	O
due	O
to	O
postpartum	O
care	O
,	O
unwillingness	O
or	O
depression	O
.	O

Characteristics	O
of	O
the	O
women	O
and	O
the	O
live	O
born	O
infants	O
are	O
shown	O
in	O
Table	O
1	O
.	O

The	O
frequency	O
of	O
egg	O
consumption	O
is	O
5	O
.	O
6	O
±	O
2	O
.	O
2	O
times	O
per	O
week	O
and	O
the	O
frequency	O
of	O
seafood	O
consumption	O
is	O
1	O
.	O
8	O
±	O
1	O
.	O
2	O
times	O
per	O
week	O
,	O
five	O
of	O
the	O
participants	O
did	O
not	O
take	O
seafood	O
products	O
,	O
15	O
participants	O
had	O
seafood	O
for	O
more	O
than	O
three	O
times	O
per	O
week	O
.	O

Based	O
on	O
a	O
False	O
Discovery	O
Rate	O
of	O
28	O
%,	O
we	O
predict	B
that	O
nine	O
of	O
these	O
spots	O
would	B
be	I
false	B
positives	I
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0002383	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Altered	O
proteins	O
in	O
the	O
nucleus	O
accumbens	O
in	O
adult	O
DVD	O
-	O
deficient	O
and	O
control	O
male	O
rats	O
.	O

We	O
merged	O
the	O
forward	O
and	O
reverse	O
reads	O
based	O
on	O
sequence	O
overlap	O
[	O
33	O
],	O
removed	O
the	O
primer	O
sequences	O
,	O
and	O
discarded	O
the	O
sequences	O
containing	O
any	O
ambiguous	O
nucleotides	O
.	O

CC	O
females	O
showed	O
an	O
increase	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Cnr2	O
,	O
and	O
Mgll	O
in	O
liver	O
,	O
but	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
and	O
Mgll	O
in	O
PAT	O
(	O
Figures4B	O
,	O
C	O
).	O

When	O
analyzing	O
maternal	O
GWG	O
as	O
a	O
continuous	O
measure	O
,	O
no	O
significant	O
effects	O
were	O
observed	O
.	O

There	O
was	O
no	B
apparent	I
change	O
in	O
the	O
expression	O
of	O
any	O
of	O
the	O
genes	O
in	O
these	O
two	O
categories	O
(	O
data	O
not	O
shown	O
).	O

Relevant	O
papers	O
were	O
selected	O
based	O
on	O
the	O
inclusion	O
criteria	O
in	O
Supplementary	O
Table	O
1	O
.	O

All	O
these	O
costs	O
could	O
be	O
identified	O
from	O
financial	O
records	O
.	O

Those	O
presently	O
taking	O
vitamin	O
D	O
drops	O
also	O
had	O
higher	O
25	O
(	O
OH	O
)	O
D	O
levels	O
(	O
92	O
.	O
2	O
±	O
34	O
.	O
6	O
nmol	O
/	O
L	O
vs	O
.	O
72	O
.	O
2	O
±	O
28	O
.	O
2	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O

Thus	B
,	O
the	O
purpose	B
of	O
this	B
study	I
was	O
to	O
conduct	O
a	O
cross	O
-	O
sectional	O
study	O
of	O
children	O
stratified	O
by	O
birth	O
weight	O
quartiles	O
to	B
identify	I
alterations	O
in	O
autonomic	O
function	O
through	O
the	O
analysis	O
of	O
heart	O
rate	O
variability	O
(	O
HRV	O
).	O

Hematoxylin	O
and	O
eosin	O
stain	O
,	O
same	O
magnification	O
in	O
all	O
pictures	O
.	O

Bodnar	O
et	O
al	O
.	O

[	O
16	O
]	O
Charatcharoen	O
-	O
witthaya	O
et	O
al	O
.	O

Standard	O
measuring	O
equipment	O
,	O
common	O
size	O
containers	O
(	O
e	O
.	O
g	O
.	O

RESULTS	O
This	O
case	O
-	O
control	O
study	O
evaluated	O
50	O
MS	O
patients	O
as	O
case	O
group	O
and	O
50	O
healthy	O
people	O
as	O
control	O
.	O

On	B
the	I
other	I
hand	I
,	O
these	O
outcomes	O
also	O
were	O
twice	O
as	O
common	O
among	O
children	O
whose	O
mothers	O
worked	O
at	O
an	O
electronics	O
assembly	O
plant	O
as	O
in	O
other	O
children	O
.	O
37	O
Animal	O
studies	O
suggest	B
potential	B
reproductive	O
implications	B
of	O
exposure	O
.	O

Women	O
with	O
a	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
of	O
≥	O
40	O
ng	O
/	O
mL	O
had	O
a	O
62	O
%	O
lower	O
risk	B
of	O
PTB	O
compared	B
to	I
those	O
with	O
concentrations	O
<	O
20	O
ng	O
/	O
mL	O
.	O

At	O
the	O
time	O
of	O
the	O
lung	O
function	O
testing	O
,	O
the	O
mean	O
body	O
weight	O
was	O
8	O
.	O
3	O
±	O
1	O
.	O
0	O
kg	O
,	O
and	O
the	O
mean	O
body	O
length	O
was	O
68	O
.	O
6	O
±	O
3	O
.	O
0	O
cm	O
.	O

[	O
16	O
]	O
evaluated	O
vitamin	O
D	O
status	O
in	O
healthy	O
young	O
Thai	O
men	O
and	O
women	O
(	O
age	O
25	O
–	O
54	O
years	O
)	O
and	O
found	O
that	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
was	O
three	O
-	O
fold	O
higher	O
in	O
females	O
than	O
in	O
males	O
(	O
43	O
.	O
1	O
%	O
in	O
females	O
compared	O
to	O
13	O
.	O
9	O
%	O
in	O
males	O
).	O

The	O
remaining	O
analyses	O
were	O
conducted	O
on	O
live	O
births	O
(	O
N	O
=	O
229	O
).	O

*	O
Family	O
planning	O
scaled	O
to	O
60	O
%	O
coverage	O
or	O
to	O
a	O
level	O
whereby	O
the	O
total	O
fertility	O
rate	O
is	O
2	O
.	O
5	O
.	O

On	O
the	O
third	O
day	O
postpartum	O
,	O
the	O
diagnosis	O
of	O
gestational	O
diabetes	O
insipidus	O
was	O
suspected	O
and	O
the	O
patient	O
was	O
started	O
on	O
intranasal	O
DDAVP	O
spray	O
5	O
mcg	O
twice	O
a	O
day	O
,	O
after	O
an	O
initial	O
dose	O
of	O
10	O
mcg	O
.	O

injection	O
of	O
1	O
.	O
25	O
mg	O
propionyl	O
-	O
promazine	O
(	O
0	O
.	O
2	O
ml	O
Combelen	O
,	O
Bayer	O
AG	O
,	O
Leverkusen	O
,	O
Germany	O
)	O
and	O
50	O
mg	O
ketamine	O
(	O
Ursotamin	O
,	O
Serumwerk	O
Bernburg	O
AG	O
,	O
Germany	O
).	O

Complete	O
blood	O
count	O
showed	O
hemoglobin	O
of	O
13	O
.	O
7	O
g	O
/	O
dL	O
,	O
hematocrit	O
42	O
.	O
6	O
%,	O
white	O
blood	O
cell	O
count	O
15	O
,	O
200	O
/	O
mm3	O
,	O
and	O
platelet	O
count	O
of	O
76	O
,	O
000	O
/	O
mm3	O
.	O

PubMed	O
Central	O
:	O

However	B
,	O
we	O
did	B
not	I
identify	B
any	O
specific	O
physiological	O
consequences	O
of	O
these	O
cord	O
25	O
(	O
OH	O
)	O
D	O
levels	O
for	O
bone	O
mineralization	O
at	O
birth	O
as	O
evidenced	B
by	O
initial	O
DXA	O
measurements	O
.	O

Such	O
an	O
approach	O
would	B
also	O
respect	O
the	O
3Rs	O
.	O

To	O
identify	O
differences	O
by	O
race	O
/	O
ethnic	O
group	O
,	O
PTB	O
rates	O
were	O
calculated	O
and	O
logistic	O
regression	O
was	O
conducted	O
for	O
white	O
and	O
non	O
-	O
white	O
women	O
.	O

Finally	O
,	O
the	O
Tth111	O
I	O
polymorphism	O
was	O
assessed	O
using	O
the	O
PCR	O
primers	O
:	O
5	O
′-	O
GGCCACAACAATAACCCAGT	O
-	O
3	O
′	O
and	O
5	O
′-	O
CCTATGACACGTATTTTGTGAAAGT	O
-	O
3	O
′.	O

Consequently	B
,	O
the	O
cannabinoid	O
receptor	O
activity	O
may	B
be	I
modified	O
.	O

©	O
Tony	O
Anderson	O
/	O
Getty	O
Images	O
There	O
is	O
much	O
about	O
lactation	O
that	O
remains	B
unknown	I
.	O

Early	O
diagnosis	O
of	O
autism	O
and	O
any	O
subsequent	O
related	O
intervention	O
(	O
s	O
)	O
may	B
serve	O
to	O
alleviate	O
the	O
challenges	B
that	O
are	O
faced	O
by	O
those	O
individuals	O
,	O
who	O
must	B
manage	O
the	O
effects	O
of	O
autism	O
on	O
an	O
ongoing	O
basis	O
,	O
including	O
patients	O
,	O
their	O
guardians	O
and	O
/	O
or	O
families	O
,	O
and	O
related	O
healthcare	O
professionals	O
.	O

The	O
object	O
of	O
this	B
study	I
was	O
to	B
examine	I
whether	B
women	O
who	O
reported	O
taking	O
a	O
prenatal	O
vitamin	O
had	O
lower	O
risk	O
of	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

Genetic	O
analysis	O
J	O
/	O
QTL	O
software	O
(	O
http	O
://	O
churchill	O
.	O
jax	O
.	O
org	O
/	O
software	O
/	O
jqtl	O
.	O
shtml	O
)	O
was	O
used	O
to	O
calculate	O
LOD	O
scores	O
for	O
the	O
whole	O
-	O
genome	O
SNP	O
analysis	O
.	O

They	O
are	O
listed	O
in	O
the	O
table	O
footnotes	O
.	O

All	O
eight	O
studies	O
included	O
in	O
the	O
final	O
review	O
were	O
observational	O
in	O
design	O
.	O

It	O
is	O
important	B
to	O
identify	O
the	O
mechanisms	O
responsible	O
for	O
initial	O
muscle	O
and	O
fat	O
cell	O
growth	O
during	O
the	O
developmental	O
stage	O
of	O
cattle	O
to	O
better	B
understand	I
IMF	O
deposition	O
in	O
later	O
life	O
.	O

Because	O
of	O
use	O
of	O
cohort	O
and	O
control	O
groups	O
,	O
it	O
not	O
only	O
allowed	O
a	O
representative	O
sample	O
of	O
Utah	O
children	O
,	O
but	O
also	O
as	O
a	O
surveillance	O
study	O
could	B
not	I
directly	O
assess	O
cases	O
and	O
controls	O
[	O
48	O
].	O

Maternal	O
dietary	O
intake	O
Maternal	O
dietary	O
intake	O
data	O
are	O
obtained	O
by	O
means	O
of	O
two	O
dietary	O
assessment	O
methods	O
,	O
namely	O
the	O
24	O
-	O
h	O
recall	O
(	O
24	O
-	O
HR	O
)	O
and	O
a	O
quantified	O
food	O
frequency	O
questionnaire	O
(	O
QFFQ	O
).	O

Whilst	B
18	O
-	O
month	O
follow	O
-	O
up	O
data	O
on	O
126	O
offspring	O
of	O
women	O
with	O
polycystic	O
ovary	O
syndrome	O
treated	O
with	O
metformin	O
during	O
pregnancy	O
have	O
not	O
revealed	O
any	O
deficiencies	O
in	O
growth	O
or	O
motor	O
-	O
social	O
development	O
,	O
this	O
may	B
be	I
too	O
short	O
a	O
time	O
frame	O
for	O
potential	B
programming	O
effects	B
of	O
metformin	O
to	O
become	O
evident	B
.	O
80	O
In	O
view	B
of	O
the	O
above	O
concerns	B
regarding	O
the	O
potential	B
of	O
glyburide	O
and	O
metformin	O
to	O
have	O
long	O
-	O
term	O
effects	B
on	O
the	O
mother	O
and	O
child	O
,	O
I	O
would	B
recommend	B
caution	B
with	O
their	O
use	O
in	O
the	O
treatment	O
of	O
GDM	O
.	O

Although	B
earlier	B
studies	I
have	O
mostly	B
examined	B
the	O
effects	B
of	O
particular	O
nutrients	O
or	O
foods	O
during	O
gestational	O
period	O
on	O
neonatal	O
anthropometric	O
measurements	O
,	O
there	O
are	O
few	B
studies	I
regarding	O
the	O
association	B
of	O
dietary	O
patterns	O
and	O
mentioned	O
measurements	O
.	O

Since	O
1991	O
/	O
1992	O
,	O
688	O
women	O
were	O
deceased	O
,	O
and	O
491	O
women	O
had	O
emigrated	O
.	O

Thus	B
,	O
these	O
neuropeptides	O
are	O
of	O
interest	B
as	O
potential	B
targets	B
for	O
novel	B
antipsychotic	O
agents	O
[	O
39	O
],[	O
40	O
].	O

In	O
the	O
USA	O
excessive	O
GWG	O
remains	B
of	O
predominant	O
concern	B
,	O
as	O
60	O
%	O
of	O
obese	O
women	O
gain	O
more	O
than	O
recommended	O
.	O

A	O
recent	O
meta	O
-	O
analysis	O
found	B
a	O
latitude	O
related	B
increase	O
in	O
schizophrenia	O
prevalence	O
that	O
was	O
greater	O
for	O
groups	O
with	O
low	O
fish	O
consumption	O
[	O
12	O
].	O

Therefore	B
,	O
the	O
down	O
-	O
regulation	O
of	O
cell	O
cycle	O
regulating	O
pathways	O
might	B
lead	O
to	O
a	O
lengthened	O
cell	O
cycle	O
in	O
LP	O
fetuses	O
and	O
offspring	O
[	O
27	O
]	O
and	O
cumulate	O
in	O
growth	O
retardation	O
in	O
LP	O
fetuses	O
.	O

For	O
instance	O
,	O
the	O
Mediterranean	O
diet	O
during	O
pregnancy	O
has	B
been	I
associated	B
with	O
a	O
reduced	O
risk	O
of	O
both	O
persistent	O
and	O
atopic	O
wheeze	O
and	O
atopy	O
in	O
children	O
at	O
6	O
.	O
5	O
years	O
old	O
[	O
1	O
,	O
2	O
].	O

When	O
mercury	O
confounder	B
was	O
adjusted	O
for	O
,	O
this	O
association	B
became	O
significant	O
:	O
4	O
.	O
0	O
(	O
1	O
.	O
3	O
to	O
6	O
.	O
7	O
).	O
Mothers	O
consuming	O
greater	O
than	O
2	O
fish	O
serves	O
per	O
week	O
had	O
infants	O
with	O
the	O
greatest	O
VRM	O
scores	O
.	O
Seafood	O
intake	O
during	O
pregnancy	O
was	O
associated	B
with	O
a	O
significant	O
reduction	O
in	O
percentage	O
of	O
children	O
with	O
suboptimal	O
IQ	O
and	O
behaviour	O
test	O
scores	O
in	O
9	O
of	O
23	O
outcomes	O
.	O
Non	O
-	O
seafood	O
consumers	O
during	O
pregnancy	O
had	O
children	O
who	O
scored	O
lower	O
on	O
tests	O
of	O
verbal	O
IQ	O
at	O
8	O
years	O
:	O
OR	O
(	O
CI	O
)	O
for	O
no	O
seafood	O
=	O
1	O
.	O
48	O
(	O
1	O
.	O
16	O
–	O
1	O
.	O
90	O
);	O
some	O
seafood	O
1	O
.	O
09	O
(	O
0	O
.	O
92	O
–	O
1	O
.	O
20	O
)	O
compared	O
with	O
>	O
340	O
g	O
per	O
week	O
[	O
overall	O
trend	O
:	O
p	O
=	O
0	O
.	O
004	O
].	O
Oily	O
fish	O
consumption	O
more	O
than	O
once	O
per	O
week	O
versus	O
no	O
oily	O
fish	O
reduced	O
the	O
risk	O
of	O
hyperactivity	O
.	O
No	O
association	O
with	O
fish	O
consumption	O
in	O
early	O
pregnancy	O
and	O
full	O
scale	O
IQ	O
,	O
however	B
,	O
total	O
fish	O
intake	O
in	O
late	O
pregnancy	O
of	O
1	O
to	O
2	O
serves	O
per	O
week	O
was	O
associated	B
with	O
having	O
a	O
child	O
with	O
higher	O
IQ	O
at	O
age	O
9	O
years	O
.	O
Higher	O
intakes	O
(	O
3	O
or	O
more	O
serves	O
per	O
week	O
)	O
did	O
not	O
show	O
a	O
statistically	O
significant	O
improvement	O
.	O
Regression	O
coefficients	O
(	O
95	O
%	O
CI	O
)	O
for	O
fish	O
consumption	O
and	O
full	O
scale	O
IQ	O
:	O
less	O
than	O
once	O
per	O
week	O
vs	O
.	O
no	O
fish	O
=	O
7	O
.	O
76	O
(	O
0	O
.	O
38	O
to	O
15	O
.	O
1	O
),	O
once	O
or	O
twice	O
per	O
week	O
vs	O
.	O
no	O
fish	O
=	O
6	O
.	O
91	O
(	O
0	O
.	O
19	O
to	O
13	O
.	O
6	O
).	O
Verbal	O
IQ	O
&	O
fish	O
consumption	O
:	O
Increase	O
of	O
7	O
.	O
32	O
(	O
0	O
.	O
26	O
to	O
14	O
.	O
4	O
)	O
with	O
fish	O
consumption	O
once	O
or	O
twice	O
per	O
week	O
.	O

The	O
registration	O
ID	O
isACTRN12612000588897	O
.	O

Taken	O
together	O
,	O
these	O
results	O
suggest	B
that	O
alterations	O
to	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
may	B
act	O
as	O
a	O
marker	O
for	O
key	O
changes	O
to	O
the	O
extent	O
of	O
methylation	O
at	O
loci	O
targeted	O
by	O
important	B
transcription	O
factors	O
for	O
normal	O
development	O
and	O
placenta	O
processes	O
necessary	O
for	O
appropriate	O
growth	O
.	O

Pregnant	O
women	O
were	O
recruited	O
from	O
gestational	O
week	O
4	O
during	O
fall	O
2013	O
and	O
spring	O
2014	O
,	O
when	O
registering	O
at	O
one	O
of	O
the	O
participating	O
antenatal	O
care	O
units	O
.	O

MicroRNA	O
RT	O
-	O
PCR	O
quantification	O
Total	O
RNA	O
was	O
extracted	O
from	O
liver	O
samples	O
using	O
the	O
TRIzol	O
reagent	O
(	O
Invitrogen	O
)	O
and	O
subsequently	O
purified	O
with	O
the	O
RNase	O
-	O
Free	O
DNase	O
Kit	O
(	O
Promega	O
)	O
according	O
to	O
the	O
manufacturer	O
׳	O
s	O
instructions	O
.	O

Lower	O
levels	O
of	O
PUFA	O
have	B
been	I
found	B
in	O
brain	O
content	O
,	O
red	O
blood	O
cells	O
and	O
skin	O
fibroblast	O
among	O
patients	O
with	O
schizophrenia	O
,	O
compared	O
with	O
a	O
healthy	O
population	O
[	O
13	O
,	O
16	O
].	O

However	B
,	O
it	O
has	B
been	I
said	O
that	O
the	O
views	O
of	O
pregnant	O
women	O
concerning	B
their	O
care	O
is	O
generally	B
positive	O
as	O
they	O
tend	B
to	O
be	O
uncritical	O
of	O
healthcare	O
,	O
accepting	O
whatever	O
care	O
they	O
receive	O
as	O
appropriate	O
[	O
29	O
].	O

,	O
2004	O
[	O
18	O
]	O
Oken	O
et	O
al	O
.	O

Conclusions	O
In	O
conclusion	O
,	O
the	O
longitudinal	O
survey	O
of	O
the	O
hepatic	O
transcriptomic	O
response	O
in	O
offspring	O
of	O
dams	O
fed	O
either	O
a	O
gestational	O
low	O
protein	O
diet	O
(	O
LP	O
,	O
6	O
%	O
CP	O
)	O
or	O
an	O
adequate	O
protein	O
diet	O
(	O
AP	O
,	O
12	O
%	O
CP	O
)	O
at	O
prenatal	O
(	O
94	O
dpc	O
),	O
perinatal	O
(	O
1	O
dpn	O
),	O
juvenile	O
(	O
28	O
dpn	O
),	O
and	O
adult	O
(	O
188	O
dpn	O
)	O
ontogenetic	O
stages	O
revealed	B
acute	O
short	O
-	O
term	O
and	O
delayed	O
long	O
-	O
term	O
modulations	O
.	O

None	O
of	O
the	O
term	O
or	O
preterm	O
women	O
were	O
administered	O
any	O
antidepressants	O
or	O
synthetic	O
glucocorticoids	O
during	O
pregnancy	O
.	O

For	O
example	O
,	O
high	O
intake	O
of	O
omega	O
-	O
3	O
fatty	O
acids	O
partly	O
replaces	O
omega	O
-	O
6	O
fatty	O
acids	O
incorporation	O
into	O
membrane	O
phospholipids	O
and	O
omega	O
-	O
3	O
fatty	O
acids	O
have	O
a	O
higher	O
affinity	O
than	O
omega	O
-	O
6	O
fatty	O
acids	O
for	O
several	O
enzymes	O
[	O
44	O
].	O

The	O
two	O
OPPs	O
and	O
two	O
heavy	O
metals	O
were	O
examined	O
individually	O
as	O
covariates	O
with	O
no	O
hierarchical	O
priors	O
.	O

This	O
is	O
important	B
since	B
children	O
with	O
low	O
birth	O
weight	O
with	O
higher	O
plasma	O
ACE	O
activity	O
would	B
presumably	B
have	O
high	O
angiotensin	O
II	O
levels	O
and	O
lower	O
associated	B
levels	O
of	O
cardiac	O
vagal	O
activity	O
.	O

There	O
were	O
194	O
children	O
who	O
participated	O
in	O
the	O
follow	O
-	O
up	O
study	O
(	O
55	O
%	O
of	O
the	O
original	O
cohort	O
),	O
but	O
blood	O
samples	O
were	O
obtained	O
from	O
133	O
of	O
those	O
children	O
.	O

These	O
can	B
cause	O
vitamin	O
D	O
deficiency	O
in	O
mothers	O
’	O
milk	O
as	O
the	O
only	O
source	O
of	O
vitamin	O
D	O
for	O
babies	O
.	O
6	O
There	O
are	O
evidences	B
showing	B
the	O
role	B
of	O
vitamin	O
D	O
in	O
keeping	O
normal	O
glucose	O
homeostasis	O
.	O
7	O
-	O
10Resistance	O
to	O
insulin	O
and	O
destruction	O
of	O
insulin	O
secretion	O
in	O
human	O
and	O
animal	O
models	B
has	O
considerably	B
been	O
related	B
to	O
vitamin	O
D	O
deficiency	O
.	O

Women	O
attending	O
ANC	O
for	O
their	O
subsequent	O
pregnancies	O
probably	B
had	O
a	O
notion	O
of	O
what	O
health	O
topics	O
were	O
discussed	O
during	O
clinic	O
sessions	O
and	O
so	O
their	O
objectives	O
at	O
ANC	O
were	O
not	O
only	B
aimed	O
at	O
acquiring	O
knowledge	O
about	O
diet	O
,	O
danger	O
signs	O
and	O
other	O
topics	O
but	O
also	O
in	O
the	O
state	O
of	O
their	O
babies	O
.	O

DISCUSSION	O
To	B
our	I
knowledge	I
this	B
is	O
the	O
first	B
African	O
trial	B
to	B
evaluate	I
the	O
effect	B
of	O
multiple	O
micronutrient	O
supplementation	O
on	O
red	O
cell	O
parameters	O
and	O
iron	O
status	O
among	O
non	O
-	O
pregnant	O
women	O
of	O
reproductive	O
age	O
.	O

However	B
,	O
it	O
could	B
be	I
argued	B
that	O
,	O
for	O
our	O
results	O
to	O
be	O
totally	O
spurious	O
in	O
those	O
included	O
in	O
our	O
analysis	O
(	O
and	O
for	O
the	O
associations	B
to	O
be	O
truly	O
null	O
in	O
the	O
population	O
as	O
a	O
whole	O
),	O
associations	B
in	O
the	O
excluded	O
mother	O
–	O
child	O
pairs	O
would	B
have	B
to	I
be	I
in	O
the	O
opposite	B
direction	O
and	O
much	O
stronger	O
,	O
compared	O
with	O
the	O
positive	O
associations	B
we	O
reported	O
in	O
the	O
included	O
mother	O
–	O
child	O
pairs	O
,	O
which	O
seems	B
extremely	O
unlikely	B
.	O

Further	B
study	I
is	B
warranted	I
to	O
understand	O
what	B
mechanisms	O
affect	B
the	O
adipogenic	O
potential	O
by	O
nutritional	O
modulation	O
during	O
the	O
fetal	O
period	O
at	O
specific	O
gestation	O
stages	O
,	O
thereafter	O
affecting	B
marbling	O
and	O
IMF	O
deposition	O
at	O
the	O
progeny	O
slaughter	O
stage	O
.	O

Thus	B
,	O
during	O
the	O
late	O
fattening	O
stage	O
of	O
beef	O
cattle	O
,	O
marbling	O
adipocytes	O
may	B
grow	O
continuously	O
even	B
though	B
development	O
of	O
abdominal	O
,	O
intermuscular	O
,	O
and	O
subcutaneous	O
fat	O
may	B
slow	O
or	O
cease	O
.	O

(	O
2015	O
)*	O
Kundakovic	O
et	O
al	O
.	O

We	O
selected	O
infants	O
considered	O
small	O
for	O
gestational	O
age	O
(	O
SGA	O
;	O
<	O
10th	O
percentile	O
of	O
birth	O
weight	O
)	O
and	O
matched	O
non	O
-	O
SGA	O
infants	O
to	O
these	O
for	O
infant	O
sex	O
,	O
maternal	O
age	O
(±	O
3	O
years	O
),	O
and	O
gestational	O
age	O
(±	O
2	O
days	O
).	O

Closing	O
gaps	B
in	O
coverage	O
,	O
equity	O
and	O
quality	O
In	O
order	O
for	O
health	O
services	O
to	O
save	O
the	O
maximum	O
number	O
of	O
lives	O
,	O
coverage	O
,	O
quality	O
and	O
equity	O
need	B
to	I
be	I
high	O
;	O
thus	B
ensuring	O
high	O
coverage	O
of	O
care	O
means	O
reaching	O
every	O
woman	O
,	O
mother	O
-	O
to	O
-	O
be	O
,	O
mother	O
,	O
newborn	O
,	O
child	O
and	O
family	O
with	O
targeted	B
interventions	B
.	O

The	O
MGM	O
could	B
arguably	O
have	O
influenced	B
her	O
daughter	O
'	O
s	O
culinary	O
and	O
dietary	O
habits	O
and	O
hence	B
her	O
grandchild	O
'	O
s	O
BMI	O
,	O
25but	B
the	O
PGM	O
is	O
associated	B
with	O
the	O
paternal	O
granddaughter	O
and	O
not	O
her	O
paternal	O
grandson	O
.	O

Curtis	O
and	O
colleagues	O
have	O
found	B
that	O
mothers	O
and	O
other	O
caregivers	O
commonly	B
report	O
that	O
they	O
wash	O
hands	O
out	O
of	O
a	O
wish	O
to	O
nurture	O
their	O
young	O
children	O
[	O
22	O
].	O

Among	O
the	O
proteins	O
,	O
beef	O
and	O
beans	O
—	O
both	O
sources	O
of	O
the	O
antioxidant	O
glutathione	O
—	O
showed	B
the	O
highest	O
inverse	B
effect	I
.	O

For	O
fatty	O
fish	O
(	O
herring	O
/	O
mackerel	O
,	O
salmon	O
-	O
type	O
fish	O
),	O
the	O
strongest	O
inverse	O
association	B
was	O
found	B
for	O
an	O
intermediate	O
intake	O
(	O
RR	O
:	O
0	O
.	O
81	O
,	O
95	O
%	O
CI	O
,	O
0	O
.	O
66	O
-	O
0	O
.	O
98	O
),	O
whereas	B
a	O
high	O
intake	O
of	O
fatty	O
fish	O
was	O
associated	B
with	O
an	O
increased	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
(	O
RR	O
:	O
1	O
.	O
90	O
,	O
95	O
%	O
CI	O
,	O
1	O
.	O
34	O
-	O
2	O
.	O
70	O
).	O

The	O
condition	O
may	B
be	I
defined	O
as	O
a	O
chronic	O
neurodevelopmental	O
disorder	O
that	O
first	O
becomes	O
prevalent	O
in	O
an	O
individual	O
during	O
his	O
/	O
her	O
early	O
childhood	O
.	O

In	O
non	O
-	O
pregnant	O
adult	O
populations	O
,	O
conflicting	B
results	O
have	B
been	I
reported	I
regarding	O
seasonal	O
variation	O
HbA1c	O
(	O
a	O
measure	O
that	O
reflects	O
average	O
circulating	O
blood	O
glucose	O
concentrations	O
for	O
the	O
previous	O
90	O
days	O
)	O
and	O
glucose	O
concentrations	O
among	O
individuals	O
with	O
type	O
2	O
diabetes	O
[	O
19	O
,	O
43	O
].	O

The	O
purpose	B
of	O
this	B
study	I
was	O
to	B
determine	I
the	O
association	B
between	O
vitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D	O
)	O
levels	O
and	O
S	O
-	O
ECC	O
.	O

For	O
example	O
,	O
in	O
a	B
study	I
of	O
women	O
and	O
infants	O
living	O
in	O
a	O
cotton	O
-	O
growing	O
region	O
of	O
northern	O
Mexico	O
where	O
DDT	O
was	O
heavily	O
used	O
,	O
Gladen	O
and	O
Rogan	O
found	B
that	O
women	O
with	O
the	O
lowest	O
DDE	O
levels	O
in	O
their	O
milk	O
shortly	O
after	O
birth	O
nursed	O
for	O
a	O
median	O
of	O
7	O
.	O
5	O
months	O
,	O
while	B
mothers	O
with	O
the	O
highest	O
DDE	O
levels	O
nursed	O
for	O
a	O
median	O
of	O
only	B
3	O
months	O
.	O
15A	B
study	I
in	O
Michigan	O
estimated	B
serum	O
levels	O
of	O
DDE	O
at	O
the	O
time	O
of	O
pregnancy	O
based	B
on	I
sampling	O
conducted	O
after	O
birth	O
.	O

However	O
,	O
smaller	O
bowls	O
and	O
different	O
sizes	O
of	O
small	O
spoons	O
are	O
used	O
for	O
infant	O
dietary	O
intake	O
to	O
ease	O
realistic	O
reporting	O
for	O
the	O
mother	O
.	O

A	O
novel	B
observation	B
of	O
our	B
study	I
is	O
that	O
the	O
hypothalamic	O
feeding	O
pathways	O
respond	O
to	O
the	O
vitamin	O
content	O
of	O
the	O
post	O
-	O
weaning	O
diet	O
.	O

Targeted	O
16S	O
rRNA	O
gene	O
sequencing	O
The	O
V4	O
-	O
V5	O
hypervariable	O
region	O
of	O
the	O
bacterial	O
16S	O
rRNA	O
gene	O
was	O
sequenced	O
at	O
the	O
Marine	O
Biological	O
Laboratory	O
(	O
MBL	O
)	O
in	O
Woods	O
Hole	O
,	O
MA	O
,	O
using	O
established	O
methods	O
[	O
31	O
,	O
32	O
].	O

Post	O
-	O
intervention	O
,	O
significantly	O
more	O
women	O
(	O
50	O
.	O
6	O
%)	O
received	O
best	O
-	O
practice	O
care	O
(	O
2	O
+	O
reviews	O
)	O
(	O
p	O
=	O
0	O
.	O
02	O
).	O

†	O
Adjusted	O
for	O
insurance	O
status	O
and	O
years	O
of	O
education	O
(	O
social	O
economic	O
status	O
proxy	O
variables	O
).	O

The	O
inter	O
-	O
assay	O
coefficient	O
of	O
variation	O
is	O
6	O
%	O
at	O
40	O
nmol	O
/	O
L	O
for	O
both	O
25OHD3and	O
25OHD2	O
.	O

The	O
possible	B
reasons	B
for	O
the	O
higher	O
uptake	O
of	O
the	O
weekly	O
supplements	O
are	O
many	B
.	O

However	O
,	O
we	O
chose	O
these	O
for	O
multiple	O
reasons	B
;	O
the	O
HAPO	O
study	O
used	O
similar	O
divisions	O
in	O
countries	O
with	O
a	O
latitude	O
of	O
41	O
.	O
9	O
–	O
43	O
.	O
7	O
°	O
North	O
[	O
7	O
],	O
mean	O
daily	O
temperatures	O
in	O
Ireland	O
are	O
highest	O
during	O
the	O
months	O
May	O
to	O
October	O
[	O
47	O
],	O
and	O
we	O
based	O
these	O
seasons	O
on	O
25OHD	O
concentrations	O
for	O
the	O
month	O
of	O
the	O
first	O
antenatal	O
visit	O
(	O
Additional	O
file1	O
:	O
Fig	O
.	O

[	O
2	O
]	O
Hypocalcemic	O
laryngospasm	O
causing	O
stridor	O
and	O
tetany	O
in	O
a	O
child	O
with	O
renal	O
dysplasia	O
has	B
also	O-
been	I
described	O
.	O

2011	O
).	O

Access	O
to	O
data	O
All	O
collected	O
data	O
will	O
be	O
accessible	O
by	O
the	O
study	O
investigators	O
.	O

For	B
this	I
reason	I
,	O
in	O
addition	O
to	O
calcitonin	O
-	O
gene	O
products	O
,	O
such	O
as	O
calcitonin	O
CGRP	O
(	O
calcitonin	O
-	O
generelated	O
-	O
peptide	O
)	O
and	O
C	O
-	O
CAP	O
(	O
katacalcin	O
),	O
MTC	O
cells	O
express	O
several	O
other	B
biochemical	O
markers	O
that	O
reflect	B
the	O
features	O
of	O
diffuse	O
neuroendocrine	O
system	O
,	O
implicated	B
in	O
the	O
pathogenesis	O
of	O
the	O
symptoms	O
(	O
flushing	O
,	O
diarrhoea	O
,	O
carcinoid	O
syndrome	O
or	O
Cushing	O
'	O
s	O
syndrome	O
)	O
that	O
may	B
occur	O
in	O
patients	O
with	O
advanced	O
disease	O
.	O

Overall	O
,	O
13	O
%	O
(	O
415	O
)	O
were	O
younger	O
than	O
18	O
years	O
(	O
range	O
:	O
12	O
–	O
17	O
),	O
80	O
%	O
(	O
2620	O
)	O
were	O
between	O
18	O
and	O
34	O
years	O
,	O
and	O
7	O
%	O
(	O
233	O
)	O
were	O
35	O
years	O
and	O
older	O
(	O
range	O
:	O
35	O
–	O
45	O
;	O
Table	O
1	O
).	O

The	O
RNA	O
-	O
Seq	O
transcriptome	O
and	O
KEGG	O
pathway	O
analyses	O
of	O
differentially	O
expressed	O
genes	O
showed	O
that	O
pathways	O
for	O
PPAR	O
signaling	O
,	O
regulation	O
of	O
the	O
actin	O
cytoskeleton	O
,	O
biosynthesis	O
of	O
unsaturated	O
fatty	O
acids	O
(	O
FA	O
),	O
and	O
Wnt	O
signaling	O
changed	O
in	O
the	O
milk	O
replacement	O
+	O
concentrate	O
+	O
roughage	O
group	O
compared	O
with	O
those	O
in	O
the	O
control	O
group	O
,	O
whereas	O
the	O
milk	O
replacement	O
+	O
concentrate	O
+	O
30	O
%	O
starch	O
diet	O
group	O
showed	O
changes	O
in	O
insulin	O
signaling	O
and	O
mTOR	O
signaling	O
pathways	O
.	O

It	O
is	O
noteworthy	B
,	O
however	O
,	O
that	O
complementary	O
researches	B
are	O
necessary	B
to	O
determine	O
the	O
mechanisms	O
involved	B
as	O
well	O
as	O
the	O
potential	B
influence	B
of	O
birth	O
weight	O
on	O
the	O
cardiac	O
autonomic	O
modulation	O
.	O

A	O
greater	B
understanding	I
of	O
the	O
variables	O
that	O
influence	B
vitamin	O
D	O
status	O
during	O
pregnancy	O
can	B
have	O
an	O
immense	O
public	B
health	I
impact	B
in	O
the	O
reduction	O
of	O
adverse	O
perinatal	O
outcomes	O
such	O
as	O
SGA	O
.	O

Kawachi	O
[	O
137	O
]	O
described	O
that	O
the	O
number	O
of	O
adipocytes	O
increases	O
in	O
muscle	O
between	O
13	O
and	O
19	O
months	O
of	O
age	O
,	O
so	O
feeding	O
a	O
vitamin	O
A	O
-	O
deficient	O
diet	O
during	O
this	O
stage	O
may	B
stimulate	O
marbling	O
.	O

There	O
was	O
also	O
a	O
correlation	B
with	O
the	O
MGM	O
for	O
both	O
boys	O
and	O
girls	O
.	O

Researchers	O
from	O
multiple	O
disciplines	O
,	O
including	O
population	O
health	O
,	O
social	O
sciences	O
,	O
computing	O
,	O
and	O
engineering	O
sciences	O
are	O
engaged	O
in	O
mHealth	O
[	O
1	O
],	O
and	O
major	O
government	O
research	O
sponsors	O
including	O
the	O
National	O
Institutes	O
of	O
Health	O
and	O
major	O
private	O
sponsors	O
such	O
as	O
the	O
Bill	O
and	O
Melinda	O
Gates	O
Foundation	O
have	O
initiatives	O
in	O
these	O
areas	O
[	O
7	O
-	O
8	O
].	O

Thus	B
,	O
pregnancy	O
following	O
thyroid	O
cancer	O
needs	B
both	O
maternal	O
and	O
foetal	O
control	O
.	O

Despite	B
we	O
found	B
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Ppar	O
γ	O
,	O
opposite	B
results	O
after	O
the	O
exposure	O
to	O
undernutrition	O
(	O
Bispham	O
et	O
al	O
.,	O
2005	O
)	O
and	O
similar	O
results	O
after	O
malnutrition	O
during	O
early	O
development	O
have	O
been	O
documented	B
(	O
Ahmad	O
et	O
al	O
.,	O
2013	O
;	O
Reynolds	O
et	O
al	O
.,	O
2014	O
).	O

In	O
our	B
study	I
,	O
we	O
have	B
shown	I
that	O
all	O
known	B
transcripts	O
of	O
GR	O
splice	O
variants	O
are	O
expressed	O
in	O
the	O
human	O
placenta	O
with	O
GR	O
α	O
being	O
the	O
predominant	B
transcript	O
in	O
all	O
categories	O
studied	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Repeat	O
element	O
methylation	O
markers	O
grouped	O
by	O
in	O
utero	O
exposures	O
.	O
Group	O
mean	O
±	O
SDExposure	O
n	O
LINE	O
-	O
1AluYb8Array	O
-	O
based	O
methylationSexMale19051	O
.	O
7	O
±	O
4	O
.	O
465	O
.	O
3	O
±	O
3	O
.	O
30	O
.	O
238	O
±	O
0	O
.	O
012Female19051	O
.	O
7	O
±	O
4	O
.	O
964	O
.	O
6	O
±	O
3	O
.	O
30	O
.	O
237	O
±	O
0	O
.	O
013	O
p	O
-	O
Value0	O
.	O
900	O
.	O
040	O
.	O
28Maternal	O
ethnicityCaucasian21751	O
.	O
4	O
±	O
4	O
.	O
564	O
.	O
9	O
±	O
3	O
.	O
30	O
.	O
239	O
±	O
0	O
.	O
013Non	O
-	O
Caucasian16352	O
.	O
0	O
±	O
4	O
.	O
865	O
.	O
1	O
±	O
3	O
.	O
30	O
.	O
236	O
±	O
0	O
.	O
011	O
p	O
-	O
Value0	O
.	O
210	O
.	O
470	O
.	O
17Maternal	O
tobacco	O
use	O
during	O
pregnancyYes3652	O
.	O
9	O
±	O
4	O
.	O
766	O
.	O
2	O
±	O
2	O
.	O
30	O
.	O
240	O
±	O
0	O
.	O
011No34351	O
.	O
6	O
±	O
4	O
.	O
664	O
.	O
8	O
±	O
3	O
.	O
40	O
.	O
237	O
±	O
0	O
.	O
012	O
p	O
-	O
Value0	O
.	O
10	O
<	O
0	O
.	O
010	O
.	O
31Maternal	O
alcohol	O
use	O
during	O
pregnancyYes355	O
.	O
0	O
±	O
1	O
.	O
066	O
.	O
0	O
±	O
3	O
.	O
40	O
.	O
230	O
±	O
0	O
.	O
001No37751	O
.	O
7	O
±	O
4	O
.	O
665	O
.	O
0	O
±	O
3	O
.	O
30	O
.	O
238	O
±	O
0	O
.	O
012	O
p	O
-	O
Value0	O
.	O
020	O
.	O
660	O
.	O
51Maternal	O
prenatal	O
vitamin	O
use	O
during	O
pregnancyYes31451	O
.	O
8	O
±	O
4	O
.	O
665	O
.	O
0	O
±	O
3	O
.	O
30	O
.	O
238	O
±	O
0	O
.	O
012No6651	O
.	O
3	O
±	O
4	O
.	O
764	O
.	O
6	O
±	O
3	O
.	O
40	O
.	O
238	O
±	O
0	O
.	O
014	O
p	O
-	O
Value0	O
.	O
500	O
.	O
290	O
.	O
80	O
p	O
-	O
Values	O
obtained	O
from	O
Kruskal	O
–	O
Wallis	O
tests	O
.	O

This	O
very	O
recent	B
report	B
correlates	B
well	O
with	O
a	O
2007	O
CDC	O
report	B
(	O
13	O
),	O
which	O
found	B
a	O
similar	B
increased	B
risk	I
for	O
the	O
wealthy	O
and	O
well	O
-	O
educated	O
,	O
findings	B
the	O
authors	O
tried	B
but	B
could	B
not	I
dismiss	I
as	O
being	O
because	B
of	O
ascertainment	O
bias	B
.	O

Non	O
-	O
normally	O
distributed	O
variables	O
were	O
log	O
transformed	O
prior	O
to	O
regression	O
analysis	O
.	O

Results	O
Of	O
the	O
506	O
non	O
-	O
Hispanic	O
white	O
and	O
black	O
infants	O
,	O
438	O
with	O
available	O
data	O
on	O
vitamin	O
D	O
status	O
,	O
BMI	O
at	O
delivery	O
,	O
prenatal	O
vitamin	O
use	O
and	O
pre	O
-	O
eclampsia	O
/	O
pregnancy	O
-	O
induced	O
hypertension	O
(	O
PIH	O
)	O
history	O
were	O
included	O
in	O
final	O
analyses	O
.	O

Transcriptional	O
excursions	O
regarding	O
cell	O
maintenance	O
and	O
proliferation	O
Mammalian	O
cell	O
division	O
is	O
precisely	O
regulated	O
by	O
variate	O
factors	O
and	O
functional	O
networks	O
.	O

To	O
this	O
end	O
,	O
one	O
of	O
the	O
very	O
useful	O
tools	O
is	O
the	O
use	O
of	O
rodent	O
strains	O
with	O
different	O
sensitivities	O
to	O
diet	O
-	O
induced	O
obesity	O
and	O
insulin	O
resistance	O
.	O

As	B
in	I
our	O
studies	O
,	O
these	O
inconsistent	B
findings	O
point	B
to	O
the	O
existence	O
of	O
complicated	B
pathways	O
for	O
the	O
function	O
of	O
vitamin	O
D	O
in	O
disease	O
processes	O
,	O
or	O
simply	O
that	O
the	O
correct	O
effective	O
dose	O
of	O
vitamin	O
D	O
supplementation	O
needs	B
to	O
be	O
better	B
defined	O
.	O

Bodnar	O
et	O
al	O
.	O

If	B
universal	O
coverage	O
of	O
selected	O
interventions	B
were	O
to	O
be	O
achieved	O
,	O
then	O
84	O
%	O
or	O
more	O
than	O
921	O
,	O
000	O
preterm	O
neonatal	O
deaths	O
could	B
be	I
prevented	B
annually	O
,	O
with	O
antenatal	O
corticosteroids	O
and	O
Kangaroo	O
Mother	O
Care	O
having	O
the	O
highest	O
impact	B
.	O

Caption	O
(	O
FIG	O
)	O
Many	B
studies	I
on	O
DDT	O
exposures	O
and	O
lactation	O
have	B
been	I
conducted	O
with	O
populations	O
of	O
Hispanic	O
women	O
who	O
work	O
on	O
farms	O
or	O
live	O
in	O
agricultural	O
areas	O
.	O

This	O
is	O
a	O
direct	O
competitive	O
chemiluminescence	O
immunoassay	O
used	O
to	O
quantitatively	O
determine	O
total	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
.	O

Two	O
previous	B
studies	I
have	O
investigated	O
but	B
not	I
found	O
any	O
association	O
between	O
25OHD	O
and	O
miscarriage	O
[	O
5	O
,	O
13	O
].	O

ESR	O
is	O
a	O
non	O
-	O
specific	O
,	O
indirect	O
measurement	O
of	O
plasma	O
acute	O
-	O
phase	O
protein	O
and	O
systemic	O
inflammatory	O
status	O
that	O
is	B
known	I
to	O
correlate	B
with	O
haemoglobin	O
and	O
plasma	O
fibrinogen	O
concentrations	O
(	O
Kanfer	O
and	O
Nicol	O
1997	O
).	O

Respondents	O
of	O
low	O
educational	O
level	O
tend	B
to	O
be	O
very	O
satisfied	O
with	O
the	O
personnel	O
'	O
s	O
competence	O
and	O
they	O
also	O
rated	O
the	O
health	O
talks	O
as	O
very	O
satisfactory	O
,	O
in	O
marked	O
contrast	O
to	O
those	O
of	O
a	O
higher	O
educational	O
level	O
who	O
were	O
much	O
more	O
likely	B
not	O
to	O
be	O
satisfied	O
with	O
the	O
health	O
talks	O
.	O

Income	O
was	O
categorized	O
as	O
>$	O
25	O
,	O
000	O
per	O
year	O
versus	O
≤$	O
25	O
,	O
000	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Flow	O
diagram	O
for	O
inclusion	O
of	O
journal	O
articles	O
[	O
17	O
].	O

To	O
calculate	O
individual	O
food	O
intake	O
when	O
animals	O
were	O
housed	O
in	O
groups	O
,	O
total	O
food	O
intake	O
from	O
each	O
cage	O
was	O
measured	O
and	O
equally	O
divided	O
according	O
to	O
the	O
number	O
of	O
pups	O
per	O
cage	O
.	O

By	O
self	O
-	O
selection	O
,	O
those	O
who	O
manifest	O
seasonal	O
allergies	O
may	B
choose	O
a	O
career	O
path	O
other	O
than	O
farming	O
(	O
i	O
.	O
e	O
.,	O
healthy	O
worker	O
effect	B
)	O
[	O
116	O
].	O

Pregnancy	O
loss	O
was	O
defined	O
as	O
both	O
spontaneous	O
abortions	O
from	O
gestational	O
week	O
4	O
and	O
intrauterine	O
fetal	O
death	O
(	O
IUFD	O
).	O

However	B
,	O
defining	B
the	O
limits	B
of	O
normal	O
variation	B
for	O
specific	O
epigenetic	O
changes	O
of	O
relevance	O
would	B
be	I
a	O
sensible	B
and	O
pragmatic	B
starting	B
point	I
.	O

F	O
.,	O
G	O
.,	O
and	O
S	O
.	O

The	O
extent	O
of	O
absorption	O
is	O
increased	O
in	O
fasting	O
status	O
and	O
decreased	O
if	B
there	O
is	O
inadequate	B
intestinal	O
absorption	O
,	O
often	B
caused	O
by	O
other	B
drugs	O
,	O
such	O
as	O
ferrous	O
sulphate	O
.	O

The	O
subjects	O
with	O
the	O
three	O
highest	O
cathelicidin	O
concentration	O
values	O
had	O
characteristics	O
including	O
25	O
(	O
OH	O
)	O
D	O
,	O
BMI	O
,	O
percent	O
fat	O
,	O
race	O
/	O
ethnicity	O
,	O
and	O
age	O
,	O
which	O
were	O
comparable	O
to	O
the	O
corresponding	O
variable	O
represented	O
in	O
the	O
entire	O
cohort	O
.	O

There	O
may	B
be	I
some	B
self	O
-	O
selection	O
bias	B
in	O
relation	O
to	O
participating	O
grandparents	O
,	O
as	B
clearly	O
grandparents	O
who	O
were	O
deceased	O
could	B
not	I
participate	O
.	O
26In	O
previous	B
analyses	O
,	O
we	O
have	B
shown	I
that	O
the	O
original	O
index	O
mothers	O
were	O
representative	O
of	O
the	O
general	O
population	O
,	O
22and	O
our	B
findings	I
were	O
consistent	B
across	O
the	O
three	O
sweeps	O
,	O
so	O
we	O
do	O
not	O
think	B
self	O
-	O
selection	O
can	O
be	O
the	O
main	O
explanatory	B
factor	B
for	O
our	B
findings	I
.	O

Marked	O
improvement	O
was	O
seen	O
in	O
the	O
patient	O
'	O
s	O
hypernatremia	O
,	O
in	O
which	O
her	O
serum	O
sodium	O
concentrations	O
decreased	O
from	O
158	O
mEq	O
/	O
L	O
to143	O
mEq	O
/	O
L	O
within	O
30	O
hours	O
from	O
the	O
initial	O
DDAVP	O
dose	O
(	O
Figure	O
1	O
),	O
and	O
normalization	O
of	O
her	O
serum	O
osmolality	O
(	O
Figure	O
2	O
).	O

According	B
to	B
our	I
knowledge	I
,	O
there	B
was	I
no	I
clinical	O
trial	O
that	O
has	O
evaluated	O
the	O
effectiveness	O
of	O
vitamin	O
D	O
on	O
perinatal	O
depression	O
.	O

The	O
sample	O
size	O
necessary	O
to	O
define	O
a	O
twofold	O
increase	O
of	O
malformation	O
rates	O
of	O
1	O
–	O
3	O
%	O
above	O
the	O
baseline	O
was	O
insufficient	B
.	O

[	O
15	O
]	O
Thus	B
,	O
Daily	O
vitamin	O
requirement	B
varies	B
with	O
ethnicity	O
,	O
and	O
this	O
is	O
relevant	B
in	O
case	O
of	O
Indian	O
population	O
.	O

All	O
data	O
are	O
expressed	O
as	O
means	O
±	O
standard	O
error	O
of	O
means	O
(	O
SEM	O
).	O

The	O
reproductive	O
safety	B
of	O
antipsychotic	O
medications	O
should	B
be	I
studied	O
using	O
a	O
prospective	O
design	O
and	O
a	O
powerful	O
sample	O
size	O
and	O
in	O
the	O
reality	O
of	O
polytherapy	O
,	O
associated	B
comorbidities	O
and	O
environmental	O
and	O
genetic	O
confounders	O
.	O

The	O
exam	O
of	O
her	O
extremities	O
showed	O
1	O
+	O
right	O
radial	O
pulse	O
and	O
2	O
+	O
left	O
radial	O
pulse	O
.	O

Inclusion	O
criteria	O
were	O
as	O
follows	O
:	O
age	O
older	O
than	O
18	O
years	O
,	O
singleton	O
pregnancy	O
,	O
and	O
gestation	O
less	O
than	O
17	O
weeks	O
based	O
on	O
last	O
menstrual	O
period	O
and	O
ultrasound	O
measurements	O
.	O

If	O
serum	O
concentration	O
exceeded	O
70	O
.	O
3	O
nmol	O
/	O
L	O
(	O
75	O
percentile	O
),	O
the	O
chance	O
of	O
endometriosis	O
development	O
was	O
much	O
higher	O
,	O
with	O
OR	O
=	O
4	O
.	O
8	O
(	O
1	O
.	O
7	O
–	O
13	O
.	O
5	O
)	O
[	O
39	O
].	O

Among	O
women	O
with	O
initial	O
25	O
(	O
OH	O
)	O
D	O
<	O
40	O
ng	O
/	O
mL	O
,	O
PTB	O
rates	O
were	O
60	O
%	O
lower	O
for	O
those	O
with	O
≥	O
40	O
vs	O
.	O
<	O
40	O
ng	O
/	O
mL	O
on	O
a	O
follow	O
-	O
up	O
test	O
(	O
p	O
=	O
0	O
.	O
006	O
);	O
38	O
%	O
for	O
whites	O
(	O
p	O
=	O
0	O
.	O
33	O
)	O
and	O
78	O
%	O
for	O
non	O
-	O
whites	O
(	O
p	O
=	O
0	O
.	O
01	O
).	O

Here	B
,	O
we	O
report	O
the	O
identification	O
of	O
two	O
pedigrees	O
based	B
on	I
their	O
skeletal	O
disfigurement	O
,	O
Skm1	O
and	O
Skm2	O
.	O

There	O
are	O
differences	B
in	O
optimal	B
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
but	B
nowadays	O
internationally	O
accepted	B
normal	O
range	O
is	O
between	O
75	O
nmol	O
/	O
L	O
and	O
200	O
nmol	O
/	O
L	O
,	O
and	O
we	O
consider	B
serum	O
level	O
below	O
75	O
nmol	O
/	O
L	O
and	O
below	O
2	O
nmol	O
/	O
L	O
as	O
insufficiency	O
and	O
deficiency	O
,	O
respectively	O
.	O
42325Even	O
it	O
seems	B
to	O
achieve	O
the	O
prevention	O
of	O
autoimmune	O
diseases	O
,	O
the	O
serum	O
level	O
of	O
vitamin	O
D	O
must	B
be	I
higher	O
than	O
the	O
level	O
required	O
to	O
reduce	O
osteoporosis	O
(	O
higher	O
than	O
75	O
nmol	O
/	O
L	O
).	O
4In	O
attention	O
to	O
high	O
prevalence	O
of	O
MS	O
in	O
Iran	O
and	O
especially	O
in	O
Isfahan	O
which	O
is	O
about	B
43	O
.	O
5	O
/	O
100	O
,	O
0002627and	O
given	B
that	O
Iran	O
is	O
located	O
in	O
an	O
latitude	O
of	O
32	O
°	O
50	O
’	O
and	O
longitude	O
of	O
51	O
°	O
43	O
’	O
with	O
enough	O
sun	O
exposure	O
and	O
because	B
nobody	O
investigated	B
the	O
relationship	B
between	O
vitamin	O
D	O
,	O
as	B
an	O
environmental	O
agent	O
,	O
and	O
MS	O
disease	O
in	O
Iran	O
before	O
,	O
we	O
decided	B
to	O
compare	O
the	O
serum	O
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
in	O
MS	O
patients	O
and	O
healthy	O
control	O
group	O
in	O
Isfahan	O
region	O
.	O

Concerning	O
to	O
cumulative	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
during	O
the	O
post	O
-	O
weaning	O
period	O
(	O
Figure2D	O
),	O
we	O
found	B
a	O
main	O
effect	B
of	O
time	O
[	O
F	O
(	O
15	O
,	O
59	O
)=	O
1712	O
.	O
38	O
,	O
P	O
<	O
0	O
.	O
001	O
]	O
and	O
sex	O
[	O
F	O
(	O
1	O
,	O
73	O
)=	O
30	O
.	O
20	O
,	O
P	O
<	O
0	O
.	O
001	O
].	O

PubMed	O
Central	O
:	O

Therefore	B
,	O
a	O
diet	O
-	O
dependent	O
tissue	O
remodelling	O
might	B
take	O
place	O
in	O
LP	O
offspring	O
as	O
observed	O
previously	B
[	O
30	O
].	O

The	O
content	O
of	O
prenatal	O
care	O
,	O
including	O
nutritional	O
education	O
,	O
is	O
an	O
important	B
factor	O
that	O
could	B
determine	O
the	O
use	O
of	O
supplements	O
during	O
pregnancy	O
,	O
but	O
women	O
may	B
also	O
receive	O
advice	O
from	O
friends	O
,	O
family	O
,	O
the	O
media	O
and	O
other	B
sources	O
.	O

Low	O
cord	O
-	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
levels	O
are	O
associated	B
with	O
poor	O
lung	O
function	O
performance	O
and	O
increased	O
respiratory	O
infection	O
in	O
infancy	O
Abstract	O
Background	O
Perinatal	O
vitamin	O
D	O
deficiency	O
is	O
associated	B
with	O
a	O
higher	O
risk	B
of	O
wheezing	O
in	O
childhood	O
.	O

We	O
need	B
facilities	O
equipped	O
with	O
life	O
-	O
saving	O
commodities	O
,	O
and	O
girls	O
,	O
and	O
women	O
who	O
are	O
educated	O
,	O
and	O
enabled	O
,	O
can	O
protect	O
their	O
own	O
health	O
,	O
and	O
that	O
of	O
their	O
babies	O
.	O

Therefore	B
,	O
it	O
seems	B
reasonable	B
to	O
recommend	B
that	O
when	O
there	O
is	O
no	O
medical	O
or	O
obstetric	O
contraindication	O
,	O
women	O
with	O
GDM	O
should	B
maintain	O
a	O
sensible	O
level	O
of	O
light	O
and	O
moderate	O
intensity	O
physical	O
activity	O
until	O
the	O
latter	O
stages	O
of	O
the	O
pregnancy	O
.	O

Results	O
Among	O
the	O
1311	O
pregnant	O
women	O
participating	O
in	O
the	O
survey	O
,	O
there	O
were	O
271	O
from	O
Brussels	O
,	O
597	O
from	O
Flanders	O
and	O
437	O
from	O
Wallonia	O
(	O
Figure	O
1	O
;	O
Table	O
1	O
).	O

Findings	O
in	O
this	O
study	O
indicate	B
that	O
children	O
with	O
autism	O
had	O
a	O
significantly	O
higher	O
history	O
of	O
meconium	O
aspiration	O
syndrome	O
than	O
the	O
controls	O
[	O
43	O
].	O

In	B
contrast	I
,	O
in	O
another	B
study	I
40	O
,	O
000	O
IU	O
vitamin	O
D	O
per	O
week	O
was	O
used	O
for	O
6	O
months	O
,	O
but	B
vitamin	O
D	O
was	O
not	O
effective	B
in	O
decreasing	O
depression	O
level	O
compared	O
to	O
the	O
control	O
group	O
[	O
68	O
].	O

It	O
does	O
not	O
include	O
substantial	O
participant	O
investment	O
of	O
time	O
and	O
effort	O
,	O
or	O
interactivity	O
.	O

It	O
is	O
structurally	O
similar	O
to	O
estrogen	O
,	O
testosterone	O
,	O
progesterone	O
and	O
all	O
the	O
steroid	O
hormones	O
.	O

The	O
Eating	O
Inventory	O
(	O
EI	O
)	O
[	O
28	O
]	O
was	O
used	O
to	O
assess	O
cognitive	O
restraint	O
and	O
disinhibition	O
.	O

When	O
appropriate	O
,	O
data	O
from	O
body	O
weight	O
,	O
caloric	O
intake	O
and	O
compulsive	O
feeding	O
test	O
over	O
time	O
were	O
analyzed	O
by	O
Student	O
'	O
s	O
t	O
-	O
test	O
or	O
three	O
-	O
way	O
repeated	O
measures	O
analysis	O
of	O
variance	O
(	O
ANOVA	O
)	O
with	O
time	O
,	O
diet	O
and	O
sex	O
as	O
factors	O
.	O

This	O
is	O
particularly	B
so	O
where	O
the	O
prevalence	O
of	O
anemia	O
is	O
above	O
20	O
%	O
among	O
women	O
of	O
reproductive	O
age	O
[	O
58	O
].	O

A	O
systematic	O
review	O
in	O
2005	O
found	O
that	O
up	O
to	O
70	O
%	O
of	O
neonatal	O
deaths	O
,	O
worldwide	O
,	O
could	B
be	I
averted	O
by	O
implementing	O
sixteen	O
evidence	O
-	O
based	O
interventions	O
at	O
near	O
universal	O
coverage	O
(	O
99	O
%)	O
that	O
incorporated	O
preconception	O
,	O
antenatal	O
,	O
intrapartum	O
and	O
postnatal	O
interventions	O
[	O
3	O
].	O

Recruitment	O
and	O
consent	O
procedures	O
Consecutive	O
sampling	O
is	O
applied	O
,	O
thus	O
,	O
all	O
accessible	O
pregnant	O
women	O
at	O
the	O
recruitment	O
sites	O
may	O
form	O
part	O
of	O
the	O
sample	O
,	O
if	O
they	O
meet	O
the	O
inclusion	O
and	O
exclusion	O
criteria	O
,	O
arrive	O
at	O
study	O
site	O
on	O
their	O
booked	O
date	O
and	O
sign	O
informed	O
consent	O
.	O

Subject	O
scanning	O
does	O
not	O
take	O
place	O
unless	O
all	O
quality	O
control	O
results	O
fall	O
within	O
acceptable	O
limits	O
.	O

A	O
previous	B
study	I
in	O
Romania	O
reported	B
that	O
supplemental	O
iron	O
was	O
taken	O
by	O
53	O
.	O
3	O
%	O
of	O
women	O
during	O
pregancy	O
[	O
14	O
].	O

Furthermore	O
,	O
the	O
diet	O
-	O
dependent	O
transcriptional	O
excursions	O
revealed	B
an	O
impact	B
on	O
N	O
-	O
metabolism	O
.	O

Tissue	O
-	O
specific	O
FGF21	O
regulation	O
was	O
shown	O
to	O
occur	O
in	O
response	O
to	O
chronic	O
cold	O
exposure	O
in	O
mice	O
(	O
Fisher	O
et	O
al	O
.,	O
2012	O
).	O

Adjusted	O
for	O
age	O
,	O
pregnancy	O
weight	O
gain	O
,	O
smoking	O
status	O
(	O
yes	O
/	O
no	O
),	O
physical	O
activity	O
(	O
strenuous	O
activity	O
more	O
than	O
once	O
per	O
week	O
,	O
yes	O
/	O
no	O
),	O
educational	O
achievement	O
(	O
A	O
levels	O
or	O
higher	O
,	O
yes	O
/	O
no	O
),	O
season	O
of	O
blood	O
sampling	O
(	O
winter	O
,	O
spring	O
,	O
summer	O
,	O
autumn	O
),	O
compliance	O
with	O
study	O
protocol	O
,	O
and	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
.	O
Bonferroni	O
-	O
corrected	O
P	O
values	O
.	O

This	O
association	O
was	O
not	O
significant	O
for	O
fish	O
consumption	O
in	O
early	O
pregnancy	O
(	O
15	O
weeks	O
gestation	O
)	O
suggesting	B
that	O
fish	O
consumption	O
may	B
be	I
of	O
more	O
benefit	O
during	O
the	O
third	O
trimester	O
[	O
21	O
].	O

Any	O
misclassification	B
of	O
other	B
causes	O
of	O
raised	O
respiratory	O
rate	O
as	O
pneumonia	O
,	O
under	O
-	O
reporting	O
,	O
or	O
over	O
-	O
reporting	O
would	B
be	I
distributed	O
equally	O
between	O
the	O
two	O
groups	O
since	O
the	O
families	O
,	O
doctors	O
,	O
radiographers	O
,	O
radiologists	O
,	O
and	O
data	O
entry	O
staff	O
were	O
masked	O
to	O
the	O
randomisation	O
groupings	O
and	O
the	O
randomisation	O
was	O
successful	O
since	O
the	O
characteristics	O
were	O
balanced	O
between	O
the	O
two	O
groups	O
.	O

These	O
children	O
could	O
re	O
-	O
enter	O
the	O
study	O
when	O
next	O
seen	O
.	O

Intravenous	O
epinephrine	O
may	B
be	I
required	B
despite	B
its	O
potential	B
to	O
cause	O
decreased	O
uteroplacental	O
blood	O
flow	O
.	O

Differently	B
from	O
what	O
is	O
observed	B
in	O
other	B
pregnancy	O
-	O
associated	B
cancers	O
,	O
no	B
metastasis	O
of	O
DTC	O
to	O
placenta	O
or	O
foetus	O
has	B
been	I
reported	B
.	O

In	B
contrast	I
,	O
the	O
RC	O
males	O
presented	O
lower	O
levels	O
in	O
the	O
gene	O
expression	O
of	O
Napepld	O
in	O
liver	O
,	O
and	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
and	O
Mgll	O
in	O
PAT	O
whereas	B
RC	O
females	O
showed	O
lower	O
levels	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Faah	O
,	O
and	O
Mgll	O
in	O
liver	O
,	O
and	O
Napepld	O
in	O
PAT	O
,	O
compared	O
to	O
those	O
of	O
their	O
respective	O
CC	O
offspring	O
(	O
Figures4B	O
,	O
C	O
).	O

Therefore	B
,	O
the	O
high	O
concentration	O
of	O
C3	O
-	O
epi	O
-	O
25	O
(	O
OH	O
)	O
D	O
in	O
infants	O
may	B
explain	B
that	O
low	O
cord	O
—	O
but	B
not	I
maternal	O
—	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
contribute	B
to	O
poor	B
lung	O
function	O
and	O
increased	B
risk	I
of	O
respiratory	O
infection	O
in	O
this	B
study	I
.	O

This	B
study	I
focuses	B
on	O
the	O
F1	O
and	O
F2	O
generations	O
after	O
F0	O
maternal	O
vitamin	O
D	O
restriction	O
.	O

Early	O
recognition	O
by	O
the	O
emergency	O
physician	O
in	O
addition	O
to	O
successful	O
coordination	O
of	O
care	O
between	O
the	O
emergency	O
physician	O
,	O
obstetrician	O
,	O
and	O
cardiothoracic	O
/	O
vascular	O
surgeon	O
is	O
necessary	B
for	O
a	O
successful	O
outcome	O
.	O

The	O
validity	O
of	O
PUFA	O
estimated	O
by	O
means	O
of	O
the	O
FFQ	O
was	O
r	O
=	O
0	O
.	O
5	O
in	O
comparison	O
to	O
adipose	O
tissue	O
composition	O
[	O
26	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
I	O
.	O
Physiological	O
changes	O
in	O
thyroid	O
function	O
during	O
pregnancy	O
.	O
IncreaseDecreaseHCG	O
(	O
TSH	O
–	O
like	O
effect	O
)	O
TSHTBG	O
,	O
serum	O
total	O
T	O
4	O
and	O
T3	O
,	O
T3	O
and	O
T4	O
pool	O
sizeHTGType	O
III	O
5	O
-	O
deiodinase	O
,	O
iodine	O
clearance	O
,	O
T3	O
and	O
T4	O
degradationThyroid	O
volume	O
Besides	O
the	O
well	B
-	I
known	I
association	B
between	O
gestational	O
hypothyroidism	O
and	O
impaired	B
intellectual	O
and	O
cognitive	O
development	O
in	O
offspring	O
,	O
untreated	O
or	O
inadequately	B
treated	O
and	O
subclinical	O
hypothyroidism	O
is	O
associated	B
with	O
foetal	O
loss	O
,	O
anaemia	O
,	O
gestational	O
hypertension	O
and	O
preeclampsia	O
,	O
abruption	O
placentae	O
,	O
increased	O
risk	O
of	O
miscarriage	O
,	O
foetal	O
growth	O
retardation	O
,	O
perinatal	O
mortality	O
and	O
neonatal	O
morbidity91315	O
-	O
172122	O
.	O

In	O
another	B
study	I
,	O
15administration	O
of	O
600	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
was	O
associated	B
with	O
a	O
significant	O
increase	O
in	O
serum	O
vitamin	O
D	O
,	O
a	O
significant	O
decrease	O
in	O
serum	O
PTH	O
,	O
and	O
hypercalcemia	O
occurring	O
in	O
4	O
%	O
of	O
the	O
subjects	O
during	O
4	O
and	O
12	O
months	O
of	O
intervention	O
.	O

In	O
addition	O
,	O
follow	O
-	O
up	O
studies	O
have	B
shown	I
no	O
significant	O
increase	O
in	O
risk	O
.	O

Research	O
considerations	O
for	O
public	O
health	O
There	O
is	O
no	B
doubt	I
that	O
humans	O
are	O
exposed	O
to	O
a	O
range	O
of	O
environmental	O
factors	B
during	O
everyday	O
life	O
.	O

These	O
results	O
are	O
in	B
keeping	I
with	I
data	O
showing	O
a	O
physiological	O
role	B
of	O
BAT	O
in	O
whole	O
-	O
body	O
energy	O
expenditure	O
,	O
glucose	O
homeostasis	O
,	O
and	O
insulin	O
sensitivity	O
in	O
humans	O
during	O
prolonged	O
cold	O
exposure	O
(	O
Chondronikola	O
et	O
al	O
.,	O
2014	O
).	O

Continuous	O
variables	O
Serum	O
total	O
IgE	O
(	O
kU	O
·	O
L	O
−	O
1	O
)	O
was	O
measured	O
by	O
fluoroimmunoassay	O
using	O
the	O
Pharmacia	O
UNICAP	O
system	O
(	O
Pharmacia	O
and	O
Upjohn	O
Diagnostics	O
,	O
Uppsala	O
,	O
Sweden	O
).	O

“	O
The	O
conventional	B
wisdom	I
has	O
been	O
that	O
mothers	O
’	O
worries	O
about	O
milk	O
supply	O
are	O
due	B
either	B
to	I
their	O-
misperception	B
of	O-
normal	O-
lactation	O-
and	O-
infant	O-
breastfeeding	O-
behaviors	O-
or	I
to	O
mismanagement	B
of	O
breastfeeding	O
technique	O
,	O
and	O
only	B
on	O
very	O
rare	B
occasions	O
due	B
to	I
an	O
intrinsic	O
inability	B
to	O
make	O
enough	O
milk	O
,”	O
says	O
Laurie	O
Nommsen	O
-	O
Rivers	O
,	O
a	O
perinatal	O
nutrition	O
specialist	O
at	O
the	O
University	O
of	O
Cincinnati	O
College	O
of	O
Allied	O
Health	O
Sciences	O
.	O

In	O
these	O
models	O
,	O
we	O
found	B
a	O
significant	O
effect	B
of	O
text4baby	O
on	O
self	B
-	I
reported	I
alcohol	O
consumption	O
postpartum	O
(	O
OR	O
0	O
.	O
212	O
,	O
95	O
%	O
CI	O
0	O
.	O
046	O
-	O
0	O
.	O
973	O
,	O
P	O
=.	O
046	O
),	O
as	B
measured	O
by	O
the	O
question	O
“	O
Since	O
you	O
found	O
out	O
about	O
your	O
pregnancy	O
,	O
have	O
you	O
consumed	O
alcoholic	O
beverages	O
?”	O
The	O
lower	O
OR	O
indicates	O
lower	O
odds	O
of	O
consuming	O
alcoholic	O
beverages	O
at	O
postpartum	O
follow	O
-	O
up	O
.	O

However	B
,	O
hypervitaminosis	O
D	O
has	O
never	B
occurred	I
when	O
physiologic	O
amounts	O
of	O
vitamin	O
D	O
are	O
ingested	O
.	O

The	O
authors	O
mentioned	O
that	O
slight	O
heat	O
stress	O
might	B
induce	O
IMF	O
deposition	O
.	O

Because	B
we	O
were	O
concerned	B
that	O
ever	O
-	O
users	O
included	O
a	O
heterogeneous	B
category	O
of	O
PNV	O
users	O
including	O
women	O
who	O
only	O
used	O
before	O
pregnancy	O
or	O
only	O
after	O
pregnancy	O
diagnosis	O
,	O
we	O
compared	O
this	O
estimate	O
to	O
an	O
analogous	O
model	O
comparing	O
women	O
who	O
used	O
both	O
before	O
and	O
after	O
pregnancy	O
diagnosis	O
(	O
always	O
users	O
,	O
n	O
=	O
477	O
)	O
to	O
never	O
users	O
(	O
n	O
=	O
256	O
).	O

The	O
program	O
applies	O
and	O
adapts	O
Social	O
Cognitive	O
Theory	B
,	O
the	O
Health	O
Belief	O
Model	B
,	O
and	O
Diffusion	O
of	O
Innovation	O
theory	B
[	O
27	O
-	O
29	O
].	O

F1	O
females	O
were	O
separated	O
at	O
21	O
days	O
from	O
the	O
SC	O
and	O
VitD	O
-	O
groups	O
to	O
produce	O
the	O
F2	O
generation	O
(	O
n	O
=	O
10	O
females	O
per	O
group	O
).	O

One	B
paediatric	O-
trial	I
showed	O
16	O
%	O
higher	O
rates	O
of	O
tuberculosis	O
symptom	O
resolution	O
,	O
29an	O
adult	O
trial	O
showed	O
23	O
%	O
greater	O
sputum	O
conversion	O
rate	O
at	O
6	O
months	O
,	O
30another	B
trial	I
showed	O
20	O
%	O
greater	O
restriction	O
of	O
BCG	O
-	O
lux	O
growth	O
in	O
blood	O
,	O
31another	B
trial	I
found	B
accelerated	O
sputum	O
conversion	O
only	B
in	O
a	O
certain	O
genotype	O
of	O
the	O
sample	O
,	O
20whereas	B
yet	B
another	O
found	B
no	O
significant	O
difference	O
in	O
sputum	O
conversion32in	O
the	O
intervention	O
compared	O
with	O
the	O
placebo	O
group	O
.	O

Such	O
findings	B
,	O
both	O
positive	O
and	O
negative	O
,	O
have	B
been	I
incorporated	O
into	O
UK	O
governmental	O
advice	B
and	O
recommendations	B
(	O
Boyd	O
et	O
al	O
.	O
2013	O
).	O

[	O
21	O
]	O
was	O
the	O
only	B
study	O
to	O
report	O
a	O
neutral	O
effect	B
of	O
seafood	O
intake	O
on	O
all	O
neurodevelopmental	O
outcomes	O
.	O

The	O
threshold	O
for	O
defining	B
vitamin	O
D	O
deficiency	O
and	O
the	O
diagnostic	O
criteria	O
for	O
GDM	O
vary	B
between	O
studies	B
,	O
which	O
might	B
affect	B
the	O
results	O
and	O
complicate	B
the	O
comparison	O
of	O
studies	B
.	O

Furthermore	O
,	O
it	O
has	B
been	I
established	O
that	O
serum	O
25	O
(	O
OH	O
)	O
D	O
≥	O
50	O
nmol	O
/	O
L	O
is	O
recommended	B
during	O
pregnancy	O
and	O
lactation	O
[	O
7	O
].	O

Because	O
subjects	O
were	O
selected	O
based	O
on	O
SGA	O
status	O
and	O
matched	O
to	O
non	O
-	O
SGA	O
infants	O
on	O
sex	O
,	O
gestational	O
age	O
,	O
and	O
maternal	O
age	O
,	O
we	O
observed	O
no	O
significant	O
differences	O
in	O
those	O
characteristics	O
among	O
birth	O
weight	O
groups	O
(	O
SGA	O
,	O
AGA	O
,	O
LGA	O
).	O

injection	O
of	O
T61	O
in	O
the	O
V	O
.	O
cava	O
cranialis	O
and	O
liver	O
samples	O
were	O
immediately	O
collected	O
(	O
approximately	O
500	O
mg	O
),	O
frozen	O
in	O
liquid	O
nitrogen	O
,	O
and	O
stored	O
at	O
-	O
80	O
°	O
C	O
until	O
analysis	O
.	O

Continuous	O
data	O
were	O
compared	O
between	O
groups	O
using	O
independent	O
t	O
tests	O
and	O
Mann	O
-	O
Whitney	O
U	O
tests	O
when	O
data	O
violated	O
assumptions	O
.	O

Supplementation	O
of	O
women	O
is	O
more	O
costly	O
per	O
person	O
,	O
but	B
has	O
a	O
stronger	O
effect	B
on	O
anaemia	O
.	O

Other	O
lifestyle	O
and	O
dress	O
habits	O
were	O
not	B
evaluated	I
,	O
and	O
all	O
participants	O
were	O
observed	O
by	O
the	O
study	O
staff	O
for	O
typical	O
Western	O
-	O
style	O
US	O
clothing	O
(	O
sleeveless	O
or	O
short	O
-	O
sleeved	O
shirts	O
in	O
the	O
summer	O
,	O
jackets	O
or	O
coats	O
in	O
the	O
winter	O
).	O

The	O
approach	O
parents	O
take	O
to	O
feeding	O
their	O
children	O
reflects	B
their	O
goals	O
for	O
their	O
children	O
'	O
s	O
eating	O
and	O
health	O
,	O
and	O
these	O
goals	O
are	O
influenced	B
by	O
culture	O
and	O
socioeconomic	O
status	O
(	O
82	O
).	O

Quantitatively	O
,	O
it	O
was	O
estimated	B
that	O
50	O
g	O
of	O
BAT	O
can	O
burn	O
as	O
much	O
as	O
20	O
%	O
of	O
daily	O
energy	O
intake	O
(	O
Rothwell	O
and	O
Stock	O
,	O
1983	O
).	O

Response	O
to	O
Antenatal	O
Cholecalciferol	O
Supplementation	O
Is	O
Associated	B
With	O
Common	O
Vitamin	O
D	O
–	O
Related	O
Genetic	O
Variants	O
Abstract	O
Context	O
:	O
Single	O
-	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
in	O
genes	O
related	B
to	O
vitamin	O
D	O
metabolism	O
have	B
been	I
associated	B
with	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
[	O
25	O
(	O
OH	O
)	O
D	O
]	O
concentration	O
,	O
but	B
these	O
relationships	B
have	O
not	B
been	I
examined	I
following	O
antenatal	O
cholecalciferol	O
supplementation	O
.	O

The	O
increase	O
in	O
haemoglobin	O
concentration	O
in	O
the	O
intervention	O
group	O
relative	O
to	O
placebo	O
was	O
more	O
marked	O
in	O
women	O
who	O
were	O
anaemic	O
at	O
the	O
start	O
of	O
the	O
study	O
(	O
Figure	O
2	O
).	O

To	O
estimate	O
the	O
total	O
intake	O
of	O
omega	O
-	O
6	O
fatty	O
acids	O
,	O
we	O
combined	O
the	O
intake	O
of	O
arachidonic	O
and	O
linoleic	O
acids	O
.	O

Correlation	B
between	O
continuous	O
T1	O
25OHD	O
and	O
continuous	O
change	O
in	O
25OHD	O
was	O
low	O
(	O
r	O
=	O
−	O
0	O
.	O
22	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
it	O
was	O
therefore	B
considered	B
acceptable	O
to	O
include	O
both	O
variables	O
in	O
the	O
same	O
model	B
.	O

Standardised	O
methods	O
of	O
the	O
International	O
Society	O
for	O
the	O
Advancement	O
of	O
Kinanthropometry	O
[	O
45	O
]	O
are	O
used	O
with	O
a	O
calibrated	O
digital	O
scale	O
for	O
weight	O
,	O
a	O
mobile	O
stadiometer	O
for	O
height	O
;	O
and	O
non	O
-	O
stretchable	O
metal	O
measuring	O
tape	O
for	O
MUAC	O
.	O

Such	O
a	O
relation	B
has	B
been	I
attributed	B
to	O
special	O
receptors	O
for	O
vitamin	O
D	O
in	O
pancreatic	O
betacells	O
.	O
9Moreover	O
,	O
vitamin	O
D	O
was	B
shown	I
to	O
have	O
positive	O
effects	B
on	O
insulin	O
sensitivity	O
,	O
and	O
its	O
deficiency	O
to	O
have	O
negative	O
effects	B
on	O
the	O
function	O
of	O
betacells	O
.	O
11In	B
agreement	I
with	O
this	O
,	O
cohort	O
studies	O
revealed	B
that	O
vitamin	O
D	O
had	O
a	O
protective	B
effect	B
against	O
diabetes	O
type	O
II	O
.	O
8	O
,	O
11Also	O
,	O
serum	O
concentration	O
of	O
vitamin	O
D	O
during	O
24	O
-	O
29thweek	O
of	O
pregnancy	O
in	O
women	O
suffering	O
from	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
was	O
lower	O
than	O
that	O
in	O
women	O
without	O
the	O
disease	O
.	O
12	O
The	O
study	O
of	O
vitamin	O
D	O
status	O
and	O
improving	O
it	O
in	O
the	O
lactating	O
mothers	O
with	O
previous	O
GDM	O
is	O
of	O
conspicuous	B
value	I
.	O
4	O
,	O
13	O
Due	O
to	O
the	O
limited	O
exposure	O
to	O
sunshine	O
and	O
inadequate	O
intake	O
,	O
the	O
level	O
of	O
vitamin	O
D	O
is	O
reduced	O
in	O
the	O
milk	O
of	O
lactating	O
mothers	O
.	O

All	O
parents	O
provided	O
written	O
informed	O
consent	O
at	O
recruitment	O
,	O
and	O
a	O
small	O
honorarium	O
was	O
provided	O
.	O

Vitamin	O
D	O
and	O
calcium	O
disturbances	O
during	O
tooth	O
development	O
may	B
result	O
in	O
dentin	O
and	O
enamel	O
defects	O
,	O
which	O
can	B
increase	O
the	O
risk	B
for	O
caries	O
.	O

Here	B
,	O
we	O
also	O
review	O
these	O
factors	O
affecting	B
IMF	O
deposition	O
in	O
cattle	O
.	O

BMI	O
,	O
body	O
mass	O
index	O
;	O
MGF	O
,	O
maternal	O
grandfather	O
;	O
MGM	O
,	O
maternal	O
grandmother	O
;	O
PGF	O
,	O
paternal	O
grandfather	O
;	O
PGM	O
,	O
paternal	O
grandmother	O
.	O

Although	B
the	O
explanation	B
for	O
this	O
association	B
is	O
still	B
unknown	I
,	O
studies	B
in	O
the	O
past	O
several	O
years	O
have	O
hinted	B
that	O
insulin	O
resistance	O
may	B
be	I
involved	B
in	O
reduced	O
lactation	O
.	O

),	O
overweight	O
or	O
obesity	O
,	O
excessive	O
gestational	O
weight	O
gain	O
,	O
excessive	O
central	O
body	O
fat	O
deposition	O
,	O
family	O
history	O
of	O
diabetes	O
,	O
short	O
stature	O
(<	O
1	O
.	O
50	O
m	O
),	O
excessive	O
fetal	O
growth	O
,	O
polyhydramnios	O
,	O
hypertension	O
or	O
preeclampsia	O
in	O
the	O
current	O
pregnancy	O
,	O
history	O
of	O
recurrent	O
miscarriage	O
,	O
offspring	O
malformation	O
,	O
fetal	O
or	O
neonatal	O
death	O
,	O
macrosomia	O
,	O
GDM	O
during	O
prior	O
pregnancies	O
and	O
polycystic	O
ovary	O
syndrome	O
.	O

Follow	O
-	O
up	O
surveys	O
were	O
primarily	O
completed	O
remotely	O
online	O
.	O

Whilst	B
this	O
study	O
is	O
inadequately	B
powered	O
to	O
demonstrate	O
safety	O
of	O
acarbose	O
,	O
it	O
is	O
not	O
absorbed	O
from	O
the	O
gut	O
,	O
and	O
therefore	B
would	B
be	I
unlikely	B
to	O
affect	B
the	O
fetus	O
.	O

Anderson	O
Cancer	O
Center	O
are	O
currently	O
conducting	O
clinical	O
trials	O
in	O
Shanghai	O
on	O
a	O
cancer	O
therapy	O
that	O
uses	O
the	O
venom	O
of	O
the	O
Asiatic	O
toad	O
(	O
Bufo	O
gargarizans	O
).	O

However	O
,	O
little	B
is	I
known	I
about	O
how	B
well	O
the	O
recommendations	O
were	O
implemented	O
.	O

METHODS	O
Our	O
study	O
was	O
a	O
case	O
-	O
control	O
type	O
.	O

Special	O
hypoallergenic	O
formula	O
(	O
extensively	O
hydrolyzed	O
,	O
not	O
soy	O
-	O
based	O
)	O
should	B
be	I
used	O
only	B
if	I
the	O
child	O
is	O
diagnosed	O
with	O
atopy	O
.	O

In	O
preliminary	B
analyses	O
of	O
all	O
infants	O
,	O
delivery	O
mode	O
,	O
feeding	O
method	O
,	O
as	O
previously	B
shown	I
in	O
our	O
cohort	O
[	O
24	O
],	O
and	O
parity	O
were	O
significantly	O
related	B
to	O
infant	O
stool	O
microbial	O
community	O
composition	O
at	O
6	O
weeks	O
of	O
age	O
.	O

In	O
brief	O
,	O
community	O
leaders	O
and	O
health	O
staff	O
at	O
all	O
levels	O
were	O
sensitized	O
,	O
promotional	O
materials	O
were	O
developed	O
,	O
and	O
village	O
health	O
workers	O
were	O
trained	O
to	O
distribute	O
supplements	O
each	O
month	O
to	O
non	O
-	O
pregnant	O
women	O
.	O

Mean	O
infant	O
birth	O
weight	O
was	O
3542	O
(	O
538	O
)	O
grams	O
and	O
mean	O
gestational	O
age	O
at	O
delivery	O
was	O
280	O
(	O
12	O
.	O
4	O
)	O
days	O
.	O

The	O
primary	O
outcome	O
variable	O
was	O
a	O
composite	O
of	O
neonatal	O
hypoglycemia	O
,	O
respiratory	O
distress	O
,	O
need	O
for	O
phototherapy	O
,	O
birth	O
trauma	O
,	O
Apgar	O
score	O
less	O
than	O
7	O
,	O
or	O
prematurity	O
.	O

Materials	O
and	O
Methods	O
2	O
.	O
1	O
.	O

Other	B
suggests	B
vitamin	O
D	O
supplementation	O
of	O
400	O
IU	O
/	O
day	O
to	O
breast	O
fed	O
infants	O
is	O
the	O
most	B
secure	O
way	O
of	O
preventing	B
rickets	O
in	O
infants	O
.	O

The	O
researchers	O
found	B
that	O
the	O
more	O
vegetables	O
,	O
fruits	O
,	O
and	O
proteins	O
a	O
woman	O
ate	O
,	O
the	O
lower	O
the	O
risk	O
of	O
her	O
child	O
having	O
leukemia	O
.	O

While	B
the	O
urban	O
/	O
rural	O
gradient	O
in	O
rickets	O
is	O
well	B
known	I
and	O
was	O
one	O
of	O
the	O
keys	B
to	O
discovering	O
that	O
sunlight	O
prevented	B
rickets	O
,	O
less	B
well	I
known	I
is	O
a	O
meta	O
-	O
analysis	O
showing	B
a	O
twofold	O
urban	O
/	O
rural	O
gradient	O
for	O
autism	O
(	O
18	O
).	O

The	O
risk	O
was	O
also	O
lower	O
for	O
women	O
with	O
a	O
high	O
intake	O
of	O
omega	O
-	O
3	O
and	O
omega	O
-	O
6	O
PUFA	O
compared	O
to	O
women	O
with	O
a	O
lower	O
intake	O
of	O
these	O
fatty	O
acids	O
.	O

There	O
is	O
now	O
increasing	B
evidence	I
that	O
the	O
newer	O
rapid	O
acting	O
insulin	O
analogs	O
lispro	O
and	O
aspart	O
are	O
also	O
safe	B
in	O
pregnancy	O
,	O
and	O
indeed	O
,	O
they	O
are	O
commonly	O
used	O
.	O

Cranial	O
ultrasound	O
was	O
done	O
following	O
the	O
seizures	O
and	O
was	O
reported	O
as	O
normal	O
.	O

Moreover	O
,	O
similar	B
to	I
that	O
find	O
by	O
Restroff	O
et	O
al	O
.	O
26serum	O
PTH	O
of	O
the	O
IG	O
decreased	O
significantly	O
by	O
22	O
%	O
in	O
our	B
study	I
.	O

Self	O
-	O
reported	O
psychotic	O
experiences	O
in	O
the	O
general	O
population	O
may	B
represent	O
the	O
developmental	O
expression	O
of	O
population	O
genetic	O
risk	O
for	O
psychosis	O
[	O
9	O
].	O

Results	O
Demographic	O
and	O
underlying	O
variables	O
from	O
the	O
two	O
groups	O
are	O
presented	O
inTable	O
1	O
.	O

College	O
Station	O
,	O
TX	O
:	O
Stata	O
Corp	O
LP	O
.)	O

A	O
significant	O
percent	O
of	O
infants	O
with	O
a	O
history	O
of	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
bronchiolitis	O
infection	O
,	O
which	O
peaks	O
during	O
the	O
winter	O
season	O
,	O
develop	O
asthma	O
[	O
64	O
].	O

[	O
24	O
]	O
included	O
supplement	O
usage	O
as	O
a	O
confounder	B
.	O

Two	O
hospital	O
-	O
based	O
case	O
-	O
control	O
studies	O
in	O
Ethiopia1and	O
India2suggest	B
that	O
vitamin	O
D	O
deficiency	O
might	B
substantially	O
increase	O
the	O
risk	O
of	O
severe	B
pneumonia	O
in	O
children	O
.	O

These	O
characteristics	O
are	O
often	B
seen	B
in	O
patients	O
with	O
psychotic	O
disorders	O
[	O
51	O
-	O
53	O
].	O

Medullary	O
Thyroid	O
Cancer	O
(	O
MTC	O
)	O
–	O
cancer	O
arising	O
from	O
parafollicular	O
thyroid	O
cells	O
Medullary	O
carcinoma	O
of	O
the	O
thyroid	O
(	O
MTC	O
)	O
constitutes	O
approximately	B
5	O
-	O
10	O
%	O
of	O
thyroid	O
cancers	O
,	O
although	B
there	B
are	I
no	I
precise	O
figures	O
for	O
incidence	O
and	O
survival	O
rates	O
because	B
of	O
the	O
large	O
geographic	O
variations	B
,	O
mainly	B
due	B
to	I
its	O
familial	O
pattern	B
.	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O

The	O
independent	O
and	O
paired	O
t	O
-	O
test	O
were	O
used	O
for	O
normally	O
distributed	O
quantitative	O
variables	O
,	O
the	O
chi	O
-	O
square	O
test	O
was	O
used	O
for	O
qualitative	O
variables	O
,	O
and	O
the	O
Mann	O
-	O
Whitney	O
U	O
and	O
Wilcoxon	O
Signed	O
-	O
Rank	O
tests	O
were	O
used	O
for	O
non	O
-	O
normally	O
distributed	O
variables	O
.	O

Repetitive	O
element	O
DNA	O
methylation	O
was	O
determined	O
by	O
bisulfite	O
pyrosequencing	O
of	O
the	O
LINE	O
-	O
1	O
and	O
the	O
AluYb8	O
repetitive	O
elements	O
as	O
previously	O
described	O
(	O
Bollati	O
et	O
al	O
.	O

This	O
supplement	O
should	B
include	O
400	O
μ	O
g	O
of	O
folic	O
acid	O
or	O
lower	O
doses	O
,	O
if	B
this	O
amount	O
is	O
not	B
available	I
[	O
7	O
].	O

In	O
the	O
third	O
trimester	O
,	O
surgery	O
may	B
induce	O
premature	O
labour	O
.	O

From	O
these	O
results	O
,	O
the	O
authors	O
have	O
suggested	B
that	O
metformin	O
is	O
a	O
safe	O
and	O
effective	O
treatment	O
for	O
GDM	O
.	O

However	O
,	O
the	O
main	O
strengths	B
of	O
the	B
current	I
study	I
include	O
its	O
multidisciplinary	O
scope	O
including	O
epidemiology	O
,	O
statistics	O
,	O
pediatrics	O
,	O
maternity	O
,	O
and	O
nutrition	O
.	O

Introduction	O
Iron	O
deficiency	O
anaemia	O
is	O
defined	O
as	O
anaemia	O
accompanied	O
by	O
depleted	O
iron	O
stores	O
and	O
signs	O
of	O
a	O
compromised	O
supply	O
of	O
iron	O
to	O
the	O
tissues	O
[	O
1	O
].	O

Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

Vitamin	O
D	O
group	O
received	O
2000	O
IU	O
vitamin	O
D3daily	O
from	O
26	O
to	O
28	O
weeks	O
of	O
gestation	O
until	O
childbirth	O
.	O

AMH	O
is	O
produced	O
by	O
ovary	O
granulosa	O
cells	O
irrespective	O
of	O
stimulation	O
with	O
gonadotropins	O
,	O
but	O
,	O
as	O
stated	O
above	O
,	O
it	O
may	B
be	I
triggered	O
by	O
VD	O
supplementation	O
.	O

Furthermore	O
,	O
there	O
are	O
data	O
supporting	B
that	O
breast	O
-	O
feeding	O
should	B
not	I
be	I
continued	O
beyond	O
9	O
months	O
of	O
age	O
because	B
doing	O
so	O
seems	B
to	O
increase	O
the	O
child	O
'	O
s	O
risk	O
for	O
atopic	O
diseases	O
,	O
such	O
as	O
atopic	O
dermatitis	O
and	O
food	O
hypersensitivity	O
[	O
116	O
].	O

The	O
RR	O
comparing	O
growing	O
up	O
outside	O
of	O
the	O
Nordic	O
countries	O
for	O
the	O
middle	O
group	O
and	O
the	O
high	O
level	O
group	O
compared	O
with	O
the	O
low	O
level	O
group	O
was	O
1	O
.	O
7	O
(	O
95	O
%	O
CI	O
,	O
1	O
.	O
5	O
-	O
2	O
.	O
0	O
)	O
and	O
5	O
.	O
6	O
(	O
95	O
%	O
CI	O
,	O
4	O
.	O
0	O
-	O
6	O
.	O
8	O
),	O
respectively	O
.	O

Adverse	O
environmental	O
conditions	O
during	O
fetal	O
development	O
provoke	B
an	O
intrauterine	O
adaptive	O
response	O
termed	O
'	O
fetal	O
programming	O
',	O
which	O
may	B
lead	O
to	O
both	O
persistently	O
biased	O
responsiveness	O
to	O
extrinsic	O
factors	O
and	O
permanent	O
consequences	O
for	O
the	O
organismal	O
phenotype	O
[	O
1	O
-	O
6	O
].	O

Among	O
the	O
four	O
seasons	O
,	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
is	O
highest	O
in	O
Summer	O
,	O
lowest	O
in	O
the	O
Winter	O
,	O
which	O
is	O
significantly	O
lower	O
than	O
summer	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
and	O
spring	O
(	O
p	O
=	O
0	O
.	O
003	O
).	O

The	O
influence	B
of	O
the	O
educational	O
level	O
of	O
respondents	O
is	O
predominant	O
here	B
as	O
it	O
is	O
noticed	B
that	O
those	O
at	O
a	O
high	O
educational	O
level	O
are	O
more	O
likely	B
to	O
be	O
critical	O
about	O
care	O
received	O
and	O
defer	O
a	O
positive	O
satisfaction	O
.	O

They	O
consume	O
more	O
eggs	O
,	O
dairy	O
,	O
fish	O
and	O
animal	O
liver	O
products	O
and	O
have	O
a	O
more	O
balanced	O
diet	O
,	O
based	O
on	O
dietary	O
records	O
.	O

The	O
protocol	O
was	O
approved	O
by	O
the	O
Animal	O
Ethics	O
Committee	O
of	O
the	O
Complutense	O
University	O
of	O
Madrid	O
.	O

Thus	B
,	O
the	O
reversibility	O
of	O
environmentally	O
induced	O
changes	O
is	O
also	O
critically	B
important	B
when	O
determining	O
the	O
true	B
potential	B
adversity	O
of	O
an	O
environmental	O
exposure	O
.	O

Vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
has	B
been	I
shown	I
to	O
positively	O
affect	B
cord	O
blood	O
vitamin	O
D	O
levels	O
at	O
birth	O
.	O
43	O
,	O
44Studies	O
of	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
thus	B
far	I
have	B
shown	I
conflicting	B
results	O
with	O
respect	O
to	O
birth	O
weight	O
and	O
reduction	O
of	O
SGA	O
.	O
43	O
,	O
45	O
,	O
46	O
,	O
47	O
,	O
48Adequately	O
powered	O
and	O
randomized	O
controlled	O
trials	O
of	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
are	B
needed	I
to	B
assess	I
the	O
impact	B
of	O
supplementation	O
on	O
SGA	O
as	O
well	O
as	O
the	O
appropriate	B
dose	O
and	O
timing	O
of	O
supplementation	O
.	O

Moreover	O
,	O
these	O
metabolic	O
alterations	O
after	O
a	O
maternal	O
calorie	O
restricted	O
diet	O
have	B
been	I
found	B
associated	B
to	O
abnormalities	O
in	O
feeding	O
behavior	O
such	O
as	O
hyperphagia	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
;	O
Breton	O
et	O
al	O
.,	O
2009	O
;	O
Manuel	O
-	O
Apolinar	O
et	O
al	O
.,	O
2014	O
)	O
or	O
high	O
preference	O
for	O
high	O
-	O
fat	O
diet	O
(	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
).	O

Biologically	O
,	O
the	O
stress	O
hormone	O
cortisol	O
acts	O
by	O
activating	O
glucocorticoid	O
receptors	O
(	O
GRs	O
).	O

The	O
estimate	O
of	O
compliance	O
did	O
not	O
differ	O
between	O
treatment	O
groups	O
(	O
MMN	O
:	O
0	O
.	O
96	O
±	O
0	O
.	O
18	O
;	O
placebo	O
:	O
0	O
.	O
92	O
±	O
0	O
.	O
19	O
,	O
p	O
=	O
0	O
.	O
15	O
).	O

Our	O
recent	B
study	I
also	O
revealed	B
that	O
growth	O
performance	O
was	O
not	O
affected	O
by	O
mild	O
heat	O
stress	O
in	O
Korean	O
cattle	O
[	O
83	O
].	O

These	O
numbers	O
for	O
control	O
group	O
were	O
9	O
(	O
18	O
%),	O
22	O
(	O
44	O
%),	O
19	O
(	O
38	O
%),	O
respectively	O
.	O

In	O
addition	O
,	O
we	O
analysed	O
13	O
infants	O
treated	O
by	O
our	O
department	O
for	O
idiopathic	O
infantile	O
hypercalcaemia	O
(	O
IIH	O
)	O
from	O
2011	O
-	O
2013	O
.	O

This	B
review	I
discusses	O
vitamin	O
D	O
metabolism	O
,	O
dietary	O
requirements	B
and	O
recommendations	B
and	O
implications	B
of	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
and	O
lactation	O
.	O

In	O
general	O
,	O
histone	O
acetylation	O
and	O
demethylation	O
are	O
associated	O
with	O
active	O
chromatin	O
(	O
euchromatin	O
),	O
while	O
histone	O
deacteylation	O
and	O
methylation	O
are	O
associated	O
with	O
repressive	O
chromatin	O
(	O
heterochromatin	O
).	O

Even	B
though	B
our	O
results	O
highlight	B
the	O
importance	B
of	O
nutritional	O
knowledge	O
in	O
the	O
decision	O
to	O
use	O
iron	O
or	O
folic	O
acid	O
,	O
we	O
cannot	B
draw	O
conclusions	O
about	O
overall	O
compliance	O
with	O
supplement	O
regimes	O
,	O
because	B
we	O
did	B
not	I
record	O
the	O
dose	O
or	O
duration	O
of	O
iron	O
,	O
folic	O
acid	O
or	O
multivitamin	O
use	O
.	O

However	B
,	O
other	B
contributing	O
factors	B
could	B
not	I
be	I
excluded	I
.	O

In	O
obese	O
mothers	O
,	O
we	O
found	O
that	O
higher	O
intake	O
of	O
sweets	O
early	O
in	O
pregnancy	O
was	O
related	B
to	O
higher	O
offspring	O
weight	O
status	O
at	O
birth	O
and	O
6	O
months	O
.	O

(	O
2011	O
)*/†	O
Peng	O
et	O
al	O
.	O

Studies	O
in	O
which	O
participants	O
were	O
chosen	O
at	O
convenience	O
were	O
not	O
considered	O
in	O
this	O
review	O
.	O

For	O
patients	O
who	O
were	O
already	O
on	O
immunotherapy	O
before	O
the	O
pregnancy	O
,	O
maintenance	O
treatment	O
may	B
be	I
continued	O
safely	O
during	O
pregnancy	O
.	O

Much	O
of	O
the	O
controversy	B
is	O
concerned	B
with	O
multigenerational	O
versus	O
transgenerational	O
epigenetic	O
toxicity	O
(	O
or	O
epigenetic	O
effect	O
(	O
s	O
)	O
versus	O
epigenetic	O
inheritance	O
)	O
(	O
Figure	O
3	O
).	O

At	O
the	O
completion	O
of	O
the	O
amplification	O
protocol	O
,	O
all	O
samples	O
were	O
subjected	O
to	O
melting	O
curve	O
analyses	O
and	O
gel	O
electrophoresis	O
to	O
verify	O
the	O
absence	O
of	O
any	O
non	O
-	O
specific	O
product	O
.	O

The	O
study	O
investigates	O
the	O
indicated	O
variables	O
from	O
early	O
pregnancy	O
to	O
infants	O
up	O
to	O
12	O
months	O
.	O

None	O
of	O
the	O
individual	O
phthalate	O
metabolites	O
or	O
BPA	O
were	O
statistically	O
significant	O
at	O
the	O
0	O
.	O
05	O
or	O
0	O
.	O
5	O
level	O
,	O
which	O
may	B
explain	B
why	B
the	O
class	O
as	O
a	O
whole	O
was	B
not	I
significantly	O
different	O
from	O
zero	O
.	O

Our	O
data	O
are	O
consistent	B
with	O
other	B
similar	B
cohort	O-
data	I
.	O

Analyses	O
used	O
intention	O
to	O
treat	O
principles	O
according	O
to	O
the	O
treatment	O
group	O
allocated	O
in	O
pregnancy	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Risk	O
factors	O
related	O
to	O
the	O
development	O
of	O
Gestational	O
Diabetes	O
Mellitus	O
stratified	O
by	O
pre	O
-	O
pregnancy	O
Body	O
Mass	O
Index	O
(	O
PPBMI	O
)	O
classification	O
in	O
a	O
sample	O
of	O
pregnant	O
women	O
at	O
diagnosis	O
of	O
the	O
disease	O
,	O
Rio	O
Grande	O
do	O
Sul	O
/	O
Brazil	O
,	O
2014	O
.	O

Interestingly	B
,	O
increased	O
risk	O
for	O
glioma	O
has	B
been	I
observed	O
in	O
patients	O
with	O
AIDS	O
-	O
related	O
immuno	O
-	O
suppression	O
[	O
122	O
–	O
124	O
],	O
but	O
not	O
in	O
those	O
with	O
iatrogenic	O
immuno	O
-	O
suppression	O
[	O
125	O
].	O

Only	O
three	O
TFBS	O
genes	O
were	O
overrepresented	O
among	O
loci	O
whose	O
methylation	O
was	O
associated	B
with	O
LINE	O
-	O
1	O
methylation	O
:	O
MEF2	O
,	O
TBX1	O
,	O
and	O
POU2F1	O
.	O

We	O
also	O
examined	O
pair	O
wise	O
EDC	O
correlation	O
in	O
a	O
heat	O
map	O
(	O
Additional	O
file1	O
:	O
Figure	O
S2	O
).	O

Not	O
alone	O
is	O
this	O
now	O
more	O
robust	B
,	O
but	O
also	O
it	O
is	O
a	O
substantial	O
scientific	O
addition	O
using	O
novel	B
data	O
to	O
build	O
on	O
our	O
previous	B
observation	B
.	O

We	O
then	O
highlight	B
evidence	B
-	I
based	I
interventions	B
for	O
preterm	O
birth	O
in	O
the	O
context	O
of	O
the	O
wider	O
health	O
system	O
drawing	O
on	O
the	O
other	O
papers	O
in	O
this	O
supplement	O
,	O
and	O
here	B
we	O
focus	B
on	O
the	O
implications	B
for	O
integrating	O
and	O
scaling	O
up	O
those	O
available	O
interventions	B
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
where	O
the	O
coverage	O
of	O
care	O
is	O
lowest	O
and	O
the	O
potential	B
lives	O
saved	O
as	O
a	O
result	O
.	O

Maternal	O
consumption	O
of	O
a	O
HF	O
diet	O
resulted	O
in	O
adult	O
offspring	O
progesterone	O
concentrations	O
that	O
were	O
significantly	O
higher	O
than	O
those	O
of	O
offspring	O
born	O
to	O
Cont	O
dams	O
(	O
p	O
<	O
0	O
.	O
05	O
;	O
Figure	O
4B	O
),	O
although	B
in	O
MHF	O
offspring	O
these	O
differences	O
did	O
not	O
reach	O
statistical	O
significance	B
.	O

It	O
is	O
also	O
possible	B
that	O
the	O
milieu	O
of	O
higher	O
melatonin	O
and	O
insulin	O
resistance	O
during	O
winter	O
in	O
early	O
pregnancy	O
may	B
set	O
the	O
scene	O
for	O
glucose	O
homeostasis	O
throughout	O
the	O
remaining	O
months	O
of	O
pregnancy	O
.	O

Only	O
lower	O
maternal	O
fat	O
intake	O
(−	O
0	O
.	O
22	O
;	O
P	O
=	O
0	O
.	O
01	O
)	O
and	O
trend	O
for	O
higher	O
carbohydrate	O
intake	O
(	O
0	O
.	O
16	O
;	O
P	O
=	O
0	O
.	O
06	O
)	O
early	O
in	O
pregnancy	O
were	O
correlated	B
with	O
higher	O
WFA	O
z	O
-	O
scores	O
at	O
6	O
months	O
.	O

However	B
this	O
recommended	B
level	O
,	O
which	O
was	O
largely	B
arbitrarily	B
set	O
,	O
seems	B
to	B
be	I
less	B
helpful	I
to	O
improve	O
the	O
nutritional	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
.	O

and	O
Camargo	O
et	O
al	O
.	O

It	O
is	O
important	B
to	I
consider	I
how	B
S	O
-	O
ECC	O
and	O
poor	B
nutritional	O
status	O
are	O
connected	B
.	O

ADP	O
,	O
ON	O
,	O
LM	O
,	O
and	O
MG	O
contributed	O
to	O
the	O
study	O
conceptualization	O
and	O
design	O
,	O
acquisition	O
of	O
data	O
,	O
analysis	O
and	O
interpretation	O
of	O
data	O
and	O
writing	O
of	O
article	O
.	O

There	O
were	O
no	O
differences	O
among	O
deeply	O
deficient	O
(	O
VD	O
<	O
50nmol	O
/	O
L	O
)	O
and	O
VD	O
insufficient	O
(	O
VD	O
<	O
75nmol	O
/	O
L	O
)	O
recipients	O
.	O

In	O
asthmatic	O
children	O
,	O
episodes	O
of	O
acute	O
exacerbation	O
relating	B
to	O
respiratory	O
infection	O
were	O
also	O
inversely	O
associated	B
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
[	O
49	O
].	O

As	O
observed	O
at	O
birth	O
(	O
Fig	O
.	O

Moreover	O
,	O
it	O
fails	O
to	O
bind	O
glucocorticoids	O
and	O
activate	O
subsequent	O
transcriptional	O
events	O
[	O
24	O
].	O

[	O
20	O
]	O
Based	B
on	I
these	O
accumulated	O
observations	B
,	O
the	O
uncertain	B
teratogenic	O
potential	B
of	O
high	O
doses	O
of	O
calciferol	O
analogs	O
or	O
of	O
the	O
associated	B
disturbances	O
in	O
mineral	O
homeostasis	O
continues	O
to	O
cause	O
concern	B
.	O

These	O
stages	O
are	O
opportunities	B
for	O
interventions	O
to	O
prevent	O
obesity	O
by	O
controlling	O
caloric	O
intake	O
and	O
increasing	O
energy	O
expenditure	O
.	O

The	O
OGTT	O
diagnostic	O
criteria	O
for	O
GDM	O
was	O
as	O
follows	O
:	O
oral	O
intake	O
of	O
83	O
g	O
glucose	O
powder	O
;	O
the	O
normal	O
fasting	O
glucose	O
level	O
was	O
5	O
.	O
1	O
mmol	O
/	O
L	O
;	O
1	O
h	O
post	O
oral	O
glucose	O
intake	O
was	O
10	O
.	O
0	O
mmol	O
/	O
L	O
;	O
2	O
h	O
post	O
oral	O
glucose	O
intake	O
was	O
8	O
.	O
5	O
mmol	O
/	O
L	O
;	O
diagnosis	O
of	O
GDM	O
was	O
reached	O
if	O
the	O
glucose	O
level	O
of	O
more	O
than	O
one	O
time	O
point	O
was	O
high	O
than	O
normal	O
.	O

Since	B
having	O
had	O
a	O
previous	O
PTB	O
is	O
a	O
significant	O
risk	B
factor	I
for	O
a	O
recurrent	O
PTB	O
,	O
we	O
also	O
assessed	B
the	O
relationship	B
between	O
PTB	O
and	O
25	O
(	O
OH	O
)	O
D	O
for	O
these	O
women	O
separately	O
.	O

Confirmation	O
and	O
expansion	O
of	O
these	O
findings	O
in	B
additional	I
populations	I
,	O
with	O
additional	B
environmental	O-
data	I
and	O
more	B
comprehensive	I
methylation	O
profiles	O
as	O
well	O
as	O
studies	O
of	O
the	O
mechanism	O
of	O
these	O
alterations	O
,	O
will	B
provide	O
additional	O
valuable	O
insights	O
into	O
the	O
epigenetic	O
mechanisms	O
controlling	O
fetal	O
growth	O
.	O

The	O
current	O
recommendation	B
of	O
health	O
care	O
professionals	O
is	O
to	O
avoid	O
anticonvulsant	O
drug	O
use	O
such	O
as	O
valproate	O
during	O
pregnancy	O
.	O

The	O
epidemiological	O
data	O
from	O
the	O
Dutch	O
Famine	O
have	O
showed	B
that	O
people	O
whose	O
mothers	O
were	O
exposed	O
to	O
undernutrition	O
in	O
early	O
gestation	O
developed	O
more	O
metabolic	O
abnormalities	O
than	O
people	O
exposed	O
in	O
other	B
pregnancy	O
stages	O
(	O
Roseboom	O
et	O
al	O
.,	O
2006	O
).	O

No	O
difference	O
in	O
the	O
ratio	O
of	O
Tpef	O
/	O
Te	O
<	O
0	O
.	O
2	O
was	O
found	O
between	O
both	O
groups	O
.	O

Just	O
as	O
it	O
is	O
no	O
longer	O
acceptable	O
for	O
people	O
with	O
HIV	O
/	O
AIDS	O
to	O
remain	O
untreated	O
because	O
they	O
live	O
in	O
poor	O
countries	O
,	O
it	O
is	O
no	O
longer	O
acceptable	O
for	O
women	O
to	O
die	O
while	O
giving	O
birth	O
.	O

We	O
will	O
use	O
this	O
data	O
to	O
calculate	O
estimates	O
of	O
neonatal	O
mortality	O
in	O
both	O
arms	O
from	O
baseline	O
to	O
the	O
end	O
of	O
the	O
intervention	O
period	O
.	O

It	B
is	I
known	I
that	O
down	O
-	O
regulation	O
of	O
calcium	O
binding	O
proteins	O
shift	O
essential	B
calcium	O
buffering	O
requirements	O
to	O
the	O
mitochondrial	O
compartment	O
,	O
which	O
,	O
in	O
turn	O
,	O
leads	O
to	O
compromised	O
mitochondrial	O
energy	O
production	O
[	O
34	O
].	O

Women	O
with	O
T3	O
25OHD	O
concentrations	O
≥	O
100	O
nmol	O
/	O
L	O
and	O
30	O
–	O
50	O
nmol	O
/	O
L	O
had	O
lower	O
OR	O
for	O
LBW	O
(	O
OR	O
=	O
0	O
.	O
22	O
,	O
p	O
=	O
0	O
.	O
046	O
and	O
OR	O
=	O
0	O
.	O
07	O
,	O
p	O
=	O
0	O
.	O
017	O
,	O
respectively	O
),	O
compared	O
to	O
vitamin	O
D	O
deficiency	O
.	O

Results	O
Mean	O
serum	O
25	O
(	O
OH	O
)	O
D	O
in	O
all	O
women	O
was	O
68	O
.	O
1	O
±	O
27	O
.	O
1	O
nmol	O
/	O
L	O
and	O
28	O
%	O
(	O
n	O
=	O
772	O
)	O
were	O
considered	O
vitamin	O
D	O
deficient	O
(<	O
50	O
nmol	O
/	O
L	O
).	O

Women	O
of	O
Indian	O
origin	O
,	O
especially	B
pregnant	O
women	O
,	O
are	O
known	B
to	O
have	O
a	O
high	O
prevalence	B
of	O
vitamin	O
D	O
deficiency	O
.	O

All	O
other	O
offspring	O
from	O
dams	O
fed	O
the	O
HV	O
diet	O
were	O
weaned	O
to	O
RV	O
,	O
HV	O
or	O
HFol	O
diets	O
.	O

A	O
more	O
recent	B
study	I
examined	B
the	O
peer	O
effects	B
on	O
adolescent	O
BMI	O
by	O
using	O
the	O
National	O
Longitudinal	O
Study	O
of	O
Adolescent	O
Health	O
(	O
98	O
).	O

P	O
<	O
0	O
.	O
05	O
was	O
regarded	O
as	O
statistically	O
significant	O
.	O

Introduction	O
WHO	O
estimates	B
suggest	B
that	O
globally	B
up	O
to	O
500	O
million	O
women	O
of	O
reproductive	O
age	O
suffer	B
from	O
anaemia	O
.	O

Skm2	O
mice	O
presented	O
a	O
more	O
severe	B
phenotype	O
and	O
were	O
readily	O
identified	O
after	O
birth	O
by	O
a	O
shortened	O
stature	O
,	O
abnormal	O
gait	O
,	O
and	O
severe	B
scoliosis	O
and	O
lordosis	O
(	O
Figure	O
1C	O
).	O

Vitamin	O
D	O
deficiency	O
increases	O
the	O
risk	O
of	O
osteoporosis	O
[	O
3	O
]	O
and	O
fractures	O
[	O
4	O
],	O
while	O
in	O
its	O
most	O
severe	O
form	O
it	O
causes	O
rickets	O
in	O
children	O
[	O
5	O
]	O
and	O
osteomalacia	O
in	O
adults	O
[	O
6	O
].	O

Biochemical	O
analyses	O
Haemoglobin	O
is	O
determined	O
on	O
site	O
in	O
whole	O
blood	O
(	O
20	O
μL	O
)	O
using	O
HemoCue	O
(	O
Hb	O
201	O
+,	O
Ängelholm	O
,	O
Sweden	O
).	O

In	O
addition	O
,	O
Japanese	O
farmers	O
generally	B
restrict	O
vitamin	O
A	O
levels	O
in	O
the	O
diet	O
during	O
the	O
mid	O
-	O
fattening	O
stage	O
to	O
produce	O
highly	O
marbled	O
Japanese	O
Black	O
cattle	O
beef	O
.	O

At	O
the	O
postnatal	O
weeks	O
21	O
–	O
23	O
,	O
adult	O
offspring	O
were	O
finally	O
weighted	O
and	O
sacrificed	O
(	O
Figure1	O
).	O

Although	B
episodes	O
of	O
wheezing	O
during	O
childhood	O
are	O
mostly	B
caused	O
by	O
a	O
viral	O
respiratory	O
infection	O
,	O
their	O
detailed	O
pathogenesis	O
and	O
relationship	B
with	O
asthma	O
are	O
unclear	B
.	O

As	O
a	O
secondary	O
investigation	O
,	O
we	O
assessed	B
the	O
association	B
of	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
by	O
trimester	O
in	O
which	O
women	O
received	O
influenza	O
vaccination	O
;	O
the	O
unvaccinated	O
group	O
was	O
used	O
as	O
a	O
control	O
for	O
all	O
models	O
.	O

Such	O
low	O
consumption	O
rate	O
and	O
amount	O
cannot	B
be	I
the	O
leading	B
cause	I
of	O
high	O
Vitamin	O
D	O
detection	B
rate	O
in	O
these	O
participants	O
.	O

That	O
is	O
,	O
analyses	O
were	O
conducted	O
assuming	O
that	O
missing	O
values	O
had	O
,	O
firstly	O
,	O
a	O
substantially	O
greater	O
incidence	O
,	O
and	O
secondly	O
,	O
a	O
substantially	O
reduced	O
incidence	O
of	O
z	O
-	O
scores	O
>	O
90th	O
percentile	O
as	O
compared	O
with	O
the	O
observed	O
data	O
.	O

Thus	B
,	O
both	O
prenatal	O
and	O
maternal	O
variables	O
can	B
increase	O
the	O
risk	B
of	O
obesity	O
in	O
even	B
the	O
youngest	O
children	O
,	O
long	O
before	O
social	O
factors	B
have	O
an	O
influence	B
.	O

Along	B
this	I
line	I
,	O
it	O
was	O
recently	B
shown	O
that	O
BAT	O
transplantation	O
into	O
the	O
abdominal	O
cavity	O
of	O
high	O
fat	O
diet	O
-	O
induced	O
obese	O
mice	O
was	O
able	O
to	O
improve	O
their	O
glucose	O
tolerance	O
,	O
increase	O
their	O
insulin	O
sensitivity	O
,	O
lower	O
their	O
body	O
weight	O
,	O
decrease	O
their	O
fat	O
mass	O
and	O
completely	O
reverse	O
their	O
insulin	O
resistance	O
(	O
Stanford	O
et	O
al	O
.,	O
2013	O
).	O

Structured	O
questionnaires	O
were	O
administered	O
to	B
assess	I
the	O
availability	O
of	O
supplements	O
at	O
each	O
level	O
of	O
the	O
distribution	O
chain	O
and	O
women	O
'	O
s	O
attitude	O
about	O
,	O
and	O
their	O
history	O
of	O
,	O
taking	O
the	O
supplements	O
[	O
13	O
].	O

Investigation	O
of	O
the	O
vitamin	O
D	O
nutritional	O
status	O
in	O
women	O
with	O
gestational	O
diabetes	O
mellitus	O
in	O
Beijing	O
Abstract	O
Background	O
Vitamin	O
D	O
deficiency	O
is	O
a	O
common	O
issue	B
,	O
which	O
has	O
relation	B
with	O
GDM	O
,	O
during	O
the	O
pregnant	O
period	O
.	O

Findings	B
from	O
other	B
studies	I
on	O
routine	O
daily	O
or	O
weekly	O
antenatal	O
iron	O
or	O
iron	O
plus	O
folic	O
acid	O
supplementation	O
showed	B
that	O
it	O
may	B
be	I
of	O
benefit	O
,	O
especially	O
where	O
pregestational	O
iron	O
deficiency	O
and	O
anaemia	O
are	O
prevalent	O
[	O
7	O
].	O

25	O
(	O
OH	O
)	O
D	O
before	O
and	O
after	O
supplementation	O
with	O
cholecalciferol	O
in	O
pregnancy	O
according	O
to	O
GRS	O
for	O
the	O
SNPs	O
rs10741657	O
(	O
CYP2R1	O
)	O
and	O
rs2282679	O
(	O
GC	O
).	O

Discussion	O
Despite	B
the	O
fact	O
that	O
more	O
than	O
60	O
%	O
of	O
the	O
pregnant	O
women	O
reported	O
taking	O
multivitamins	O
containing	O
vitamin	O
D	O
during	O
pregnancy	O
,	O
nearly	O
45	O
%	O
of	O
the	O
women	O
were	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
).	O

Guidelines	O
from	O
Australia	O
,	O
Europe	O
and	O
the	O
USA	O
encourage	B
fish	O
consumption	O
during	O
pregnancy	O
.	O

An	O
adequate	O
pre	O
-	O
pregnancy	O
nutritional	O
status	O
was	O
associated	B
with	O
gestational	O
weight	O
gain	O
above	O
recommendations	O
.	O

Interestingly	B
,	O
GAS5	O
and	O
GR	O
α	O
were	O
the	O
predominant	B
transcripts	O
in	O
both	O
term	O
and	O
preterm	O
placentas	O
.	O

Methods	O
:	O
Placental	O
tissues	O
and	O
associated	O
demographic	O
and	O
clinical	O
data	O
were	O
obtained	O
from	O
subjects	O
delivering	O
at	O
Women	O
and	O
Infants	O
Hospital	O
in	O
Providence	O
,	O
Rhode	O
Island	O
(	O
USA	O
).	O

Decreases	O
in	O
the	O
HRV	O
parameters	O
were	O
noted	B
in	O
newborns	O
at	O
term	O
with	O
low	O
weight	O
[	O
34	O
],	O
while	B
other	B
studies	I
observed	B
a	O
normal	O
cardiac	O
autonomic	O
balance	O
in	O
these	O
neonates	O
[	O
17	O
,	O
35	O
].	O

Energy	O
and	O
nutrients	O
intake	O
of	O
the	O
study	O
participants	O
across	O
different	O
categories	O
of	O
healthy	O
,	O
western	O
,	O
and	O
traditional	O
dietary	O
patterns	O
were	O
reported	O
in	O
Tables3	O
,	O
4	O
,	O
and5	O
,	O
respectively	O
.	O

Implement	O
•	O
Strengthen	O
health	O
systems	O
for	O
quality	O
maternal	O
and	O
neonatal	O
care	O
,	O
including	O
improved	O
community	O
awareness	B
and	O
demand	O
for	O
RMNCH	O
services	O
and	O
adopt	O
policies	O
to	O
promote	O
universal	O
access	O
to	O
quality	O
preconception	O
and	O
maternal	O
and	O
perinatal	O
services	O
.	O

Women	O
with	O
an	O
increase	O
in	O
25OHD	O
≥	O
30	O
nmol	O
/	O
L	O
from	O
T1	O
to	O
T3	O
had	O
the	O
lowest	O
odds	O
of	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

Multivariable	O
linear	O
regression	O
[	O
5	O
,	O
13	O
,	O
24	O
]	O
with	O
selected	O
predictors	O
[	O
30	O
]	O
is	O
another	B
method	O
,	O
but	B
it	O
can	B
produce	O
unreliable	B
estimates	B
due	B
to	I
the	O
highly	O
correlated	O
nature	O
of	O
some	O
EDCs	O
[	O
31	O
].	O

We	O
used	O
the	O
R	O
package	O
‘	O
glmnet	O
’	O
[	O
42	O
],	O
and	O
included	O
the	O
BHLM	O
confounders	O
(	O
Table3	O
)	O
in	O
the	O
regression	O
as	O
unpenalized	O
variables	O
.	O

FLNB	O
comprises	O
an	O
actin	O
-	O
binding	O
domain	O
(	O
ABD	O
)	O
containing	O
two	O
calponin	O
homology	O
(	O
CH	O
)	O
domains	O
at	O
the	O
amino	O
terminus	O
,	O
followed	O
by	O
24	O
filamin	O
repeat	O
domains	O
that	O
are	O
separated	O
by	O
two	O
hinge	O
(	O
1H	O
-	O
2	O
)	O
regions	O
.	O

Immature	O
glomeruli	O
begin	O
to	O
disappear	O
at	O
10	O
days	O
,	O
but	B
at	O
this	O
age	O
,	O
F1	O
-	O
VitD	O
-	O
mice	O
had	O
more	O
immature	O
and	O
mature	O
glomeruli	O
than	O
F1	O
-	O
SC	O
mice	O
.	O

There	O
are	O
many	B
documented	I
health	O
benefits	O
from	O
fish	O
consumption	O
with	O
regard	O
to	O
foetal	O
health	O
,	O
including	O
improved	O
neurodevelopment	O
,	O
increased	O
birth	O
weight	O
and	O
a	O
reduced	O
risk	O
of	O
spontaneous	O
abortion	O
[	O
11	O
,	O
12	O
].	O

Of	O
the	O
infants	O
,	O
367	O
were	O
girls	O
and	O
356	O
boys	O
.	O

Although	B
the	O
developmental	O
stage	O
of	O
formal	O
operational	O
thought	O
enables	O
skills	O
such	O
as	O
enhanced	O
problem	O
solving	O
,	O
decision	O
making	O
,	O
and	O
abstract	O
reasoning	O
(	O
90	O
),	O
the	O
underdeveloped	O
prefrontal	O
cortex	O
(	O
99	O
)	O
still	B
leaves	O
adolescents	O
at	B
risk	I
for	O
behaviors	O
that	O
may	B
increase	O
the	O
risk	B
of	O
obesity	O
.	O

Prevalence	O
and	O
Burden	O
of	O
Iron	O
Deficiency	O
Anaemia	O
in	O
Pregnancy	O
in	O
Developing	O
Countries	O
Worldwide	O
,	O
anemia	O
affects	O
over	O
two	O
billion	O
people	O
and	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
)	O
has	O
estimated	B
that	O
half	O
of	O
these	O
are	O
due	B
to	I
iron	O
deficiency	O
[	O
5	O
,	O
6	O
].	O

If	B
the	O
proportion	O
of	O
non	O
-	O
urbanized	O
participants	O
was	O
high	O
in	O
the	O
study	O
population	O
this	O
could	B
have	O
confounded	B
our	O
results	O
,	O
nevertheless	B
this	O
is	O
not	O
the	O
case	O
in	O
the	O
Swedish	O
population	O
.	O

Folate	O
Status	O
Both	O
brain	O
(	O
Figure	O
6a	O
)	O
and	O
plasma	O
(	O
Figure	O
6b	O
)	O
folate	O
levels	O
were	O
unaffected	O
by	O
the	O
diets	O
of	O
the	O
dams	O
but	B
were	O
elevated	O
by	O
the	O
high	O
multivitamin	O
or	O
high	O
folate	O
pup	O
diet	O
.	O

Whereas	B
in	O
pregnancy	O
,	O
serum	O
ferritin	O
levels	O
decline	O
even	B
in	O
women	O
ingesting	O
daily	O
supplements	O
of	O
iron	O
[	O
22	O
–	O
24	O
].	O

Recent	B
studies	I
have	B
shown	I
that	O
a	O
wide	O
range	O
of	O
disorders	O
,	O
including	O
neuropsychiatric	O
disorders	O
and	O
autism	O
,	O
are	O
associated	B
with	O
increased	O
homocysteine	O
levels	O
in	O
biological	O
fluids	O
.	O

(	O
2012	O
)*/†	O
MethylmercuryMouseOral	O
(	O
water	O
)	O
(	O
0	O
.	O
5	O
mg	O
/	O
kg	O
)	O
In	O
utero	O
+	O
neonatalAdulthoodBehavioral	O
abnormalitiesHistone	O
modification	O
DNA	O
methylationOnishchenko	O
et	O
al	O
.	O

PubMed	O
Central	O
:	O

In	O
this	O
study	O
,	O
they	O
selected	O
mothers	O
who	O
needed	O
antidepressant	O
drugs	O
after	O
childbirth	O
as	O
the	O
case	O
group	O
.	O

The	O
items	O
that	O
were	O
too	O
difficult	O
,	O
too	O
easy	O
,	O
or	O
that	O
were	O
found	O
to	O
have	O
near	O
-	O
zero	O
or	O
negative	O
discrimination	O
were	O
eliminated	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
7	O
Targets	O
for	O
action	O
by	O
2025	O
.	O

If	B
these	O
two	O
interventions	B
were	O
added	O
to	O
existing	O
health	O
system	O
packages	O
,	O
especially	B
noting	O
the	O
recent	B
shifts	O
to	O
more	O
facility	O
births	O
in	O
Africa	O
and	O
Asia	O
,	O
then	O
a	O
high	O
impact	B
is	O
possible	B
even	B
in	O
a	O
relatively	O
short	O
time	O
frame	O
.	O

1	O
).	O
Fig	O
.	O

Pre	O
-	O
pregnancy	O
weekly	O
supplements	O
that	O
contain	O
folic	O
acid	O
may	B
also	O
decrease	O
the	O
risk	B
of	O
neural	O
tube	O
defects	O
.	O

A	O
single	O
24	O
-	O
HR	O
,	O
which	O
obtains	O
details	O
about	O
nutritional	O
supplement	O
use	O
as	O
well	O
,	O
is	O
administered	O
at	O
phases	O
1	O
,	O
2	O
and	O
3	O
in	O
pregnancy	O
,	O
as	O
well	O
as	O
at	O
6	O
months	O
postnatally	O
(	O
phase	O
6	O
).	O

Data	O
processing	O
and	O
statistical	O
analysis	O
We	O
identified	O
open	O
reference	O
operational	O
taxonomic	O
units	O
(	O
OTUs	O
)	O
using	O
QIIME	O
version	O
1	O
.	O
9	O
.	O
1	O
[	O
35	O
]	O
with	O
the	O
UCLUST	O
algorithm	O
and	O
97	O
%	O
similarity	O
[	O
36	O
].	O

These	B
findings	I
are	O
consistent	B
with	O
the	O
premise	B
that	O
modification	O
in	O
the	O
fetal	O
environment	O
could	B
alter	O
ANS	O
development	O
.	O

The	O
prior	O
distribution	O
depends	O
on	O
hyperparameters	O
,	O
including	O
a	O
mean	O
μβand	O
standard	O
deviation	O
σβ	O
,	O
which	O
are	O
informed	O
by	O
the	O
data	O
and	O
can	O
be	O
quantified	O
when	O
fitted	O
to	O
the	O
data	O
.	O

The	O
FFQ	O
lacked	O
quantitative	O
information	O
on	O
soft	O
drink	O
consumption	O
and	O
this	O
will	B
have	O
led	O
to	O
underestimation	B
of	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
.	O

Mean	O
glucose	O
concentrations	O
1	O
-	O
hour	O
after	O
a	O
50	O
-	O
gram	O
oral	O
glucose	O
challenge	O
were	O
16	O
.	O
3	O
mg	O
/	O
dl	O
higher	O
in	O
women	O
who	O
reported	O
sleeping	O
≤	O
4	O
hours	O
(	O
95	O
%	O
CI	O
1	O
.	O
1	O
-	O
31	O
.	O
6	O
,	O
p	O
=	O
0	O
.	O
04	O
),	O
2	O
.	O
3	O
mg	O
/	O
dl	O
higher	O
for	O
women	O
who	O
reported	O
sleeping	O
5	O
-	O
8	O
hours	O
(	O
95	O
%	O
CI	O
-	O
1	O
.	O
8	O
-	O
6	O
.	O
3	O
,	O
p	O
=	O
0	O
.	O
27	O
),	O
and	O
6	O
.	O
3	O
mg	O
/	O
dl	O
higher	O
for	O
women	O
who	O
reported	O
sleeping	O
≥	O
10	O
hours	O
(	O
95	O
%	O
CI	O
-	O
0	O
.	O
5	O
-	O
13	O
.	O
2	O
,	O
p	O
=	O
0	O
.	O
07	O
)	O
compared	O
with	O
those	O
who	O
reported	O
sleeping	O
9	O
hours	O
per	O
night	O
.	O

Nonetheless	B
,	O
in	O
our	B
study	I
,	O
the	O
vitamin	O
D	O
group	O
had	O
significantly	O
lower	O
depression	O
scores	O
after	O
intervention	O
.	O

Free	O
vitamin	O
D	O
supplements	O
were	O
offered	O
and	O
the	O
treatment	O
goal	O
was	O
≥	O
40	O
ng	O
/	O
mL	O
.	O

Elastic	O
Net	O
selected	O
the	O
same	O
variables	O
as	O
LASSO	O
,	O
as	O
well	O
as	O
an	O
additional	O
5	O
PCBs	O
and	O
1	O
PBDE	O
.	O

Several	O
small	B
studies	I
have	O
examined	O
whether	B
regular	O
exercise	O
is	O
also	O
beneficial	O
in	O
the	O
management	O
of	O
GDM	O
Jovanavic	O
-	O
Petersen	O
randomized	O
19	O
women	O
with	O
GDM	O
to	O
a	O
regime	O
of	O
diet	O
alone	O
,	O
or	O
diet	O
with	O
20	O
minutes	O
of	O
supervised	O
aerobic	O
training	O
three	O
days	O
per	O
week	O
for	O
six	O
weeks	O
.	O
31This	O
modest	O
amount	O
of	O
physical	O
activity	O
resulted	O
in	O
lower	O
fasting	O
glucose	O
levels	O
,	O
lower	O
glucose	O
responses	O
to	O
a	O
glucose	O
challenge	O
,	O
and	O
a	O
lower	O
HbA1c	O
.	O

Preterm	O
delivery	O
occurred	O
in	O
ten	O
pregnancies	O
.	O

Using	O
PSM	O
,	O
we	O
observed	B
a	O
protective	B
effect	B
of	O
influenza	O
vaccination	O
on	O
PTB	O
and	O
LBW	O
among	O
those	O
vaccinated	O
in	O
the	O
second	O
and	O
third	O
trimester	O
.	O

In	O
animal	O
models	O
,	O
prenatal	O
exposures	O
to	O
overnutrition	O
,	O
high	O
-	O
fat	O
and	O
high	O
-	O
protein	O
diets	O
,	O
“	O
junk	O
”	O
food	O
,	O
and	O
stress	O
have	O
been	O
linked	B
with	O
greater	O
adiposity	O
in	O
offspring	O
[	O
10	O
–	O
12	O
].	O

Comparing	O
perinatal	O
and	O
juvenile	O
piglets	O
(	O
period	O
II	O
)	O
991	O
probe	O
-	O
sets	O
were	O
regulated	O
in	O
a	O
different	O
manner	O
in	O
AP	O
offspring	O
and	O
in	O
LP	O
offspring	O
.	O

Data	O
from	O
three	O
trials	O
involving	O
463	O
women	O
show	B
a	O
trend	B
for	O
women	O
who	O
receive	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
to	O
more	O
frequently	O
have	O
a	O
baby	O
with	O
a	O
birth	O
weight	O
below	O
2500	O
grams	O
than	O
those	O
women	O
receiving	O
no	O
treatment	O
or	O
placebo	O
,	O
although	B
the	O
statistical	O
significance	O
was	O
borderline	O
.	O

However	B
,	O
when	O
each	O
pregnancy	O
complication	O
was	O
analysed	O
separately	O
,	O
a	O
53	O
%	O
decreased	O
risk	O
for	O
GDM	O
was	O
observed	O
with	O
high	O
vitamin	O
D	O
status	O
when	O
compared	O
to	O
moderate	O
-	O
high	O
status	O
(	O
aRR	O
:	O
0	O
.	O
47	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
23	O
,	O
0	O
.	O
96	O
).	O

Free	O
sugar	O
does	O
not	O
include	O
lactose	O
when	O
naturally	O
present	O
in	O
milk	O
and	O
milk	O
products	O
or	O
the	O
sugars	O
contained	O
within	O
the	O
cellular	O
structure	O
of	O
fruits	O
and	O
vegetables	O
.	O

9	O
).	O

The	O
correlation	B
between	O
VD	O
and	O
AMH	O
was	O
confirmed	B
in	O
a	O
multi	O
-	O
center	O
study	O
in	O
patients	O
over	O
their	O
40th	O
years	O
of	O
life	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Estimated	O
lives	O
saved	O
of	O
premature	O
babies	O
in	O
settings	O
with	O
universal	O
coverage	O
of	O
interventionsIntervention	O
reaching	O
95	O
%	O
coverageAlso	O
saves	O
mothers	O
or	O
other	O
babiesBy	O
2015By	O
2025	O
%	O
Deaths	O
avertedLives	O
saved	O
%	O
Deaths	O
avertedLives	O
savedFamily	O
planning	O
*	O
M	O
,	O
SB	O
,	O
N24228	O
,	O
00032345	O
,	O
000Antenatal	O
corticosteroidsN40373	O
,	O
00041444	O
,	O
000Antibiotics	O
for	O
pPRoMN985	O
,	O
0009101	O
,	O
000Immediate	O
assessment	O
and	O
simple	O
care	O
of	O
all	O
babiesN544	O
,	O
000553	O
,	O
000Neonatal	O
resuscitationN765	O
,	O
000777	O
,	O
000Thermal	O
careN15142	O
,	O
00016171	O
,	O
000Kangaroo	O
mother	O
careN48452	O
,	O
00048531	O
,	O
000Interventions	O
implemented	O
togetherM	O
,	O
SB	O
,	O
N81757	O
,	O
00084921	O
,	O
000	O
Note	O
:	O
interventions	O
marked	O
with	O
M	O
will	O
also	O
save	O
maternal	O
lives	O
,	O
SB	O
would	O
avert	O
stillbirth	O
,	O
and	O
N	O
will	O
save	O
newborns	O
dying	O
from	O
causes	O
other	O
than	O
preterm	O
birth	O
.	O

Growth	O
arrest	O
-	O
specific	O
transcript	O
5	O
(	O
GAS5	O
)	O
encodes	O
a	O
single	O
strand	O
noncoding	O
RNA	O
(	O
ncRNA	O
)	O
and	O
,	O
as	O
its	O
name	O
suggests	O
,	O
can	O
accumulate	O
in	O
growth	O
-	O
arrested	O
cells	O
[	O
7	O
].	O

The	O
results	O
of	O
this	O
study	O
to	O
address	O
these	O
hypotheses	O
are	O
presented	O
here	O
.	O

[	O
17	O
]	O
New	B
research	I
suggests	B
that	O
women	O
who	O
take	O
high	O
doses	O
of	O
vitamin	O
D	O
during	O
pregnancy	O
have	O
a	O
greatly	O
reduced	O
risk	B
of	O
complications	B
,	O
including	O
gestational	O
diabetes	O
,	O
preterm	O
birth	O
,	O
and	O
infection	O
.	O

[	O
23	O
]	O
Preeclampsia	O
is	O
associated	B
with	O
low	O
circulating	O
levels	O
of	O
IGF	O
-	O
I	O
and	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
and	O
,	O
in	O
vitro	O
,	O
IGF	O
-	O
1	O
increases	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
production	O
by	O
primary	O
human	O
syncytiotrophoblasts	O
from	O
placentas	O
from	O
normal	O
pregnancies	O
but	B
not	I
from	O
preeclamptic	O
pregnancies	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Concentrations	O
(	O
μg	O
/	O
g	O
creatinine	O
phthalates	O
and	O
BPA	O
,	O
ng	O
/	O
g	O
lipids	O
PCBs	O
,	O
PBDEs	O
and	O
OCPs	O
,	O
μg	O
/	O
L	O
serum	O
PFAS	O
,	O
DEP	O
,	O
DMP	O
and	O
Hg	O
,	O
μg	O
/	O
dL	O
Pb	O
)	O
of	O
EDCs	O
collected	O
via	O
urine	O
or	O
blood	O
sample	O
from	O
pregnant	O
women	O
for	O
HOME	O
Study	O
,	O
2003	O
-	O
2006	O
,	O
Cincinnati	O
,	O
OH	O
,	O
n	O
=	O
272PercentilesIncluded	O
in	O
AnalysesMedian	O
NHANES	O
(	O
2003	O
-	O
2004	O
)	O
EDC	O
%>	O
LODMean	O
LODbGM	O
(	O
GSD	O
)	O
25th50th75thMBP1000	O
.	O
6027	O
.	O
2	O
(	O
1	O
.	O
9	O
)	O
17	O
.	O
625	O
.	O
837	O
.	O
8Yes24MIBP990	O
.	O
305	O
.	O
9	O
(	O
1	O
.	O
9	O
)	O
4	O
.	O
06	O
.	O
19	O
.	O
1Yes4	O
.	O
0MEP1000	O
.	O
53152	O
(	O
3	O
.	O
0	O
)	O
77	O
.	O
4143330	O
.	O
7Yes120MBZP980	O
.	O
229	O
.	O
8	O
(	O
2	O
.	O
4	O
)	O
5	O
.	O
610	O
.	O
714	O
.	O
9Yes10MCPP990	O
.	O
202	O
.	O
4	O
(	O
1	O
.	O
9	O
)	O
1	O
.	O
62	O
.	O
33	O
.	O
4Yes2	O
.	O
9MEHP981	O
.	O
205	O
.	O
9	O
(	O
2	O
.	O
8	O
)	O
3	O
.	O
34	O
.	O
710	O
.	O
4Yes2	O
.	O
2MECPP1000	O
.	O
6041	O
.	O
3	O
(	O
2	O
.	O
5	O
)	O
21	O
.	O
534	O
.	O
970Yes31MEHHP1000	O
.	O
7028	O
.	O
7	O
(	O
2	O
.	O
6	O
)	O
14	O
.	O
925	O
.	O
353	O
.	O
2Yes19MEOHP1000	O
.	O
7022	O
.	O
3	O
(	O
2	O
.	O
5	O
)	O
12	O
.	O
31840	O
.	O
3YesaBPA960	O
.	O
42	O
.	O
1	O
(	O
1	O
.	O
9	O
)	O
1	O
.	O
41	O
.	O
92	O
.	O
9Yes2	O
.	O
7PCB	O
-	O
28820	O
.	O
790	O
.	O
7	O
(	O
3	O
.	O
1	O
)	O
0	O
.	O
611	O
.	O
4No5	O
.	O
0PCB	O
-	O
44920	O
.	O
530	O
.	O
07	O
(	O
1	O
.	O
8	O
)	O
0	O
.	O
040	O
.	O
060	O
.	O
09YesaPCB	O
-	O
491000	O
.	O
530	O
.	O
06	O
(	O
1	O
.	O
8	O
)	O
0	O
.	O
040	O
.	O
050	O
.	O
07YesaPCB	O
-	O
52910	O
.	O
530	O
.	O
1	O
(	O
3	O
.	O
1	O
)	O
0	O
.	O
040	O
.	O
070	O
.	O
2YesaPCB	O
-	O
66750	O
.	O
530	O
.	O
4	O
(	O
3	O
.	O
7	O
)	O
0	O
.	O
10	O
.	O
61No1	O
.	O
4PCB	O
-	O
74990	O
.	O
632	O
.	O
8	O
(	O
1	O
.	O
8	O
)	O
1	O
.	O
92	O
.	O
74Yes5	O
.	O
4PCB	O
-	O
871000	O
.	O
530	O
.	O
09	O
(	O
2	O
.	O
9	O
)	O
0	O
.	O
040	O
.	O
060	O
.	O
2YesaPCB	O
-	O
99990	O
.	O
532	O
.	O
7	O
(	O
2	O
.	O
1	O
)	O
1	O
.	O
72	O
.	O
83	O
.	O
9Yes3	O
.	O
9PCB	O
-	O
101320	O
.	O
530	O
.	O
1	O
(	O
2	O
.	O
1	O
)	O
0	O
.	O
050	O
.	O
070	O
.	O
4No1	O
.	O
6PCB	O
-	O
105930	O
.	O
531	O
(	O
2	O
.	O
8	O
)	O
0	O
.	O
61	O
.	O
11	O
.	O
7Yes1	O
.	O
2PCB	O
-	O
110990	O
.	O
530	O
.	O
09	O
(	O
3	O
)	O
0	O
.	O
040	O
.	O
060	O
.	O
1YesaPCB	O
-	O
118990	O
.	O
785	O
(	O
1	O
.	O
9	O
)	O
3	O
.	O
14	O
.	O
87Yes5	O
.	O
0PCB	O
-	O
128970	O
.	O
530	O
.	O
07	O
(	O
2	O
.	O
5	O
)	O
0	O
.	O
040	O
.	O
050	O
.	O
08YesaPCB	O
-	O
146930	O
.	O
531	O
(	O
2	O
.	O
9	O
)	O
0	O
.	O
81	O
.	O
11	O
.	O
8Yes2	O
.	O
3PCB	O
-	O
149970	O
.	O
530	O
.	O
08	O
(	O
2	O
.	O
5	O
)	O
0	O
.	O
040	O
.	O
060	O
.	O
1YesaPCB	O
-	O
151970	O
.	O
530	O
.	O
07	O
(	O
2	O
.	O
2	O
)	O
0	O
.	O
040	O
.	O
050	O
.	O
08YesaPCB	O
-	O
1531000	O
.	O
8111	O
.	O
4	O
(	O
1	O
.	O
9	O
)	O
7	O
.	O
510	O
.	O
915	O
.	O
3Yes22PCB	O
-	O
156960	O
.	O
531	O
.	O
6	O
(	O
2	O
.	O
4	O
)	O
11	O
.	O
62	O
.	O
7Yes3	O
.	O
4PCB	O
-	O
157510	O
.	O
530	O
.	O
2	O
(	O
3	O
.	O
7	O
)	O
0	O
.	O
060	O
.	O
20	O
.	O
6No0	O
.	O
9PCB	O
-	O
167590	O
.	O
530	O
.	O
2	O
(	O
3	O
.	O
9	O
)	O
0	O
.	O
060	O
.	O
30	O
.	O
6No0	O
.	O
9PCB	O
-	O
1701000	O
.	O
612	O
.	O
9	O
(	O
2	O
.	O
2	O
)	O
1	O
.	O
82	O
.	O
84	O
.	O
3Yes6	O
.	O
3PCB	O
-	O
172340	O
.	O
530	O
.	O
1	O
(	O
3	O
.	O
5	O
)	O
0	O
.	O
050	O
.	O
080	O
.	O
4No0	O
.	O
9PCB	O
-	O
177610	O
.	O
530	O
.	O
2	O
(	O
4	O
.	O
1	O
)	O
0	O
.	O
070	O
.	O
40	O
.	O
7No1	O
.	O
3PCB	O
-	O
178520	O
.	O
530	O
.	O
2	O
(	O
4	O
)	O
0	O
.	O
060	O
.	O
20	O
.	O
7No1	O
.	O
2PCB	O
-	O
1801000	O
.	O
786	O
.	O
7	O
(	O
2	O
.	O
1	O
)	O
4	O
.	O
16	O
.	O
39	O
.	O
7YesaPCB	O
-	O
183870	O
.	O
530	O
.	O
7	O
(	O
3	O
.	O
3	O
)	O
0	O
.	O
50	O
.	O
81	O
.	O
4Yes1	O
.	O
7PCB	O
-	O
187980	O
.	O
532	O
(	O
2	O
.	O
4	O
)	O
1	O
.	O
323	O
.	O
2Yes4	O
.	O
6PCB	O
-	O
189970	O
.	O
530	O
.	O
07	O
(	O
2	O
.	O
1	O
)	O
0	O
.	O
040	O
.	O
050	O
.	O
08YesaPCB	O
-	O
194920	O
.	O
531	O
.	O
3	O
(	O
2	O
.	O
7	O
)	O
0	O
.	O
91	O
.	O
42	O
.	O
2Yes4	O
.	O
0PCB	O
-	O
195390	O
.	O
530	O
.	O
1	O
(	O
3	O
.	O
5	O
)	O
0	O
.	O
050	O
.	O
080	O
.	O
5No0	O
.	O
6PCB	O
-	O
199930	O
.	O
531	O
.	O
2	O
(	O
2	O
.	O
9	O
)	O
0	O
.	O
81	O
.	O
32	O
.	O
2Yes3	O
.	O
7PCB	O
-	O
206810	O
.	O
530	O
.	O
9	O
(	O
3	O
.	O
5	O
)	O
0	O
.	O
40	O
.	O
91	O
.	O
3Yes2	O
.	O
3PCB	O
-	O
209350	O
.	O
530	O
.	O
1	O
(	O
3	O
.	O
2	O
)	O
0	O
.	O
050	O
.	O
080	O
.	O
4No1	O
.	O
2PCB	O
-	O
38	O
/	O
158990	O
.	O
788	O
(	O
2	O
.	O
1	O
)	O
5	O
.	O
27	O
.	O
811	O
.	O
3No16PCB	O
-	O
196	O
/	O
203960	O
.	O
531	O
.	O
5	O
(	O
2	O
.	O
4	O
)	O
1	O
.	O
11	O
.	O
62	O
.	O
6No3	O
.	O
3PFOA1006	O
.	O
055	O
.	O
6	O
(	O
1	O
.	O
7	O
)	O
3	O
.	O
85	O
.	O
48	O
.	O
1Yes3	O
.	O
6PFOS10014	O
.	O
213	O
.	O
6	O
(	O
1	O
.	O
5	O
)	O
1014	O
.	O
417	O
.	O
9Yes18PFNA1000	O
.	O
961	O
(	O
1	O
.	O
4	O
)	O
0	O
.	O
811	O
.	O
2Yes0	O
.	O
9PFHXS1001	O
.	O
961	O
.	O
6	O
(	O
2	O
)	O
11	O
.	O
62	O
.	O
6Yes1	O
.	O
6PFDEA300	O
.	O
210	O
.	O
2	O
(	O
1	O
.	O
6	O
)	O
0	O
.	O
20	O
.	O
20	O
.	O
3YesaBB	O
-	O
153850	O
.	O
530	O
.	O
9	O
(	O
4	O
.	O
1	O
)	O
0	O
.	O
51	O
.	O
12NoaPBDE	O
-	O
17960	O
.	O
530	O
.	O
07	O
(	O
2	O
.	O
2	O
)	O
0	O
.	O
040	O
.	O
060	O
.	O
08YesaPBDE	O
-	O
28810	O
.	O
530	O
.	O
7	O
(	O
4	O
.	O
1	O
)	O
0	O
.	O
30	O
.	O
91	O
.	O
7Yes1	O
.	O
0PBDE	O
-	O
471000	O
.	O
8619	O
.	O
1	O
(	O
2	O
.	O
7	O
)	O
9	O
.	O
61830Yes19PBDE	O
-	O
66920	O
.	O
530	O
.	O
06	O
(	O
2	O
)	O
0	O
.	O
040	O
.	O
050	O
.	O
07YesaPBDE	O
-	O
85490	O
.	O
530	O
.	O
2	O
(	O
4	O
.	O
8	O
)	O
0	O
.	O
060	O
.	O
20	O
.	O
7Yes	O
<	O
LODPBDE	O
-	O
991000	O
.	O
654	O
.	O
4	O
(	O
2	O
.	O
9	O
)	O
2	O
.	O
24	O
.	O
27	O
.	O
4Yes	O
<	O
LODPBDE	O
-	O
100990	O
.	O
533	O
.	O
7	O
(	O
3	O
)	O
23	O
.	O
56	O
.	O
4Yes3	O
.	O
2PBDE	O
-	O
153990	O
.	O
535	O
.	O
2	O
(	O
3	O
.	O
3	O
)	O
2	O
.	O
44	O
.	O
29	O
.	O
2Yes4	O
.	O
0PBDE	O
-	O
154420	O
.	O
530	O
.	O
2	O
(	O
4	O
.	O
7	O
)	O
0	O
.	O
050	O
.	O
10	O
.	O
6No0	O
.	O
8PBDE	O
-	O
18380	O
.	O
530	O
.	O
1	O
(	O
3	O
.	O
3	O
)	O
0	O
.	O
040	O
.	O
070	O
.	O
2Yesaβ	O
-	O
HCH272	O
.	O
630	O
.	O
5	O
(	O
3	O
.	O
5	O
)	O
0	O
.	O
220	O
.	O
321	O
.	O
6Yes	O
<	O
LODHCB943	O
.	O
926	O
.	O
6	O
(	O
1	O
.	O
9	O
)	O
5	O
.	O
57	O
.	O
29	O
.	O
1Yes16p	O
'	O
p	O
'-	O
DDT522	O
.	O
631	O
.	O
1	O
(	O
3	O
.	O
7	O
)	O
0	O
.	O
321	O
.	O
93	O
.	O
2Yes	O
<	O
LODp	O
'	O
p	O
'-	O
DDE1002	O
.	O
6374	O
(	O
1	O
.	O
8	O
)	O
5170102Yes206Oxychlordane902	O
.	O
634	O
.	O
4	O
(	O
2	O
.	O
5	O
)	O
3	O
.	O
45	O
.	O
17	O
.	O
5Yes11	O
trans	O
-	O
Nonachlor972	O
.	O
637	O
.	O
5	O
(	O
2	O
.	O
1	O
)	O
5	O
.	O
17	O
.	O
512Yes15DEP80	O
.	O
560	O
.	O
08	O
(	O
5	O
.	O
4	O
)	O
0	O
.	O
020	O
.	O
090	O
.	O
3YesaDMP270	O
.	O
620	O
.	O
4	O
(	O
4	O
.	O
2	O
)	O
0	O
.	O
10	O
.	O
40	O
.	O
9YesaPb960	O
.	O
250	O
.	O
7	O
(	O
1	O
.	O
4	O
)	O
0	O
.	O
50	O
.	O
70	O
.	O
8YesaHg790	O
.	O
20	O
.	O
6	O
(	O
2	O
.	O
3	O
)	O
0	O
.	O
40	O
.	O
61	O
.	O
0Yesa	O
Abbreviations	O
:	O
GM	O
geometric	O
mean	O
,	O
GSD	O
geometric	O
standard	O
deviation	O
,	O
BPA	O
bisphenol	O
A	O
,	O
β	O
-	O
HCH	O
beta	O
-	O
hexachlorocyclohexane	O
,	O
HCB	O
Hexachlorobenzene	O
,	O
DDT	O
dichlorodiphenoltrichloroethane	O
,	O
DDE	O
dichlorodiphenoldichloroethylene	O
aData	O
not	O
available	O
.	O
bLODs	O
varied	O
by	O
sample	O
size	O
;	O
LODs	O
for	O
PCBs	O
,	O
PBDEs	O
and	O
OCPs	O
are	O
lipid	O
-	O
adjusted	O
and	O
measured	O
in	O
pg	O
/	O
g	O
Potential	O
Confounders	O
We	O
drew	O
a	O
directed	O
acyclic	O
graph	O
to	O
select	O
confounders	O
based	B
on	I
the	O
relationships	B
between	O
the	O
HOME	O
Study	O
[	O
10	O
,	O
34	O
]	O
covariates	O
and	O
EDCs	O
and	O
birth	O
weight	O
(	O
Additional	O
file1	O
:	O
Figure	O
S1	O
).	O

Our	O
study	O
sample	O
was	O
drawn	O
from	O
Northern	O
New	O
England	O
,	O
which	O
has	O
a	O
relatively	O
homogenous	O
population	O
;	O
this	O
could	B
limit	B
the	O
generalizability	O
of	O
the	O
study	O
.	O

This	O
multi	B
-	I
colinearity	I
is	O
expected	B
,	O
as	B
these	O
variables	B
are	O
physiologically	O
interrelated	B
.	O

Osteocrin	O
,	O
a	O
bone	O
-	O
secreted	O
protein	O
important	B
in	O
osteoblast	O
regulation	B
,	O
shows	B
homology	O
to	O
the	O
NP	O
family	O
and	O
can	O
also	O
bind	O
to	O
NPR	O
-	O
C	O
(	O
Moffatt	O
et	O
al	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Primary	O
Prevention	O
of	O
Asthma	O
and	O
Allergies	O
in	O
Early	O
LifePreventive	O
Measures	O
Smoking	O
and	O
exposure	O
to	O
environmental	O
tobacco	O
smoke	O
should	B
be	I
avoided	O
,	O
especially	O
during	O
pregnancy	O
and	O
early	O
childhood	O
Alcohol	O
consumption	O
should	B
be	I
avoided	O
by	O
the	O
mother	O
during	O
pregnancy	O
and	O
lactation	O
Damp	O
housing	O
conditions	O
should	B
be	I
avoided	O
and	O
indoor	O
air	O
pollutants	O
reduced	O
,	O
especially	O
for	O
high	O
-	O
risk	O
children	O
(	O
history	O
of	O
atopy	O
or	O
allergy	O
in	O
a	O
first	O
-	O
degree	O
relative	O
)	O
Breast	O
-	O
feeding	O
should	B
be	I
performed	O
exclusively	O
until	O
6	O
months	O
with	O
no	O
special	O
diet	O
for	O
the	O
lactating	O
mother	O
(	O
except	O
when	O
the	O
mother	O
is	O
already	O
diagnosed	O
with	O
food	O
allergy	O
)	O
Nonprescription	O
drugs	O
should	B
be	I
avoided	O
during	O
pregnancy	O
and	O
lactation	O
unless	B
recommended	O
by	O
a	O
physician	O
Smoking	O
and	O
Alcohol	O
Smoking	O
and	O
passive	O
exposure	O
to	O
cigarette	O
smoke	O
as	O
well	O
as	O
alcohol	O
consumption	O
should	B
be	I
strictly	O
avoided	O
.	O

Methods	O
:	O
This	O
is	O
a	O
randomized	O
clinical	O
trial	O
with	O
the	O
follow	O
-	O
up	O
period	O
of	O
3	O
months	O
.	O

The	O
heightened	O
preference	O
for	O
sweet	O
taste	O
,	O
which	O
is	O
evident	O
within	O
hours	O
after	O
birth	O
and	O
persists	O
until	O
adolescence	O
(	O
27	O
,	O
28	O
)	O
most	B
likely	I
evolved	O
because	B
sweet	O
-	O
tasting	O
foods	O
are	O
high	O
in	O
energy	O
.	O

Thus	B
,	O
focal	O
cortical	O
dysplasias	O
may	B
be	I
a	O
risk	O
factor	O
for	O
ASD	O
patients	O
.	O

Measured	O
the	O
odds	O
of	O
improved	O
development	O
scores	O
due	O
to	O
fish	O
intake	O
.	O

UCP1	O
is	O
expressed	O
in	O
classical	O
brown	O
adipocytes	O
,	O
as	O
well	O
as	O
in	O
“	O
beige	O
cells	O
”	O
in	O
white	O
adipose	O
tissue	O
(	O
WAT	O
).	O

Exposure	O
to	O
psychotropic	O
polytherapy	O
was	O
reported	O
in	O
72	O
.	O
2	O
%	O
of	O
the	O
assessed	O
cohort	O
.	O

After	O
electrophoresis	O
,	O
the	O
proteins	O
were	O
electroblotted	O
on	O
to	O
PVDF	O
transfer	O
membranes	O
(	O
Hybond	O
-	O
P	O
;	O
Amersham	O
Biosciences	O
).	O

The	O
effectiveness	B
of	O
calcium	O
supplementation	O
on	O
prevention	O
of	O
perinatal	O
depression	O
has	B
been	I
shown	I
in	O
a	O
previous	B
study	I
[	O
65	O
].	O

Preterm	O
birth	O
as	O
a	O
marker	B
for	O
women	O
'	O
s	O
and	O
children	O
'	O
s	O
health	O
The	O
Born	O
Too	O
Soon	O
report	O
,	O
published	O
in	O
2012	O
,	O
drew	O
global	B
attention	B
to	O
the	O
issue	B
of	O
preterm	O
birth	O
and	O
reported	B
that	O
more	O
than	O
1	O
in	O
10	O
of	O
the	O
world	O
'	O
s	O
babies	O
are	O
born	O
too	O
soon	O
each	O
year	O
,	O
15	O
million	O
each	O
year	O
[	O
1	O
].	O

All	O
participants	O
provided	O
written	O
or	O
verbal	O
informed	O
consent	O
.	O

Promotion	O
of	O
handwashing	O
with	O
soap	O
before	O
umbilical	O
cord	O
care	O
should	B
be	I
emphasized	I
in	O
antenatal	O
and	O
neonatal	O
care	O
messaging	O
,	O
given	B
existing	B
evidence	I
supporting	B
prevention	B
of	O
umbilical	O
cord	O
infections	O
by	O
caregiver	O
handwashing	O
.	O

Methods	O
A	O
search	O
of	O
the	O
Canada	O
Vigilance	O
Database	O
from	O
April	O
1	O
,	O
2008	O
to	O
August	O
31	O
,	O
2013	O
identified	O
15	O
cases	O
of	O
anaphylaxis	O
and	O
16	O
reports	O
of	O
serious	O
non	O
-	O
anaphylactic	O
allergic	O
reactions	O
.	O

Whether	B
women	O
treated	O
for	O
thyroid	O
cancer	O
should	B
become	O
pregnant	O
was	O
once	O
a	O
matter	O
of	O
concern	B
,	O
but	B
current	B
evidence	I
suggests	B
that	O
DTC	O
should	B
not	O
discourage	O
intended	O
pregnancy	O
,	O
with	O
the	O
usual	O
recommendation	B
to	O
postpone	O
it	O
to	O
at	B
least	I
6	O
months	O
after	O
radioiodine	O
therapy	O
.	O

The	O
association	O
between	O
fish	O
,	O
fatty	O
acids	O
or	O
vitamin	O
D	O
and	O
psychotic	O
-	O
like	O
symptoms	O
was	O
summarized	O
in	O
terms	O
of	O
relative	O
risk	O
ratios	O
(	O
RRRs	O
)	O
and	O
corresponding	O
95	O
%	O
confidence	O
intervals	O
,	O
and	O
it	O
was	O
evaluated	O
by	O
energy	O
-	O
adjusted	O
multinomial	O
logistic	O
regression	O
(	O
polytomous	O
logistic	O
regression	O
),	O
for	O
example	O
:	O
RRR	O
=	O
P	O
(	O
y	O
=	O
high	O
level	O
group	O
;	O
fish	O
intake	O
>	O
2	O
/	O
week	O
)/	O
P	O
(	O
y	O
=	O
low	O
level	O
group	O
;	O
fish	O
intake	O
>	O
2	O
/	O
week	O
)/	O
P	O
(	O
y	O
=	O
high	O
level	O
group	O
;	O
no	O
fish	O
intake	O
)/	O
P	O
(	O
y	O
=	O
low	O
level	O
group	O
;	O
no	O
fish	O
intake	O
).	O

Proper	O
nutritional	O
levels	O
and	O
proper	O
selection	O
of	O
the	O
types	O
of	O
energy	O
sources	O
for	O
dams	O
during	O
each	O
period	O
of	O
gestation	O
stages	O
may	B
improve	O
future	B
production	O
efficiency	O
of	O
progeny	O
.	O

Nine	O
integrated	O
public	O
health	O
centres	O
which	O
accounted	O
for	O
about	O
two	O
thirds	O
of	O
the	O
total	O
study	O
population	O
were	O
selected	O
as	O
study	O
sites	O
.	O

Impact	B
of	O
an	O
Intensive	O
Perinatal	O
Handwashing	O
Promotion	O
Intervention	O
on	O
Maternal	O
Handwashing	O
Behavior	O
in	O
the	O
Neonatal	O
Period	O
:	O
Findings	B
from	O
a	O
Randomized	O
Controlled	O
Trial	O
in	O
Rural	O
Bangladesh	O
Abstract	O
One	O
-	O
quarter	O
of	O
neonatal	O
deaths	O
are	O
attributed	B
to	O
infections	O
.	O

Ratios	O
range	O
from	O
0	O
to	O
1	O
:	O
β	O
=	O
1	O
indicates	O
complete	O
methylation	O
and	O
β	O
=	O
0	O
represents	O
no	O
methylation	O
.	O

P04	O
.	O
49	O
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
with	O
no	O
PNV	O
use	O
(	O
vs	O
.	O
use	O
before	O
and	O
after	O
pregnancy	O
diagnosis	O
)	O
had	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
(	O
adjusted	O
OR	O
2	O
.	O
8	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
9	O
,	O
4	O
.	O
3	O
)	O
earlier	O
in	O
pregnancy	O
,	O
and	O
no	O
difference	O
later	O
in	O
pregnancy	O
(	O
adjusted	O
OR	O
1	O
.	O
3	O
,	O
95	O
%	O
CI	O
:	O
0	O
.	O
8	O
,	O
2	O
.	O
0	O
).	O

The	O
health	O
care	O
education	O
topics	O
were	O
similar	O
among	O
the	O
studies	O
reviewed	O
though	B
there	O
were	O
some	O
disparities	B
in	O
the	O
frequency	O
.	O

Indeed	O
,	O
it	O
negatively	O
regulates	O
the	O
energy	O
balance	O
by	O
increasing	O
energy	O
expenditure	O
.	O

PubMed	O
Central	O
:	O

Improvement	O
occurred	O
with	O
vitamin	O
D	O
supplementation	O
and	O
was	O
not	O
related	O
to	O
changes	O
in	O
bone	O
mineral	O
content	O
.	O

Their	O
liver	O
showed	O
a	O
decreased	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Ppar	O
α	O
,	O
Ppar	O
γ	O
,	O
the	O
eCBs	O
-	O
degrading	O
enzymes	O
Faah	O
and	O
Mgll	O
,	O
the	O
de	O
novo	O
lipogenic	O
enzymes	O
Acaca	O
and	O
Fasn	O
,	O
and	O
the	O
liver	O
-	O
specific	O
cholesterol	O
biosynthesis	O
regulators	O
Insig1	O
and	O
Hmgcr	O
.	O

Alarmingly	B
,	O
in	O
the	O
birth	O
cohort	O
study	O
from	O
the	O
Isle	O
of	O
Wight	O
,	O
about	O
43	O
%	O
of	O
children	O
had	O
been	O
exposed	O
to	O
environmental	O
tobacco	O
smoke	O
during	O
their	O
first	O
year	O
of	O
life	O
[	O
38	O
].	O

High	O
birth	O
weight	O
is	O
an	O
important	B
predictor	O
of	O
adult	O
obesity	O
[	O
171	O
],	O
and	O
a	O
higher	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
has	B
been	I
linked	B
to	O
greater	O
risk	O
for	O
adult	O
-	O
onset	O
glioma	O
[	O
172	O
].	O

Both	O
hyperplasia	O
and	O
hypertrophy	O
are	O
involved	B
in	O
IMF	O
deposition	O
(	O
Figure	O
1	O
).	O

The	O
purpose	B
of	O
this	B
study	I
was	O
to	B
determine	I
the	O
association	B
between	O
serum	O
concentrations	O
of	O
25	O
(	O
OH	O
)	O
D	O
and	O
S	O
-	O
ECC	O
in	O
preschool	O
children	O
.	O

Birth	O
size	O
,	O
including	O
birth	O
weight	O
(	O
kg	O
),	O
length	O
(	O
cm	O
),	O
and	O
head	O
circumference	O
(	O
cm	O
),	O
was	O
measured	O
by	O
midwives	O
according	O
to	O
standard	O
procedure	O
.	O

These	O
independent	O
variables	O
explained	O
23	O
%	O
of	O
the	O
variability	O
in	O
PNN50	O
index	O
(	O
R2	O
=	O
0	O
.	O
23	O
)	O
(	O
Table	O
2	O
).	O

linear	O
mixed	O
effects	O
models	O
),	O
adjusting	O
for	O
potential	O
time	O
-	O
dependent	O
and	O
static	O
covariates	O
.	O

At	O
present	O
,	O
consensus	B
has	B
been	I
reached	O
on	O
the	O
fact	O
that	O
radioiodine	O
treatment	O
of	O
DTC	O
does	O
not	O
affect	O
pregnancy	O
outcome	O
and	O
does	O
not	O
appear	B
to	I
be	I
associated	B
with	O
any	O
genetic	O
risk	O
,	O
with	O
the	O
usual	O
recommendation	B
to	O
delay	O
pregnancy	O
for	O
6	O
-	O
12	O
months	O
after	O
radioiodine	O
exposure	O
,	O
even	B
if	B
there	O
is	O
no	B
evidence	I
that	O
pregnancy	O
before	O
this	O
period	O
could	B
lead	B
to	I
a	O
less	B
favourable	I
outcome2238	O
.	O

A	O
large	O
laboratory	O
(	O
Quest	O
Diagnostics	O
)	O
recently	B
reported	B
the	O
possibility	B
of	O
thousands	O
of	O
incorrect	B
vitamin	O
D	O
level	O
results	O
.	O

However	B
,	O
no	B
significant	O-
correlation	O-
was	O-
noted	I
in	O
the	O
preterm	O
group	O
between	O
fetal	O
weight	O
or	O
maternal	O
stress	O
and	O
the	O
relative	O
expression	O
of	O
GRs	O
and	O
GAS5	O
.	O

Medical	O
history	O
of	O
bone	O
mineral	O
metabolic	O
disease	O
;	O
2	O
).	O

We	O
have	O
identified	B
a	O
specific	O
group	O
of	O
mothers	O
(	O
Tht	O
III	O
I	O
polymorphism	O
,	O
CC	O
group	O
)	O
in	O
whom	O
maternal	O
attitudes	O
predicted	B
fetal	O
weight	O
.	O

It	O
would	B
have	I
been	I
worthwhile	I
to	O
include	O
some	O
more	O
topics	O
such	O
as	O
management	O
of	O
severely	O
acute	O
malnutrition	O
,	O
examples	O
of	O
high	O
,	O
low	O
and	O
moderate	O
glycaemic	O
index	O
foods	O
,	O
how	O
to	O
read	O
food	O
labels	O
(	O
with	O
examples	O
),	O
etc	O
and	O
also	O
additional	O
references	O
for	O
further	O
reading	O
would	B
have	I
been	I
beneficial	I
as	O
the	O
chapters	O
are	O
a	O
quick	O
guide	O
to	O
appraise	O
the	O
topic	O
.	O

For	O
each	O
animal	O
,	O
two	O
gels	O
were	O
averaged	O
.	O

In	O
a	O
community	O
dwelling	O
sample	O
of	O
2	O
,	O
751	O
middle	O
aged	O
men	O
and	O
women	O
,	O
Kumari	O
et	O
al	O
reported	B
that	O
short	O
sleep	O
duration	O
and	O
increased	O
sleep	O
disturbance	O
are	O
independently	B
associated	B
with	O
diurnal	O
slope	O
in	O
cortisol	O
secretion	O
[	O
45	O
].	O

UNIMMAP	O
is	O
a	O
balanced	O
preparation	O
of	O
15	O
vitamins	O
and	O
minerals	O
formulated	O
by	O
an	O
Expert	O
Committee	O
of	O
the	O
United	O
Nations	O
Children	O
'	O
s	O
Fund	O
,	O
World	O
Health	O
Organization	O
and	O
the	O
United	O
Nations	O
University	O
,	O
primarily	O
for	O
use	O
by	O
pregnant	O
and	O
lactating	O
women	O
.	O

The	O
comparison	O
of	O
maternal	O
characteristics	O
of	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
is	O
summarised	O
in	O
Table1	O
.	O

Body	O
weight	O
and	O
caloric	O
intake	O
of	O
offspring	O
were	O
monitored	O
from	O
birth	O
(	O
PND0	O
)	O
to	O
adulthood	O
(	O
postnatal	O
weeks	O
21	O
–	O
23	O
).	O

However	B
,	O
an	O
accelerated	O
reproductive	O
tempo	O
may	B
not	O
be	O
maintained	O
in	O
the	O
face	O
of	O
later	O
nutritional	O
constraints	O
.	O

Thirty	O
-	O
six	O
hours	O
after	O
birth	O
,	O
the	O
lightest	O
and	O
the	O
heaviest	O
piglet	O
within	O
one	O
litter	O
were	O
killed	O
by	O
i	O
.	O
m	O
.	O

Introduction	O
Aortic	O
dissection	O
is	O
a	O
rare	B
complication	B
of	O
pregnancy	O
with	O
significant	O
morbidity	O
and	O
mortality	O
for	O
both	O
the	O
mother	O
and	O
infant	O
.	O

Examples	O
include	O
the	O
occurrence	O
of	O
generalized	O
eczema	O
requiring	O
identification	O
of	O
the	O
cause	O
before	O
treatment	O
or	O
a	O
suspected	O
allergy	O
to	O
a	O
drug	O
needed	O
for	O
therapy	O
of	O
the	O
mother	O
(	O
eg	O
,	O
penicillin	O
for	O
treating	O
syphilis	O
)	O
[	O
50	O
].	O

Understanding	B
the	O
reasons	B
for	O
racial	O
and	O
ethnic	O
disparities	B
in	O
preterm	O
birth	O
will	B
advance	O
the	O
field	O
of	O
pregnancy	O
health	O
broadly	O
,	O
as	O
well	O
as	O
accelerate	O
solutions	O
for	O
those	O
populations	O
most	O
in	O
need	B
.	O

In	O
human	O
body	O
,	O
the	O
most	O
important	O
source	O
of	O
vitamin	O
D	O
is	O
the	O
skin	O
where	O
7	O
-	O
dehydrocholesterol	O
is	O
converted	O
to	O
vitamin	O
D3in	O
response	O
to	O
UV	O
exposure	O
.	O

Vitamin	O
D	O
levels	O
in	O
an	O
Australian	O
and	O
New	O
Zealand	O
cohort	O
and	O
the	O
association	B
with	O
pregnancy	O
outcome	O
Abstract	O
Background	O
Pregnant	O
women	O
are	O
at	O
increased	B
susceptibility	I
to	O
vitamin	O
D	O
deficiency	O
.	O

This	O
involves	O
global	O
DNA	O
demethylation	O
and	O
changes	O
in	O
histone	O
modifications	O
and	O
non	O
-	O
coding	O
RNA	O
expression	O
to	O
effectively	O
‘	O
reset	O
’	O
the	O
zygote	O
epigenome	O
and	O
thus	O
genome	O
.	O

Pregnancy	O
loss	O
before	O
gestational	O
week	O
22	O
was	O
based	O
on	O
self	O
-	O
report	O
data	O
and	O
medical	O
records	O
to	O
verify	O
miscarriage	O
were	O
not	B
available	I
.	O

Studies	B
have	B
shown	I
that	O
at	B
least	I
three	O
polymorphisms	O
are	O
associated	B
with	O
altered	O
glucocorticoid	O
sensitivity	O
and	O
also	O
with	O
changes	O
in	O
body	O
composition	O
and	O
metabolic	O
parameters	O
[	O
10	O
,	O
11	O
],	O
which	O
could	B
affect	B
fetal	O
development	O
as	O
well	O
.	O

Adipocyte	O
diameter	O
in	O
subcutaneous	O
,	O
mesenteric	O
,	O
and	O
omental	O
fat	O
was	O
larger	O
in	O
offspring	O
of	O
dams	O
nutritionally	O
restricted	O
than	O
in	O
animals	O
from	O
dams	O
with	O
normal	O
dietary	O
intake	O
(	O
100	O
%	O
of	O
NRC	O
recommendations	O
),	O
but	O
marbling	O
data	O
were	O
not	B
reported	I
.	O

Then	O
,	O
the	O
tissue	O
samples	O
were	O
dehydrated	O
by	O
placing	O
them	O
in	O
ethanol	O
solutions	O
(	O
70	O
%,	O
90	O
%,	O
and	O
100	O
%)	O
for	O
5	O
minutes	O
.	O

A	O
non	O
parametric	O
test	O
(	O
Mann	O
Whitney	O
U	O
test	O
)	O
was	O
used	O
whenever	O
the	O
continuous	O
measures	O
were	O
not	O
normally	O
distributed	O
.	O

To	O
some	B
real	O-
but	B
unknown	B
extent	I
,	O
autism	O
is	O
an	O
iatrogenic	B
disease	O
,	O
caused	B
by	O
governments	O
,	O
organizations	O
,	O
committees	O
,	O
newspapers	O
and	O
physicians	O
who	O
promulgated	B
the	O
current	O
warnings	B
about	O
sun	O
-	O
exposure	O
for	O
pregnant	O
women	O
and	O
young	O
children	O
without	B
any	I
understanding	I
of	O
the	O
tragedy	B
they	O
engendered	B
.	O

A	O
multi	O
-	O
centered	O
study	O
of	O
four	O
Midwest	O
states	O
examining	O
rural	O
and	O
farm	O
exposures	O
observed	O
a	O
statistically	O
significant	O
increased	O
risk	O
of	O
adult	O
gliomas	O
for	O
springtime	O
births	O
,	O
but	B
only	I
among	O
those	O
born	O
“	O
off	O
”	O
a	O
farm	O
[	O
21	O
].	O

Furthermore	O
,	O
inverse	O
relationships	B
between	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
both	O
fasting	O
glucose	O
and	O
fasting	O
insulin	O
have	B
been	I
shown	I
during	O
pregnancy	O
indicating	B
poorer	O
glycaemic	O
control	O
[	O
19	O
,	O
43	O
].	O

CYP2R1	O
encodes	O
a	O
25	O
-	O
hydroxylase	O
,	O
a	O
key	B
enzyme	O
involved	B
in	O
the	O
conversion	O
of	O
vitamin	O
D	O
to	O
25	O
(	O
OH	O
)	O
D	O
(	O
23	O
).	O

Excess	O
energy	O
supplied	O
to	O
mature	O
animals	O
during	O
the	O
late	O
fattening	O
period	O
may	B
significantly	O
decrease	O
feed	O
efficiency	O
.	O

By	O
clustering	O
,	O
we	O
hoped	O
to	O
uncover	O
biologically	O
meaningful	O
groups	O
of	O
CpG	O
loci	O
,	O
with	O
similar	O
methylation	O
patterns	O
,	O
which	O
may	B
share	O
biological	O
characteristics	O
such	O
as	O
comparable	O
functionality	O
in	O
certain	O
developmental	O
pathways	O
or	O
location	O
in	O
similar	O
genomic	O
regions	O
.	O

To	O
understand	O
this	O
result	O
,	O
it	O
should	B
be	I
emphasized	I
that	O
nephrogenesis	O
in	O
rodents	O
,	O
unlike	B
in	O
humans	O
,	O
continues	O
after	O
delivery	O
for	O
the	O
first	O
10	O
days	O
of	O
postnatal	O
life	O
.	O

However	B
,	O
significantly	O
more	O
children	O
receiving	O
vitamin	O
D	O
drops	O
belonged	O
to	O
the	O
caries	O
-	O
free	O
group	O
(	O
14	O
.	O
0	O
%	O
S	O
-	O
ECC	O
(	O
n	O
=	O
6	O
)	O
vs	O
.	O
86	O
.	O
0	O
%	O
caries	O
-	O
free	O
(	O
n	O
=	O
37	O
),	O
p	O
<	O
0	O
.	O
001	O
).	O

This	O
was	O
largely	B
driven	I
by	I
a	O
55	O
%	O
decreased	O
risk	O
of	O
GDM	O
in	O
women	O
with	O
a	O
male	O
fetus	O
with	O
high	O
standardised	O
serum	O
25	O
(	O
OH	O
)	O
D	O
when	O
compared	O
to	O
those	O
carrying	O
a	O
male	O
fetus	O
with	O
moderate	O
-	O
high	O
serum	O
25	O
(	O
OH	O
)	O
D	O
(	O
aRR	O
:	O
0	O
.	O
45	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
15	O
,	O
1	O
.	O
38	O
).	O

We	O
informed	O
all	O
patients	O
about	O
details	O
and	O
goals	O
of	O
this	O
study	O
before	O
the	O
start	O
.	O

Fetal	O
heart	O
tones	O
were	O
155	O
.	O

Given	O
the	O
significant	O
number	O
of	O
characteristic	O
and	O
lifestyle	O
differences	B
between	O
the	O
two	O
populations	O
,	O
this	O
is	O
not	O
overly	O
surprising	O
.	O

In	O
animals	O
,	O
D3is	O
synthesized	O
in	O
the	O
skin	O
from	O
its	O
derivate	O
(	O
7	O
-	O
dehydrocholesterol	O
)	O
in	O
the	O
presence	O
of	O
ultraviolet	O
B	O
radiation	O
(	O
UVB	O
),	O
while	O
D2is	O
made	O
in	O
fungi	O
and	O
yeast	O
.	O

An	O
associated	B
issue	B
is	O
that	O
,	O
after	O
the	O
start	O
of	O
our	O
trial	O
,	O
speculations	B
arose	O
that	O
high	O
fluctuations	O
of	O
natural	O
or	O
supplemented	O
vitamin	O
D	O
intake	O
might	B
be	O
linked	B
to	O
negative	O
outcomes	O
.	O

Conversely	B
,	O
Janghorbani	O
et	O
al	O
.	O

These	O
visits	O
will	O
be	O
made	O
between	O
12	O
and	O
14	O
weeks	O
,	O
20	O
–	O
24	O
weeks	O
,	O
28	O
–	O
32	O
weeks	O
,	O
within	O
24	O
h	O
of	O
delivery	O
,	O
7	O
–	O
10	O
days	O
after	O
delivery	O
,	O
38	O
–	O
42	O
days	O
after	O
delivery	O
(	O
Fig	O
.	O

However	B
,	O
attitudes	O
are	B
changing	I
towards	O
the	O
“	O
minimum	O
of	O
4	O
visits	O
”	O
recommended	B
by	O
the	O
WHO	O
after	O
the	O
work	O
of	O
Nigenda	O
et	O
al	O
[	O
21	O
]	O
and	O
Langer	O
et	O
al	O
.	O

These	O
extremely	O
low	O
values	O
are	O
not	B
commonly	I
reported	O
in	O
the	O
United	O
States	O
,	O
although	B
we	O
speculate	B
that	O
an	O
increasing	O
number	B
of	I
cases	O
may	B
be	I
reported	O
in	O
the	O
future	B
due	B
to	I
increased	B
awareness	I
of	O
vitamin	O
D	O
deficiency	O
.	O

Further	B
research	I
should	B
investigate	O
variables	B
in	O
family	O
relationships	B
,	O
the	O
home	O
,	O
and	O
the	O
extended	O
environment	O
that	O
influence	B
eating	O
.	O

Anaemia	O
prevalence	O
was	O
almost	O
halved	O
in	O
supplemented	O
women	O
and	O
anaemic	O
women	O
showed	B
the	O
greatest	O
increase	O
in	O
haemoglobin	O
concentration	O
following	O
supplementation	O
(+	O
1	O
.	O
2g	O
/	O
dL	O
).	O

Children	O
were	O
assessed	O
using	O
the	O
dmft	O
index	O
(	O
a	O
cumulative	O
score	O
of	O
decayed	O
,	O
missing	O
,	O
filled	O
primary	O
teeth	O
).	O

The	O
role	B
of	O
maternal	O
disease	O
cannot	B
be	I
ignored	I
as	B
antiphospholipid	O
syndrome	O
and	O
perinatal	O
inflammation	O
may	B
have	O
important	B
roles	B
in	O
the	O
eventual	O
development	O
of	O
autism	O
.	O

The	O
group	O
noted	B
that	O
low	O
birth	O
weight	O
increased	O
chances	O
of	O
developing	O
ASD	O
,	O
as	O
well	O
as	O
rapid	O
head	O
growth	O
.	O

We	O
randomized	O
126	O
(	O
49	O
.	O
8	O
%)	O
participants	O
to	O
the	O
intervention	O
arm	O
and	O
127	O
(	O
50	O
.	O
2	O
%)	O
to	O
the	O
control	O
arm	O
.	O

Our	O
inclusion	O
criteria	O
were	O
infants	O
aged	O
1	O
–	O
11	O
months	O
and	O
living	O
in	O
our	O
study	O
region	O
.	O

We	O
suggest	B
the	O
long	O
-	O
term	O
fallow	O
up	O
of	O
mothers	O
and	O
infants	O
with	O
more	O
abundant	O
sample	O
.	O

Using	O
RNA	O
FISH	O
,	O
GAS5	O
localized	O
primarily	B
in	O
syncytiotrophoblasts	O
(	O
Figure	O
2	O
(	O
c	O
)).	O

A	O
further	O
limitation	B
of	O
our	O
study	O
is	O
that	O
it	O
was	O
not	B
feasible	I
to	O
undertake	O
biochemical	O
assessment	O
of	O
the	O
supplements	O
or	O
assess	O
serum	O
concentrations	O
in	O
all	O
participants	O
after	O
each	O
and	O
between	O
supplementation	O
.	O

Knowledge	O
of	O
child	O
feeding	O
has	O
largely	B
evolved	B
from	I
laboratory	O
studies	O
that	O
address	O
cause	O
and	O
effect	O
but	B
provide	O
limited	B
insight	B
on	O
the	O
usual	O
environments	O
and	O
social	O
interactions	B
surrounding	O
children	O
'	O
s	O
behavior	O
.	O

This	O
effect	O
,	O
exerted	O
within	O
the	O
ventromedial	O
hypothalamus	O
(	O
VMH	O
),	O
was	O
described	O
as	O
being	O
AMPK	O
-	O
dependent	O
,	O
resulting	O
in	O
the	O
activation	O
of	O
the	O
sympathetic	O
outlflow	O
to	O
BAT	O
,	O
without	O
any	O
change	O
in	O
the	O
feeding	O
behavior	O
(	O
Whittle	O
et	O
al	O
.,	O
2012	O
;	O
Contreras	O
et	O
al	O
.,	O
2014	O
).	O

Another	B
important	B
need	B
is	O
for	O
standardised	O
methods	O
for	O
diagnosing	O
and	O
treating	O
prematurity	O
-	O
related	B
impairment	O
in	O
childhood	O
and	O
more	O
consistent	B
measures	O
and	O
timing	O
for	O
assessing	O
multi	O
-	O
domain	O
impairments	O
[	O
33	O
,	O
34	O
].	O

However	O
,	O
routine	O
vitamin	O
D	O
supplementation	O
did	O
not	O
occur	O
during	O
the	O
time	O
period	O
the	O
women	O
in	O
the	O
current	O
study	O
were	O
recruited	O
.	O

Interpretations	O
Quarterly	O
bolus	O
doses	O
of	O
oral	O
vitamin	O
D3supplementation	O
to	O
infants	O
are	O
not	O
an	O
effective	O
intervention	O
to	O
reduce	O
the	O
incidence	O
of	O
pneumonia	O
in	O
infants	O
in	O
this	O
setting	O
.	O

The	O
mean	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
level	O
for	O
our	O
study	O
population	O
(	O
n	O
=	O
438	O
)	O
was	O
46	O
.	O
9	O
nmol	O
l	O
−	O
1	O
,	O
with	O
a	O
range	O
of	O
5	O
.	O
0	O
to	O
135	O
.	O
8	O
nmol	O
l	O
−	O
1	O
.	O

The	O
restriction	O
enzyme	O
Tsp509I	O
(	O
10	O
U	O
)	O
was	O
used	O
to	O
digest	O
the	O
PCR	O
products	O
at	O
65	O
°	O
C	O
for	O
4	O
hours	O
.	O

With	O
regards	O
to	O
pharmacokinetics	O
,	O
oral	O
dosing	O
produces	O
therapeutic	O
effects	O
within	O
3	O
-	O
5	O
days	O
.	O

(	O
2009	O
).	O

The	O
25	O
µl	O
reactions	O
were	O
incubated	O
for	O
1	O
h	O
at	O
42	O
°	O
Cand	O
then	O
at	O
95	O
°	O
C	O
for	O
5	O
min	O
.	O

Results	O
showed	B
that	O
at	O
baseline	O
,	O
in	O
72	O
.	O
8	O
%	O
of	O
the	O
participants	O
,	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
were	O
lower	O
than20	O
ng	O
/	O
mL	O
.	O

Eligible	O
women	O
were	O
contacted	O
to	O
arrange	O
a	O
follow	O
-	O
up	O
assessment	O
of	O
their	O
child	O
,	O
either	O
at	O
the	O
hospital	O
of	O
their	O
birth	O
,	O
or	O
if	O
more	O
convenient	O
,	O
for	O
a	O
research	O
assistant	O
to	O
visit	O
their	O
home	O
.	O

Larger	B
studies	I
are	B
needed	I
in	O
diverse	O
populations	O
at	O
various	O
latitudes	O
to	O
further	B
characterize	O
the	O
relationship	B
between	O
vitamin	O
D	O
supplementation	O
and	O
bone	O
mineral	O
content	O
.	O

For	O
all	O
women	O
included	O
in	O
the	O
study	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
was	O
obtained	O
from	O
weight	O
and	O
height	O
recorded	O
by	O
the	O
gynaecologist	O
during	O
the	O
first	O
prenatal	O
consultation	O
in	O
the	O
beginning	O
of	O
the	O
first	O
trimester	O
of	O
pregnancy	O
.	O

This	B
study	I
is	O
novel	B
due	O
to	O
the	O
comprehensive	O
set	O
of	O
nutrition	O
related	B
data	O
and	O
indicators	O
of	O
maternal	O
and	O
infant	O
health	O
being	O
obtained	O
in	O
a	O
South	O
African	O
setting	O
.	O

Vitamin	O
D	O
is	O
to	O
a	O
large	O
extent	O
metabolized	O
in	O
the	O
body	O
through	O
sun	O
exposure	O
,	O
and	O
people	O
with	O
dark	O
skin	O
need	O
more	O
sun	O
exposure	O
to	O
maintain	O
adequate	O
blood	O
levels	O
.	O

This	B
paper	I
presents	O
an	O
up	O
-	O
to	O
-	O
date	O
review	O
of	O
current	B
knowledge	I
concerning	O
the	O
role	B
of	O
cholecalciferol	O
in	O
human	O
reproduction	O
.	O

Education	O
was	O
re	O
-	O
categorised	O
into	O
‘	O
lower	O
’	O
and	O
‘	O
higher	O
’	O
education	O
(	O
lower	O
=	O
lower	O
or	O
upper	O
secondary	O
or	O
post	O
-	O
secondary	O
non	O
-	O
tertiary	O
education	O
,	O
higher	O
=	O
first	O
or	O
second	O
stage	O
of	O
tertiary	O
education	O
),	O
due	B
to	I
a	O
low	B
number	O
of	O
subjects	O
in	O
other	O
education	O
categories	O
.	O

Additionally	O
,	O
it	O
has	B
been	I
revealed	B
that	O
some	B
ECS	O
components	O
are	O
sensible	O
to	O
dietary	O
conditions	O
.	O

Pregnant	O
and	O
lactating	O
women	O
should	B
widen	O
their	O
food	O
choices	O
to	O
include	O
as	O
many	O
flavorful	O
and	O
healthy	O
foods	O
as	O
possible	O
.	O

Adjusted	O
analyses	O
included	O
the	O
stratification	O
variables	O
BMI	O
category	O
,	O
parity	O
and	O
centre	O
,	O
as	O
well	O
as	O
maternal	O
age	O
,	O
socioeconomic	O
status	O
and	O
maternal	O
smoking	O
.	O

They	O
reported	O
that	O
the	O
average	O
breed	O
type	O
list	O
included	O
purebred	O
or	O
crossbred	O
Angus	O
,	O
Brahman	O
,	O
Simmental	O
,	O
Charolais	O
,	O
Hereford	O
,	O
Jersey	O
,	O
Korean	O
Brown	O
cattle	O
,	O
Maine	O
Anjou	O
,	O
Pinzgauer	O
,	O
Sahiwal	O
,	O
Salers	O
,	O
and	O
South	O
Devon	O
with	O
estimates	O
MS	O
heritability	O
of	O
0	O
.	O
37	O
(	O
range	O
0	O
.	O
30	O
to	O
0	O
.	O
57	O
).	O

These	O
actions	B
would	B
reduce	O
disability	O
and	O
chronic	O
disease	O
,	O
improve	O
reproductive	O
and	O
maternal	O
health	O
,	O
and	O
build	O
sustainable	O
health	O
systems	O
.	O

This	O
study	O
was	O
conducted	O
according	O
to	O
the	O
Declaration	O
of	O
Helsinki	O
and	O
all	O
procedures	O
were	O
approved	O
by	O
the	O
Regional	O
Ethics	O
Committee	O
in	O
Gothenburg	O
,	O
Sweden	O
.	O

The	O
DiNEH	O
(	O
Diné	O
Network	O
for	O
Environmental	O
Health	O
)	O
Project	O
was	O
originally	O
started	O
to	O
address	O
community	O
concerns	B
about	O
the	O
high	O
rate	O
of	O
kidney	O
disease	O
in	O
this	O
population	O
,	O
which	O
some	B
community	O
leaders	O
and	O
health	O
professionals	O
suspected	B
was	O
related	B
to	O
drinking	O
contaminated	O
water	O
.	O

Maternal	O
serum	O
T1	O
and	O
T3	O
samples	O
were	O
analysed	O
in	O
sequence	O
.	O

We	O
calculated	O
person	O
-	O
time	O
at	O
risk	O
for	O
each	O
child	O
up	O
to	O
the	O
date	O
a	O
child	O
reached	O
our	O
primary	O
endpoint	O
,	O
was	O
last	O
seen	O
at	O
the	O
end	O
of	O
our	O
study	O
,	O
or	O
when	O
censored	O
because	O
they	O
were	O
lost	O
to	O
follow	O
-	O
up	O
.	O

Similar	B
magnitudes	O
of	O
decreased	O
risk	B
for	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
vs	O
.	O
<	O
20	O
ng	O
/	O
mL	O
were	O
observed	B
among	O
PTB	O
subtypes	O
:	O
spontaneous	O
PTB	O
(	O
58	O
%)	O
and	O
indicated	O
PTB	O
(	O
61	O
%).	O

The	O
sum	O
of	O
the	O
total	O
deposits	O
of	O
perirenal	O
and	O
perigonadal	O
fat	O
determines	O
the	O
amount	O
of	O
abdominal	O
fat	O
.	O

But	B
,	O
adjustment	O
for	O
multivitamin	O
supplement	O
intake	O
,	O
containing	O
vitamin	O
D	O
,	O
did	O
not	O
change	O
the	O
estimates	B
.	O

Age	O
,	O
depression	O
score	O
,	O
amount	O
of	O
sun	O
exposure	O
and	O
seasons	O
were	O
compared	O
between	O
women	O
with	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
of	O
<	O
20	O
ng	O
/	O
mL	O
and	O
who	O
had	O
concentrations	O
of	O
≥	O
20	O
ng	O
/	O
mL	O
(	O
Table	O
2	O
).	O

Therefore	B
,	O
a	O
decreased	O
perinatal	O
depression	O
level	O
is	O
justifiable	B
.	O

Total	O
GWG	O
was	O
computed	O
based	O
on	O
pregravid	O
weight	O
and	O
weight	O
at	O
the	O
last	O
clinic	O
visit	O
prior	O
to	O
delivery	O
.	O

Logistic	O
regression	O
for	O
S	O
-	O
ECC	O
including	O
variables	O
associated	O
at	O
the	O
bivariate	O
level	O
was	O
also	O
performed	O
.	O

Following	O
in	O
utero	O
exposure	O
to	O
a	O
gestational	O
low	O
protein	O
diet	O
at	O
1	O
dpn	O
we	O
could	O
not	O
find	O
significant	O
regulatory	O
changes	O
of	O
genes	O
of	O
any	O
molecular	O
route	O
in	O
porcine	O
perinatal	O
liver	O
.	O

The	O
incidence	O
rate	O
of	O
repeat	O
episodes	O
of	O
all	O
type	O
pneumonia	O
was	O
significantly	O
higher	O
in	O
the	O
vitamin	O
D	O
group	O
(	O
table	O
3	O
).	O

White	O
perirenal	O
and	O
perigonadal	O
fat	O
were	O
completely	O
dissected	O
out	O
,	O
weighed	O
,	O
frozen	O
,	O
and	O
stored	O
at	O
−	O
80	O
°	O
C	O
until	O
RT	O
-	O
qPCR	O
analyses	O
.	O

Sex	O
and	O
age	O
was	O
matched	O
between	O
the	O
two	O
groups	O
.	O

However	B
,	O
very	B
few	B
studies	I
have	B
been	I
in	O
position	O
to	O
examine	O
this	O
association	B
directly	O
in	O
animals	O
.	O

Hence	B
,	O
pre	O
-	O
pregnancy	O
BMI	O
appears	B
to	I
be	I
a	O
determining	O
factor	B
in	O
creating	O
the	O
difference	O
and	O
the	O
amount	O
of	O
maternal	O
plasma	O
visfatin	O
during	O
pregnancy	O
,	O
which	O
can	O
predict	B
maternal	O
serum	O
visfatin	O
and	O
neonatal	O
and	O
maternal	O
outcomes	O
.	O

However	O
,	O
the	O
associations	B
between	O
maternal	O
diet	O
and	O
infant	O
gut	O
microbial	O
communities	O
did	O
not	O
always	O
differ	O
by	O
delivery	O
mode	O
.	O

To	O
account	O
for	O
differences	O
in	O
baseline	O
and	O
trajectories	O
of	O
infant	O
gut	O
microbial	O
profiles	O
,	O
we	O
stratified	O
analyses	O
by	O
delivery	O
mode	O
.	O

The	O
offspring	O
are	O
hypertensive	O
,	O
show	O
vascular	O
changes	O
,	O
and	O
have	O
high	O
blood	O
insulin	O
levels	O
.	O

Data	O
inTable	O
7represent	O
the	O
crude	O
and	O
adjusted	O
odds	O
ratio	O
(	O
OR	O
)	O
and	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
for	O
ORs	O
from	O
the	O
multivariate	O
analysis	O
,	O
where	O
neonatal	O
anthropometric	O
measurements	O
are	O
the	O
dependent	O
variables	O
and	O
major	O
maternal	O
dietary	O
patterns	O
the	O
independent	O
variables	O
.	O

Several	B
studies	I
of	O
advertising	O
on	O
children	O
'	O
s	O
television	O
programs	O
found	B
that	O
the	O
foods	O
promoted	O
increased	O
the	O
risk	B
of	O
becoming	O
obese	O
.	O

in	O
their	O
study	O
used	O
a	O
dosage	O
of	O
14	O
,	O
000	O
IU	O
vitamin	O
D	O
supplement	O
per	O
week	O
,	O
equal	O
to	O
2000	O
IU	O
per	O
day	O
,	O
started	O
at	O
27	O
–	O
30	O
weeks	O
of	O
gestation	O
.	O

Several	B
studies	I
emphasize	B
the	O
importance	B
of	O
the	O
relationship	B
between	O
iron	O
,	O
folic	O
acid	O
or	O
multivitamin	O
intake	O
and	O
socio	O
-	O
demographic	O
factors	O
such	O
as	O
age	O
,	O
level	O
of	O
education	O
,	O
area	O
of	O
residence	O
,	O
marital	O
status	O
,	O
parity	O
,	O
economical	O
status	O
and	O
characteristics	O
of	O
prenatal	O
care	O
(	O
including	O
gestational	O
age	O
at	O
the	O
beginning	O
of	O
prenatal	O
care	O
and	O
the	O
number	O
of	O
prenatal	O
consultations	O
)	O
[	O
15	O
-	O
19	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
.	O

Detailed	O
data	O
collection	O
procedures	O
have	O
been	O
published	O
elsewhere	O
[	O
23	O
].	O

All	O
study	O
procedures	O
were	O
approved	O
by	O
The	O
Hospital	O
for	O
Sick	O
Children	O
Research	O
Ethics	O
Board	O
.	O

Gut	O
microbiome	O
profiling	O
will	O
be	O
done	O
by	O
isolating	O
microbial	O
DNA	O
from	O
the	O
collected	O
rectal	O
swabs	O
using	O
Qiagen	O
Stool	O
minikit	O
and	O
analysing	O
the	O
16S	O
rRNA	O
genes	O
DNA	O
sequences	O
on	O
the	O
Ion	O
Torrent	O
16S	O
metagenomics	O
solution	O
offered	O
by	O
ThermoFisher	O
Scientific	O
.	O

Discussion	O
Current	O
study	O
on	O
812	O
subjects	O
is	O
one	O
of	O
the	O
largest	O
studies	O
evaluating	O
the	O
association	B
between	O
major	O
maternal	O
dietary	O
patterns	O
during	O
the	O
first	O
-	O
trimester	O
period	O
of	O
pregnancy	O
and	O
neonatal	O
anthropometric	O
measurements	O
.	O

Therefore	B
,	O
podocin	O
expression	O
was	O
significantly	O
different	O
between	O
the	O
F1	O
and	O
F2	O
generations	O
among	O
VitD	O
-	O
offspring	O
at	O
weaning	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
and	O
at	O
6	O
months	O
of	O
age	O
(	O
P	O
=	O
0	O
.	O
004	O
).	O

DMP	O
exposure	O
was	O
associated	B
with	O
a	O
57	O
g	O
reduction	O
in	O
birth	O
weight	O
(	O
95	O
%	O
CI	O
(-	O
123	O
,	O
10	O
),	O
50	O
%	O
CI	O
(-	O
79	O
,	O
-	O
34	O
)).	O

Almost	O
all	O
participants	O
were	O
found	O
to	O
have	O
water	O
,	O
but	B
just	O
15	O
(	O
12	O
%)	O
in	O
each	O
arm	O
were	O
observed	O
to	O
have	O
bar	O
soap	O
at	O
the	O
main	O
handwashing	O
station	O
;	O
other	O
types	O
of	O
soap	O
were	O
rarely	B
observed	I
.	O

A	O
deficiency	B
in	O
this	O
protein	O
in	B
conjunction	I
with	I
undesirable	B
vitamin	O
D	O
,	O
PTH	O
,	O
and	O
calcium	O
levels	O
may	B
suggest	B
that	O
children	O
with	O
S	O
-	O
ECC	O
have	O
nutritional	O
deficiencies	B
.	O

Rojroongwasonkul	O
et	O
al	O
.	O

Vitamin	O
D	O
is	O
definitely	O
not	O
a	O
Trojan	O
Horse	O
in	O
reproductive	O
health	O
since	O
there	O
were	O
no	O
adverse	O
effects	B
reported	B
for	O
vitamin	O
D	O
intake	O
of	O
up	O
to	O
10	O
,	O
000	O
IU	O
/	O
d	O
[	O
66	O
],	O
but	B
to	O
proclaim	B
it	O
the	O
Golden	O
Fleece	O
,	O
more	B
evidence	I
is	I
still	O-
required	I
.	O

Pre	O
-	O
publication	O
history	O
The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O
http	O
://	O
www	O
.	O
biomedcentral	O
.	O
com	O
/	O
1471	O
-	O
2458	O
/	O
13	O
/	O
1105	O
/	O
prepub	O
Supplementary	O
Material	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Additional	O
file	O
1	O
Nutritional	O
knowledge	O
questionnaire	O
.	O

Models	O
adjusted	O
for	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
albendazol	O
consumption	O
during	O
pregnancy	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
delivery	O
hospital	O
,	O
sex	O
of	O
the	O
baby	O
,	O
type	O
of	O
fuel	O
used	O
for	O
cooking	O
,	O
reporting	O
receiving	O
at	O
least	O
one	O
tetanus	O
vaccine	O
,	O
number	O
of	O
parturitions	O
,	O
education	O
level	O
,	O
age	O
,	O
reporting	O
at	O
least	O
one	O
episode	O
of	O
influenza	O
-	O
like	O
illness	O
during	O
pregnancy	O
(	O
ILI	O
),	O
race	O
and	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
for	O
mothers	O
vaccinated	O
in	O
the	O
first	O
trimester	O
;	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
influenza	O
circulation	O
,	O
aspirin	O
consumption	O
during	O
pregnancy	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
delivery	O
hospital	O
,	O
and	O
,	O
number	O
of	O
antenatal	O
visits	O
for	O
mothers	O
vaccinated	O
in	O
the	O
second	O
trimester	O
;	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
albendazol	O
consumption	O
during	O
pregnancy	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
delivery	O
hospital	O
,	O
sex	O
of	O
the	O
baby	O
,	O
race	O
and	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
for	O
mothers	O
vaccinated	O
in	O
the	O
third	O
trimester	O
.	O

(	O
2016	O
)	O
examined	B
occupational	O
EDC	O
exposures	O
in	O
a	O
meta	O
-	O
analysis	O
of	O
European	O
birth	O
cohorts	O
and	O
found	B
that	O
pregnant	O
women	O
exposed	O
to	O
more	O
than	O
1	O
EDC	O
class	O
were	O
more	O
likely	B
to	O
have	O
a	O
low	O
birth	O
weight	O
infant	O
[	O
15	O
].	O

This	O
finding	B
was	O
possibly	B
confounded	B
by	O
smoking	O
,	O
which	O
was	O
more	O
prevalent	B
in	O
the	O
deficient	O
GDM	O
mothers	O
compared	O
with	O
deficient	O
non	O
-	O
GDM	O
mothers	O
.	O

Forty	O
participants	O
in	O
this	O
study	O
had	O
plasma	O
samples	O
collected	O
at	O
two	O
subsequent	O
yearly	O
visits	O
,	O
spaced	O
roughly	O
twelve	O
months	O
apart	O
.	O

Our	O
novel	B
findings	I
imply	B
that	O
seasonal	O
variation	O
in	O
insulin	O
resistance	O
may	B
not	I
be	O
fully	O
explained	B
by	O
differences	O
in	O
vitamin	O
D	O
status	O
.	O

Only	B
one	O
stool	O
sample	O
showed	B
hookworm	O
infection	O
.	O

Test	O
for	O
normality	O
will	O
be	O
performed	O
by	O
the	O
Shapiro	O
-	O
Wilk	O
test	O
.	O

Thus	B
,	O
with	O
differing	B
results	I
it	O
is	O
evident	B
that	O
more	B
specific	O-
studies	I
need	B
to	I
be	I
conducted	O
on	O
infertility	O
treatments	O
keeping	B
in	I
mind	I
specific	O
subtypes	O
and	O
their	O
effect	B
on	O
autism	O
in	O
children	O
.	O

At	O
baseline	O
,	O
the	O
majority	O
in	O
each	O
arm	O
,	O
67	O
%	O
of	O
controls	O
and	O
60	O
%	O
of	O
intervention	O
participants	O
,	O
indicated	O
that	O
their	O
main	O
handwashing	O
station	O
was	O
near	O
the	O
tubewell	O
.	O

Studies	O
in	O
adults	O
have	O
found	B
a	O
greater	O
increase	O
in	O
25	O
(	O
OH	O
)	O
D	O
levels	O
in	O
subjects	O
who	O
started	O
at	O
a	O
lower	O
level	O
before	O
supplementation	O
[	O
17	O
].	O

Couples	O
with	O
serum	O
concentration	O
exceeding	O
50	O
nmol	O
/	O
L	O
have	O
a	O
higher	O
chance	B
of	O
conception	O
,	O
but	O
this	O
does	B
not	I
regard	I
all	O
patients	O
,	O
where	O
especially	B
males	O
should	B
be	I
supplemented	O
with	O
vitamin	O
D	O
from	O
the	O
beginning	O
of	O
the	O
therapy	O
.	O

It	O
is	O
conceivable	B
that	O
a	O
slight	O
reduction	O
in	O
calcium	O
buffering	O
proteins	O
may	B
affect	B
the	O
ability	O
of	O
neurons	O
within	O
the	O
nucleus	O
accumbens	O
to	O
repolarise	O
in	O
response	O
to	O
psychomimetic	O
agents	O
.	O

Lastly	O
,	O
we	O
conducted	B
these	O
analyses	O
under	O
the	O
assumption	B
that	O
structurally	O
similar	B
chemicals	O
would	B
have	O
similar	B
modes	O
of	O
action	O
and	O
therefore	B
should	O
be	O
grouped	O
together	O
.	O

These	O
confounders	B
included	O
women	O
'	O
s	O
age	O
and	O
BMI	O
and	O
were	O
not	B
explained	I
by	O
gestational	O
age	O
.	O

This	O
test	O
allows	O
us	O
to	O
measure	O
food	O
intake	O
,	O
chocolate	O
preference	O
as	O
well	O
as	O
to	O
detect	O
the	O
development	O
of	O
inflexible	O
feeding	O
behavior	O
.	O

This	O
estimate	O
includes	O
financial	O
costs	O
(	O
for	O
supplies	O
,	O
training	O
),	O
and	O
costs	O
of	O
health	O
care	O
workers	O
'	O
time	O
.	O

As	O
such	O
,	O
this	O
study	O
should	B
be	I
repeated	O
with	O
a	O
larger	O
sample	O
size	O
to	O
replicate	O
its	O
findings	B
.	O

Pethick	O
et	O
al	O
[	O
69	O
]	O
suggested	B
that	O
a	O
prolonged	O
feeding	O
period	O
gives	O
the	O
cattle	O
time	O
to	O
obtain	O
high	O
IMF	O
levels	O
because	O
time	O
is	O
needed	O
for	O
muscle	O
to	O
reach	O
maturity	O
,	O
followed	O
by	O
time	O
for	O
the	O
muscle	O
to	O
fill	O
up	O
with	O
IMF	O
.	O

Further	O
adjustment	O
for	O
race	O
did	O
not	O
substantially	O
change	O
these	O
estimates	O
(	O
Table	O
3	O
).	O

Therefore	B
,	O
an	O
average	O
daily	O
dose	O
of	O
4	O
–	O
6	O
mg	O
of	O
iron	O
is	O
required	B
in	O
the	O
second	O
and	O
third	O
trimesters	O
of	O
pregnancy	O
[	O
14	O
].	O

Sample	O
suspensions	O
were	O
sonicated	O
3	O
×	O
10	O
sec	O
at	O
40	O
%	O
intensity	O
and	O
centrifuged	O
at	O
14	O
,	O
000	O
×	O
g	O
for	O
20	O
min	O
at	O
15	O
°	O
C	O
.	O

Usually	B
the	O
dosage	O
needs	B
to	O
be	O
increased	O
as	O
early	O
as	O
during	O
the	O
fifth	O
week	O
of	O
gestation	O
,	O
and	O
fT4	O
TSH	O
monitoring	O
is	O
recommended	B
every	O
6	O
weeks	O
for	O
adequate	O
adjustment	O
of	O
dosage	O
.	O

These	O
works	O
of	O
literature	O
were	O
obtained	O
from	O
the	O
commonly	O
used	O
medical	O
databases	O
such	O
as	O
PubMed	O
(	O
Medline	O
),	O
AJOL	O
,	O
and	O
Google	O
Scholar	O
;	O
in	O
addition	O
,	O
Cochrane	O
Library	O
was	O
used	O
as	O
source	O
for	O
systematic	O
reviews	O
on	O
the	O
subject	O
matter	O
.	O

Based	B
on	I
the	O
results	O
from	O
these	O
observational	O
studies	O
the	O
current	O
recommendation	B
of	O
two	O
to	O
three	O
servings	O
per	O
week	O
appears	B
appropriate	O
.	O

The	O
odds	O
ratio	O
(	O
OR	O
)	O
and	O
relative	O
risk	O
(	O
RR	O
)	O
for	O
anaemia	O
in	O
relation	O
to	O
MMN	O
supplement	O
,	O
age	O
and	O
ESR	O
were	O
computed	O
using	O
logistic	O
regression	O
.	O

'	O
s	O
analysis	O
showed	B
induction	O
increase	O
in	O
the	O
risk	O
of	O
autism	O
by	O
72	O
%	O
in	O
three	O
clinic	O
based	O
studies	O
,	O
while	B
the	O
selected	O
population	O
-	O
based	O
studies	O
reported	B
no	O
association	O
[	O
57	O
].	O

a	O
Principal	O
coordinate	O
plot	O
of	O
generalized	O
UniFrac	O
distances	O
(	O
PERMANOVA	O
p	O
=	O
0	O
.	O
034	O
for	O
maternal	O
dairy	O
as	O
a	O
continuous	O
variable	O
),	O
colored	O
by	O
maternal	O
dairy	O
intake	O
tertiles	O
.	O

Bacterial	O
culture	O
of	O
nasopharyngeal	O
swab	O
At	O
1	O
month	O
of	O
age	O
,	O
specimens	O
were	O
collected	O
through	O
the	O
nose	O
with	O
a	O
cotton	O
-	O
tipped	O
swab	O
(	O
Copan	O
Swab	O
Applicator	O
,	O
Copan	O
Diagnostics	O
,	O
Brescia	O
,	O
Italy	O
).	O

In	O
this	B
study	I
,	O
the	O
mean	O
25	O
(	O
OH	O
)	O
D	O
level	O
in	O
the	O
cord	O
serum	O
(	O
13	O
.	O
8	O
ng	O
/	O
mL	O
)	O
was	O
comparable	B
with	O
other	B
reports	B
,	O
but	B
a	O
lower	O
mean	O
level	O
in	O
the	O
maternal	O
serum	O
(	O
15	O
.	O
0	O
ng	O
/	O
mL	O
)	O
was	O
observed	B
.	O

Second	O
,	O
the	O
model	O
also	O
excluded	B
non	O
-	O
linear	O
relationships	O
,	O
including	O
potential	B
threshold	O
effects	B
that	O
could	B
yield	O
important	B
information	B
about	O
the	O
relationships	B
between	O
EDC	O
exposure	O
and	O
birth	O
weight	O
.	O

Similarly	B
,	O
little	B
is	I
known	I
about	O
the	O
role	B
of	O
GR	O
-	O
P	O
,	O
a	O
truncated	O
isoform	O
that	O
lacks	O
a	O
large	O
part	O
of	O
the	O
ligand	O
-	O
binding	O
domain	O
,	O
including	O
the	O
domains	O
for	O
silencing	O
of	O
GR	O
in	O
the	O
absence	O
of	O
hormone	O
and	O
transcriptional	O
activation	O
[	O
24	O
].	O

If	O
the	O
pregnancy	O
test	O
is	O
positive	O
and	O
the	O
pregnancy	O
is	O
within	O
the	O
first	O
trimester	O
,	O
the	O
Field	O
Implementers	O
will	O
register	O
the	O
mother	O
and	O
seek	O
written	O
consent	O
.	O

Among	O
the	O
baseline	O
participants	O
,	O
48	O
.	O
7	O
%	O
(	O
459	O
/	O
943	O
)	O
completed	O
a	O
4	O
-	O
week	O
follow	O
-	O
up	O
survey	O
and	O
24	O
.	O
5	O
%	O
(	O
231	O
/	O
943	O
)	O
completed	O
a	O
postpartum	O
follow	O
-	O
up	O
.	O

Iranian	O
usual	O
diet	O
also	O
contains	O
high	O
amounts	O
of	O
salt	O
,	O
which	O
means	O
that	O
salt	O
intake	O
among	O
them	O
is	O
almost	O
twofold	O
the	O
recommended	O
levels	O
.	O

A	O
number	B
of	I
reporter	O
mouse	O
models	B
,	O
including	O
the	O
Agouti	O
Avy	O
,	O
CabpIAP	O
and	O
AuxinFu	O
,	O
have	B
also	O-
been	I
used	O
to	O
investigate	O
environmentally	O
induced	O
epigenetic	O
changes	O
in	O
in	O
vivo	O
exploratory	O
research	O
(	O
Dolinoy	O
et	O
al	O
.	O
2007	O
;	O
Waterland	O
et	O
al	O
.	O
2006	O
;	O
Rosenfeld2010	O
).	O

2	O
.	O
3	O
.	O

Preterm	O
labor	O
is	O
associated	B
with	O
high	B
mortality	O
and	O
morbidity	O
[	O
22	O
]	O
and	O
a	O
recent	B
study	I
pointed	B
towards	O
an	O
association	B
between	O
maternal	O
stress	O
and	O
complications	B
of	O
pregnancy	O
,	O
especially	B
preterm	O
birth	O
[	O
23	O
].	O

Meticulous	O
observation	O
should	B
include	O
seasonal	O
and	O
regional	O
patterns	B
.	O

The	O
corresponding	O
RR	O
for	O
lean	O
women	O
(<	O
25	O
kg	O
/	O
m2	O
)	O
was	O
3	O
.	O
23	O
(	O
95	O
%	O
CI	O
0	O
.	O
34	O
-	O
30	O
.	O
41	O
)	O
and	O
9	O
.	O
83	O
(	O
95	O
%	O
CI	O
1	O
.	O
12	O
-	O
86	O
.	O
32	O
)	O
for	O
overweight	O
women	O
(≥	O
25	O
kg	O
/	O
m2	O
).	O

The	O
general	O
principles	O
of	O
treatment	O
of	O
pregnant	O
women	O
with	O
asthma	O
[	O
21	O
,	O
22	O
,	O
28	O
]	O
and	O
AR	O
[	O
29	O
]	O
do	O
not	O
differ	O
from	O
the	O
stepwise	O
approach	O
recommended	B
for	O
treatment	O
of	O
nonpregnant	O
women	O
.	O

2011	O
;	O
Wilhelm	O
et	O
al	O
.	O

Low	O
maternal	O
fish	O
and	O
seafood	O
consumption	O
during	O
pregnancy	O
is	O
reported	B
to	O
increase	O
the	O
risk	O
for	O
a	O
low	O
IQ	O
and	O
suboptimal	O
neuro	O
-	O
developmental	O
outcomes	O
in	O
childhood	O
[	O
10	O
],	O
factors	B
that	O
in	O
turn	O
are	O
associated	B
with	O
an	O
increased	O
risk	O
for	O
adult	O
mental	O
disorders	O
like	O
schizophrenia	O
[	O
11	O
].	O

Results	O
:	O
Black	O
race	O
,	O
Medicaid	O
status	O
,	O
mean	O
body	O
mass	O
index	O
at	O
delivery	O
and	O
lack	O
of	O
prenatal	O
vitamin	O
use	O
were	O
associated	B
with	O
vitamin	O
D	O
deficiency	O
.	O

Proliferative	O
potential	O
is	O
lower	O
in	O
intramuscular	O
preadipocytes	O
than	O
in	O
subcutaneous	O
preadipocytes	O
[	O
97	O
].	O

As	O
described	O
previously	O
[	O
27	O
,	O
28	O
],	O
eligible	O
participants	O
for	O
the	O
NHBCS	O
are	O
pregnant	O
women	O
obtaining	O
prenatal	O
care	O
in	O
New	O
Hampshire	O
,	O
US	O
clinics	O
,	O
who	O
reported	O
relying	O
on	O
a	O
private	O
,	O
unregulated	O
well	O
as	O
their	O
home	O
water	O
source	O
.	O

(	O
2014	O
)*	O
Pascual	O
et	O
al	O
.	O

The	O
risk	O
of	O
autism	O
spectrum	O
disorders	O
was	B
shown	I
to	O
be	O
doubled	O
with	O
maternal	O
use	O
of	O
SSRIs	O
in	O
a	O
recent	B
case	O-
controlled	O-
study	I
of	O
298	O
children	O
,	O
with	O
prenatal	O
exposure	O
reported	B
for	O
20	O
of	O
those	O
children	O
[	O
36	O
].	O

New	B
alternatives	O
focusing	O
on	O
adipose	O
tissue	O
function	O
could	B
potentially	B
be	O
of	O
therapeutic	O
relevance	O
in	O
the	O
future	B
.	O

However	B
,	O
there	O
was	O
a	O
significant	O
increase	O
in	O
BM	O
in	O
both	O
generations	O
of	O
VitD	O
-	O
offspring	O
at	O
six	O
months	O
of	O
age	O
,	O
but	B
the	O
BM	O
was	O
higher	O
only	B
in	O
the	O
F2	O
-	O
VitD	O
-	O
group	O
at	O
weaning	O
.	O

We	O
acknowledge	B
that	O
our	O
sample	O
included	O
small	B
numbers	O
in	O
certain	O
categories	O
of	O
polymorphic	O
groups	O
.	O

miRNAs	O
targeting	O
GR	O
were	O
predicted	O
using	O
the	O
PITA	O
algorithm	O
.	O

Prenatal	O
vitamin	O
D	O
inadequacy	O
has	B
been	I
hypothesized	B
as	O
a	O
risk	O
factor	O
for	O
pediatric	O
atopy	O
and	O
asthma	O
.	O

While	O
maternal	O
age	O
is	O
also	O
a	O
known	B
risk	B
factor	I
,	O
it	O
was	B
not	I
associated	O
with	O
PTB	O
in	O
univariate	O
analysis	O
within	O
this	O
cohort	O
(	O
p	O
=	O
0	O
.	O
87	O
).	O

A	O
patient	O
’	O
s	O
innate	O
and	O
adaptive	O
immune	O
response	O
and	O
a	O
host	O
of	O
hormonal	O
and	O
metabolic	O
factors	O
,	O
likely	B
play	O
important	B
and	O
closely	O
interrelated	B
roles	B
in	O
understanding	O
the	O
complex	B
biologic	O
and	O
etiologic	O
mechanisms	O
in	O
the	O
season	O
of	O
birth	O
effect	B
for	O
adult	O
gliomas	O
.	O

More	O
than	O
half	O
of	O
the	O
surveyed	O
women	O
(	O
57	O
%)	O
reported	O
having	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
);	O
conditions	O
were	O
more	B
common	I
among	O
vaccinated	O
(	O
60	O
%)	O
than	O
unvaccinated	O
women	O
(	O
53	O
%)	O
(	O
p	O
-	O
value	O
<	O
0	O
.	O
01	O
).	O

By	O
means	O
of	O
succeeding	O
direct	O
and	O
indirect	O
interactions	O
of	O
downstream	O
target	O
genes	O
,	O
mRNA	O
expression	O
regarding	O
metabolic	O
,	O
behavioural	O
,	O
cardiovascular	O
and	O
immune	O
functions	O
is	O
modulated	O
.	O

Protein	O
Expression	O
in	O
the	O
Nucleus	O
Accumbens	O
of	O
Rats	O
Exposed	O
to	O
Developmental	O
Vitamin	O
D	O
Deficiency	O
Abstract	O
Introduction	O
Developmental	O
vitamin	O
D	O
(	O
DVD	O
)	O
deficiency	O
is	O
a	O
candidate	B
risk	O
factor	O
for	O
schizophrenia	O
.	O

Urine	O
samples	O
are	O
transferred	O
into	O
labelled	O
microtubes	O
and	O
stored	O
at	O
−	O
20	O
°	O
C	O
within	O
4	O
h	O
.	O
Breast	O
milk	O
samples	O
(	O
fore	O
-	O
milk	O
)	O
are	O
collected	O
from	O
lactating	O
mothers	O
at	O
phases	O
5	O
and	O
6	O
as	O
described	O
previously	O
[	O
68	O
].	O

However	O
,	O
at	O
94	O
dpc	O
and	O
188	O
dpn	O
179	O
probe	O
-	O
sets	O
were	O
differentially	O
regulated	O
in	O
both	O
stages	O
between	O
LP	O
and	O
AP	O
.	O

Murphy	O
et	O
al	O
.	O

Interestingly	B
,	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
decreased	O
with	O
more	O
frequent	O
use	O
of	O
sunscreen	O
lotion	O
and	O
increased	O
for	O
women	O
who	O
reported	O
preference	O
for	O
shadow	O
(	O
Table	O
5	O
).	O

In	B
accordance	I
to	O
a	O
guideline	B
by	O
Holick	O
et	O
al	O
.,	O
6	O
–	O
8	O
weeks	O
consumption	O
of	O
a	O
high	O
dose	O
vitamin	O
D	O
supplement	O
are	O
essential	B
to	O
obtain	O
an	O
adequate	O
blood	O
reserves	O
of	O
vitamin	O
D	O
[	O
19	O
].	O

Mothers	O
are	O
instructed	O
on	O
how	O
to	O
complete	O
the	O
calendar	O
and	O
to	O
return	O
completed	O
calendars	O
at	O
each	O
visit	O
.	O

Of	O
279	O
papers	O
sourced	O
,	O
eight	O
were	O
included	O
in	O
the	O
final	O
review	O
.	O

When	O
surgery	O
is	O
planned	O
during	O
pregnancy	O
,	O
it	O
is	O
important	B
to	O
consider	B
both	O
gestational	O
age	O
and	O
the	O
type	O
of	O
general	O
anaesthesia	O
.	O

Despite	B
employing	O
nurture	O
as	O
a	O
primary	O
driver	O
of	O
handwashing	O
behavior	O
and	O
including	O
in	O
the	O
intervention	O
all	O
secondary	O
caregivers	O
,	O
not	O
only	O
the	O
mother	O
,	O
there	O
was	O
limited	B
behavioral	O-
impact	I
of	O
the	O
intervention	O
.	O

They	O
were	O
randomized	O
to	O
receive	O
treatment	O
for	O
GDM	O
,	O
including	O
dietary	O
advice	O
,	O
blood	O
glucose	O
monitoring	O
,	O
and	O
insulin	O
as	O
required	O
,	O
or	O
standard	O
pregnancy	O
care	O
.	O

Other	B
disadvantages	B
of	O
intravenous	O
iron	O
supplementation	O
include	O
cost	O
and	O
invasiveness	O
of	O
the	O
procedure	O
.	O

The	O
authors	O
concluded	B
that	O
higher	O
subjective	O
social	O
standing	O
in	O
school	O
might	B
protect	B
against	O
weight	O
gain	O
in	O
adolescent	O
girls	O
.	O

Dryness	O
,	O
rashes	O
,	O
and	O
related	O
skin	O
conditions	O
,	O
to	O
which	O
infants	O
may	B
be	I
particularly	O
susceptible	O
,	O
serve	O
to	O
disrupt	O
the	O
protective	O
barrier	O
of	O
the	O
skin	O
[	O
36	O
,	O
38	O
].	O

The	O
impact	B
of	O
nutritional	O
knowledge	O
on	O
the	O
use	O
of	O
folic	O
acid	O
was	O
emphasised	B
in	O
a	O
study	O
conducted	O
in	O
Turkey	O
,	O
where	O
factors	O
negatively	O
associated	B
with	O
pre	O
-	O
conception	O
supplementation	O
were	O
low	O
socio	O
-	O
economic	O
status	O
,	O
age	O
below	O
30	O
years	O
,	O
low	O
levels	O
of	O
education	O
and	O
unplanned	O
pregnancy	O
.	O

The	O
timing	O
of	O
supplementation	O
may	B
likewise	B
be	O
a	O
crucial	B
factor	B
(	O
Owens	O
and	O
Fall	O
2008	O
).	O

We	O
present	O
that	O
the	O
hepatic	O
expression	O
profiles	O
showed	O
considerable	B
modulation	O
during	O
prenatal	O
and	O
postnatal	O
stages	O
,	O
i	O
.	O
e	O
.	O

Calcitonin	O
is	O
the	O
most	O
clinically	O
useful	O
biochemical	O
marker	O
for	O
these	O
tumours	O
,	O
and	O
C	O
cell	O
hyperplasia	O
represents	B
a	O
pre	O
-	O
cancerous	O
stage	O
.	O

The	O
US	O
Preventive	O
Services	O
Task	O
Force	O
does	O
not	O
comment	O
for	O
or	O
against	O
routine	O
screening	O
for	O
vitamin	O
D	O
deficiency	O
in	O
pregnant	O
women	O
.	O

UNICEF	O
has	O
reported	B
deaths	O
of	O
an	O
estimated	B
50	O
,	O
000	O
young	O
women	O
per	O
year	O
globally	O
in	O
pregnancy	O
and	O
childbirth	O
due	B
to	I
severe	B
iron	O
deficiency	O
anemia	O
[	O
12	O
].	O

However	B
the	O
costs	O
of	O
potential	B
strategies	B
for	O
achieving	O
this	O
are	O
currently	B
unknown	B
.	O

Finally	O
,	O
lambda	O
stat	O
was	O
used	O
to	O
compare	O
correlation	O
coefficients	O
of	O
variables	O
in	O
the	O
two	O
groups	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

Although	B
the	O
literature	O
from	O
rigorous	O
studies	B
of	O
smoking	O
cessation	O
,	O
treatment	O
adherence	O
,	O
and	O
some	B
other	O
chronic	O
disease	O
prevention	O
and	O
management	O
studies	B
show	B
that	O
mHealth	O
programs	O
can	B
promote	O
behavior	O
change	O
,	O
more	O
randomized	O
controlled	O
trials	O
(	O
RCTs	O
)	O
are	B
needed	I
[	O
11	O
].	O

However	B
,	O
the	O
depression	O
scores	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
were	O
not	O
different	O
significantly	O
(	O
p	O
=	O
0	O
.	O
217	O
).	O

Thus	B
it	B
is	I
possible	I
that	O
longer	O
follow	O
up	O
may	B
be	I
needed	B
to	O
determine	O
significant	O
associations	B
.	O

This	O
process	O
has	O
been	O
called	O
nutritional	O
programming	O
(	O
Lucas	O
,	O
1991	O
;	O
Hales	O
and	O
Barker	O
,	O
2001	O
;	O
Gluckman	O
and	O
Hanson	O
,	O
2004	O
;	O
Barker	O
,	O
2007	O
;	O
Vaag	O
et	O
al	O
.,	O
2012	O
).	O

2a	O
;	O
Additional	O
file	O
1	O
:	O
Table	O
S3	O
).	O

EDCs	O
with	O
measurements	O
below	O
the	O
limit	O
of	O
detection	O
(	O
LOD	O
)	O
were	O
assigned	O
LOD	O
/√	O
2	O
[	O
10	O
,	O
35	O
,	O
36	O
].	O

A	O
cross	O
-	O
sectional	O
survey	O
during	O
the	O
high	O
-	O
risk	O
winter	O
months	O
in	O
2005	O
showed	B
that	O
greater	O
than	O
95	O
%	O
of	O
children	O
younger	O
than	O
5	O
years	O
in	O
a	O
socioeconomically	O
deprived	O
part	O
of	O
Kabul	O
had	O
serum	O
calcifediol	O
levels	O
of	O
less	O
than	O
37	O
·	O
5	O
nmol	O
/	O
L	O
.	O
12	O
On	B
the	I
basis	I
of	I
findings	O
that	O
vitamin	O
D	O
is	O
an	O
immunomodulator	O
,	O
that	O
deficiency	O
is	O
a	O
risk	O
factor	O
for	O
pneumonia	O
,	O
and	O
that	O
quarterly	O
supplementation	O
had	O
better	O
compliance	O
than	O
daily	O
or	O
weekly	O
supplementation	O
,	O
13	O
,	O
14we	O
aimed	B
to	B
test	I
the	O
hypothesis	B
that	O
quarterly	O
100	O
000	O
IU	O
vitamin	O
D	O
supplementation	O
would	B
reduce	O
the	O
incidence	O
of	O
radiologically	O
confirmed	O
pneumonia	O
by	O
35	O
%	O
in	O
our	O
study	O
population	O
.	O

What	B
is	O
the	O
role	B
of	O
cholecalciferol	O
in	O
human	O
reproduction	O
?	B

Germany	O
)	O
to	O
the	O
nearest	O
0	O
.	O
1	O
kg	O
and	O
height	O
was	O
measured	O
without	O
shoes	O
to	O
the	O
nearest	O
0	O
.	O
1	O
cm	O
using	O
a	O
wall	O
-	O
mounted	O
stadiometer	O
.	O

In	O
addition	O
,	O
treating	O
the	O
infant	O
with	O
DDAVP	O
besides	O
intravenous	O
fluids	O
may	B
also	O
be	O
beneficial	O
.	O

Suboptimal	O
vitamin	O
D	O
status	O
was	O
defined	B
as	B
25	O
(	O
OH	O
)	O
D	O
<	O
80	O
nmol	O
/	O
L	O
,	O
and	O
optimal	O
vitamin	O
D	O
status	O
as	B
25	O
(	O
OH	O
)	O
D	O
≥	O
80	O
nmol	O
/	O
L	O
,	O
as	B
has	B
been	I
suggested	I
based	B
on	I
calcium	O
absorption	O
studies	B
[	O
18	O
].	O

Significant	O
correlations	B
were	O
observed	B
in	O
both	O
groups	O
between	O
first	O
trimester	O
visfatin	O
(	O
pa	O
=	O
0	O
.	O
002	O
,	O
ra	O
=	O
0	O
.	O
713	O
,	O
pb	O
=	O
0	O
.	O
005	O
,	O
rb	O
=-	O
0	O
.	O
540	O
,	O
in	O
A	O
and	O
B	O
group	O
,	O
respectively	O
)	O
and	O
second	O
trimester	O
visfatin	O
(	O
pa	O
=	O
0	O
.	O
009	O
,	O
ra	O
=	O
0	O
.	O
628	O
and	O
pb	O
=	O
0	O
.	O
008	O
,	O
rb	O
=-	O
0	O
.	O
518	O
,	O
in	O
groups	O
A	O
and	O
B	O
,	O
respectively	O
)	O
with	O
infant	O
’	O
s	O
height	O
.	O

Results	O
Effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
body	O
weight	O
and	O
caloric	O
intake	O
in	O
dams	O
and	O
their	O
offspring	O
in	O
gestation	O
,	O
lactation	O
,	O
and	O
/	O
or	O
postweaning	O
periods	O
Body	O
weight	O
gain	O
and	O
cumulative	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
in	O
dams	O
were	O
evaluated	O
after	O
the	O
gestation	O
and	O
lactation	O
periods	O
(	O
Figure2A	O
).	O

Studies	B
of	O
text4baby	O
have	O
helped	O
establish	O
and	O
expand	O
the	O
mHealth	O
evidence	B
base	I
.	O

Shea	O
et	O
al	O
studied	O
2500	O
elderly	O
adults	O
and	O
found	B
that	O
lack	O
of	O
PNV	O
use	O
was	O
associated	B
with	O
higher	O
odds	O
of	O
vitamin	O
D	O
insufficiency	O
(<	O
75	O
nmol	O
/	O
L	O
)	O
in	O
both	O
black	O
(	O
5	O
.	O
2	O
(	O
95	O
%	O
CI	O
:	O
3	O
.	O
5	O
,	O
7	O
.	O
7	O
))	O
and	O
white	O
participants	O
(	O
OR	O
2	O
.	O
6	O
,	O
95	O
%	O
CI	O
:	O
2	O
.	O
0	O
,	O
3	O
.	O
2	O
),	O
however	B
these	O
subjects	O
were	O
much	O
older	O
and	O
not	O
pregnant	O
.	O
26A	O
small	B
Turkish	O-
study	I
of	O
79	O
pregnant	O
women	O
showed	B
significantly	O
higher	O
25	O
(	O
OH	O
)	O
D	O
levels	O
among	O
women	O
reporting	O
PNV	O
use	O
in	O
the	O
third	O
trimester	O
,	O
27but	B
this	O
study	O
did	B
not	I
include	O
women	O
of	O
African	O
descent	O
and	O
did	B
not	I
have	O
the	O
power	O
to	O
address	O
potential	B
interaction	B
by	O
BMI	O
.	O

Limited	B
data	I
are	O
available	O
regarding	O
the	O
association	B
of	O
maternal	O
dietary	O
patterns	O
and	O
neonatal	O
anthropometric	O
measurements	O
in	O
Middle	O
Eastern	O
countries	O
,	O
where	O
mentioned	O
factors	O
are	O
different	O
from	O
western	O
population	O
[	O
19	O
].	O

Multivariable	O
logistic	O
regression	O
models	O
were	O
used	O
to	O
evaluate	O
associations	O
between	O
maternal	O
characteristics	O
,	O
vitamin	O
D	O
status	O
and	O
SGA	O
.	O

Different	B
factors	O
can	O
partially	B
explain	B
the	O
discrepancies	B
found	B
in	O
food	O
preferences	O
.	O

The	O
signals	O
that	O
mediate	O
the	O
effects	B
of	O
maternal	O
metabolic	O
disorders	O
in	O
overfed	O
offspring	O
have	B
not	I
been	I
fully	I
identified	I
.	O

Social	O
and	O
racial	O
disparities	B
in	O
preterm	O
birth	O
rates	O
are	O
a	O
major	B
issue	B
,	O
yet	B
remain	B
poorly	B
understood	I
.	O

Previous	B
studies	I
identify	B
edible	O
fungi	O
as	B
the	O
primary	O
plant	O
-	O
based	O
dietary	O
source	O
of	O
Vitamin	O
D	O
.	O
However	B
,	O
edible	O
fungi	O
were	O
hardly	O
seen	B
in	O
the	O
dietary	O
records	O
among	O
participants	O
in	O
this	B
study	I
.	O

The	O
mothers	O
of	O
autistic	O
children	O
were	O
studied	O
,	O
and	O
it	O
was	O
demonstrated	B
that	O
the	O
cases	O
with	O
autism	O
had	O
more	O
pregnancy	O
complications	B
.	O

Some	O
have	O
proposed	B
that	O
maternal	O
vaccination	O
may	B
also	O
have	O
beneficial	O
effects	B
on	O
birth	O
outcomes	O
.	O

Maternal	O
depression	O
and	O
fatigue	O
Perinatal	O
depression	O
is	O
assessed	O
at	O
phases	O
1	O
to	O
3	O
during	O
pregnancy	O
and	O
at	O
phases	O
5	O
,	O
6	O
and	O
8	O
postnatally	O
using	O
the	O
Edinburgh	O
Postnatal	O
Depression	O
Scale	O
(	O
EPDS	O
).	O

Adverse	O
environmental	O
conditions	O
during	O
fetal	O
development	O
provoke	B
an	O
intrauterine	O
adaptive	O
response	O
termed	O
'	O
fetal	O
programming	O
',	O
which	O
may	B
lead	O
to	O
both	O
persistently	O
biased	O
responsiveness	O
to	O
extrinsic	O
factors	O
and	O
permanent	O
consequences	O
for	O
the	O
organismal	O
phenotype	O
.	O

This	O
ability	O
has	B
been	I
documented	B
at	O
meals	O
(	O
42	O
,	O
43	O
)	O
and	O
during	O
the	O
course	O
of	O
a	O
day	O
(	O
44	O
).	O

(	O
2015	O
)‡	O
Susiarjo	O
et	O
al	O
.	O

Metformin	O
alters	O
gene	O
expression	O
in	O
mice	O
livers	O
and	O
has	B
been	I
demonstrated	I
to	O
have	O
an	O
antiproliferative	O
effect	B
through	O
reductions	O
in	O
cyclin	O
D1	O
and	O
activation	O
of	O
AMP	O
kinase	O
.	O
79The	O
programming	O
and	O
developmental	O
effects	B
of	O
these	O
on	O
a	O
fetus	O
are	O
unknown	B
.	O

Controlling	O
for	O
mediators	O
may	B
attenuate	O
the	O
total	O
effect	B
of	O
EDCs	O
on	O
birth	O
weight	O
.	O

Both	O
non	O
-	O
esterified	O
fatty	O
acids	O
(	O
NEFAs	O
)	O
and	O
a	O
glycerol	O
backbone	O
are	O
required	O
for	O
TG	O
synthesis	O
.	O

Presently	O
,	O
over	O
40	O
million	O
pregnant	O
women	O
suffer	B
from	O
iron	O
deficiency	O
(	O
ID	O
)	O
and	O
its	O
consequences	B
in	O
developing	O
countries	O
[	O
8	O
].	O

Development	O
of	O
new	B
fusion	O
technologies	O
(	O
e	O
.	O
g	O
.,	O
nutrigenomics	O
)	O
with	O
genetic	O
,	O
epigenetic	O
,	O
and	O
nutritional	O
factors	O
may	B
be	I
more	O
efficient	O
to	O
optimize	O
IMF	O
deposition	O
and	O
improve	O
feed	O
efficiency	O
.	O

The	O
latter	O
result	O
did	B
not	I
remain	B
significant	O
after	O
multivariate	O
adjustment	O
(	O
Table2	O
).	O

From	O
this	O
information	O
,	O
we	O
categorized	O
participants	O
as	O
snoring	O
if	O
their	O
reported	O
snoring	O
most	O
or	O
all	O
of	O
the	O
time	O
;	O
all	O
other	O
women	O
were	O
classified	O
as	O
non	O
-	O
snorers	O
.	O

Finally	O
,	O
to	O
determine	O
the	O
combined	O
effects	O
of	O
SNPs	O
,	O
a	O
genotype	O
risk	O
score	O
(	O
GRS	O
)	O
was	O
calculated	O
as	O
the	O
sum	O
of	O
the	O
number	O
of	O
risk	O
alleles	O
at	O
rs10741657	O
(	O
G	O
)	O
and	O
rs2282679	O
(	O
C	O
),	O
as	O
identified	O
in	O
the	O
previous	O
analysis	O
.	O

Pregnancy	O
loss	O
The	O
total	O
rate	O
of	O
pregnancy	O
loss	O
was	O
4	O
.	O
7	O
%	O
and	O
the	O
rate	O
of	O
late	O
pregnancy	O
loss	O
(	O
gestational	O
week	O
≥	O
14	O
+	O
0	O
)	O
was	O
1	O
.	O
5	O
%	O
(	O
Table1	O
).	O

Therefore	B
,	O
there	O
is	O
a	O
need	B
to	O
establish	O
effective	O
and	O
safe	B
doses	O
of	O
supplemental	O
iron	O
with	O
folic	O
acid	O
either	B
as	O-
daily	O-
or	I
weekly	O
supplementation	O
;	O
this	O
should	B
take	O
into	O
consideration	B
nutritional	O
and	O
haematological	O
status	O
of	O
women	O
in	O
developing	O
countries	O
.	O

Multiple	O
linear	O
and	O
logistic	O
regression	O
models	O
were	O
constructed	O
to	O
investigate	O
significant	O
predictors	O
of	O
the	O
outcomes	O
of	O
interest	O
.	O

Nimitphong	O
et	O
al	O
.	O

When	O
examined	O
by	O
gender	O
,	O
girls	O
were	O
only	O
weakly	O
correlated	B
with	O
the	O
mother	O
,	O
but	O
with	O
boys	O
the	O
correlation	B
was	O
much	O
stronger	O
.	O

The	O
interest	B
of	O
OECD	O
member	O
countries	O
in	O
epigenetics	O
within	O
the	O
former	O
expert	O
group	O
is	O
particularly	O
strong	O
,	O
where	O
epigenetic	O
mechanisms	O
are	O
playing	O
a	O
pivotal	B
role	B
in	O
the	O
development	O
of	O
tools	O
for	O
improved	O
chemical	O
safety	B
assessment	O
(	O
Jacobs	O
et	O
al	O
.	O
2015	O
).	O

Similarly	B
,	O
38	O
%	O
of	O
exposed	O
women	O
in	O
this	O
earlier	O
study	O
,	O
in	B
contrast	I
to	I
18	O
%	O
in	O
the	O
current	O
study	O
,	O
reported	O
smoking	O
during	O
pregnancy	O
—	O
a	O
risk	B
factor	I
that	O
has	B
also	O-
been	I
associated	B
with	O
elevated	O
risks	B
of	O
small	O
for	O
gestational	O
age39	O
–	O
41and	O
intrauterine	O
growth	O
-	O
restricted42neonates	O
.	O

Hence	B
,	O
thyroid	O
cancer	O
ranks	O
among	O
the	O
most	B
common	I
cancers	O
during	O
pregnancy	O
,	O
with	O
a	O
prevalence	O
of	O
3	O
.	O
6	O
-	O
14	O
per	O
100	O
,	O
000	O
live	O
births	O
,	O
mirroring	O
the	O
its	O
incidence1	O
-	O
4	O
.	O

Phase	O
1	O
data	O
are	O
collected	O
at	O
<	O
18	O
weeks	O
’	O
gestation	O
(	O
as	O
confirmed	O
by	O
obstetric	O
ultrasound	O
).	O

In	O
addition	O
the	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
was	O
threefold	O
higher	O
among	O
women	O
of	O
Asiatic	O
descent	O
,	O
six	O
fold	O
higher	O
for	O
North	O
African	O
women	O
and	O
five	O
fold	O
higher	O
for	O
women	O
of	O
Hispanic	O
descent	O
compared	O
to	O
Caucasians	O
.	O

These	B
findings	I
preserved	B
even	B
after	O
adjusting	O
for	O
prematurity	O
,	O
gender	O
,	O
age	O
,	O
BMI	O
,	O
physical	O
activity	O
index	O
and	O
SBP	O
levels	O
.	O

The	O
findings	O
of	O
the	O
formative	O
study	O
suggested	B
that	O
introduction	O
of	O
IFA	O
supplements	O
early	O
in	O
pregnancy	O
is	O
feasible	B
with	O
support	O
from	O
BRAC	O
or	O
government	O
community	O
health	O
workers	O
.	O

Thus	O
,	O
it	O
will	B
be	O
important	B
to	O
investigate	O
whether	B
maternal	O
dairy	O
consumption	O
fosters	O
the	O
growth	O
of	O
potentially	B
pathogenic	O
microbes	O
in	O
the	O
infant	O
gut	O
,	O
particularly	O
for	O
infants	O
delivered	O
operatively	O
.	O

Sustained	O
effort	O
by	O
healthcare	O
leaders	O
and	O
advocates	O
at	O
all	O
levels	O
,	O
inside	O
and	O
outside	O
of	O
government	O
,	O
has	O
elevated	O
the	O
issue	B
of	O
preterm	O
birth	O
on	O
the	O
nation	O
'	O
s	O
health	O
agenda	B
,	O
contributing	O
to	O
an	O
announcement	O
of	O
new	O
federal	O
resources	O
to	O
test	O
promising	B
practices	O
in	O
February	O
2012	O
.	O

Although	B
toddlers	O
were	O
more	O
likely	B
to	O
eat	O
fruits	O
than	O
vegetables	O
,	O
1	O
in	O
4	O
did	O
not	O
eat	O
any	O
vegetables	O
on	O
a	O
given	O
day	O
.	O

A	O
recent	B
mouse	O-
study	I
by	O
Lambrot	O
et	O
al	O
.	O

Rats	O
had	O
ad	O
libitum	O
access	O
to	O
the	O
standard	O
chow	O
and	O
water	O
,	O
and	O
had	O
limited	O
access	O
to	O
the	O
chocolate	O
for	O
1	O
h	O
during	O
the	O
light	O
phase	O
.	O

Moreover	O
,	O
accumulating	B
evidence	I
link	B
habitual	O
snoring	O
and	O
sleep	O
apnea	O
,	O
both	O
part	O
of	O
a	O
spectrum	O
of	O
sleep	O
-	O
related	O
breathing	O
disorders	O
,	O
with	O
cardiometabolic	O
abnormalities	O
that	O
include	O
hypertension	O
,	O
dyslipidemia	O
,	O
obesity	O
,	O
hyperglycemia	O
,	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
[	O
2	O
,	O
7	O
,	O
12	O
-	O
15	O
].	O

Food	O
Fortification	O
with	O
Iron	O
Food	O
fortification	O
with	O
iron	O
has	B
also	O-
been	I
shown	B
to	O
be	O
an	O
equally	O
effective	O
strategy	B
of	O
boosting	O
haemoglobin	O
level	O
in	O
the	O
population	O
,	O
including	O
pregnant	O
women	O
.	O

This	O
is	O
because	O
the	O
male	O
and	O
female	O
pronuclei	O
are	O
differentially	O
imprinted	O
;	O
that	O
is	O
certain	O
genes	O
carry	O
a	O
parent	O
-	O
of	O
-	O
origin	O
epigenetic	O
mark	O
so	O
that	O
they	O
are	O
only	O
expressed	O
from	O
a	O
single	O
parental	O
allele	O
,	O
ensuring	O
the	O
correct	O
dosage	O
of	O
maternally	O
and	O
paternally	O
derived	O
gene	O
products	O
(	O
reviewed	O
in	O
Bartolomei	O
&	O
Ferguson	O
-	O
Smith2011	O
).	O

AM251	O
(	O
Tocris	O
,	O
Bioscence	O
,	O
Bristol	O
,	O
UK	O
)	O
was	O
dissolved	O
in	O
a	O
vehicle	O
containing	O
5	O
%	O
Tween	O
80	O
and	O
95	O
%	O
saline	O
.	O

2011	O
)	O
and	O
may	B
arise	O
sporadically	O
or	B
as	O
the	O
result	O
of	O
an	O
underlying	B
heritable	O
abnormality	O
in	O
genes	O
that	O
contribute	B
to	O
vertebral	O
development	O
.	O

Additionally	O
,	O
classes	O
7	O
,	O
11	O
,	O
and	O
12	O
were	O
marginally	O
positively	O
associated	B
with	O
AluYb8	O
methylation	O
levels	O
,	O
with	O
CpGs	O
exhibiting	O
low	O
to	O
intermediate	O
methylation	O
.	O

Outcome	O
assessment	O
Binary	O
variables	O
Current	O
doctor	O
-	O
diagnosed	O
asthma	O
was	O
defined	O
in	O
children	O
at	O
age	O
7	O
.	O
5	O
years	O
(	O
primary	O
outcome	O
)	O
if	O
mothers	O
responded	O
positively	O
to	O
the	O
question	O
“	O
Has	O
a	O
doctor	O
ever	O
actually	O
said	O
that	O
your	O
study	O
child	O
has	O
asthma	O
?”	O
and	O
to	O
one	O
or	O
both	O
of	O
the	O
questions	O
“	O
Has	O
your	O
child	O
had	O
any	O
of	O
the	O
following	O
in	O
the	O
past	O
12	O
months	O
:	O
wheezing	O
with	O
whistling	O
;	O
asthma	O
?”	O
Current	O
wheezing	O
,	O
eczema	O
and	O
hay	O
fever	O
in	O
children	O
at	O
age	O
7	O
.	O
5	O
years	O
were	O
defined	O
by	O
a	O
positive	O
answer	O
to	O
the	O
question	O
:	O
“	O
Has	O
your	O
child	O
had	O
any	O
of	O
the	O
following	O
in	O
the	O
past	O
12	O
months	O
:	O
wheezing	O
with	O
whistling	O
;	O
eczema	O
;	O
hay	O
fever	O
?”	O
Atopy	O
at	O
age	O
7	O
years	O
was	O
defined	O
as	O
a	O
positive	O
reaction	O
(	O
maximum	O
diameter	O
of	O
any	O
detectable	O
weal	O
)	O
to	O
Dermatophagoidespteronyssinus	O
,	O
cat	O
or	O
grass	O
(	O
after	O
subtracting	O
positive	O
saline	O
reactions	O
from	O
histamine	O
and	O
allergen	O
weals	O
,	O
and	O
excluding	O
children	O
unreactive	O
to	O
1	O
%	O
histamine	O
).	O

A	O
considerable	B
amount	O
of	O
glucose	O
is	O
absorbed	O
from	O
the	O
small	O
intestine	O
when	O
high	O
-	O
starch	O
diets	O
are	O
fed	O
,	O
especially	O
during	O
the	O
beef	O
cattle	O
fattening	O
period	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Summary	O
of	O
vitamin	O
D	O
status	O
in	O
Thai	O
peopleStudyChailurkit	O
et	O
al	O
.	O

The	O
assertion	B
that	O
autism	O
patients	O
engage	O
in	O
repetitive	O
,	O
behavioral	O
patterns	O
has	O
arguably	O
become	O
stereotyped	B
.	O

While	B
such	O
studies	O
are	O
more	O
difficult	B
to	O
interpret	O
with	O
respect	O
to	O
epigenetic	O
toxicity	O
(	O
and	O
so	O
were	O
not	O
included	O
in	O
this	B
review	I
),	O
they	O
may	B
still	B
provide	O
useful	O
mechanistic	O
data	O
.	O

Supplementation	O
with	O
400	O
IU	O
/	O
day	O
of	O
vitamin	O
D	O
to	O
these	O
infants	O
led	B
to	I
a	O
relatively	O
greater	O
increase	O
in	O
those	O
who	O
were	O
born	O
with	O
the	O
lowest	O
vitamin	O
D	O
status	O
and	O
there	O
was	O
no	O
suggestion	O
of	O
any	O
bone	O
mineral	O
outcome	O
deficits	O
at	O
one	O
week	O
or	O
three	O
months	O
of	O
age	O
in	O
infants	O
with	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

As	B
such	I
a	O
dose	O
is	O
far	O
higher	O
than	O
the	O
daily	O
dietary	O
allowance	O
recommended	B
for	O
lactating	O
mothers	O
its	O
safety	B
over	O
prolonged	O
periods	O
is	O
not	B
known	I
and	O
should	B
be	I
examined	O
.	O

However	B
,	O
in	O
contrary	B
to	O
these	O
reports	B
,	O
a	O
survey	O
in	O
Canadian	O
children	O
showed	B
that	O
both	O
low	O
and	O
high	O
vitamin	O
D	O
levels	O
were	O
related	B
to	O
increased	B
risk	I
of	O
wheeze	O
and	O
reduced	O
performance	O
of	O
lung	O
function	O
[	O
35	O
].	O

One	O
notion	B
is	O
that	O
primitive	O
mesenchymal	O
cells	O
differentiate	O
into	O
normal	O
osteoblasts	O
in	O
the	O
wrong	O
location	O
.	O

Preventive	O
pharmacotherapy	O
and	O
immunotherapy	O
will	B
not	I
be	I
discussed	I
.	O

Do	B
we	O
run	B
the	I
risk	I
of	O
banning	O
a	O
chemical	O
that	O
does	O
not	O
demonstrate	O
any	O
epigenetic	O
toxicity	O
at	O
the	O
levels	O
found	O
within	O
the	O
environment	O
or	O
human	O
populations	O
only	B
to	O
replace	O
it	O
with	O
an	O
alternative	B
whose	O
characteristics	O
and	O
potential	B
effects	B
we	O
know	B
even	B
less	B
about	O
?	B

This	O
racial	O
difference	O
may	B
reflect	O
an	O
impact	B
on	O
pet	O
owner	O
behavior	O
resulting	O
in	O
increased	O
outdoor	O
exposure	O
that	O
is	O
limited	O
to	O
lighter	O
skinned	O
individuals	O
.	O

Two	O
-	O
way	O
ANOVA	O
showed	B
a	O
main	O
effect	B
of	O
the	O
diet	O
on	O
the	O
gene	O
expression	O
of	O
Cpt1a	O
,	O
Cpt1b	O
,	O
and	O
Acox1	O
in	O
liver	O
and	O
PAT	O
,	O
Acaca	O
,	O
Fasn	O
,	O
Insig1	O
,	O
and	O
Hmgcr	O
in	O
liver	O
,	O
and	O
Chrebp	O
,	O
Scd1	O
,	O
and	O
Cox4i1	O
in	O
PAT	O
(	O
see	O
TableS3for	O
statistical	O
values	O
).	O

Camargo	O
et	O
al	O
.	O

WAT	O
is	O
an	O
energy	O
-	O
storing	O
tissue	O
that	O
has	O
evolutionary	O
enabled	O
humans	O
to	O
survive	O
for	O
longer	O
periods	O
between	O
meals	O
,	O
storing	O
energy	O
mainly	O
as	O
triglycerides	O
and	O
releasing	O
fatty	O
acids	O
during	O
fasting	O
periods	O
.	O

Wilcoxon	O
test	O
.	O

Information	O
on	O
usage	O
of	O
over	O
-	O
the	O
-	O
counter	O
and	O
prescription	O
medications	O
,	O
substance	O
use	O
and	O
breastfeeding	O
was	O
collected	O
as	O
well	O
.	O

Today	O
,	O
after	O
decades	O
of	O
inactivity	O
,	O
the	O
uranium	O
from	O
these	O
ponds	O
,	O
waste	O
and	O
tailings	O
piles	O
,	O
and	O
the	O
mines	O
themselves	O
is	O
still	B
present	O
in	O
highly	O
chemically	O
soluble	O
forms6	O
,	O
21that	O
have	B
been	I
leaching	O
into	O
the	O
area	O
’	O
s	O
drinking	O
water	O
,	O
according	B
to	I
water	O
testing	O
by	O
the	O
EPA	O
and	O
the	O
Army	O
Corps	O
of	O
Engineers	O
.	O
22	O
In	O
a	O
small	O
,	O
one	O
-	O
story	O
adobe	O
building	O
tucked	O
into	O
the	O
far	O
edge	O
of	O
the	O
University	O
of	O
New	O
Mexico	O
campus	O
,	O
Johnnye	O
Lewis	O
,	O
a	O
professor	O
of	O
toxicology	O
,	O
has	O
spent	O
more	O
than	O
a	O
decade	O
studying	O
mining	O
-	O
related	B
health	O
effects	B
in	O
the	O
Navajo	O
people	O
.	O

Prepregnancy	O
weight	O
and	O
weight	O
recorded	O
in	O
prenatal	O
clinics	O
were	O
utilised	O
to	O
calculate	O
gestational	O
weight	O
gain	O
(	O
GWG	O
)	O
(	O
kg	O
).	O

In	O
univariate	O
analyses	O
,	O
thyroxine	O
therapy	O
apparently	B
helps	O
decrease	O
cancer	O
-	O
related	B
death	O
rates	O
among	O
patients	O
with	O
PTC	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
No	O
.	O

Yet	B
,	O
specific	O
DNA	O
demethylase	O
enzyme	O
(	O
s	O
)	O
in	O
mammals	O
remained	B
elusive	B
until	O
the	O
discovery	O
of	O
the	O
10	O
–	O
11	O
translocation	O
(	O
TET	O
)	O
enzyme	O
family	O
.	O

Part	O
1	O
:	O
Specific	O
Allergic	O
Diseases	O
in	O
Pregnancy	O
Epidemiology	O
:	O
Prevalence	O
of	O
Asthma	O
and	O
Allergy	O
in	O
Pregnant	O
Women	O
Allergic	O
sensitization	O
to	O
common	O
allergens	O
can	O
be	O
detected	O
in	O
approximately	B
25	O
%	O
to	O
35	O
%	O
of	O
the	O
general	O
population	O
in	O
industrialized	O
countries	O
[	O
7	O
].	O

It	O
is	O
established	O
that	O
diet	O
is	O
an	O
important	B
driver	O
of	O
the	O
gut	O
microbiome	O
.	O

Subsequently	O
,	O
the	O
title	O
of	O
an	O
article	O
in	O
Scientific	O
American	O
recently	B
asked	B
,	O
‘	O
What	B
if	B
vitamin	O
D	O
deficiency	O
is	O
a	O
cause	O
of	O
autism	O
?’	B
(	O
3	O
)	O
Since	O
then	O
,	O
an	O
article	B
on	O
vitamin	O
D	O
and	O
autism	O
in	O
Acta	O
Paediatrica	O
(	O
4	O
)	O
and	O
the	O
accompanying	O
commentary	B
(	O
5	O
)	O
have	O
added	O
to	O
the	O
accelerating	B
suspicion	B
that	O
vitamin	O
D	O
deficiency	O
–	O
either	B
during	O-
pregnancy	O-
or	I
early	O
childhood	O
–	O
may	B
be	I
an	O
environmental	O
trigger	B
for	O
the	O
genetic	O
disease	O
of	O
autism	O
.	O

A	O
recent	B
movement	O
suggests	B
minimizing	O
screen	O
time	O
for	O
youth	O
because	B
television	O
,	O
computers	O
,	O
and	O
video	O
games	O
contribute	B
to	O
sedentary	O
behavior	O
.	O

Experiences	O
on	O
parenteral	O
iron	O
use	O
are	O
predominantly	O
,	O
but	B
not	I
exclusively	O
,	O
from	O
the	O
developed	O
world	O
as	B
reports	O
of	O
its	O
prophylactic	O
use	O
in	O
pregnancy	O
are	O
scant	B
;	O
this	O
may	B
be	I
related	B
to	O
concerns	B
about	O
adverse	O
reactions	O
associated	B
with	O
its	O
use	O
in	O
parenteral	O
form	O
.	O

Birth	O
weight	O
is	O
an	O
independent	O
predictor	O
of	O
the	O
development	O
of	O
obesity	O
;	O
however	B
,	O
increases	O
in	O
weight	O
during	O
the	O
first	O
3	O
–	O
6	O
months	O
of	O
life	O
are	O
also	O
influential	B
on	O
long	O
-	O
term	O
increased	O
risk	O
of	O
obesity	O
[	O
47	O
,	O
48	O
].	O

For	O
example	O
,	O
VDP	O
rises	O
early	O
in	O
pregnancy	O
,	O
and	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
increases	O
during	O
the	O
second	O
and	O
third	O
trimesters	O
(	O
12	O
).	O

These	B
findings	I
are	O
compatible	O
with	O
a	O
previous	B
report	O
of	O
early	O
puberty	O
following	O
high	O
fat	O
nutrition	O
during	O
pregnancy	O
[	O
57	O
].	O

BMC	O
was	O
highly	O
correlated	B
to	O
body	O
weight	O
(	O
r	O
=	O
0	O
.	O
86	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
as	O
was	O
BMD	O
(	O
r	O
=	O
0	O
.	O
56	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O

In	O
general	O
,	O
the	O
term	O
obesity	O
applies	O
to	O
both	O
the	O
obese	O
and	O
the	O
overweight	O
subjects	O
.	O

We	O
considered	O
infants	O
with	O
cord	O
25	O
(	O
OH	O
)	O
D	O
below	O
20	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
above	O
20	O
ng	O
/	O
mL	O
regardless	O
of	O
ethnicity	O
.	O

The	O
deleterious	O
effects	B
on	O
development	O
often	B
vary	B
in	B
accordance	I
to	O
nature	O
of	O
the	O
cause	O
and	O
period	O
of	O
exposure	O
to	O
adverse	O
factors	B
which	O
have	O
led	B
to	I
low	O
birth	O
weight	O
.	O

After	O
DNase	O
treatment	O
a	O
column	O
-	O
based	O
purification	O
using	O
the	O
RNeasy	O
Mini	O
Kit	O
(	O
Qiagen	O
,	O
Hilden	O
,	O
Germany	O
)	O
was	O
done	O
.	O

Weight	O
at	O
the	O
last	O
clinic	O
visit	O
was	O
objectively	O
measured	O
using	O
a	O
calibrated	O
digital	O
or	O
balance	O
beam	O
scale	O
by	O
research	O
assistant	O
or	O
clinic	O
staff	O
.	O

Progesterone	O
Measures	O
Circulating	O
progesterone	O
concentrations	O
were	O
measured	O
in	O
adult	O
female	O
offspring	O
in	O
the	O
proestrous	O
stage	O
.	O

